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As for other organs, nuclear magnetic resonance (NMR) of skeletal muscle can be repeated 
as many times as needed, making it perfectly suited for a non-invasive longitudinal monitoring of 
neuromuscular patients during clinical trials. The aim of the thesis is to investigate the sensitivity of 
novel NMR outcome measures (OM) aiming to quantify pathological changes in the dystrophic 
muscle. Muscular dystrophy (MD) refers to a heterogeneous group of diseases with progressive 
muscle wasting and associated weakness characterized by variable degrees of necrosis, regeneration, 
ionic homeostasis disturbances, chronic inflammation, and, ultimately, resulting in the replacement 
of muscles by fibro-fatty tissue. My focus was on the evaluation of 23Na NMR and advanced 1H 
transverse relaxation time (T2) techniques as early, sensitive OM. 23Na NMR measures the tightly 
controlled sodium concentrations and distribution in skeletal muscle tissue. This biophysical 
information can be used to assess ion homeostasis and cell integrity. However, 23Na NMR suffers 
from a low sensitivity and in vivo concentration compared to 1H. Alterations in the muscle 1H T2, 
commonly interpreted as an indicator of disease activity, are linked to a variety of non-specific events 
like oedema, inflammation, or necrosis that precede the actual muscle replacement by fat.  
Protocols including different 23Na NMR and 1H T2 methods were implemented to evaluate 
healthy and dystrophic skeletal muscle tissues of animal models and patients. First, a non-localized 
23Na NMR protocol was developed in order to reduce the usually long acquisition times of 23Na NMR 
and it was validated on healthy subjects under different vascular filling conditions. The 23Na NMR 
approach was more sensitive than standard global 1H T2 to monitor acute changes in extracellular 
volume fractions of the leg. Our 23Na NMR protocol permits the monitoring of total and intracellular 
weighted 23Na signal in less than 15 minutes. In the context of MD, these OM offer novel options to 
investigate ion channel/transporter impairments, membrane integrity, or even, indirectly, fibrosis 
formation. 
Murine models represent a valuable tool to study the pathological progress of MD and to test 
possible therapeutic interventions. Additionally, the specificity of NMR techniques to monitor certain 
pathologies can be validated on well-described murine models. Here, a new murine model for 
dysferlinopathy named MMex38 was characterized by standard NMR techniques. Severity of disease 
activity and progression was reflected by the significant fatty replacement, showing for the first time 




the 23Na and 1H T2 OM demonstrated hydro-ionic homeostasis disturbances in different murine MD 
models.  
In a natural history study on Duchenne muscular dystrophy (DMD) patients in Erlangen, 
different NMR imaging and spectroscopy methods were combined to evaluate their sensitivity to 
monitor the pathological processes of MD at an early stage of the disease. We demonstrated that 
DMD patients exhibit elevated total sodium concentrations and 23Na intracellular weighted signal as 
well as water T2 at the early disease stage preceding the fibro-fatty infiltration. Intracellular sodium 
accumulations did not systematically parallel water T2 increases. This work provides evidence that 
23Na NMR could offer a sensitive outcome measure able to monitor specific alteration of the 




Wie bei anderen Organen kann die Magnetresonanztomographie (MRT) der 
Skelettmuskulatur so oft wie nötig wiederholt werden, da keine ionisierende Strahlung eingesetzt 
wird. Aufgrund dieser Eigenschaft ist sie perfekt für eine nicht-invasive longitudinale Überwachung 
neuromuskulärer Patienten im Rahmen von klinischen Studien geeignet. Ziel meiner Dissertation war 
es, die Sensitivität neuer MRT-basierter Biomarker zur Quantifizierung pathologischer 
Veränderungen im dystrophischen Muskel zu untersuchen. Muskeldystrophie (MD) beschreibt eine 
heterogene Gruppe von Krankheiten mit progressivem Muskelschwund und Muskelschwäche, die 
durch unterschiedlichen Grad an Nekrose, Regeneration, Ionenhaushaltstörungen, chronischer 
Entzündung und schließlich Fett- und Bindegewebs-einlagerungen im Muskel charakterisiert wird. 
Mein Schwerpunkt lag auf der Evaluierung von 23Na MRT Messungen und Messungen der 
transversalen 1H Relaxationszeit (T2) als sensitive und frühe Biomarker. Mittels 23Na MRT kann die 
streng regulierte Natriumkonzentration und ihre Verteilung im Muskelgewebe untersucht werden. 
Diese biophysikalischen Informationen können verwendet werden, um den Ionenhaushalt und die 
Zellintegrität zu bewerten. Allerdings wird 23Na MRT durch eine geringere Sensitivität und in-vivo-
Konzentration der Natriumionen im Vergleich zu 1H MRT beeinträchtigt. Veränderungen der 1H T2-
Zeit im Muskel, die gemeinhin als Indikator für die Krankheitsaktivität der Muskeldystrophie 
interpretiert werden, sind mit einer Vielzahl von unspezifischen Ereignissen wie Ödemen, 
Entzündungen oder Nekrose verbunden, die dem tatsächlichen Ersatz von Muskel- durch Fettgewebe 
vorausgehen. 
In dieser Arbeit wurden Protokolle mit verschiedenen 23Na-MRT- und 1H-T2-Methoden 
implementiert, um gesundes und dystrophisches Skelettmuskelgewebe von Tiermodellen und 
Patienten zu bewerten. Zunächst wurde ein nicht-lokalisiertes 23Na MRT-Protokoll entwickelt, um die 
meist langen Aufnahmezeiten der 23Na MRT zu reduzieren. Dieses Protokoll wurde bei gesunden 
Probanden unter verschiedenen Gefäßfüllbedingungen validiert. Der 23Na MRT-Ansatz erwies sich als 
sensibler und somit als geeigneter zur Überwachung akuter Veränderungen des extrazellulären 
Volumenanteils des Beins als die Standard 1H T2-Messungen. Unser 23Na MRT-Protokoll erlaubt die 
Überwachung des gesamten und intrazellulär gewichteten 23Na-Signals in weniger als 15 Minuten. Im 
Zusammenhang mit MD bieten diese Biomarker neuartige Möglichkeiten, Beeinträchtigungen der 





Mausmodelle stellen einen wertvollen Modellorganismus dar, um den pathologischen 
Fortschritt von MD zu untersuchen und mögliche therapeutische Interventionen zu prüfen. Darüber 
hinaus kann die Spezifität von MRT-Techniken zur Überwachung bestimmter Pathologien mittels gut 
beschriebener Mausmodelle validiert werden. Hier wurde ein neues Mausmodell für 
Dysferlinopathie namens MMex38 durch Standard-MRT-Techniken charakterisiert. Der Schweregrad 
der Erkrankungsaktivität und des -fortschrittes wurde durch die signifikante Fettinfiltration 
reflektiert. Dies zeigte zum ersten Mal in Mäusen Ähnlichkeiten mit dem Phänotyp, der bei 
Menschen beschrieben wird. Ein umfassendes Protokoll mit 23Na MRT und 1H T2-basierenden 
Biomarkern zeigte zusätzlich hydroionische Haushaltsstörungen in verschiedenen Mausmodellen für 
MD. 
Für eine Verlaufsstudie bei Patienten mit Duchenne Muskeldystrophie (DMD) in Erlangen 
wurden verschiedene MRT-Bildgebungs- und Spektroskopiemethoden kombiniert, um deren 
Empfindlichkeit zur Überwachung der pathologischen Prozesse von MD in einem frühen Stadium der 
Erkrankung zu bewerten. Wir haben gezeigt, dass DMD Patienten erhöhte Gesamtnatrium-
konzentrationen und intrazellulär gewichtetes 23Na Signal, sowie Wasser T2 in der frühen Krankheits-
stufe vor der Fett- und Bindegewebsinfiltration aufweisen. Das intrazellulär gewichtete Natriumsignal 
war systematisch erhöht, auch bei normalen Wasser T2-Werten. Diese Arbeit lieferte Beweise dafür, 
dass 23Na MRT sensible Biomarker bieten könnte, die eine spezifische Veränderung des 




La résonance magnétique nucléaire (RMN) du muscle squelettique est parfaitement adaptée 
à une surveillance longitudinale des patients atteints de maladies neuromusculaires. Le but de la 
thèse était d'étudier la sensibilité de nouveaux biomarqueurs RMN visant à quantifier les 
changements pathologiques dans le muscle dystrophique. La dystrophie musculaire (DM) désigne un 
groupe hétérogène de maladies avec une atrophie musculaire progressive associée à un état de 
faiblesse. Elle est caractérisée par des degrés variables de nécrose, de régénération, de troubles de 
l'homéostasie ionique, d'inflammation chronique et finalement par le remplacement des muscles par 
du tissu fibro-graisseux. Mon objectif était d’évaluer la RMN du 23Na et les techniques avancées de 
mesure du temps de relaxation transversal 1H (T2) en tant que des biomarqueurs sensibles et 
précoces. La RMN du 23Na mesure les concentrations de sodium étroitement contrôlées et donne sa 
distribution dans le tissu. Cette information peut être utilisée pour évaluer l'homéostasie ionique et 
l'intégrité cellulaire. Cependant, la concentration in vivo en 23Na est faible, la RMN du 23Na souffre 
donc d'une faible sensibilité par rapport à 1H. L’altération du T2 1H du muscle, communément 
interprétée comme un indicateur de l'activité de la maladie, est liée à une variété d’événements non-
spécifiques tels que l'œdème, l'inflammation ou la nécrose, qui précèdent le remplacement 
musculaire par la graisse. 
Des protocoles comprenant diverses méthodes de RMN du 23Na et de 1H T2 ont été mis en 
œuvre pour évaluer les tissus musculaires squelettiques sains et dystrophiques sur des modèles 
animaux et sur patients. Tout d'abord, un protocole de RMN du 23Na non localisé a été développé 
afin de réduire les temps d'acquisition habituellement longs de la RMN du 23Na. Ce protocole a été 
validé sur des sujets sains sous différentes conditions de remplissage vasculaire. L'approche de la 
RMN du 23Na était plus sensible que celle du 1H T2 standard pour surveiller les changements aigus 
importants dans les fractions de volume extracellulaire de la jambe. Notre protocole de RMN du 23Na 
permet la surveillance du signal de 23Na total et intracellulaire pondéré en moins de 15 minutes. Ces 
biomarqueurs offrent de nouvelles options pour étudier les altérations des canaux 
ioniques/transporteurs, l'intégrité de la membrane ou même, indirectement, la formation de fibrose. 
Les modèles murins représentent un outil précieux pour étudier l’avancée pathologique de la 
maladie. De plus, la spécificité des techniques de RMN pour le suivi de certaines pathologies peut 
être validée sur des modèles murins bien décrits. Ici, un nouveau modèle murin de dysferlinopathie 




maladie et sa progression ont été reflétées par un remplacement graisseux significatif, montrant 
pour la première fois chez la souris une certaine similitude avec le phénotype observé chez l'homme. 
Un protocole complet comprenant les biomarqueurs de 23Na et 1H T2 a démontré des perturbations 
de l'homéostasie hydro-ionique pour différents modèles murins de MD. 
Dans une étude d'histoire naturelle sur des patients atteints de dystrophie musculaire de 
Duchenne (DMD) réalisée à Erlangen, différentes méthodes d'imagerie et de spectroscopie ont été 
combinées pour évaluer leur sensibilité dans la surveillance de processus pathologiques à un stade 
précoce de la maladie. Ces patients présentaient des concentrations élevées de sodium total et un 
signal pondéré intracellulaire de 23Na élevé ainsi que de 1H T2 élevé au stade précoce de la maladie 
précédant l'infiltration fibro-grasseuse. Les accumulations de sodium intracellulaire ne sont pas 
systématiquement parallèles aux augmentations du 1H T2. Ce travail fournit des preuves que la RMN 
du 23Na pourrait offrir un biomarqueur sensible capable de surveiller l'altération spécifique du 
muscle dystrophique à un stade très précoce. 
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Résumé extensif : Caractérisation du 
muscle dystrophique par RMN du 
23Na et spectres RMN du T2 du 1H 
 
Introduction générale 
La dystrophie musculaire (DM) désigne un groupe hétérogène de maladies neuromusculaires 
qui se caractérisent par une dégénérescence du tissu musculaire se traduisant par une atrophie du 
muscle et une perte de force. Cela peut provoquer dès l’enfance des difficultés pour marcher ou se 
servir de ses bras ou de ses mains. La Dystrophie Musculaire de Duchenne (DMD) est un exemple 
connu de myopathie causée par une mutation du gène codant la protéine dystrophine. Les fibres 
musculaires détruites sont progressivement remplacées par de la graisse et du tissu conjonctif, 
provoquant une perte totale de l’ambulation au cours de l’adolescence. Ces patients meurent avant 
d’atteindre l’âge adulte, généralement à cause d’insuffisance respiratoire ou cardiaque. Bien que 
cette maladie soit rare, elle touche tout de même un garçon sur 3500.  
L’imagerie par Résonance Magnétique Nucléaire (RMN) est généralement utilisée pour le 
suivi longitudinal de la pathologie et dans l’évaluation de traitement car elle permet de réaliser des 
examens atraumatiques et non ionisants. Les progrès méthodologiques et instrumentaux réalisés en 
RMN au cours des trois dernières décennies ont été considérables. Ce passage d’une imagerie 
contemplative (localisation et détermination de la taille apparente d’une lésion) à une imagerie 
quantitative (extraction de paramètres caractérisant le degré physiopathologique de la lésion) a 
permis d’améliorer considérablement le suivi clinique, mais nécessite de définir des biomarqueurs 
quantitatifs. Trois indicateurs de RMN sont couramment intégrés dans les protocoles de recherche 
clinique : le volume musculaire contractile, le pourcentage de graisse intramusculaire et le temps de 
relaxation transversal (T2) de l’eau musculaire. Ils permettent de quantifier respectivement la 
trophicité du muscle, les dégénérescences graisseuses chroniques et l’œdème tissulaire. Le 
pourcentage de graisse est un biomarqueur important chez les patients, mais il caractérise un 
processus chronique tardif et irréversible. Le T2 de l’eau est un marqueur plus précoce de l’activité de 
la maladie, mais il est non spécifique et peut refléter de l’inflammation, de la nécrose, une 
dénervation...  
Résumé extensif  
 
xii 
De nombreux efforts sont réalisés pour développer des biomarqueurs de processus 
spécifiques et plus précoces. Les infiltrations graisseuses sont généralement précédées par une 
altération métabolique incluant des redistributions ioniques et un cycle de nécroses et de 
réparations. Pour cela, la RMN du sodium (23Na) et les spectres RMN du proton (1H) représentent des 
outils d’évaluation prometteurs car ils permettent de quantifier des paramètres dont les valeurs sont 
modifiées dès le début de la pathologie. Des dizaines d’études cliniques ont pour objectif de 
développer des médicaments pour guérir les maladies neuromusculaires ou du moins ralentir leur 
progression. Le développement de ces outils d’évaluation permettrait non seulement la 
quantification des effets des traitements, mais aussi de mener des études plus fondamentales visant 
à comprendre les mécanismes sous-jacents des myopathies. Dans ce contexte, les spectres du 23Na et 
du 1H, représentant des biomarqueurs plus spécifiques, méritent d’être davantage explorés.    
Etat de l’art 
L’ion sodium (Na+) joue un rôle fondamental dans la physiologie du corps humain, est 
impliqué dans un grand nombre de fonctions au niveau cellulaire, et produit, après le 1H, le signal 
RMN le plus important parmi les atomes biologiques d’intérêt. La RMN du 23Na est donc considérée 
depuis de nombreuses années comme un complément attrayant à la RMN du 1H pour la détection et 
l'évaluation de plusieurs anomalies physiologiques. Depuis les années 1970, des équipes ont 
développé des séquences de spectroscopie et d’imagerie, et des développements sont actuellement 
réalisés afin de les appliquer dans des protocoles cliniques.  
L’ion Na+ est important dans le maintien de l'osmolalité plasmatique, il influe sur les 
phénomènes de contraction-dilatation du volume cellulaire. À l'extérieur de la cellule, la 
concentration en Na+ est 10 fois plus importante qu'à l'intérieur de la cellule, ce qui contribue à la 
différence de potentiel électrique entre l'intérieur et l'extérieur. Il y a un influx entrant d’ions Na+ 
passif d‘un point de vue énergétique. Par contre, il existe aussi un autre flux inverse, qui compense le 
flux passif des ions Na+. Ce flux inverse est entretenu par la pompe sodium-potassium 
consommatrice d'énergie. La pompe à sodium permet donc de rejeter les ions Na+ en dehors de la 
cellule pour maintenir constant le gradient de concentration. Les modifications de la concentration 
en sodium intracellulaire sont généralement causées par des pathologies altérant la 
fonction/intégrité des cellules, ou alors responsables d'altérations métaboliques, ce qui est le cas de 
nombreuses DM. Chez les patients atteints de Dystrophie Musculaire de Duchenne par exemple, la 
concentration en sodium intracellulaire peut être multipliée par trois ou quatre par rapport à un 
niveau normal. Tous ces changements métaboliques ont lieu avant le replacement graisseux du 
muscle squelettique. A la ligne pour la RMN du 23Na, la séparation des signaux intracellulaires et 
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extracellulaires est alors cruciale afin d’établir des biomarqueurs sensibles aux altérations 
métaboliques. Plusieurs techniques de RMN permettent de discriminer le signal du 23Na provenant 
des compartiments intracellulaires et extracellulaires.  
Les études les plus anciennes ont proposé de séparer le signal extracellulaire du signal 
intracellulaire grâce à des agents de contraste permettant de décaler la fréquence de résonance du 
sodium extracellulaire. Néanmoins, ces réactifs sont toxiques pour l’homme et ne peuvent être 
utilisés que sur des modèles animaux pour de la recherche fondamentale. Une autre méthode, 
applicable chez l’homme, consiste à profiter de la différence de temps de relaxation longitudinale 
entre les deux compartiments et à utiliser une séquence d’inversion-récupération avec un temps 
d’inversion permettant d’éliminer le signal provenant de l’un ou l’autre des compartiments. Le signal 
des ions Na+ peu mobiles peut être également recueilli grâce à des séquences de filtrage quantique. 
Ce signal provient de l’ensemble des ions proches ou liés à des macromolécules, et dans le contexte 
des DM, il pourrait représenter un paramètre intéressant pour caractériser l’intégrité des 
membranes cellulaires, mais aussi la formation de fibrose interstitielle.  
Récemment, grâce à l’augmentation des champs magnétiques des scanners de RMN 
cliniques, des séquences d’imagerie du sodium avec des résolutions spatiales de l’ordre de quelques 
millimètres cube ont été développées. Néanmoins, les temps d’acquisitions correspondants et les 
rapports signal-sur-bruit obtenus sur les images restent encore loin de ce qui peut être réalisé en 
proton. Pour les séquences les plus évoluées, il faut environ 10 minutes pour obtenir une image 
reflétant la concentration totale en sodium. Cette image correspond de plus à un mélange des 
signaux provenant de tous les compartiments. Afin d’obtenir une information relative à la bio-
distribution du sodium il faut également acquérir une deuxième séquence qui sera pondérée en 
signal intracellulaire  et dont le temps d’acquisition est généralement supérieur. Pour cela, nous 
proposons dans cette thèse un protocole spectroscopique, permettant de mesurer plusieurs 
paramètres relatifs à la bio-distribution du sodium et aux interactions avec les macromolécules avec 
un temps d’acquisition égal à celui nécessaire pour obtenir une seule image en sodium. 
D’autre part, la relaxation transversale T2 des protons de l’eau dans le muscle est déterminée 
majoritairement par la structure et la concentration en macromolécules, qui sont altérées par les 
processus d’inflammation et de nécrose, communément observés dans les DM. Les techniques de 
cartographies T2 permettent de détecter et de quantifier ces sites d’inflammation et de nécrose et 
sont caractérisés par une élévation du T2 global (mono-exponentiel) des protons de l’eau. 
Néanmoins, il est connu depuis de nombreuses années que la relaxation T2 du signal RMN du 1H est 
multi-exponentielle. Ce comportement est interprété comme une conséquence de la 
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compartimentation anatomique de l’eau tissulaire et les échanges dans les espaces intracellulaire, 
interstitiel et vasculaire. La séquence de spectroscopie CPMG permet d’acquérir des courbes de 
relaxation T2 avec une résolution temporelle et un rapport signal-sur-bruit suffisant pour une analyse 
multi-exponentielle robuste. Chez les sujets sains, l’extraction des spectres de T2 à partir des données 
CPMG permet de caractériser les différents compartiments par la valeur intrinsèque de leur T2 et 
leurs fractions relatives. Des études préliminaires menées chez des patients souffrant de maladies 
neuromusculaires ont montré que ces spectres T2 pouvaient être largement modifiés. 
Pour mieux comprendre les changements pathologiques, il serait donc très utile de combiner 
l’information de comportement obtenue par les spectres de T2 du 1H avec l’information sur la bio-
distribution du sodium mesurée par la RMN du 23Na. Bien que quelques études suggèrent déjà que 
certains paramètres métaboliques du 23Na peuvent être altérés dans les maladies neuromusculaires, 
aucun essai clinique multicentrique n'a pour l’instant été entrepris. Seules quelques études de 
faisabilité ont été rapportées au niveau du muscle squelettique concernant les maladies musculaires 
et l'exercice.  
Objectif 
L’objectif de ce travail de thèse est la caractérisation du muscle squelettique par RMN dans le 
contexte des DM. Il s’agit de développer, d’optimiser des séquences de spectroscopie du 23Na et de 
les évaluer en combinaison avec des spectres RMN du T2 du 1H et des séquences standards tout en 
tenant compte des restrictions associées à la pratique clinique. Il faudra également démontrer 
l’utilité et la valeur ajoutée du sodium par rapport la RMN conventionnelle du 1H. 
Des protocoles comprenant différentes méthodes de RMN du 23Na et de 1H T2 ont été mis en 
œuvre pour évaluer les tissus musculaires squelettiques sains et dystrophiques de modèles animaux 
et de patients. Tout d'abord, un protocole de RMN du 23Na non localisé a été développé afin de 
réduire les temps d'acquisition habituellement longs pour la RMN du 23Na. Ce protocole a été validé 
sur des sujets sains sous différentes conditions de remplissage vasculaire. Au cours de cette étude, la 
valeur ajoutée de la RMN du 23Na a été démontrée par rapport aux séquences standards mesurant le 
T2 de l’eau.  
Par la suite, des protocoles de RMN du 23Na et du 1H ont été développés sur des modèles 
animaux afin de les caractériser. Les modèles murins représentent un outil précieux pour étudier 
l’avancée pathologique de la maladie et pour tester d'éventuelles interventions thérapeutiques. De 
plus, la spécificité des techniques de RMN pour le suivi de certaines pathologies peut être validée sur 
des modèles murins bien décrits. Ici, un nouveau modèle murin de dysferlinopathie nommé MMex38 
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a été caractérisé par des techniques de RMN standard. De plus, un protocole complet comprenant 
les biomarqueur de 23Na et 1H T2 a investigué des perturbations de l'homéostasie hydro-ionique de 
différents modèles murins de MD. 
Dans une étude d'histoire naturelle, réalisée à Erlangen chez des patients atteints de DMD, 
différentes méthodes d'imagerie et de spectroscopie ont été combinées pour évaluer leur sensibilité 
afin de surveiller les processus pathologiques de cette maladie à un stade précoce.  
Démarche expérimentale 
Le protocole de RMN du 23Na non localisé a été développé sur un scanner 3T corps entier 
avec une antenne linéaire 23Na optimisée pour la jambe. Le protocole (Figure R.1) consistait en une 
séquence de décroissance d'induction libre (FID), de triple filtrage quantique (TQF) et d'inversion-
récupération (IR-LL) pour un temps d'acquisition total de 14 minutes.  
Le signal FID correspond à la somme du sodium extra- et intracellulaire, il représente alors la 
concentration totale en sodium. La séquence de filtrage quantique a été utilisée pour mesurer la 
concentration des noyaux en mouvement restreint dans le tissu musculaire. Le rapport TQF/FID 
calculé comme un index reflétant les fractions relatives et les concentrations en 23Na des 
compartiments intracellulaire et proche des membranes, et extracellulaire.  
Nous avons aussi évalué les temps de relaxation longitudinale et transversale du 23Na. Des 
spectres T2* ont été obtenus à partir de la décroissance temporelle du signal de FID par une méthode 
de déconvolution. Ceci a permis de déterminer une fraction à T2* court du sodium ainsi que les 
valeurs des T2* courts et longs. Un temps de relaxation T1 global a été estimé à partir de la séquence 
IR-LL par un ajustement mono-exponentiel de la repousse du signal à différents moments après 
inversion de l'aimantation. 
Toutes ces séquences ont tout d’abord été appliquées sur fantômes (de l’eau avec des 
concentrations différentes de NaCl et d'agarose). Ensuite, des premières expériences in vivo ont été 
réalisées sur des volontaires sains. Ces tests ont validé les séquences développées pour des études 
plus sophistiquées. Le but de cette première étude était d'acquérir des spectres du sodium sur la 
jambe droite de volontaires dont le volume extracellulaire était modifié par compression avec une 
bande élastique (Figure R.2). Les séquences optimisées de RMN du 23Na (FID, TQF, IR-LL) ont été 
utilisées pour caractériser les fractions relatives et les concentrations en 23Na des compartiments 
intracellulaire, extracellulaire et proche des membranes au cours de ce paradigme de drainage 
vasculaire, remplissage vasculaire et retour à des conditions basales. 




Figure R.1: Chronogrammes des trois séquences 23Na utilisées (FID, TQF et IR-LL) avec un 
exemple de spectres obtenus ou d’évolution des signaux temporels.  
Des variations significatives de signaux FID, de signaux TQF, de rapports TQF/FID, de valeurs de 
T1 et de la fraction en T2* court ont été observées entre les trois conditions. Les signaux FID et les 
valeurs de T1 étaient augmentés au cours du remplissage vasculaire et diminués au cours du drainage 
par rapport aux conditions de contrôle, alors que la tendance inverse a été observée pour le T2* 
court, le rapport TQF/FID ainsi que le signal TQF. Le rapport TQF/FID a été l'indice le plus robuste et 
le plus sensible pour discriminer les trois conditions. Des corrélations significatives ont été mesurées 
entre T1 et le rapport TQF/FID et entre la fraction en T2* court et le rapport TQF/FID. Cette première 
étude a démontré que la spectroscopie RMN du 23Na, des indices sensibles aux changements de la 
bio-distribution du sodium et de l'interaction avec les macromolécules peuvent être acquis dans les 
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muscles squelettiques humains avec des temps d'acquisition compatibles avec l'investigation des 
patients dans un cadre de recherche clinique. 
Figure R.2: Graphe représentant le déroulement de l’étude dans laquelle le volume 
extracellulaire était modifié par compression avec une bande élastique (en haut à 
gauche) ; le protocole était: drainage vasculaire, puis remplissage vasculaire et 
finalement une condition de contrôle (en haut à droite) ; les changements de paramètres 
du 23Na entre des volumes extracellulaire différents sont également représentés. 
La sensibilité de ce protocole de RMN du 23Na a été comparée aux séquences plus standards 
de RMN du proton. L'approche de RMN du 23Na était plus sensible que celle du 1H T2 standard pour 
détecter les changements importants dans les fractions de volume extracellulaire de la jambe. Notre 
protocole de RMN du 23Na permet donc un suivi quantitatif du signal de 23Na total et pondéré 
intracellulaire en moins de 15 minutes. Dans le cadre de la MD, ces biomarqueurs offrent de 
nouvelles options pour étudier les altérations des canaux ioniques/transporteurs, l'intégrité de la 
membrane ou même, indirectement, la formation de fibrose. 
Au cours de ce travail de thèse, j’ai également géré un projet d’imagerie RMN en collaboration 
avec l’ECRC à Berlin où a été développé un nouveau modèle murin de dysferlinopathie. Les 
dysferlinopathie sont des dystrophies musculaires récessives dues à des mutations dans le gène de la 
dysferline, une protéine transmembranaire impliquée dans la réparation des membranes. Ce 
nouveau modèle murin de dysferlinopathie, nommé MMex38, a été étudié par RMN du 1H sur un 
scanner préclinique 7T. Pour faire cela, j’ai paramétré des séquences comprenant de l’imagerie 
anatomique, des cartographies T2 et T1 ainsi que de la spectroscopie localisée du 1H (PRESS). Le 
muscle malade du modèle murin de dysferlinopathie a été étudié et comparé avec des muscles de 
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souris saines et avec un deuxième modèle de Dysferlinopathie plus établi nommé BLAJ. À ma 
connaissance, cette étude a été la première description complète d'un modèle murin de 
dysferlinopathie par différentes modalités de RMN. La coloration au Oil Red O et la microscopie 
électronique ont déjà révélé des accumulations lipidiques significatives au sein des myofibres de 
souris déficientes en dysferline. Cette importante infiltration graisseuse, plus prononcée dans les 
muscles proximaux que dans les muscles distaux, a été confirmée par l'augmentation des taux de 
graisse mesuré par RMN. La sévérité de l'activité de la maladie et sa progression ont été reflétées par 
un remplacement graisseux significatif, montrant pour la première fois chez la souris une certaine 
similitude avec le phénotype observé chez l'homme (Figure R.3). Notre description du modèle 
confirme ainsi la pertinence du modèle MMex38 pour imiter l'activité de la maladie et la progression 
de LGMD 2B humaine (Myopathie des ceintures avec déficit en dysferline). Ceci est en contraste avec 
d'autres modèles dystrophiques murins comme le mdx, un modèle de la myopathie de Duchenne, 
qui ne parviennent pas à reproduire l'importante altération de la trophicité musculaire présente chez 
les patients humains. 
 
Figure R.3: Images 1H représentant les cuisses d’une souris saine (wild-type), du nouveau 
modèle murin de dysferlinopathie, MMex38, et du modèle de Dysferlinopathie plus 
établis, BLAJ. 
En complément, des souris MMex38 saines et des souris mdx ont été étudiées avec un 
protocole complet comprenant les biomarqueurs de 23Na et 1H T2. Nous avons observé des 
perturbations de l'homéostasie hydro-ionique chez les différents modèles murins de MD. Les indices 
RMN du 23Na étaient sensibles pour distinguer le muscle dystrophique du tissu musculaire 
squelettique sain. Alors que les souris MMex38 ont montré une augmentation du T1 du sodium et 
une diminution de TQF/FID, les souris mdx ont montré une augmentation du rapport TQF/FID avec 
un T1 du sodium inchangé. Ceci pourrait refléter différents processus physiopathologiques tels 
qu'une augmentation de la concentration de sodium intracellulaire et une redistribution de l'eau 
dans les différents compartiments tissulaires. Ce fut la première étude RMN du 23Na sur le muscle 
dystrophique murin. Le deuxième paramètre de validation était d’obtenir/de mesurer les spectres de 
T2 à partir de la séquence ISIS-CPMG. Une augmentation du T2 court a été observée chez les souris 
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mdx par rapport aux souris saines, ce qui pourrait être expliqué par une augmentation de l'eau dans 
le compartiment extravasculaire avec des fractions relatives constantes. La même tendance a été 
observée par la suite chez les patients dystrophiques (voir ci-dessous). Ces résultats encourageants 
nous incitent à une corrélation systématique des images RMN aves des coupes histologiques afin de 
comprendre les processus physiopathologiques responsables de ces variations. Ainsi, les spectres 1H 
T2 et les indices RMN du 23Na se sont avérés sensibles pour détecter les changements dans le muscle 
dystrophique dans une petite cohorte. 
 
Figure R.4: Cartographies A) du T2 du 1H, B) de la concentration totale en sodium, et C) 
du signal de sodium pondéré intracellulaire au niveau de la jambe de deux garçons 
atteints de DMD. Alors que les cartes de T2 du 1H et la concentration totale en sodium 
présentent les muscles avec des valeurs normales, les signaux de sodium pondérés 
intracellulaire sont élevés.  
Enfin, j'ai démontré l'utilité de la RMN du 23Na dans un contexte clinique. Weber et al. ont déjà 
démontré que la concentration de Na+ musculaire, détectée par RMN chez les garçons atteints de 
DMD, était augmentée et restait élevée lors d'un réexamen par rapport à des témoins sains. Sur la 
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base de ces expériences préliminaires, nous avons en outre voulu étudier le potentiel de la RMN du 
23Na pour servir de biomarqueur précoce et sensible dans les DM. Dans une étude d'histoire 
naturelle sur les patients atteints de DMD réalisée à Erlangen, différentes séquences d'imagerie et de 
spectroscopie ont été acquises pour évaluer leur sensibilité afin de suivre les processus 
pathologiques de la MD à un stade précoce de la maladie. Nous avons démontré que les patients 
atteints de DMD présentaient des concentrations élevées en sodium total mais aussi que le signal 
pondéré intracellulaire de 23Na ainsi que du T2 d’eau au stade précoce de la maladie précédant 
l'infiltration fibro-grasseuse. Les accumulations de sodium intracellulaire ne sont cependant pas 
systématiquement parallèles aux augmentations du T2 d’eau. Certains muscles relativement 
épargnés, comme le tibial antérieur, présentaient tout de même une augmentation de la 
concentration totale en sodium et un signal sodium pondéré intracellulaire chez les patients atteints 
de DMD. Alors que nous avons trouvé une bonne corrélation entre le T2 de l’eau et la concentration 
totale en sodium, ce qui pourrait refléter des changements œdémateux, le signal de sodium pondéré 
intracellulaire s'est également révélé élevé en présence du T2 d’eau normale (Figure R.4). Ainsi, le 
signal de sodium pondéré intracellulaire est très probablement un biomarqueur plus sensible que la 
concentration totale en sodium ou le T2 de l’eau pour détecter les déséquilibres en Na+. 
Aujourd'hui, l’utilisation de la RMN du 23Na lors d’examens cliniques reste limitée en raison des 
coûts élevés, des longs temps d'acquisition ainsi que de sa complexité de mise en place. Ainsi, la 
question est de savoir si cela vaut la peine de d’étendre la RMN du 23Na au-delà du champ de 
recherche pour répondre au besoin d'un biomarqueur précoce et sensible. Ce serait le cas si la RMN 
du 23Na s'avère plus sensible à certains changements pathologiques que la RMN du 1H, fournissant 
des informations supplémentaires, qui ne peuvent être récupérées par d'autres méthodes. Mon 
travail fournit des preuves que le RMN du 23Na pourrait offrir une biomarqueur sensible capable de 











The general introduction addresses the need for non-invasive biomarkers that monitor 
disease progression and the response to the treatment. For that, I will introduce NMR as a non-
invasive tool for skeletal muscle characterization and its role to offer outcome measures in the field 
of muscular dystrophies. Finally, I will highlight the objective of the work and the structure of this 
manuscript.  
1.1 The role of nuclear magnetic resonance in establishing biomarkers for 
diseased muscles 
Muscular dystrophy (MD) refers to a group of hereditary diseases with progressive muscle 
weakness involvement and loss of muscle mass. Different genetic mutations lead to distinct forms of 
muscular dystrophy with a broad spectra of symptom’s severity. The most common type of MD in 
children is Duchenne muscular dystrophy (DMD) which alone affects about 1 in every 3,500 to 5,000 
born boys. The mutation in DMD patients leads to an increased permeability of the cell membrane, 
to chronic inflammation and ultimately to progressive muscle degeneration, where the muscle tissue 
is replaced by fatty and fibrotic tissue [1].  
Yet, there is no cure for any form of muscular dystrophy. Current medication and therapy 
manage the symptoms and at the most decelerate the disease progression. However, MDs have 
been recently receiving increasing attention and several programs have been launched at a (multi-) 
national level (see for example: https://www.afm-telethon.fr/guerir/traitements-638, 
http://treatnmd.ncl.ac.uk/, http://www.aktionbenniundco.de, http://www.parentprojectmd.org, 
https://www.jain-foundation.org/scientific-resources/therapeutic-strategies). Moreover, the 
progress of gene therapy and pharmacogenetics is on the edge to change the course of MD [2], [3]. 
In September 2016, the U.S. Food and Drug Administration conditionally approved the first exon-
skipping based drug, named eteplirsen, to treat DMD after a hot debate over its therapeutic effect. A 
response of the European Medicines Agency for conditional approval in the European Union is 
anticipated in the coming weeks. Because of these developments in the therapeutic field, new needs 
have emerged over the past years with the necessity to monitor muscle response to interventions. 
To date, the clinical investigation of muscular dystrophies commonly involves genetic, biochemical, 
and histopathological methods along with physical examinations. The gold standard for muscle 
evaluation is a muscle biopsy combined with molecular staining. This method is invasive and strongly 
site dependent as the sampled volume is small. In addition, strength and functional tests are 




for functional tests are the six-minute walk test, ten-meter walk/run, rise from floor, or grip test. A 
main drawback of these assessments is the dependency of patient’s motivation and ability, which can 
represent a challenge for children and patients at a later stage of disease. Further, these methods are 
also in parts biased by the investigator/physician/physiotherapist. Thus, there is a need for non-
invasive biomarkers that can provide reliable and sequential information about the disease 
progression monitoring natural disease progression and response to treatment. 
Muscle-imaging techniques are non-invasive tools that can complement the physical 
examinations as well as expand our understanding of the pathophysiological evolution. Imaging tools 
in medicine have been developed for more than one century, which led to the application of many 
advanced imaging techniques. At the beginning, they have been exploited to anatomically investigate 
the structure of the human body (X-ray, ultrasound and NMR imaging). Nowadays, they can be 
additionally used to analyse the function and metabolism of organs in vivo in a non-invasive manner 
(NMR spectroscopy, functional NMR imaging, Ultrasound Doppler, and nuclear imaging e.g. positron 
emission tomography and single photon emission computed tomography). In the 1980s, ultrasound 
has been for example reported to detect the pathological changes in dystrophic muscle and also to 
guide muscle biopsies [4]. Although this technique is easily accessible and inexpensive compared to 
other imaging tools, US is highly operator-dependent and the visualization of deeper muscles 
embodies another limitation. In addition, X-ray computed tomography (CT) was used to study the 
dystrophic muscle and the disease related intramuscular fat infiltration [5]. This technique is not 
operator dependent and enables an improved view of deeper muscles, but the applied radiation 
potentially damages body cells.  
Over the last two decades, NMR has become an important non-invasive tool for studying the 
muscle structure and composition. Radiologists successfully and frequently use NMR for clinical 
investigation of soft tissue. In the field of muscle research, NMR has replaced CT for several reasons. 
First, NMR has a higher sensitivity than CT for early fat infiltration in muscles and offers an improved 
view of anatomical details in soft tissue. Another benefit of nuclear magnetic resonance is the 
absence of ionizing radiation. Additionally, it enables multi-planar scanning, which is of importance 
for patients who are not able to stay in the desired position during the scan. The on-going research in 
the NMR field has accelerated the clinical use and the development of biomarkers to investigate 
disease progression and response to treatment. These days, NMR is applied for several purposes in 
muscle related areas e.g. measurement of diffusion, skeletal-muscle perfusion, blood flow, and 
tumour metabolism [6]–[8]. 
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Recently, various NMR techniques have been developed and applied to examine muscular 
dystrophies [9]. Imaging tools allow the quantification of muscle wasting and its processes of muscle 
degradation including inflammation and fat infiltration. A variety of NMR methods can be employed 
to identify affected muscle groups, to quantify the severity of muscle wasting, and to visualize the 
microstructure of the tissue by assessing the diffusion properties [10].  
To date, some quantitative NMR techniques made it already into clinical trials fulfilling the 
prerequisites to be used as quantitative reliable outcome measures [9]. The three established 
outcome measures, which have been used to provide information about disease progression and to 
monitor the treatment response, are:  
- Muscle trophicity by measuring either muscle surface or volume 
- Fat infiltration (chronic degeneration) by quantifying the percentage of fat signal in 
the affected muscles 
- Disease activity by measuring the transverse relaxation time (T2) of the affected 
muscles 
Several clinical studies on muscular dystrophies employed these outcome measures (3.4.1). 
The NMR outcome measures correlate well with the functional tests and can provide complementary 
information about the cause of decreased muscle strength. The imaging approach also has been 
proven to better detect and monitor the effect of therapy when compared to motor function 
measure [11]. Nevertheless, the assessment of the fat infiltration might not be a predictive marker of 
the disease evolution. The disease progression can be highly heterogeneous between patients as well 
as in an individual patient, which hinders the establishment of a biomarker based solely on the fat 
quantification. Another NMR contrast is the tissue T2 reflecting the motility of the water protons in 
the tissue. Changes in the tissue T2 occur during pathological processes including inflammation, 
necrosis, or oedema. Thus, water T2 can serve as a sensitive biomarker for pathological alterations 
that precede the actual muscle replacement by fat. In DMD, the muscle water T2 is very sensitive to 
the steroid treatment. Yet, water T2 values almost normalize with steroid treatment, which is the 
standard treatment against the chronic inflammation in DMD [12]. Therefore, any beneficial effects 
of other treatments like exon-skipping could occur unnoticed in steroid-treated patients. 
Thus, the research focus lies on the identification of NMR outcome measures that are more 
specific to physiological or biochemical changes. Ideally, they can serve as predictive and sensitive 
biomarkers at early disease evolution, possibly preceding any macroscopic degenerative changes in 
muscle tissue. In this manner, other potential biomarkers of disease activity in MD patients have 




pathophysiological relevant cellular changes in patients such as energy metabolism and tissue pH 
alterations. Since biochemical changes commonly precede morphological and functional alterations, 
31P NMRS presents itself as a promising tool for an early evaluation of muscle dystrophies. The 
muscles of DMD patients possess a leaky membrane leading to an altered ion distribution. Other 
neuromuscular diseases are related to mutations in genes of ion channel proteins. Advanced nuclear 
magnetic resonance sequences such as sodium (23Na) NMR could track these alterations in the ion 
distribution [13].   
To conclude, NMR is becoming more important in the field of muscular dystrophies. It has 
the potential to assess muscle wasting and to measure changes in the muscle properties even in 
early stages of muscular dystrophies. It thus holds a promise to clarify functional and metabolic 
alterations in healthy and diseased state. However, further investigations still need to establish NMR 
applications as indispensable biomarkers in clinic that complement current outcome measures to 
track disease progression and therapy efficacy. 
1.2 Thesis objectives 
The aim of the thesis is to investigate the dystrophic muscle using different NMR techniques. 
I evaluated the potential of these NMR techniques in providing predictive and sensitive biomarkers 
for the evaluation of disease progression in MD. The thesis focuses on the evaluation of two different 
methods, 23Na NMR and advanced proton (1H) T2 techniques, which were applied to investigate 
healthy and dystrophic skeletal muscle tissue. Both, sodium concentration and T2 of water are 
sensitive to (patho-) physiological changes in skeletal muscle tissue. On one hand, 23Na NMR 
quantifies the sodium content and distribution in skeletal muscle tissue. On the other hand, methods 
measuring the 1H T2 are commonly used to highlight and quantify sites of inflammation, oedema, and 
necrosis – or more generally the disease activity.  
 Sodium (Na+) is an essential component in the maintenance of the body homeostasis and in 
the transmembrane electrochemical gradient. Changes in the Na+ gradient across the cell membrane 
indicate a pathological process such as an increased intracellular sodium concentration resulting in 
cell swelling and eventually cell death. Thus, 23Na NMR helps to assess directly and quantitatively 
new metabolic information about the cell viability and provides important information 
complementary to the standard 1H NMR imaging (NMRI). The first developments of 23Na NMR 
already dates back to the late 70s with a recent increased attention in the past years. In DMD among 
other diseases, 23Na NMRI detected increased muscular Na+ concentration compared to healthy age-
matched controls [14]. Nevertheless, 23Na NMR is not a clinical tool due to several limitations that 
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lead to a low signal to noise ratio (SNR) and thus long acquisition times. Additionally, the extracellular 
sodium signal cannot be separated unambiguously from the intracellular sodium signal without the 
help of toxic shift reagents. In order to add 23Na NMR to clinical examination protocols, short 
acquisition times are crucial. Thus, we tested the feasibility and sensitivity of the spectroscopy 
approach leading to much shorter acquisition times than with imaging sequences.  
 In contrast to 23Na NMR, proton T2 is much more frequently employed for the non-invasive 
muscle tissue characterization. As aforementioned, 1H T2 is used to investigate the progressive 
destruction of muscle tissues in DMD since it is a sensitive biomarker of the inflammatory, necrotic, 
and oedematous processes. The oedema-like muscular changes increase 1H T2 values. This process 
can be osmotically and mainly intracellular driven. As the sodium ion is a main player in the water 
balance, it is of great interest to compare alterations in the 1H T2 with the 23Na NMR signal. Although 
1H T2 represents an intensively investigated NMR biomarker, one important consideration of the 1H 
T2 measurement remains the origin of the signal. It is a non-specific marker affected by different 
underlying (patho-) physiological events. Furthermore, global T2 measurements are biased by the 
presence of fat infiltration in the muscle. This bias can be very important in the dystrophic muscle 
tissue. Thus, a significant presence of fat can completely mask such events as inflammation or 
oedema in case of global T2 measurement. Different methods exist to extract the muscle water T2, 
including more sophisticated fitting approaches like bi-component extended phase graph (EPG) [15] 
or tri-exponential models [16]. Besides, a localized spectroscopy approach, namely ISIS-CPMG (image 
selected in vivo spectroscopy Carr-Purcell-Meiboom-Gill method) [17], provides T2 spectra allowing 
to investigate the multi-component 1H T2 relaxation behaviour in skeletal muscle.  
Given that the focus of the thesis is on identification and evaluation of new NMR outcome 
measures, 23Na NMR methods to investigate cellular function were combined with advanced 1H T2 
techniques to examine the muscle composition. During this work, protocols including different 23Na 
NMR methods and 1H T2 quantification approaches were applied to study first the healthy skeletal 
muscle and then the dystrophic muscle of animal models and patients. Ultimately, this work also 
aimed to establish reference data for MDs and to provide a basis for the development of 23Na-based 





1.3 Structure of the thesis 
The manuscript consists of three parts: The first part provides a deeper theoretical 
background to understand the pathological processes in the dystrophic muscle and the applied NMR 
methods (Chapter 2 and 3). The second part presents the results of the investigations I performed in 
humans and mice (Chapter 4-7). Finally, I summarize and discuss the main contributions to the 
scientific field (Chapter 8). 
Chapter 2 comprises of a theoretical part about skeletal muscle tissue and introduces the 
architecture of muscle as well as MD and their underlying pathophysiology. It highlights the 
important role of the sodium ion in human’s metabolism as well as associated alterations in MD. 
Chapter 3 is a theoretical chapter on NMR imaging and spectroscopy including the basic 
concepts of nuclear magnetic resonance. It also illustrates some important approaches for sodium 
assessment including inversion recovery and multiple quantum filters. Finally, the focus lies on the 
application of NMR as outcome measure to study the pathological processes in dystrophic muscles 
and on initial 23Na NMR studies to monitor changes in the homeostasis in MD patients.   
The second part describes the different experiments, which I performed on the clinical and 
on the preclinical NMR scanners at Institute of Myology in Paris. Additionally, I worked on a clinical 
NMR scanner at the University Hospital Erlangen in collaboration with its Radiology Department.  
Chapter 4 illustrates the NMR sequences that have been implemented in different protocols 
during the thesis work. In particularly, it explains two different methods for fast 23Na NMR acquisition 
in skeletal muscle tissue. First, we combined three different non-localized 23Na NMR sequences to 
establish a short protocol for lower leg tissue characterization. Additionally, a fast sodium imaging 
method, developed by Armin Nagel [18], is introduced that was later used in the DMD clinical study.  
Chapter 5 comprises four different studies using non-localized 23Na NMR sequences to 
characterize the skeletal muscle tissue at rest and during different vascular filling conditions. This 
chapter describes also an approach to quantify the non-localized 23Na NMR signals. These studies can 
be seen as feasibility and evaluation tests towards the development of sensitive 23Na-based NMR 
outcome measures of disease progression. The first study presented in this chapter was published in 
the Physiological Reports Journal (Gerhalter et al. 2017 Acute changes in extracellular volume 
fraction in skeletal muscle monitored by 23Na NMR spectroscopy) [19]. Other results are the object of 
five proceedings contributions (Marty et al. 2015 ISMRM, Gerhalter et al. 2015 ESMRMB, Gerhalter 
et al. 2016 Myology, Gerhalter et al. 2016 ESMRMB, Gerhalter et al. 2017 ESMRMB). 
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In chapter 6, the murine dystrophic muscles of different MD models were characterized by 
23Na, 31P, and 1H NMR methods. On one hand, a new murine model for dysferlinopathy named 
MMex38 was characterized for the first time by standard 1H and 31P NMR techniques. The results 
were compared to an established and well-characterized murine model for dysferlinopathy (BLAJ). 
The preliminary results are the object of two proceedings contributions (Gerhalter et al. 2016 WMS, 
Gerhalter et al. 2016 SFM). Part of this NMR characterization study is in redaction to be submitted to 
the Metabolism - Experimental and Clinical Journal complemented by metabolomics data. Then, the 
proposed 23Na and 1H based NMR outcome measures were tested on MMex38 and mdx mice, which 
are the most common used animal model for DMD. 
Chapter 7 presents a natural history study on DMD patients in Erlangen. A dozen of young 
DMD patients and age-matched healthy controls underwent a quantitative characterization of their 
lower leg by 23Na and 1H NMR. The origin of NMR signal changes present in dystrophic muscle tissues 
was analysed by combining the different parameters. This study also evaluated the specificity of 23Na 
NMR biomarkers and their applicability in clinical studies. This study is still ongoing as we invite the 
patients to come back every six months for a longitudinal NMR examination. Nine DMD patients 
came so far for a second time, which allows a longitudinal examination of the disease progression. 
Hence, I evaluated with the second visit the short-term sensitivity of the 23Na-based outcome 
measure to the disease progression. This chapter comprises one paper in redaction and international 
proceedings contributions. A methodological paper is under preparation to be submitted to the 
Radiology Journal. Other results are the object of three accepted proceeding contributions (Gerhalter 
et al. 2018 ISMRM, Gerhalter et al. 2018 ISMRM workshop: MR Imaging of nX-Nuclei, and Gerhalter 
et al. 2018 ICNMD). 
Finally, chapter 8 briefly summarizes the work and methodological contributions of the 





A brief reminder on skeletal muscle 
This chapter deals first with the anatomy and architecture (2.1) and energy metabolism (2.2) 
of the skeletal muscle tissue followed by a description of the essential role of the sodium ion in 
muscle function and homeostasis (2.3). Then, the regeneration process upon muscle damage is 
explained (2.4). The final subchapter introduces the broad family of muscular dystrophies with a 
special focus on DMD and limb-girdle muscular dystrophy of type 2B (LGMD 2B) (2.5).  
2.1    Anatomy and architecture of skeletal muscle 
Skeletal muscle, smooth muscle, and cardiac muscle are the three main types of muscle 
tissues found in mammalians. Skeletal muscle has a striated pattern and tendons attach the tissue to 
the skeleton. The somatic nervous system controls voluntarily the contraction of the skeletal muscle 
fibres. They make up 40 to 50 % of the body mass in humans and more than 400 different sizes of 
skeletal muscle exist [20]. Skeletal muscles are indispensable for several physiological processes such 
as locomotion, maintenance of posture, and metabolic activity.  
 
Figure 1: Scheme of skeletal muscle and associated structures [21].  
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The skeletal muscle has a highly organized architecture; bundles of longitudinal fibres are 
arranged within a bundle structure (Figure 1). A dense network of blood vessels provides the muscle 
with nutrients and oxygen, whereas connective tissue layers provide support and protection to 
withstand external forces of contraction to the myofibres. Tens to hundreds muscle fibres, called 
fasciculus, form one muscle covered by a connective tissue layer known as epimysium. The fascicles 
are made up of many smaller bundles consisting of muscle cells (myofibres) and are held together by 
the connective tissue called perimysium. The perimysium provides a pathway to the veins and 
arteries and nerves through the muscle. The third connective tissue layer in the skeletal muscle 
called endomysium is located between the fibres. It ensheathes individual myofibres and provides a 
pathway for capillaries and motor neurons endings.  
Myofibres represent the cellular units of the skeletal muscle and they are organized in a 
linear and repetitive fashion for muscle contraction. The myofibres exhibit a distinctive banding 
pattern under the microscope originating from the arrangement of cytoskeletal elements (Figure 2). 
The main elements are myosin and actin, also known as thick and thin filaments, organized in a 
repetitive fashion parallel to each other and to the axis of the cell in the so-called sarcomere. Six 
actin filaments surround one myosin filament. Those two elements are crucial for the sarcomere 
shortening and muscle contraction. The sarcomere’s cytoskeleton is composed of transversal 
structures including the Z and M lines and longitudinal filaments that are parallel with the thick and 
thin filament. During muscle contraction, the myosin (thick filament) slides past the actin (thin 
filament) forming a sort of cross-bridge between the myosin head on the actin filament. 
 
Figure 2: Distinctive banding pattern of muscle myofibrils originating from the arrangement 
of actin and myosin filaments. Zoom-in from [20]. 
Myofibres are multinucleated cells surrounded by the sarcolemma (plasma membrane) and 
the basement membrane (layer of extracellular matrix). The basement membrane provides a scaffold 
for the myofibres and some components of this membrane play an active role in regenerative 
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process after injury. The sarcolemma represents a barrier limiting the myocytes intracellular 
environment to the extracellular space. The permeability of the sarcolemma to ions and other 
compounds plays an important role in the origin of electrical potential and in the metabolic activity 
(2.3). The rest of the cytoplasm of a single myofibre is densely packed with organelles of different 
cellular functions e.g. mitochondria for the energy production, sarcoplasmic reticulum for calcium 
storage and release, and Golgi apparatus for protein sorting among other structures. The myonuclei 
are usually located in the space between myofibres and the sarcolemma at the periphery of each 
myofibre. They are flattened post-mitotic nuclei, thus cannot divide. In addition, satellite cells (SC) 
are located between the basement membrane and the sarcolemma. The muscle SC possess the 
capacity to self-renew and are responsible for skeletal muscle growth and repair after injuries or in 
conditions of muscle wasting [22].  
Table 1: The four major classes of fibre and their phenotypes identified in mammalian muscle 
based on the MyHC composition. Note that IIb fibres are usually not found in human. MyHC, myosin 
heavy chain. Data extracted from [23].  
 
Muscle fibres can adapt their size as well as internal structure such as the number of 
mitochondria and extracellular surroundings (e.g. capillary density) to the metabolic activity [24]. 
Muscle fibres are classified by myosin ATPase activity at differing pH and different isoforms of the 
myosin heavy chain (MyHC), a part of the myosin protein that is involved in cross-bridge cycling and 
sarcomere shortening. In human muscles, three major isoforms of MyHC are expressed: fibre type I, 
IIa, and IIx (Table 1). Type I fibres are slow twitching oxidative fibres with a slow shortening velocity 
and are highly resistant to fatigue with a great energy efficiency. Type II fibres are fast twitching 
fibres with a strong ATPase activity at alkaline pH that are divided into several subtypes based on the 
MyHC isoform. IIx fibres display a glycolytic metabolism and can contract fast and generate short 
bursts of strength, hence have a low endurance and low energy efficiency. Fibre type IIa have 
oxidative and glycolytic enzymes making them more resistant to fatigue than IIx fibres and faster 
regarding twitch duration and shortening velocity than fibre I. In rodents a fourth major form called 
IIb was identified expressing a very fast form of myosin. The fibre type distribution in the body 
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depends on the action and task of the muscle. Hybrid muscle fibres exist expressing more than one 
MyHC isoform. This heterogeneity might be important in the muscle plasticity [23], [25].  
2.2    Energy metabolism 
Muscle function highly depends on optimal energy supply and efficient source utilization. The 
energy is supplied in form of adenosine triphosphate (ATP), which is hydrolysed into adenosine 
diphosphate (ADP) and one phosphate (Figure 3). This hydrolysis releases more than 7300 calories of 
energy. Removal of the second phosphate converts the ADP further into adenosine monophosphate 
(AMP) releasing again energy for the muscle contraction. To maintain a constant ATP amount of 
around 4 mM, the muscle continuously forms ATP to sustain the muscle metabolic system. The three 
main metabolic systems provide ATP supply: 1) phosphocreatine - creatine system, 2) glycogen - 
lactic acid system, and 3) aerobic system. For further details the reader is referred to [20].   
 
Figure 3: Muscle metabolism systems supplying energy for muscle contraction. Adapted from [20]. 
2.3    Role of sodium in biological tissue 
Numerous ions play a crucial role in the function of the human body. Sodium is an essential 
component that is responsible for the transmembrane electrochemical gradient and the 
maintenance of the body homeostasis.  
2.3.1 Transmembrane electrochemical gradient 
Various physiological processes in the human body are electrochemical controlled and are 
based on the maintenance of ion gradients between different fluid compartments. Even small 
disturbances in the electrolyte balance can lead to severe functional changes. The lipid bilayer of cell 
membranes functions as a barrier for most polar molecules (having an electric di- or multi-pole 
moment) and thus maintains different concentrations of solutes in the intra- and extracellular 
compartment. The combination of selective passive permeability and active transport leads to large 
differences of ion concentrations inside and outside the cell (Table 2). In the muscle, the extracellular 
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compartment contains for example a ten-fold higher sodium ion concentration than the intracellular 
space ([Na]i = 5 to 15 mM compared to [Na]e = 145 mM). This concentration differences allow the cell 
to store potential energy as an electrochemical gradient for various purposes (e.g. to drive transport 
processes across the membrane, to convey electrical signals in electrically excitable cells, to generate 
ATP…).  
Table 2: Ion concentrations of intracellular and extracellular compartment of a mammalian 






Na+ 5 to15 145 
K+ 140 5 
Mg2+ 0.5 1 - 2 
Ca2+ 10-4 1 - 2 
Cl- 5 to 15 110 
Various ion channels and transporters regulate the concentration of Na+ (Figure 4). Sodium 
channels allow Na+ ions to diffuse faster down their electrochemical gradients across the lipid bilayer 
and are responsible for the initial rise and the propagation of action potentials in muscles. They are 
voltage driven, which means that they are not continuously open like pores but are instead gated by 
a voltage stimuli. The number of Na+ channels and their activated fraction controls the excitability of 
myofibres. In skeletal muscles two isoforms of the Na+ channel are expressed, namely Nav1.4 and 
Nav1.5. While Nav1.5 is only expressed in immatured and denervated muscles, Nav1.4 is found in 
slow and fast fibres of adults [24], [27]–[29].  
Two important protein pumps that play a key role in the regulation of sodium are the 
sodium/calcium exchanger (NCX) and the sodium/hydrogen exchanger (NHE). The NCX uses the Na+ 
gradient to pump Ca2+ out of the cell. Its transportation rate depends on the concentration of both 
ions as well as the membrane potential. An increase of ATP can activate the NCX, which plays a 
crucial role in the calcium extrusion after contraction. Another vital factor for muscles is the pH of 
the intracellular compartment in order to ensure for example the best functionality of enzymes. NHE 
directly transports H+ out of the cell coupled to an influx of Na+ maintaining the intracellular pH. 
Almost all tissues express the Na-H antiporters, but yet only the isoform NHE1 was found in skeletal 
muscle. Intracellular acidosis activates the NHE via proton binding to the transporter and is thus one 
of the main transporters for pH regulation [24], [26], [30]. 




Figure 4: Schematic diagram of main Na+ fluxes across the membrane. The following 
transmembrane proteins are involved: Na channel, Na-H exchanger, Na-Ca exchanger, and the Na-K 
ATPase.  
On the contrary, only one significant mechanism pumps Na+ out of the cell in order to 
maintain the concentration differences between inside and outside of cells. The Na-K ATPase uses 
the energy of ATP hydrolysis to exchange three intracellular Na+ ions for two extracellular K+ ions. 
This results in a net current across the membrane making the cell’s inside more negative. During 
excitation of the muscle cells, Na-K pumps have a crucial function in the clearance of extracellular K+, 
which is a main contributor to muscle fatigue. They also aid to reverse depolarization resulting from 
exercise and muscle disease. Inhibiting the Na-K pump activity or reduction of their content reduces 
the muscle contractility and vice versa. Consequently, activity and capacity of the Na-K pump are 
regulated to fulfil the needs of skeletal muscle cells. In the short term, quick activation of the Na-K 
ATPase is possible by an increase in transport activity. Different hormones and conditions can 
stimulate this acute activation. The most widespread stimulus is a higher intracellular Na+ 
concentration due to an excitation-induced Na+ influx. Additionally, other stimuli can regulate the 
content of Na-K ATPase in a long-lasting and slower term. Such stimuli increasing Na-K ATPase 
performance include training, insulin, K+ overload among others. Negative stimuli are e.g. 
immobilization, K+ deficiency, diabetes, and some muscle diseases [31].  
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2.3.2 Homeostasis of organism 
 Besides being part of the electrochemical gradient, sodium holds also a central position in 
the homeostasis of the organism including the fluid and electrolyte balance. Cellular life depends on 
the ability to control tightly the solute/water balance. Most tissues including the muscle consist of 70 
- 80 % water by weight, which is divided into the extracellular fluid and the intracellular fluid 
compartments [32]. The water flux between the compartments is directed by osmotic and hydraulic 
gradients. Extracellular fluid surrounds a cell with a relatively constant concentration of electrolytes 
in order to function properly. There is a variety of osmotically active ions and molecules that are 
involved in the volume control mechanisms [20]. Since Na+ makes up about 94 % of the extracellular 
osmoles, it is the only cation exerting significant osmotic pressure. Normally, Na+ levels are tightly 
controlled around 140 mM in the extracellular volume and remain somewhat stable with seldom 
changes more than 2 - 3 % [20]. If they do, the blood pressure and intracellular/interstitial fluid 
volumes alter consequently. Several mechanisms are responsible for the regulation of osmolarity, 
with two main actors: (i) the osmoreceptor-ADH system and (ii) the aldosterone mechanism (see [20] 
for details). The Na+ balance is thus crucial for the osmoregulation and it disturbance leads to 
pathological states such as hypertension or oedema [30], [32], [33]. Disruptions in the tightly 
controlled sodium gradient are also linked with some MDs (2.5). 
2.4    Skeletal muscle damage and regeneration 
As previously described, the skeletal muscle is a highly organized tissue needed for many 
physiological processes. Muscle tissue withstands chronic mechanical and physiological stress 
provoking degenerative processes on a daily base. Regeneration mechanism try to maintain a proper 
contractile function. Depending on the size of the membrane injury, different membrane repair 
mechanisms are triggered to reseal the membrane disruption. Tiny membrane injuries are 
spontaneously resealed without the help of an active membrane repair mechanism. Injuries bigger 
than one-nanometre trigger an active resealing mechanism. Smaller injuries activate a Ca2+ (calcium)-
dependent active repair process that involves the formation of a lipid patch built by fusion of 
intracellular vesicles (local membrane repair). This active repair process is described in 2.5.1 due to 
the involvement of the dysferlin protein in the membrane-repair mechanism (Mutations in the 
dysferlin-encoding gene are linked to certain MD). After a larger injury, SC take responsibility of the 
muscle regeneration and mediate the restoration of functional muscle fibres (Figure 5) [34].  




Figure 5: Scheme of skeletal muscle regeneration represented by the four interrelated and 
time-dependent phases: necrosis, inflammation, regeneration, and remodelling and maturation of the 
injured myofibre. Time line based on murine experiments. Adapted from [34]. h hours, d days, SC 
satellite cells.  
The SC-involved regeneration activates several cell types sequentially in four interrelated and 
time-dependent phases after injury: (i) necrosis, (ii) inflammation, (iii) regeneration, and (iv) 
remodelling/maturation. Upon sarcolemma rupture, Ca2+ ions move into the cell inducing proteolysis 
of the fibres. This rapid necrosis activates a controlled inflammation where specific inflammatory cell 
populations (e.g. neutrophils, macrophages) invade the muscle to clean the area and activate SC. 
During the regeneration phase, activated SC and fibroblasts initiate the remodelling and maturation 
of myofibres and remodelling of connective tissue, respectively. The new formed myofibres align and 
either form new fibres or fuse to the remaining myofibres [35].  
This cycle represents the common injury/regeneration process with transient collagen 
deposition and inflammatory infiltration. In the case of chronic disease/injury, the regeneration 
process is exhausted and remodelling of the connective tissue occurs with permanent deposition of 
fibrotic tissue (Figure 6). During the chronic inflammation, an increased number of macrophages rises 
pro-fibrotic factors leading to excessive extracellular matrix (ECM) accumulation in muscle tissue and 
altering the satellite cell function and regeneration [36]. As a result, SC are exhausted over time or 
lose the ability of self-renewal, thus the muscle tissue becomes replaced by adipose and fibrotic 
tissue [37]. The accumulation of ECM leads finally to muscle tissue dysfunction.  




Figure 6: Inflammatory infiltration in acute and chronic muscle repair. Acute injury of skeletal 
muscle leads to a rapid and controlled inflammation. Transient inflammatory infiltration occurs to 
remove damaged myofibres and promote regeneration and remodelling of the muscle. During chronic 
injury on the contrary, a persistent inflammatory infiltration leads to an excessive accumulation of 
extracellular matrix components. This deposition inhibits the myofibres repair and muscle 
replacement by fibrotic tissue occurs [37]. Bars = 50 µm. 
2.5    The diverse group of muscular dystrophies 
MD are inherited disorders characterized by variable degrees and distribution of skeletal 
muscle wasting and weakness. Although, they have their primary defect within the skeletal muscles, 
the heart can be also seriously affected in some types [1]. So far, more than 30 types of MD have 
been identified that involve mutations encoding different proteins [22]. In many MD, proteins that 
should stabilize the sarcolemma are affected impairing their initial role. The mutations lead to a 
fragile or leaky membrane with an increase in Ca2+ influx and cycles of inflammation and 
regeneration. Thus, the genetic defects cause persistent fibre degeneration with chronic 
inflammation and excessive deposition of collagen. The fibro-fatty infiltration reduces patient’s 
mobility progressively so that they become eventually restricted to a wheelchair. The symptoms vary 
highly in age of onset, severity of symptoms, and rate of progression. Table 3 lists a selection of 
dystrophies that are relevant to this manuscript [1], [38], [39].  
As MD differ in gene mutations, also the affected muscle groups, the age of onset, as the rate 
of muscle degeneration are not the same. In addition, different mutations in the same gene can lead 
to several different forms of dystrophy and even the same mutation has been shown to give rise to 
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different forms of dystrophy [40]. This diversity turns the diagnostic as well as management and 
treatment of the patients to an important but difficult task. So far, treatment can only decelerate 
disease progression. For example, DMD patients are commonly under anti-fibrotic treatment to 
counteract the increase in fibrotic tissue, which represents a predictive marker of a poor motor 
outcome [41], [36].  
Table 3: Selection of muscular dystrophies that are relevant to the current work. Note that all 
these diseases are inherited. 
Muscular dystrophy Progressive muscle wasting affecting Onset age 
Becker muscular 
dystrophy (BMD) 
Lower limb, hips, shoulders, heart 
Child- or adulthood (mild 
form of DMD) 
Duchenne muscular 
dystrophy (DMD) 
Lower limb, hips, shoulders, heart Childhood 
Facioscapulohumeral 
dystrophy (FSHD) 





Proximal muscle of pelvis and shoulders, 
sometimes heart, 32 different types 
Childhood, late 
adolescence to adulthood 
Myotonic dystrophy 
(MD1 and MD2) 
Distal, neck or face, later heart 
At birth (MD1) or 
adulthood (MD2) 
2.5.1 Dysferlinopathies and the role of dysferlin in the membrane repair mechanism 
 Among the many mutations leading to MD are those that are found in the large-sized 
dysferlin gene (DYSF), which encodes for the transmembrane protein of the same name [42], [43]. 
The mutations in DYSF cause the most frequent adult-onset limb girdle muscular dystrophy, LGMD 
2B, the Miyoshi myopathy, and other more rare forms of dysferlinopathies [44]. Dysferlinopathy 
patients show muscle weakness starting mainly in the lower limbs. Later, the disease progresses 
involving paravertebral and proximal upper girdle muscles. Patients lose their ambulation within ten 
to fifteen years after onset. These symptoms are paralleled commonly with high levels of creatine 
kinase, which indicates an increase of sarcolemma permeability and it’s gradually degeneration [45].  
Dysferlin is a large transmembrane protein that is highly expressed in skeletal muscle and 
heart. In the skeletal muscle, it is located to the plasma membrane and t-tubule network. The exact 
role of dysferlin in the membrane is no yet fully understood, but it is involved in protein vesicle 
trafficking and fusion linked to the membrane repair [46].  
Since membrane damage occurs physiologically and frequently in skeletal muscle, active 
membrane-repair mechanisms are conserved across eukaryotic cells. As aforementioned, the repair 
of large injuries involves the activation of SC as described in 2.4. For smaller injuries, a Ca2+-
dependent membrane repair mechanism is triggered without SC involvement. Dysferlin plays a key 
role in this Ca2+-dependent process [47]; it comprises of multiple Ca2+ sensitive domains and 
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regulates Ca2+ homeostasis. It was found to be enriched in t-tubule membrane, where it is implicated 
in maintaining Ca2+ homeostasis following cellular stress [48]. A membrane disruption provokes Ca2+ 
influx into the cell leading to an area of high Ca2+ concentration around the damaged zone (Figure 7). 
The altered Ca2+ concentration triggers among other mechanisms the aggregation of dysferlin-
carrying vesicles in this area, which then fuse with the plasma membrane in order to reseal it [49]. 
Alternatively, dysferlin-deficient muscle fibres undergo disruption of Ca2+ homeostasis following 
acute mechanical stress that leads to damage, inflammation, and necrosis. In the following, inter-
myofibrillar lipids and progressive adipocyte replacement causes the progressive decrease of muscle 
function [50]. 
 
Figure 7: Dysferlin plays a key role in the Ca2+-dependent membrane repair. The dysferlin 
protein is located in the cell membrane and cytoplasmic vesicles. After a local injury, the Ca+ influx 
activates local calpains that cleave dysferlin protein. Dysferlin-containing cytoplasmic vesicles are 
recruited to the site of membrane injury. These vesicles fuse with one another and with the 
sarcolemma thus resealing the disrupted area. Adapted from [35]. 
2.5.2 The pathological disease progression of Duchenne muscular dystrophy and concurrent 
ion alterations 
DMD is an X-linked genetic disease caused by mutations in the dystrophin gene. Dystrophin is 
a cytoskeletal protein that maintains the mechanical stability of myofibres during contractions and its 
loss causes aberrant mechanotransduction [51]. Furthermore, this protein shows complex 
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interactions with other structural and signalling molecules, thus playing a central role in muscle 
differentiation and organization of myofibres as contractile units [52] as well as in membrane repair 
in skeletal muscle [47]. The onset of DMD occurs in early childhood with difficulties in running and 
later on to stand up. The progressive muscle loss and fibrosis causes an early death through cardiac 
and respiratory failure in the early adulthood [1], [41]. Mutations in the dystrophin gene cause 
compared with DMD the milder Becker muscular dystrophy (BMD). The age of onset of BMD is 
around twelve years, while some patients show symptoms much later. The course of the disease is 
more benign and death occurs usually in the fourth or fifth decade of life. In contrast with DMD, the 
dystrophin protein is not completely absent in BMD, however, it is not fully functional; the amount is 
either reduced or its size is abnormal [53].  
 
Figure 8: The dystrophin-glycoprotein complex (DGC) connects actin filaments through the cell 
membrane to the surrounding ECM [54]. 
Dystrophin is part of the dystrophin-glycoprotein complex (DGC) that connects the 
cytoskeleton through the cell membrane to the surrounding ECM, the fibrous endomysium (Figure 
8). The dystrophin-mediated link stabilizes the sarcolemmal structure and transmits force laterally. 
Thus, an absence or impairment reduces muscle stiffness; the sarcolemmal integrity and stability is 
lost. The loss of sarcolemmal integrity in patients suffering from DMD or BMD leads eventually to the 
aforementioned symptoms of muscle degeneration, necrosis, and fibrosis [55], [56]. Although, 
dysferlin is not a part of the DGC, altered expression levels have been also demonstrated in DMD 
patients [57]. 
The high concentration of plasma creatine kinase implies an increased membrane 
permeability that allows muscle specific enzymes to leak out of the cell and extracellular ions such as 
Ca2+ to enter the cell. Dystrophic cells show indeed an increase of intracellular Ca2+, which in return 
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activates proteases leading to cell necrosis [56]. The exact function of dystrophin and the role of the 
observed abnormal intracellular calcium concentration ([Cai]) remain unclear despite years of 
research. Turner et al. [58] showed already in the late 1980s that the absence of dystrophin results in 
the inability to maintain a low [Cai] and leads to a prolonged elevation of the [Cai] during stimulation. 
The higher [Cai] thus resulted in a greater myofibre degradation. However, besides the Ca2+ entry 
pathways across the sarcolemma, modifications of ion transport proteins could play a crucial role in 
the generation of abnormal high Ca2+ concentrations in MD. Moreover, cells lacking dystrophin not 
only demonstrated altered Ca2+ concentrations, but also increased [Nai]. However, the underlying 
cellular mechanisms are still unclear with several possibilities including deregulation of the Na-K 
ATPase, sodium channels, and exchangers. 
Dunn et al. [59] reported an increase of the Na-K ATPase content in mdx mice suggesting that 
the elevated activity is caused by increased Na-K pump concentration. Furthermore, the absence of 
dystrophin modifies the expression level, distribution, and gating properties of the Nav1.4 channel 
leading to an abnormally high sodium concentration [60]. Hirn et al. [61] showed that deregulation of 
Nav1.4 significantly alters the Na+ influx into the dystrophic cell leading to increased [Nai]. They 
further reported that in the absence of dystrophin the Nav1.4 channel protein is not anchorage 
properly in the membrane. Besides, the NCX has a high capacity to transport Ca2+ from the cell; this 
transport works also in the reversed mode following the transmembrane ion gradients. Deval et al. 
[62] demonstrated that an increase of [Cai] can be triggered by a decrease of external Na+ thus 
stimulating the reverse mode of the exchange mechanism of the NCX. This produced elevated [Cai] in 
DMD myotubes, which they related to an enhanced mechanism of Ca2+-induced Ca2+-released 
process. Additionally, the isoform NHE-1 can elevate the [Nai] and produce elevated [Cai] via coupling 
to the NCX. Iwata et al. [63] demonstrated in dystrophic hamsters and mice that NHE inhibition has a 
protective effect against muscle degeneration by reducing muscle damage and improving the muscle 
performance.  
Regardless the underlying cause of increased Nai levels in DMD, the Na+ alterations 
motivated researchers to monitor sodium concentrations by 23Na NMR. 3.4.2 presents later in more 





Nuclear magnetic resonance 
This chapter describes selected aspects of the NMR theory that are relevant to this work. 
Every technique that relies on the NMR phenomenon in order to analyse liquids, solids, or tissues 
involves three basic steps: 
- Magnetic polarization: an alignment of the magnetic nuclear spins due to the 
application of an external magnetic field 
- Excitation: a perturbation of the aligned system by absorption of specific radio 
frequency pulse  
- Relaxation: a return from the excited state caused by the excitation to the minimum 
potential energy state (thermal equilibrium) while the emitted electromagnetic 
signal is detected  
The appropriate combination of those basic steps enables one to analyse physical properties 
of the system of interest. The first part, which was inspired by textbooks of de Graaf [64] and Levitt 
[65], explains the basic concepts of the NMR phenomenon (3.1) to understand spectroscopic and 
imaging acquisitions (3.2). 3.3 talks about the NMR properties of the sodium nucleus and the 
different approach to separate the intracellular from the extracellular 23Na signal. Finally, 3.4 
highlights the role of NMR as an outcome measure of MD.  
3.1    Basic principles of nuclear magnetic resonance 
The phenomenon of NMR can be explained using two different approaches: with classical 
and quantum mechanics. Here, I first use quantum mechanics to describe the concept of nuclear 
spin, which is a form of angular momentum. Then, the weak interactions of nuclei with a magnetic 
field (polarization, excitation, and relaxation) are introduced based on the classical description with 
Bloch equations. 
3.1.1 Magnetic polarization and Larmor frequency 
In quantum mechanics, the angular momentum, I, is quantized taking only discrete values 
(half-integral (1/2, 3/2, 5/2 …) and integral numbers (0, 1, 2, 3 …). Non-zero nuclear spins are a 
prerequisite for NMR. In general, the angular momenta are distributed on 2I + 1 cones. Nuclei with a 
spin of 1/2, e.g. 1H, have thus two possible spin states m = 1/2 and m = - 1/2 according to m = - I, -
I + 1 ,… + I. In the absence of an external field, each of the 2I + 1 cones with the same I but 
different m have the same energy; they are degenerated. In the presence of an external magnetic 




level (Figure 9). This splitting of the energy levels in an external magnetic field is called Zeeman 
splitting.  
 
Figure 9: Zeeman splitting of energy levels of a nucleus with spin I = 1/2. The degeneracy of 
the m sublevels is broken in the presence of an external magnetic field causing an energy separation 
between the m sublevels.  
For a spin of 1/2, the state m = 1/2, which has magnetic moment parallel with the magnetic 
field B0, has a lower energy and is more stable than m = - 1/2 (magnetic moment anti-parallel to B0). 
The energy difference between the two different states ∆E is given by: 
∆ =    2   
Where h is the Planck’s constant and γ the gyromagnetic ratio, which is dependent on the 
nuclei under investigation. 
 
Figure 10: Zeeman diagrams from spin I= 1/2 (1H and 31P) and spin I= 3/2 (23Na) in an external 
magnetic field 0 = 3T. 
Figure 10 shows sketches of the Zeeman diagrams for 1H, 31P, and 23Na nuclei as a function of 
applied magnetic field. The 1H and the 31P nuclei are both spin 1/2, thus the nuclear ground state (no 
external magnetic field applied) splits in two sublevels when exposed to a magnetic field. The 23Na 
nucleus has a spin of 3/2; so the nuclear ground state splits into four levels according to the 2I + 1 
degeneration rule. The energy difference between the levels differs between the nuclei in the same 
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magnetic field, because of the different gyromagnetic ratios of the nuclei. The gyromagnetic ratio of 
1H is about two and a half times higher than the one of 31P and four times higher than γ of 23Na, 
making the 1H nucleus more sensitive than the other nuclei and thus the Zeeman splitting of 1H larger 
at the same magnetic field. 
 
Figure 11: Population of spins in the presence of an external magnetic field 0. While the 
lower energy level corresponds to the magnetic moments parallel with 0, the spins in the higher 
energy level are aligned anti-parallel with 0.  
A macroscopic sample contains many spins that are randomly distributed on the 2I + 1 
cones. The presence of an external magnetic field causes a small energy difference between the spin 
states and thus a small difference in the population of these spin states with a bias towards the lower 
energy state (Figure 11). This difference in population gives rise to a net magnetization M0 of the 
macroscopic sample that is proportional to B0:  
 =  2
  4  
Where k is the Boltzmann constant, T the absolute temperature, and n the total number of 
nuclear spins in the macroscopic sample. Thus, the magnetization and therefore the final received 
NMR signal are proportional to the population difference of the spin states.  
In the following, the classical description is used to explain the interaction of the resulting 
magnetic moment μ with external magnetic fields. The rotating nuclei feel a torque in the presence 
of an external magnetic field B0. The interaction between μ and B0 is described by: 
%&
%' =   &  (   
The amplitude of the magnetic moment is constant and changes only its orientation relative 
to the magnetic field. Thus, the magnetic moment precesses about B0 in an angle Θ and with a 





Figure 12: Magnetic moment & precessing in an external magnetic field 0. 
The precession frequency, the so-called Larmor frequency, ωL is directly proportional to the 
applied magnetic field B0 and the gyromagnetic ratio γ, which depends on the nucleus of interest. 
This is described by the Larmor equation: 
ω* =  0 
A resonant absorption by nuclear spins only occurs when the correct frequency equalling the 
Larmor precession frequency is applied to match the discrete energy differences ∆E between the 
levels in a constant magnetic field B0. The magnetic moment emerged in an external magnetic field 
possess the magnetic energy defined as follows: 
 =  +μ  (    =  +μ  ,-./ 
Where / describes the angle between the external magnetic field B0 and the magnetic 
moment μ. At θ = 180°, the magnetic energy is maximized, while it is minimized when μ is parallel 
with B0 (θ = 0°).  
3.1.2 Magnetization excitation 
At thermal equilibrium, the net magnetization has only a longitudinal component in the z-
axis. In order to study the nuclear magnetization, the net longitudinal magnetization vector needs to 
be rotated towards the xy-plane (transverse plane). The deflection of the longitudinal magnetization 
can be realised by a second magnetic field B4 applied perpendicular to B0 as an RF pulse applied at 
the Larmor frequency (switched on for a finite time and turned off again). The net magnetization M 
initially aligned with the +z-axis precesses about the static magnetic field B0 and the RF field B4 in the 
transverse plane during the RF pulse. Because of the experienced torque from the applied B4 field, 
M rotates towards the transverse plane. If the applied RF pulse is long enough, M can completely 
rotate onto the transverse plane or flip to the -z-axis (Figure 13).  




Figure 13: Excitation of magnetization in the rotating frequency frame. A) At thermal 
equilibrium, a net magnetization vector along +z without a net magnetization in the transverse plane. 
B) The net magnetization rotates towards the +y-axis during the application of 4. C) If the RF pulse is 
calibrated for a complete excitation, a net magnetization vector along +y-axis is created and no 
magnetization remains along z-axis.  
Since the two magnetic fields B and B4 act simultaneously on the net magnetization, the 
rotation of M is rather complex. At thermal equilibrium, the z-component of M is constant: 
%67'8%' = 0 
While the x- and y-components are randomly organized on the cone and precess about B at 
the Lamor frequency:  
9:;7<8
9< =  +  =   and  9:>7<89< =  +  ?  
During excitation, a RF pulse is applied in the form of: 
47'8 =  4  cos7C'8DEF + 4  sin7 C'8DHF  
Where E I% H are the unit vectors along the x and y axes. The combined effect of B and B4 
on the magnetization are then described by the so-called Bloch equations in the laboratory frame: 
%?7'8%' =  J=7'8 +  67'84 sin7C'8K 
%=7'8%' =  J67'84 cos7C'8 +  ?7'8K 
%67'8%' =  J?7'84 sin7C'8 +  =7'84 cos7C'8K 
To simplify the analysis of NMR phenomena, the complex motion of precessing can be 
described in the rotating frame of reference. Thus, the precessional motion around B is frozen by 
transforming the coordinate system so the observer rotates with spins at Larmor frequency. In this 
rotating frame of reference concept, the Cartesian axes (x’, y’, z’) rotate about B with frequency ω. 
Thus, the three components of the magnetization in the rotating frame are given by:  




3.1.3 Longitudinal and transverse relaxation 
After an RF pulse, some part of the magnetization is placed in the transverse plane resulting 
in a transverse magnetization. Afterwards, the transverse magnetization experiences only the 
magnetic field B0 and starts to precess coherently about B0 at the Larmor frequency. This induces an 
electromotive force (EMF) in the receiver coil located in the transverse plane during NMR 
experiments. The induced EMF directly creates the NMR signal, and its time dependency is called 
free induction decay (FID). 
The components of the net magnetization M return to the thermal equilibrium in an 
exponential manner, but with different time constants T1 and T2. The relaxation processes for the 
three components of the magnetization vector M in the rotating frame can be written as: 
9:;M>M7<8
9< =  +
:;M>M7<8
NO ,  and  
9:PM7<8
9< =  + :PM7<8Q :RNS   
The longitudinal relaxation time T1 or also called spin-lattice relaxation time refers to the 
return of longitudinal magnetization Mz after the excitation RF pulse. It involves energy transfer from 
the spins to the surrounding lattice. T2 is the transverse relaxation time or spin-spin relaxation time. 
It involves the energy transfer between spins and represents the disappearance of transverse 
magnetizations Mx and My, which is an entropy process. The energy exchange between the spins 
causes a reduction in phase coherence and an increase in entropy. T2 is always less than or equal to 
T1.  
Thus, the signal intensity Mz recovers following a 90° RF pulse through T1 relaxation during 
the recovery time t according to (Figure 14): 
67'8 =  71 + TQ <NS8 
The T1 is the time constant for regrowth of longitudinal magnetization that is specific for each 
tissue. It is the time required for the z-component of the magnetization to reach about 63 % of its 
maximal value. The T1 relaxation time can be calculated by obtaining NMR spectra at different 
recovery times. The saturation recovery or inversion recovery methods are very wide used 
techniques to measure the T1 relaxation (4.3).  




Figure 14: Spin-lattice (T1) relaxation. A) The longitudinal magnetization relaxes back to 
thermal equilibrium value with a T1 relaxation time constant. B) After a 90° RF pulse no net 
macroscopic magnetization Mz’ remains. Given time, the longitudinal magnetization returns in an 
exponential manner. 
Following a 90° RF pulse rotating M in the transverse plane, the induced transverse 
magnetization Mxy decreases as a function of time due to T2 relaxation (Figure 15). The corresponding 
spectrum is fitted to an exponential curve derived from the Bloch equations according to: 
?=7'8 = ?=708 ( TQ</NO 
The T2 is the time constant for decay of transverse magnetization. It is the time required for 
the transverse magnetization to fall to about 37 % of its initial value. However, macroscopic and 
microscopic inhomogeneities, which lead to locally different B0 magnetic fields across the object 
resulting in a distribution of Larmor frequencies in the magnetic field B0, accelerate this T2 relaxation. 
Therefore, the resulting signal of a macroscopic object in the presence of inhomogeneity is described 
by T2* relaxation referring to the more rapid loss of transverse magnetization than caused by pure T2 





Figure 15: Spin-spin (T2) relaxation. A) The transverse magnetization decays with a T2 
relaxation time constant in a perfect homogeneous magnetic field and with a T2* relaxation time 
constant at presence of magnetic field inhomogeneity. B) After a 90° RF pulse excitation, the net 
magnetization is rotated towards +y’-axis and phase coherence is generated (transverse 
magnetization along the +y’-axis). During the relaxation, the phase coherence decreases in the 
transverse plane and the resulting transverse magnetization disappears with time. 
The mechanism by which the longitudinal relaxation occurs is the dipolar coupling between 
nuclear magnetic dipoles. On the other hand, the transverse relaxation occurs due to exchange of 
energy between excited nuclei and low energy state nuclei that leads to the randomization of spins in 
xy-plane. Both mechanisms are related to the correlation time τc of the nuclei:  
UV =  4  W
X Y
3    
Where k is the Boltzmann constant, T the absolute temperature, Y the viscosity coefficient, 
and r the radius. τc is by definition the time it takes a molecule to rotate one radian (360°/2π). The 
formula demonstrates that the larger the molecule the slower it moves. Small molecules (like free 
water) can rapidly rotate having long T1 and T2 times. As the motion gets slower, like in proteins or 
solids, T2 shortens and T1 increases again (Figure 16).  




Figure 16: T1 and T2 relaxation times as a function of the correlation rate. The minimum of T1 
and the “dip” of the T2 are at Larmor frequency f0.  
 Since the T1 relaxation is dominated by the exchange of energy between spins and 
environment, the relaxation time of T1 has its optimum at the Larmor frequency. On the contrary, the 
T2 relaxation is based on the energy exchange between spins. So the slower the spins move (the 
greater their contact), the more efficient can be this energy transfer and the shorter is T2.  
3.1.4 Chemical shift 
Chemical shift refers to changes in the resonance frequency of a nucleus due to alterations in 
molecular environment. This relative shift in Larmor frequency is caused by shielding of the nuclei 
from B0 by surrounding electrons (and other nuclei). These electrons rotate in an opposite sense to 
the spin precession in B0, which in return involves motion of charge and therefore induces an 
additional magnetic moment µe. The electrons decrease therefore the magnetic field sensed by the 
atomic nuclei and the real resonance condition is as follows:  
ω =  71 + \8 
Where \ is the shielding constant depending on the chemical environment. One example of 
this effect is the fat-water shift in 1H NMR. The shift caused by non-uniformity in the local magnetic 
field is linearly dependent on the magnetic field strength. For practical reasons, the chemical shift δ is 
expressed in parts per million (ppm), which makes it independent of magnetic field strength:  
] =  C^_<`a + Cb_cCb_c  ( 10d 
Where ωmetab and ωref correspond to the frequencies of the metabolite of interest and a 
reference resonance, respectively. The investigated metabolite is commonly referred to a reference 
compound whose chemical shift should be independent of external variables such as temperature 





3.2    From nuclear magnetic resonance spectroscopy to imaging  
3.2.1 Nuclear magnetic resonance spectroscopy 
NMRS is a powerful tool to analyse the chemical structure of molecules that consist of nuclei 
with a magnetic moment. Examples of commonly used nuclei for in vivo NMRS applications are 1H, 
31P, and 23 Na (Table 4). 
Table 4: NMR properties of commonly used nuclei. Values extracted from [64]. 
Element Spin 
Gyromagnetic ratio 
(107 rad T-1s-1) 
Gyromagnetic ratio 
relative to 1H 
Natural 
abundance (%) 
1H 1 2j  26.75 - 99.99 
31P 1 2j  10.84 0.4 100 
23 Na 3 2j  7.08 0.26 100 
The 1H nucleus is the most sensitive nucleus to NMR due to its high gyromagnetic ratio and 
high natural abundance. 1H NMRS enables the detection of a large number of biologically relevant 
metabolites such as different neurotransmitters and related compounds in the brain. In skeletal 
muscles, it is possible among others to observe intra- and extramyocellular lipids on 1H NMRS (4.5.2). 
The second most used NMRS technique relies on the 31P nucleus to study the energy metabolism, pH, 
and magnesium concentration (4.5.1). 23Na NMR is a subject of increased interest in medical research 
as it can inform about the tissue viability and can therefore provide complementary information to 
the common used 1H and 31P NMRS (3.4.2).  
In NMRS, the collected signal of the object of interest represents a sum of chemical 
compounds. The obtained time signal is visualised in the frequency domain by the Fourier 
transformation, which allows the quantification of the individual contribution of each chemical 
compound (Figure 17). The spectra can be evaluated through calculation of the area under the peak 
or more advanced fitting approaches. The spectra can be further analysed by the ratios of the 
different peaks and by quantification using internal or external references. Thus, depending on the 
experimental design, relative or absolute quantification can be achieved. Different metabolites are 
detected and quantified in vivo enabling to study a variety of metabolites present in biological 
tissues. To date, a variety of metabolic markers has been explored to detect and quantify disease 
progression. 
Concentrations and composition of metabolites change in vivo throughout the object. The 
use of a surface coil is one simple way of signal localization. This approach is nevertheless restricted 
to areas close to the body surface. NMRS is often combined with localization methods (e.g. point 
resolved spectroscopy (PRESS) [66], image selected in vivo spectroscopy (ISIS) [67],…). A combination 
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of excitation pulse sequences and gradient sequences selects the volume of interest. The PRESS 
method for example consists of a slice-selective 90° excitation pulse, followed by two slice-selective 
180° refocusing pulses. The slice selections are orthogonal, which preserves only the signal from the 
volume of interest at the intersection of the three selected slices. 
 
Figure 17: The free induction decay following an excitation pulse in the time-domain. The 
corresponding frequency-domain spectrum is obtained by computing the Fourier transform of the FID.  
3.2.2 Nuclear magnetic resonance imaging 
While NMRS provides quantitative identification of metabolites in tissues and fluids, NMRI 
takes images of the body represented as the sum of all metabolites in one voxel (dominated by the 
water resonance due to high abundance). By adjusting different experimental parameters, great soft 
tissue contrast can be generated (T1 weighted, T2 weighted, proton density weighted…). To acquire 
an image of an object, magnetic field gradients make the resonance frequency and phase dependent 
on its spatial position. Usually, a NMRI magnet comprises three gradient coils to encode 
independently all three dimensions (see [64] for more details). The signal acquisition in NMR imaging 
requires sampling of the so-called k-space in the spatial frequency domain. The complex values 





3.3    A special nucleus: sodium 
23Na NMR has the potential to assess directly and quantitatively metabolic information about 
the cell viability and to add important information to the standard 1H NMR. Still challenges related to 
the properties of the sodium nucleus hinder its broad utilization. Nevertheless, 23Na NMR represents 
a subject of increasing interest in biomedical research due to recent availability of high field 
scanners. The following section provides an understanding of the quadrupolar nature of the sodium 
nucleus (3.3.1). Then, I will discuss the quantification of total sodium content (3.3.2) and different 
methods to achieve an intracellular weighting of the 23Na signal (3.3.3). 
3.3.1 NMR properties of 23Na 
The sodium nucleus has a relatively high gyromagnetic ratio and yields the second strongest 
NMR signal after 1H. The NMR sensitivity for sodium is 9.3 % of the proton sensitivity, but the 
concentration in biological tissues is a few thousand times smaller than that of water (Table 5) 
causing a much lower SNR.  
Table 5: List of main biological and physical differences between 1H and 23Na NMR.  
 
1H NMR 23Na NMR 
Spin 1 2j  3 2j  
Gyromagnetic ratio  
(106 rad s-1T-1) 
267.5 70.8 
Concentration  
in skeletal tissue ~ 80 M 
10 - 140 mM 
T2 relaxation  
in skeletal muscle 
Multi-exponential (short T2 of 32 ms, 
long T2 of 120-180 ms…) 
Bi-exponential (short T2 of 0.5- 1 
ms and long T2 of 10-20 ms) 
Spin 1/2 nuclei such as 1H exhibit only a magnetic dipole moment. In contrast, the sodium 
nucleus possesses a 3/2 spin. The nuclear ground state splits into four levels according to the 2I + 1 
degeneration rule (3.1.1). Additionally, the electric charge distribution of the nucleus is not 
spherically symmetrical (Figure 18). In that case, the relaxation process is not dominated by dipole-
dipole interactions but rather by the quadrupolar moment of the nucleus that interacts with the 
electric field gradient (EFG) produced by the molecular environment. The electric field gradient is a 
tensor with three principal values associated with three principal axes. The parameter eq is the 
largest principal value of the EFG. The EFG fluctuates in time because of thermal motion. Depending 
on its frequency, this fluctuation modulates the relative energies of the nuclear spin states. 




Figure 18: Electric charge distribution of 1/2 and 3/2 nuclei. A spin 1/2 is spherical exhibiting 
no electric interaction between the nucleus and the electric field. On the other hand, a spin of 3/2 has 
a quadrupolar electric charge distribution that interacts with the electric field gradient.  
The averaged quadrupolar interaction frequency ωlmmmm that is sensed by the nucleus is defined 
by the simplified equation [68]: 
Cnmmmm =  To Tp 4 ħ  73 ,-./ + 18 
Where ħ is the Dirac’s constant, eQ the electric quadrupole moment of the nucleus, eq the 
major element of the diagonalized EFG tensor, and θ the angle between the element’s direction and 
the direction of the magnetic field B0. Thus, the quadrupolar coupling depends on the nuclear 
quadrupole moment (for 23Na nucleus 10.4 x 10-28 m²) and the molecular property represented by 
the EFG that are created by the surrounding electrons [65].  
 
Figure 19: Time dependence of quadrupolar interactions in the laboratory frame. The 
quadrupolar interaction frequency ωQ is modulated in time due to thermal motion within the lattice. 
In liquid, the quadrupolar interactions are averaged to zero in a relatively short time. In biological 
tissue, the quadrupolar interaction frequency is slower resulting in non-zero averaged ωQ. Adapted 




Figure 19 depicts the time dependence of quadrupolar interactions in different 
environments. In liquids, the static quadrupolar interactions are averaged to zero since the ωQ 
fluctuations are so fast that the correlation time is small compared with the reciprocal of the Larmor 
frequency, ωL-1 (case ωL ⨯ τc << 1 with the rotational correlation time τc). In contrast, sodium nuclei 
experience in solids nonzero averaged quadrupolar interactions (ωlmmmm w 0). In biological tissues, the 
sodium ions are in close contact with negatively charged macromolecules, which results in slower 
modulation of the ωQ. This slower modulation is superimposed on the fast zero-averaged 
fluctuations, which are produced by the on-going modulations of the hydration shells of the sodium 
ions. Thus, the overall ωlmmmm is not zero. In biological samples such a muscle tissue, the half-period of 
the slower fluctuation is similar to ωL-1, but still less than the ωlmmmm-1, which leads to a spectrum with 
three isochronous resonances (case ωL ⨯ τc ≈ 18. 
 
Figure 20: A) In vivo 23Na spectrum from human calf: the three single quantum coherences 
give rise to one broad peak. B) Energy levels of sodium nucleus in an external magnetic field. The spin 
3/2 nuclei can undergo single (-3/2 ↔ -1/2, -1/2 ↔ +1/2, +1/2 ↔ +3/2), double (-3/2 ↔ +1/2, -1/2 
↔ +3/2), and triple (-3/2 ↔ +3/2) quantum coherences/transitions. 
The central resonance is superimposed on the broader satellite resonances giving one single 
broad peak in the 23Na in vivo spectrum (Figure 20A). In biological tissues, the quadrupolar 
interaction usually causes bi-exponential relaxation behaviour. As a result of these quadrupolar 
interactions, the relaxation times of 23Na are extremely sensitive to the surrounding environment 
and are much shorter than those of 1H [68]–[70]. As a nucleus with a spin higher than 1/2, sodium 
exhibits more than one allowed transition between Zeeman split energy levels. It can undergo single, 
double, and triple quantum transitions/coherences as shown in Figure 20B. A single quantum 
coherence (SQC) corresponds to a change of quantum state of Δm = ± 1. Double quantum 
coherence (DQC) and triple quantum coherence (TQC) refer to the quantum spin state that changes 
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by Δm = ± 2 or Δm = ± 3, respectively. While only SQCs are observable relating to the transverse 
magnetization, the DQC and TQC are generally not observable. 
As 23Na has four nuclear spin states (energy levels), three single quantum transitions are 
possible with the relative contributions of 3:4:3. The corresponding energy levels and relaxation rates 
depend on the motional regime of the system and therefore on the nature of the molecular 
environment. If the quadrupolar nucleus is in a spatially homogeneous system such as in a fluid, it 
can tumble very fast and the three transitions have the same resonance frequency, which results in a 
single mono-exponential T2 and T1 relaxation. However, if the sodium nucleus is in biological tissue, 
static and dynamic quadrupolar effects slow down the tumbling motion. Thus, the two outer 
transitions (-3/2 ↔ -1/2 and +1/2 ↔ +3/2) relax faster than the inner transition (-1/2 ↔ +1/2) 
leading to bi-exponential relaxation. In this case (ωL ⨯ τc≈18, the bi-exponential relaxation behaviour 
is described with short and long relaxation times [69], [71]: 
67'8 = 71 + 0.2 TQ <NS| + 0.8 TQ <NS}8 
?=7'8 = ?=708 70.6 TQ <NO| + 0.4 TQ <NO}8 
Where T1s and T1l are the short and long longitudinal relaxation times, and T2s and T2l the 
short and long transverse relaxation time values. In biological tissues, the transverse magnetization 
decays with a short T2 of about 0.5 to 3 ms and a longer T2 of about 15 to 30 ms [70]. Since usually 
mono- and bi-exponential pools exist, the short/long component contribution can deviate from the 
3:2 ratio of relative T2 contribution. Conversely, only a mono-exponential T1 is measured in practice 
due to the small short fraction of T1s and closer relaxation values of T1s and T1l. A change in the 
interaction between sodium nucleus and its environment can be observed in altered relaxation times 
and in the relative contributions of the mono-exponential and bi-exponential pools [64], [69], [72].  
3.3.2 Quantification of the total sodium content 
To quantify the total sodium concentration (TSC) of biological tissue, the signal intensity of 
the tissue is compared to the signal of an externally placed calibration standard of known Na+ 
concentration. This strategy relies on the linearity between signal and concentration. However, the 
fast decay of the short T2 in biological tissue introduces a bias if data acquisition is run with an echo 
time (TE) that is relatively long compared to the short T2. This is because the short T2 accounts for 60 
% of the total 23Na signal. Standard sequences fully sample the k-space on a Cartesian grid, which 
leads to relatively long TEs. Normally these TEs are longer than the 23Na T2s causing signal loss. Boada 




This bias can be partially overcome by the application of ultra-short echo time (UTE) 
sequences that use echo times below 0.5 ms. The reduction of the TE can be achieved by different k-
space sampling schemes such is sampling on centre-out radial lines (4.6.3). However, TSC might not 
be sufficient to monitor Na+ homeostasis in vivo due to a lack of differentiation between the extra- 
and intracellular Na+. The next section of this chapter explains the three methods to selectively gain 
information about the “intracellular” sodium with a focus on multiple quantum filters.   
3.3.3 NMR techniques to probe sodium in different compartments 
Sodium alterations in the intra- and extracellular compartments can be probed using shift 
reagents, inversion recovery sequences, and multiple quantum filters. Paramagnetic compounds, so-
called shift reagents (SR), can induce frequency shifts of a nuclear spin. Several SR have been proven 
to not cross the cell membrane and thereby create a large shift in the resonance frequency of only 
the extracellular sodium [74]. These SR studies used injections of anionic complexes of Dy(PPPi)27- 
[75], Dy(TTHA)3- [76]–[78], and Tm(DOTP)5- [79]–[82] in skeletal muscle, heart, and brain. They clearly 
distinct the intra- from the extracellular sodium resonances, but due to their toxicity after 
decomposition, SR are only used in animal studies. 
The inversion recovery (IR) technique is a non-invasive alternative for SR. This technique 
takes advantage of T1 relaxation differences of the sodium nucleus in different compartments. It is 
based on the assumption that the T1 relaxation time of the extracellular sodium is significantly longer 
than the T1 of the intracellular sodium. An appropriate inversion time (TI) can be selected to suppress 
the signal from the extracellular Na+ pool: 
  = ln  21 + TQN/NS (   4 
The IR method, however, allows only a weighting towards intracellular sodium signal. It can 
still have significant contributions from the extracellular compartment, because the IR pulse does not 
completely eliminate the extracellular 23Na signal due to possible differences in T1. So far, no SR 
experiment has investigated the contributions of the extracellular 23Na. To date, only IR 23Na NMRI 
monitored the intracellular weighted 23Na signal in myopathies including muscular channelopathies 
and DMD [14], [83] (3.4.2).  
The third method for intracellular sodium analysis consists of multiple quantum filters (MQF). 
As discussed above, the relaxation behaviour of motionally restricted sodium ions becomes bi-
exponential, which can be detected by MQF sequences [84], [85]. Thus, MQF select signal arising 
from Na+ ions of restricted movement. These filters usually consist of three RF pulses and depending 
on their amplitude and phases, DQC or TQC are generated [86]. However, the resulting signal is only 
3.3 A special nucleus: sodium 
 
39 
a small fraction of the maximum single quantum signal, thus MQF suffer from poor signal intensities. 
Figure 21 shows the basic MQF pulse sequence with corresponding coherence transfer pathways. 
 
Figure 21: Schema of multiple quantum filter RF diagram with corresponding coherence order 
transfers and tensors Tl,p. A typical MQF sequence consists of three RF pulse of angle Θ and phase Φ. 
By proper phase cycling, DQC and TQC are selected and detected at the end of the third RF pulse.  
 
Table 6: Irreducible spherical tensor operators for spin I= 3/2. Values taken from [70]. 
Irreducible spherical 
tensor operator 
Spin 3/2 Definition 
T00 1 Identity 
T10 Iz Longitudinal magnetization 
T1±1 ± 4√ I± Rank 1 single quantum coherence 
T20 4√d 73IZ² - I 7I + 188  Quadrupolar magnetization 
T2±1 ± 4  DIz , I±F+ Rank 2 single quantum coherence 
T2±2 4 I±² Rank 2 double quantum coherence 
T30 4√4 75 IZ3 – 73I 7I + 18-18 Iz8  Octopolar magnetization 
T3±1 ± 4   X4 D5 Iz3 - I 7I + 18- 4, I±F+ Rank 3 single quantum coherence 
T3±2  √X  DIz , I±2F+ Rank 3 double quantum coherence 




A commonly used formalism to describe the complex processes during MQF sequences is 
based on the irreducible spherical tensor operator basis Tl p where l denotes the rank and p the order 
(or coherence) of the tensor with abs7p8 ≤ l. These tensors are defined by the spin operators Iz and 
I± = Ix ± i Iy representing the spin angular momentum components along the three Cartesian axes. 
Table 6 lists the irreducible spherical tensor operators used to describe the density operator for spin 
of 3/2 (operator describing quantum state of entire sampl/system) [65]. 
In general, the signal intensity in a MQF experiment is the sum of all contributions of all 
possible coherence transfer pathways. All coherence pathways start at p = 0 and end at the 
detectable p = -1. Each coherence pathway can be described by its quantum numbers p and l (Figure 
21). In the following theoretical analysis, the evolution of the tensor operator Tl p under the influence 
of RF pulses and transverse relaxation is discussed under on-resonance condition (no B0 
inhomogeneities). The signal intensity for a spin of quantum number I after the filter is a 
superposition of the signals from different coherence pathways S,7t8 and depends on the 
preparation time τ1 and evolution time τ2, the receiver phase Ψ, the RF pulse phases ϕ4, ϕ, ϕX, and 
the flip angle of the RF pulses θ4, θ, θX. The recorded signal is generally given by a sum of complex 
signals with amplitudes A and phases Ψ [87]: 












The phase factor ψ, consist of contributions of the RF pulses and receiver phases as well as 
phases accumulated during the preparation and evolution time:  
  , =  ,7U4, U, ¡4, ¡, ¡X, Ψ8 = Φ,7¡4, ¡, ¡X, Ψ8 + Δ,7U4, U8 
The amplitude A, = A,7τ4, τ, θ4, θ, θX, t 8 of the coherence pathways consist of 
contributions of the RF pulses that can be calculated via the Wigner rotation matrix elements dM,  
and relaxation functions fM, 7t8 during preparation, evolution, and acquisition time t.  
Using to the tensor operator Tl p formalism, two rules help to understand the different events 
taking place during the MQF sequence. First, a non-selective RF pulse changes the coherence p only 
within the limits of |p| ≤ l. Second, the rank l changes solely due to relaxation and modulation by 
quadrupolar, dipolar, or J-coupling, conserving the current coherence value p [88]. J-coupling refers 
to the indirect spin-spin coupling over bonding electrons that is independent of the applied magnetic 
field (see [65] or [64] for a detailed explanation). Thus, the general evolution of the tensor operator 
under an RF pulse of flip angle / and phase ¡ is given by [89]: 
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 Where p’ is the new coherence order, Δp = p’-p the change of order under the influence of 
the pulse. Note that the rank of the tensor remains unchanged. The Wigner rotation matrix elements 
dM, are listed in [90]. The first RF pulse of angle θ1 and phase φ1 flips the longitudinal magnetization 
T10 into the transverse plane resulting in a transverse magnetization T1±1. The tensor operator Tl p 
further changes under the influence of quadrupolar relaxation, which changes the rank but conserves 
the order. SQC with different ranks (T2±1, T3±1) evolve during the so-called preparation time τ1. The 
evolution of T1,1 under the influence of transverse relaxation and residual quadrupolar interaction 
(RQI) during τ1 is given as [91]: 
 44  _`?`<³´ µ n­®®®®®®®®®®®®¯  ¶4,44 7'8  44 +  ¶,44 7'8  4 +  ¶X,44 7'8  X4   [1] 
With the relaxation functions ¶M, 7'8: 
¶4,44 7'8 = 4· ¸3 T
Q< NO|j cos7Cn'8 +  2 TQ< NO}j ¹  [2] 
¶,44 7'8 = ¶4,4 7'8 = X· ¸TQ
< NO|j i sin7Cn'8¹  [3] 
¶X,44 7'8 = ¶4,X4 7'8 = √d· ¸T
Q< NO|j cos7Cn'8 + TQ< NO}j ¹  [4] 
Where T2s and T2l are the short and long T2, respectively, and 2ωQ the quadrupolar coupling. 
The relaxation functions fM, 7t8 for spin-3/2 nuclei can be found in [92]. By looking at equations [1] 
and [3], one sees that in isotropic liquids, only odd rank tensors T3±1 are formed due the absence of 
RQI (ωlmmmm = 0). In anisotropic media, the quadrupolar coupling does not average to zero leading to the 
formation of an even rank tensor T2±1. A second pulse of angle θ2 and phase φ2 converts the SQC into 
double and triple quantum coherences (T2±2, T3±2, and T3±3). The MQCs evolve with their characteristic 
relaxation times during the evolution time τ2, which should be kept very short to prevent their decay. 
These coherences are then quickly read out by applying a third pulse of angle θ3 and phase φ3 to 
convert the DQC and TQC into SQCs T2-1and T3-1, which evolve under relaxation or quadrupolar 
coupling during acquisition time t into the detectable T1-1 rank.  
A MQF experiment is realized with a proper phase cycling scheme so that out of the 21 
possible coherence pathways only the desired ones are detected. During TQF experiments, the first 
RF pulse creates first order coherences (p = ±1), which the second pulse converts into triple 
quantum coherences (p = ±3).  
The selection of the coherences is done by acquiring N repetitions with different RF pulse and 




up while the phases of undesired coherences cancel out one another. For TQF 7p = ±38, the 
sequence usually consists of a six-phase cycling scheme with following flip angles and phases [93]:  
 ¡4 = º4 + 3 , ¡ =  º +

3 ,         ¡X = 0  Ψ = ,  = 0,1,2,3 
 
Initial phases are commonly set to α1 = 30° and α2 = 120°. With this cycle scheme, only four 
components (l = ±1, p = ±3) are conserved in the measured TQF signal: 
Nn7'8 =   ,7'8 =
X
  QX




The TQF signal can be then calculated as: 
 Nn7/4, /, /X, U4, U, '8 =   ¶X,44 7U48¶XXX 7U8¶X44 7'8 ¼XX7/4, /, /X, U4, U8  
With the relaxation functions fX,44 7τ48, fX,XX 7τ8, and f4,X4 7t8, as well as the factor F33. In case 
the evolution time U is chosen as short as possible (τ2 ≈ 50 µs), the relaxation during the evolution 
time can be neglected (fX,XX 7τ8 ≈ 1). If the quadrupolar coupling is sufficiently strong, the relaxation 
functions can be simplified to: 
¶X,44 7U48¶X,44 7'8 ∝  ¿cos CnU4 TQÀS/ÁO| +  TQÀS/ÁO} Â¿cos Cn' TQ</NO| +  TQ</NOÃÂ 
The factor F33 depends on the flip angle (θ4 = θ = θX) and includes normalization factors 
arising from Wigner rotation matrix elements [89]:  
¼XX =  %4,4 7/8J%X,4X 7/8 +  %X,Q4X 7/8K 
The Wigner rotation matrix elements for double and triple quantum filtered coherence 
pathways are summarized in [90]: 
%4,4 7/8 = 4√ sin7/8, %X,4X 7/8 = √4·Ä sin²7/871 + cos7/88, and %X,Q4X 7/8 = √4·Ä sin²7/871 + cos7/88 
Using the Wigner coefficients, the FID obtained after TQF sequence is proportional to [70]: 
Nn ¿U4, ', CnÂ ∝  1516 sin·7/8 T
Q ÀSNO} + cos¿Cn  U4Â TQ ÀSNO| ÅTQ <NO} +  cos¿Cn 'Â TQ <NO|Æ  
Where θ is the flip angle of the 2nd and 3rd RF pulse, τ1 the preparation time, t the acquisition 
time, T2s and T2l the short and long transverse relaxation times, respectively, and ωl  residual 
quadrupolar interaction frequency. Thus, the FID after TQF consists only of one term originating from 
T31.  
In biological tissues, the residual quadrupolar interaction can be greater than the fast T2 
relaxation rate (regime ωl >> 1/T2f). In that case, two kinds of DQC are contributing to the signal: 
even rank (T2±2) and odd rank DQC (T3±2) (see equation [1]). For DQF (p = ±2), the commonly used 
parameters comprise a four-phase cycling scheme [94]:  
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¡4 =  ¡ =  2 , ¡X = 0  Ψ = ,  = 0,1,2,3 
With this cycle scheme, only four components (l = ±1, p = ±2) are conserved in the 
measured DQF signal: 
Çn7'8 =   ,7'8 =

  Q




The DQC signal can be then calculated with the relaxation functions and normalization 
factors arising from Wigner rotation matrix elements [90]: 
 Çn7/4, /, /X, U4, U, '8
=  Çn,_È_´7/4, /, /X, U4, U, '8 +  Çn,³997/4, /, /X, U4, U, '8  
= ¶44 7U48¶ 7U8¶44 7'8 ¼7/4, /, /X, U4, U8
+ ¶X44 7U48¶X 7U8¶X44 7'8 ¼X7/4, /, /X, U4, U8 
 
Thus, the FID obtained after DQF sequence is proportional to (again assuming f,X 7τ8 ≈ 1, 
f, 7τ8 ≈ 1 and sufficiently strong quadrupolar coupling) [95]: 
Çn ¿U4, ', CnÂ ∝  + 32 sinX7/8 sin¿Cn  U4Â T
Q ÀSNO|  sin¿Cn 'Â TQ <NO|   
+ 38 sinX7/8 73 cos / + 18  T
Q ÀSNO} +  cos¿Cn  U4Â TQ ÀSNO| ÅTQ <NO| +  cos¿Cn  'Â TQ <NO|Æ  
The observed decay is thus a sum of two terms: the first term represents the formation of 
second rank tensor T2,1 and the second term results from the third rank tensor T3,1. For isotropic 
solutions (ωl mmmmm = 0), the term for the T2,-1 tensor disappears.  
 
Figure 22: Dependency of the transfer functions of second rank tensor T2-1 for DQF and of 
third rank tensor T3-1 for DQF and TQF on the flip angle in MQF experiments. At the magic angle 




Figure 22 demonstrates the effect of the flip angle (FA) on the double and triple quantum 
coherences using the transfer functions of T2-1 and of T3-1 for the DQF (
X
  sin7θ8 and 
X
Ä  sin7θ8 73 cos θ + 18, respectively) and the transfer function T3-1 for the TQF ( É4d  sin7θ8). In the 
case of RQI and θ1 = 90° and θ2 = θ3 = 54.7° (known as the magic angle), the DQF comprises only of 
the T2±1 term that originates from molecules experiencing anisotropic motion [91]. Thus, DQF spectra 
with a magic angle (DQF-MA) give an indication of order in the tissue or in other words, they 
represent sodium ions in anisotropic motion due to their binding to ordered structures [95]. 
While performing MQF experiments, one has to choose carefully the parameters. MQF signal 
intensities are highly dependent on the preparation time. Each tissue has a characteristic preparation 
time resulting in maximum signal intensity. For TQF sequences, the preparation time U4 can be 
optimized as in [84] to maximize the signal using the short and long relaxation components: 
U4,³<NnÌ =  
ln Í  ÎÏ1 Î +  
1 
 
The optimal evolution time can be also evaluated empirically by stepwise increasing U4 for a 
series of acquisitions. For DQF-MA sequences, the optimum preparation time can be calculated using 
the strength of quadrupolar coupling and the short relaxation component [96]:   
U4,³< ÐÑÒ©ÓÔ = 1Cn tanQ4¿Cn ÎÂ 
Several research groups have demonstrated that MQF methods can be used to study tissue 
samples including tumour growth in brain, liver damage, spinal disc, and myocardial infarction [97]–
[101]. However, one big drawback of MQF remains their sensibility to magnetic field inhomogeneity. 
In the presence of B0 offsets, signal loss occurs because of destructive interference between the 
different coherence pathways contributing to the MQF signal. Thus, B0 and B1 field variations across 
the volumes sample have been proven to introduce a significant bias and lead to unwanted signal 
loss [102], [87], [103]. Nowadays, TQF is preferred over the DQF, because it has a theoretical 50 % 
larger signal amplitude [84], [89]. Several methods have been develop based on TQF to increase the 
poor SNR in still moderate acquisition times and compensate the B0 inhomogeneity sensitivity [104]–
[106]. For example, an extra 180° RF pulse can be applied after the first RF pulse at t = τ1/2 to 
refocus the spin in presence of prominent magnetic field inhomogeneity [88]. Also a combination of 
SQF and TQF method named SISTINA (SImultaneous Single quantum and Triple quantum NMR 
Imaging of 23Na) has been developed in an interleaved fashion to allow simultaneous acquisition of 
TQF and TSC weighted images providing more information for analysis of pathologies [107].  
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Finally, the motivation behind the application of MQF remains the separation of the signals 
from different compartments (intra- vs. extracellular sodium pool). SR experiments investigated the 
contribution of the extracellular Na+ to the MQF signal. The proportion of TQF signal arising from the 
extracellular sodium pool was between 30 to 60 % depending on the experimental set-up [108]–
[111]. Nevertheless, the TQF signal possesses a linear correlation with [Nai] [109], which suggest the 
TQF as a non-invasive tool to monitor intracellular sodium alterations. The ex vivo DQF signal shows 
also dominant contribution from the extracellular sodium pool during SR experiments with FA of 90° 
[112]. If the FA was set to the magic angle, the ex vivo DQF-MA spectrum acquired with SR showed 




3.4    Applications of NMR in the dystrophic skeletal muscle 
In the 1980s, Murphy and his colleagues [113] analysed for the first time systematically 
several muscle disorders including DMD, LGMD, FSHD, and poliomyelitis by NMRI. They were able to 
see common patterns of muscle abnormalities including changes in the muscle size and muscle 
replacement by fat. Since then, different NMR methods have been increasingly utilised to evaluate 
the disease processes in dystrophic muscles. The following section highlights the use of NMR as 
outcome measure (3.4.1) followed by initial 23Na NMR studies on muscular dystrophies (3.4.2).  
3.4.1 NMR-based outcome measures in the dystrophic skeletal muscle 
Dystrophic muscles suffer from important fatty infiltration since fatty tissue replaces 
progressively the muscle tissue. Either chemical shift based imaging methods (Dixon) or single-voxel 
1H spectroscopy can be used to quantify lipid concentrations of muscular dystrophy patients (4.2) 
[12], [114]–[123]. Regardless of the used method, intramuscular lipid fractions in DMD patients are 
higher than in the healthy control group while the fraction increases in a sigmoidal fashion with age 
of the patient [116], [124]–[126] (Figure 23). In the quadriceps, the mean fat fraction (FF) increased 
by an average of 5 % per year starting from an age between three and four years, whereas a cut-off 
value for mean FF of 50 % predicted loss of ambulation [123]. In the forearms, non-ambulant DMD 
patients showed a much faster progression of fatty infiltration when compared to ambulant DMD 
patients [121], [125]. On a one-year corticosteroids treatment, the fatty infiltration progression was 
significantly slowed down for young boys (aged 5 - 6.9 years) [12]. These studies demonstrated the 
drawback of high inter- and intra-individual variability of the disease progression. The different on-
set and non-linear progression of the disease necessitate additional prognostic indices based on 
other measures than fat fraction determination. 
 
Figure 23: Dixon-based fat fraction plotted against the age at baseline and one-year follow 
up. The FF in the upper limb correlated with age. Ambulatory patients are represented in blue, non-
ambulant in red. Adapted from [125]. 
The second frequently used quantitative approach to study muscular structure and 
compositions is T2 mapping (4.4) [127]. Elevated water T2 values, commonly interpreted as an 
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indicator of disease activity, observed in dystrophic skeletal muscles are linked to a variety of non-
specific events like oedema, inflammation, or necrosis that precede the actual muscle replacement 
by fat. Although, there is a big effort to establish T2 as an outcome measure in trials, so far no 
consensus exists regarding the T2 measurement method. Studies report different number of echoes 
and TEs. Most importantly, the T2 decay is mainly fitted to a mono-exponential model resulting in a 
global T2. However, the presence of fat in chronically affected muscle complicates the fitting 
approach: since fat possesses a much longer transverse relaxation time than tissue water, a mono-
exponential fit of non-fat-supressed signal decays result in a global T2 reflecting predominantly the 
degree of fat infiltration [115], [128]–[130]. The global T2 increases with age in muscles of DMD boys 
due to the increased fat fraction [115], [126]. This bias masks possible underlying alterations in 
muscle water T2. Thus, more sophisticated models for water T2 measurement have been proposed 
taking into account the prominent fat infiltration in the dystrophic muscle tissue [131]. Various multi-
exponential models can be used to fit the signal decay with at least two components (fat and water). 
A tri-exponential model with two components for fat and one for water was previously introduced 
[16]. Other models do not rely on exponential curves but instead use exact trajectories of spin 
echoes and stimulated echoes to represent the evolution of the magnetization signal during the 
multi-echo experiment. The EPG formalism has been proposed to model the T2 relaxometry [132]. By 
assuming a multi-component model representing fat and water in muscle tissue, a water T2 can be 
estimated [15].  
 
Figure 24: 1H NMRS based water T2 values for the soleus and vastus lateralis muscles were 
lower in CS boys compared to CS-naïve boys. CS corticosteroid treatment. Adapted from [12]. 
In DMD patients, the water T2 was always elevated compared to healthy boys but decreased 
with age [115], [121]. The muscle water T2 was however not abnormally elevated in the less severe 
form BMD [133]. In the upper arm of ambulatory and non-ambulatory boys, the water T2 values also 
correlated with functional tests [125]. Finally, DMD patients on corticosteroid treatment 
demonstrated lower muscle water T2 than DMD boys without corticosteroids suggesting decreased 
inflammation/muscle damage [12] (Figure 24). These water T2 values seemed even to be too 




healthy subjects. This could hamper the detection of beneficial effects of any additional intervention 
in patients that are routinely treated with steroids.  
Besides the structural changes, dystrophic muscles show also metabolic changes that can be 
assessed by NMRS. It is considered that metabolic and subcellular changes occur even before 
structural changes such as fatty infiltration and fibrosis. Therefore, metabolic alterations could serve 
as a valuable biomarker in muscle diseases. Metabolic ratios obtained by 1H spectroscopy were 
decreased in patients with DMD when compared with controls [134]. The reduced 
trimethylammonium/water ratio might be related to loss of muscle mass. The reduced total 
creatine/water ratio suggests an abnormality in membrane and energy metabolism. 31P NMRS has 
been applied to measure the concentration of phosphorylated metabolites and intracellular pH in the 
sarcoplasm of muscles at rest and during and after exercise. Wokke et al. [53] published recently a 
significantly elevated PDE (phosphodiester)/ATP ratio detected by 31P NMRS in BMD prior to any fat 
infiltration (Figure 25). Elevated PDE/ATP levels could indicate membrane anomalies more precisely 
an increase in the turnover of membrane phospholipids. Their findings evoke that PDE/ATP ratios 
assessed by 31P NMRS could be a useful parameter to monitor the muscle membrane damage in early 
state of disease and before structural changes occur.  
 
Figure 25: PDE/ATP ratios are increased in leg muscles in BMD patients with non-increased 
fat levels (NIFL) and increased fat levels (IFL) compared to healthy controls. * significantly higher 
PDE/ATP in BMD NIFL compared to controls. ▪ significantly higher PDE/ATP in BMD IFL compared to 
controls. GCL gastrocnemius lateralis, GCM, gastrocnemius medialis, PER, peroneus, SOL soleus, and 
TA tibialis anterior [53].  
Compared to healthy controls, DMD patients also showed higher pH, Pi (inorganic 
phosphorus)/PCr (phosphocreatine) ratios, and PDE/ATP ratios in leg muscles indicating anomalies in 
energy and phospholipid metabolism [124], [135]. In dystrophic muscle, increases in the pH could be 
used as a marker of the membrane leakiness and the impairment of ionic intracellular homeostasis. 
Reduced PCr/ATP levels could indicate a loss of metabolic activity/contractile tissue. In the forearm 
of DMD patients, metabolic and pH anomalies were present at early age and the slope of 
degeneration in metabolic ratios increased several fold after loss of ambulation [121]. Another study 
with female carriers of DMD or BMD revealed a higher Pi/PCr ratio during exercise and a lower post-
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exercise recovery of PCr/Pi ratio indicating impairments in muscle energy metabolism not only in the 
patients but also in female carriers who live a normal life [136]. Elevated Pi/PCr ratios indicating 
higher ADP levels relate to a dysregulation of the mitochondrial oxidative phosphorylation control or 
unusual energy demand to preserve the ionic homeostasis. A recently published study investigated 
the origin of the alkaline pH in DMD by comparing the chemical shift of carnosine in the 1H spectrum 
with the chemical shift of the Pi in the 31P spectrum [137]. The pH based on 31P was increased 
whereas the pH based on 1H was not systematically increased in DMD compared to controls (Figure 
26). They concluded that in the group where both pH values were increased, the alkaline change 
originated from the intracellular compartment reflecting ionic dysregulation. For the second group 
with normal intracellular pH (normal 1H-based pH), the increased 31P pH might, as suggested by the 
authors, reflect an expansion of the interstitial volume fraction that is often seen during fibrotic 
changes.   
 
Figure 26: Correlations between the water T2 and 1H-based pH (A) or the 31P-based pH (B). A 
group of DMD patients had normal 1H-measured pH values but elevated 31P-based pH and increased 
water T2. .... cut-off value: mean value plus two standard deviation in young healthy group [137]. 
Although the majority of quantitative NMR studies focuses on DMD/BMD among muscular 
dystrophies, others studies investigated the fat infiltration and/or metabolic changes in more rare 
MD including LGMD 2I [138], [139] and FSHD [140]–[142]. Finally, a multicentre longitudinal study 
with more than 100 DMD patients proved the feasibility of implementing a standardized protocol to 
establish the sensitivity of NMR biomarkers including global T2 mapping and fat quantification across 
multiple vendor platforms [126]. Alterations in the FF, water T2, and metabolic ratios as shown in 
these studies proved that NMR could be a powerful outcome measure for clinical trials. However, a 
predictive and sensitive NMR outcome measure, which is more specific to physiological or 
biochemical changes at early disease evolution, still has to be established. In this manner, 23Na NMR 
could track appearing alterations in the ion distribution that precede any macroscopic degenerative 
changes in muscle tissue. Thus, 23Na NMR presents itself as a promising tool for an early evaluation of 




3.4.2 23Na NMR research in muscle dystrophies 
Since 23Na NMR is still a research tool and not widely used in clinics, only few studies 
investigated the sodium homeostasis in MDs by 23Na NMR. In 2000, Constantinides et al. [143] 
reported an up to 70 % increase of the sodium signal intensity in affected muscles of myotonic 
dystrophy patients when compared with unaffected muscle groups (Figure 27). These results were in 
line with a previous 23Na TQF spectroscopy study of myotonic dystrophy patients, which quantified 
the disease progression by measuring Na+/water ratio and 23Na T2 relaxation times [144]. The total 
sodium levels in the patients increased by up to two fold when compared to healthy subjects. Both 
the Na+/water ratio and the sodium short T2 tended to increase as the disease progresses indicating a 
correlation between 23Na NMR parameters and disease severity.  
 
Figure 27: 1H (left) and 23Na NMR (right) image of a patient with myotonic dystrophy. 
Significant elevations in normalized 23Na signal intensities were measured in the patient (up to 70 % 
compared to not affected side). Adapted from [143]. 
These initial studies suggested in vivo measurement of TSC and 23Na relaxation behaviour as 
a promising tool for the study of physiological and pathophysiological processes in the skeletal 
muscle with possible clinical application in early disease stages. Since then, only few studies have 
been performed on patients with MD. Eleven patients with DMD were examined by 1H NMRI and 
23Na density-adapted 3D radial NMRI sequence (see 4.6.3 for 23Na sequence) [14]. DMD boys 
demonstrated higher muscular fat content and oedema-like changes than in volunteers. The patients 
furthermore demonstrated considerably increased TSC with an average of 38.4 mmol/L compared to 
age-matched control group with an average TSC of 25.4 mmol/L. In DMD patients, the 23Na IR signal 
intensity was also increased to 0.77 a.u. compared with 0.50 a.u. in volunteers. The IR signal intensity 
and TSC were slightly higher in the older than in the younger DMD patients, whereas patients 
without glucocorticoid medication demonstrated higher sodium values than treated patients. Seven 
patients were then re-examined about seven months later with the same NMR protocol [60]. At the 
second visit, the 23Na IR signal intensity and TSC remained constant as did the oedema-like changes 
and fat content. They further suggested that elevated muscular sodium concentration in DMD could 
cause muscle oedema, which was present in all participating DMD patients. If the oedema is mainly 
osmotic rather than inflammatory, diuretics could replace the glucocorticoid treatment, which 
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demonstrates grave adverse effects such as weight increase, osteoporosis, and cortisone-induced 
cardiomyopathy [145].  
 
Figure 28: Temporal changes of TSC in DMD patients before and after start of treatment. 
While the first patient (on the left) underwent eplerenone treatment, the second patient (on the right) 
was under glucocorticoid treatment. Both DMD patients were seven years old. 23Na signals were 
normalized using one phantom filled with 51.3 mM NaCl in 5 % agarose [145]. 
In a pilot study, they therefore addressed the question if the treatment of the dual overload 
of sodium ions and water has a beneficial effect on the dystrophic process. One DMD patient, who 
had so far no glucocorticoid therapy, started the treatment with eplerenone, a diuretic drug with a 
high repolarising power [146]. During seven months of treatment, the cytoplasmic sodium and water 
overload decreased slightly paralleled with increased muscle strength and mobility (Figure 28). They 
concluded that the diuretic treatment has a beneficial effect and oedema should be treated before 
the deleterious fatty degeneration takes place. In line with this observation, another two DMD boys 
were examined by 1H and 23Na NMRI, one with glucocorticoid and the other with eplerenone 
treatment [145]. The TSC and 23Na IR signal intensity decreased during the six-month treatment in 
both treated DMD boys at roughly 20 %, whereas the fatty infiltration remained constant. The 
muscular water content was more reduced in the boy with eplerenone treatment. Nevertheless, the 
clinical abilities of both DMD patients were mostly constant. These studies confirmed that 23Na NMRI 





One of the big limitations of these initial studies are the small number of subjects. Due to the 
low to very low incidence of MD, patient recruitment is a lengthy and difficult task. Furthermore, 
clinical 23Na NMR is still in its infancy. So far, these studies demonstrated only the feasibility to 
quantify changes of sodium homeostasis in different muscle pathologies with known sodium 
impairments. In general, no consistency exists as to the 23Na quantification. Studies on muscle TSC 
quantification report different echo times and repetition times. The sodium nuclei however possess 
ultra-short and bi-exponential relaxation behaviour, which makes specialized (UTE) NMRI sequences 
for quantification necessary. Absolute TSC quantification is subjected to confounding effects of T1, T2 
relaxation, and B1 inhomogeneities. Thus, tissue and reference signals require corrections for T1 
saturation and T2 decay if not taken into account in the experimental design. Furthermore, the 
calibration of the signal should be standardized for reproducibility between different sides. In 
literature, one can find signal calibration approaches based on one to four standard phantoms with 
different concentrations of NaCl and with or without agarose. However, agarose phantoms mimic 
better the bi-exponential relaxation behaviour of skeletal muscle tissue.  
Other concerns affect the origin of the signal and interpretation of the results. In patients 
with a significant fat infiltration, partial volume effects may lower the measured TSC, since fat tissue 
has lower sodium concentrations than muscle tissue. This has not yet been taken into account. Also, 
intra- and extracellular sodium cannot be currently unambiguously distinguished without the use of 
toxic shift reagents. The intracellular weighted sodium signal is commonly obtained by IR 
experiments in human. Nevertheless, the contribution of the extracellular 23Na signal in this 
approach remains unclear. Another interesting contribution would be a combination of measured 
alterations of Na+ levels with metabolic changes. Adding 31P NMRS or 1H NMRS to the 23Na protocols 
could help to better understand the underlying pathophysiological changes. 
23Na NMR started at standard clinical field strength below 3 Tesla, but nowadays several 
studies have been carried out at (ultra-) high magnetic fields, which potentially offers an increased 
spatial resolution and faster scanning. The 3D density-adapted projection reconstruction sequence 
used in the DMD studies quantifies the TSC within less than ten minutes with a nominal spatial 
resolution of 5 × 5 × 5 mm3 at 3T [83]. At 7T, the feasibility of performing a 3D gradient-echo radial 
23Na image of human skeletal muscle with a spatial resolution of 4 × 4 × 4 mm3 has been 
demonstrated with an acquisition time of less than seven minutes [147]. Another group published a 
time-efficient interleaved 23Na and 1H imaging approach consisting of Dixon and T2* mapping 
sequences as well as TSC and 23Na IR sequences [148]. Their protocol was completed within 30 
minutes at 7T, which allows new promising clinical protocols within a relevant timescale. To make 
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this recent development of 23Na NMR possible, many challenges have been tackled that are caused 
by the low SNR in biological tissues. Besides, 23Na spectroscopy could provide a fast approach to 
distinguish fast and slow relaxing sodium ions if exact localization of signal is not important. 
Nevertheless, the main issue remains: to be successful in clinical settings, 23Na NMR needs to add 






Methods for quantitative NMR 
acquisitions in the skeletal muscle 
This chapter introduces the NMR sequences and the corresponding postprocessing tools that 
have been implemented and used during the course of the thesis. After the description of the 
hardware (4.1), I will briefly describe 1H imaging and spectroscopy sequences for fat fraction (4.2), 
global T1 (4.3) and muscle water T2 (4.4) quantification. Furthermore, two different approaches to 
measure the muscle tissue pH are explained in few words (4.5). Finally, 23Na NMR spectroscopy and 
imaging sequences are presented to assess the sodium distribution in healthy and dystrophic skeletal 
muscle. A short, non-localized 23Na spectroscopic protocol, which includes FID, TQF, and inversion-
recovery Look-Locker (IR-LL) sequences, will be introduced in more detail (4.6.1) as well as the DQF-
MA sequence (4.6.2) that was applied on healthy skeletal muscle. Then, a density-adapted 3D radial 
sequence is presented for fast 23Na imaging of the leg (4.6.3).  
4.1    Hardware 
4.1.1 NMR scanners 
The human NMR experiments were performed on the 3T whole-body NMR scanner (TIM 
TRIO; upgraded to PRISMA FIT in January 2015; SIEMENS Healthineers, Erlangen, Germany) at the 
Institute of Myology in Paris. Experiments in Erlangen were performed using the 3T whole-body NMR 
scanner (Magnetom SKYRA; SIEMENS Healthineers, Erlangen, Germany) at the Imaging Science 
Institute at the University Hospital Erlangen. All animal experiments were conducted using a small-
animal NMR scanner (Bruker Pharma Scan 7T, bore diameter 16 cm using ParaVision Version 6) 
located at the Institute of Myology in Paris. 
4.1.2 Coils 
At 3T, 23Na NMR sequences were first acquired with a homemade linear volume 23Na knee 
coil (inner diameter 16 cm with a length of 15 cm). From 2016 onwards, 23Na NMR acquisitions were 
performed with a new 23Na knee coil showing a higher B1 homogeneity (inner diameter 18 cm with a 
length of 16 cm; Stark Contrast, Erlangen, Germany). While proton acquisitions were performed with 
a 15-channel 1H knee coil (SIEMENS Healthineers, Erlangen, Germany). 
At 7T, a whole-body 38 mm-linear 1H coil (Bruker, Billerica, USA) was used for the 1H 
sequences as well as for anatomical reference imaging and B0-mapping for X-nuclei acquisitions. 23Na 
NMR sequences were acquired with a homemade saddle-shaped 23Na transceiver coil (inner 
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diameter 10 mm, length 10 mm). A homemade saddle-shaped 31P coil with 8 mm diameter and 10 
mm length was used to acquire 31P spectra of the murine leg. During the murine ischemia 
experiments, the lower leg was scanned using a homemade saddle-shaped 1H coil (10 mm diameter 
and 10 mm length). 
4.2    Fat quantification 
The fat content of the skeletal muscle was measured to evaluate the disease progression in 
dystrophic muscles. The so-called Dixon method named after its inventor was used for the clinical 
study on DMD patients [149]. This commonly used imaging method quantifies the fat content in 
skeletal muscle and relies on the chemical shift between fat and water signal. Since no Dixon method 
was implemented on the 7T preclinical machine, we measured the fat fraction in murine muscle by 
localized 1H spectroscopy. 
4.2.1 1H spectroscopy 
1H spectroscopy is the gold standard for fat quantification. In tissue, the 1H NMR spectra is 
dominated by the water peak as the other 1H containing metabolites have a more than 1000 fold 
lower concentration. Water suppression techniques like VAPOR (variable power and optimized 
relaxation delays) suppress completely or partially the water resonance. Figure 29 displays a water 
supressed 1H spectrum from the murine skeletal muscle with different lipid resonances. The signals 
between 0.8 and 2.8 ppm (Lipid -CO-CH2-(CH2)n and lipid -(CH2)n and -(CH3)) originate from methylene 
and methyl protons of triglycerides or fatty acids [150]. Downfield relatively to the water signal at 4.7 
ppm, olefinic protons resonate between 5.3 and 5.7 ppm (Lipid -HC=CH-).  
 
Figure 29: Typical localized in vivo 1H NMR spectra from a murine skeletal muscle (acquired at 
7T) with water suppression showing the different resonances originating from lipids.  
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In our murine experiments, two 1H spectra were obtained: one with water peak suppression 
using VAPOR (variable power and optimized relaxation delays) and an unsuppressed water spectrum. 
The area under the curve was integrated for each of the three lipid peaks from the water supressed 
spectrum. In the unsuppressed spectrum, the area under the water peak was integrated. The values 
of water and lipids were divided with factorcorr to correct for T1 relaxation effects due to the short 
repetition time: 
¶I,'-WÕ³bb = 1 +  TQNN4  
Where T1 is the longitudinal relaxation time of fat and muscle (T1 of fat 535 ms and T1 of 
muscle 1684 ms, obtained at 7T from T1 measurements) and TR the repetition time of the 
experiment. Fat ratios for each voxel were then calculated using the lipid and fat peaks: 
¼I' WI'×- =  WTI*9 4 + WTI*9  + WTI*9 XWTI*9 4 + WTI*9  + WTI*9 X +  WTIØ 
Where Lipid 1 corresponds to the lipid signals in the range of σ = 0.8 - 1.8, Lipid 2 to the signal 
in the range of σ = 2 - 2.8, and Lipid 3 to the olefinic protons (σ = 5.3 - 5.7).  
4.2.2 Dixon 
The Dixon method [149] relies on the chemical shift difference between water and fat that is 
used to generate phase differences. Originally, two gradient echo images are acquired with different 
TEs (2-point Dixon): one with fat and water signals in phase at the centre of the echo (IP) and another 
with a different TE so that the fat and water signals are out-of-phase (OP).  
Ù = Ú + ¼ and ÛÙ = Ú + ¼ 
W and F are the signal contributions from water and fat, respectively. The sum and 
difference for each pixel of the in- and out-of-phase images result in a water (W) and fat image (F): 
ÝµÞÝ
 = 7ßµÌ8µ7ßQÌ8 = Ú and ÝQÞÝ = 7ßµÌ8Q7ßQÌ8 = ¼ 
In off-resonance conditions, the classical the 2-point Dixon approach is prone to errors in the 
decomposition of F and W images. Today, several modified approaches overcome B0 inhomogeneity-
related artefacts including the 3-point Dixon that was used in our studies [151]. Images are acquired 
with three different echo times [151], generally in - out – in conditions, so B0 maps can be obtained 
to correct water and fat signals for each pixel. The corresponding fat fraction maps (FFmap) are 
generated by computing the ratio between the fat signal and the sum of water and fat signal:  
¼¼àIá =  ¼àIá7¼àIá +  ÚàIá8 
Figure 30 shows the fat map (Fmap) and the water map (Wmap) with the resultant FFmap 
obtained in the calf of a young woman.  




Figure 30: The fat fraction map (FFmap) are generated by computing pixel wise the ratio 
between the fat map (Fmap) and the sum of water map (Wmap) and fat map (Fmap) based on the 3-
point Dixon approach. 
4.3    Fast T1 measurement 
 The muscle longitudinal relaxation time represents a fundamental tissue property that can 
change in the course of different pathological processes. For example, T1 time lengthens with 
interstitial expansion as a result of oedema or fibrosis and shortens in the presence of fat. The 
spatially resolved quantification of T1, so called T1 mapping, represents thus a promising tool to 
investigate muscle diseases. Due to the impractical long acquisition times with the gold standard 
inversion-recovery method [152], fast acquisition scheme have been used in our study. For the 
characterization of the murine dystrophic muscle, we acquired a fast spin echo sequence, namely 
RARE, at different repetition times. 
4.3.1 Fast spin-echo sequence 
The Rapid Acquisition with Relaxation Enhancement (RARE) sequence is based on multiple 
spin-echoes (Figure 31). Thereby, n 180° pulses are applied after every excitation RF pulse leading to 
n echoes. After each refocusing pulse, the echo undergoes a different amount of phase-encoding, so 
that each echo can be used as different line in the k-space of an image. With a RARE factor of eight, a 
multiple-echo sequence with eight echoes contributes eight phase-encoded lines to a single image or 
four phase-encoded lines if two images are acquired. This approach reduces the number of required 
excitations and thus also the acquisition time. However, each line has a different echo time hence T2 
weighting, which limits the acceleration that can be achieved for quantitative mapping. As a trade-
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off, we acquired our images with a RARE factor of eight. Before the echo train, a saturation recovery 
module using a spoiler gradient of 4.2 ms duration is launched. For the T1 mapping, we acquired 19 
images with the RARE sequence with different TRs: 54.6, 100, 200, 300, 400, 500, 600, 700, 800, 
1000, 1300, 1600, 200, 2400, 2900, 3400, 4000, 5000, and 6500 ms. The total acquisition time was 
less than eight minutes. In each pixel, the T1 value was then computed using a mono-exponential 
model:  
7 â8 =   ã1 +  TQ NNS ä 
Where S7TR8 is the signal for a given repetition time TR, T1 the longitudinal relaxation time, 
and A the thermal equilibrium magnetization.  
 
Figure 31: General diagram of the RARE sequence showing the RF-pulse sequence and 
sampling scheme of the k-space. The individual echoes are used to fill the lines of the k-space of a 
single image. 
4.4    Water T2 measurement 
Elevated water T2 values are linked to a variety of non-specific events like oedema, 
inflammation, or necrosis. Commonly, the T2 decay of the signal obtained with a multi-spin echo 
sequence is fitted to a mono-exponential model resulting in a global T2. However, the presence of fat 
in chronically affected muscles complicates the interpretation of the extracted T2, because fat 
possesses a much longer transverse relaxation time than tissue water. Thus, mono-exponential 
fitting of non-fat-supressed signal decays results in elevated global T2 values that predominantly 
reflect the degree of fat infiltration in MD patients. For this reason, we used a tri-exponential model 
that accounts for water and fat signal to characterise the disease activity of dystrophic muscles. 
4.4.1 Advanced models for water T2 mapping 
The T2 relaxation times are commonly extracted from so-called T2 maps. We generated water 
T2 maps from a standard multi-slice multi-echo sequence (MSME). During the NMR experiment, 
several echoes (between 17 and 32) were recorded after the RF excitation pulse by a spin-echo train 
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to measure the transverse magnetization in several slices during the same TR (Figure 32). The echo 
amplitudes are steadily decreasing in intensity due to coherence losses between the nuclei spins of 
the sample representing the decay of T2.A theoretical model is then fitted to the resulting amplitudes 
of the echo train.   
 
Figure 32: The spin echo pulse sequence consists of an initial 90° RF pulse followed by train of 
180° RF pulses and results in multiple spin echo formations.  
We computed the water T2 value in each pixel using the tri-exponential model introduced by 
Azzabou et al. [16]. This approach determines the water T2 since the multi-exponential model 
accounts for the water and fat components. 
 
Figure 33: Plot of 1H T2-decay curve of muscle tissue obtained for a healthy subject. Examples 
of images acquired at different echo times are assigned to the relaxation curve. The green line fitting 
the blue points corresponds to the tri-component exponential fit without the two first points. T2 
values are calculated pixel wise to compute the corresponding T2 map. 
Figure 33 presents one example of the 1H T2 decay curve fit and corresponding water T2 maps 
obtained in a young woman. The signal decay is fitted with the following three-component model: 
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Where S7TE8 is the signal for a given echo time TE. T2fl and T2fs are the long and short T2 
times of the two fat components, respectively. T2m is the T2 of the muscle water component. Af and 
Am are the two coefficients reflecting the proportion of fat component and muscle water in the 
signal, respectively. cl and cs are coefficients of the bi-exponential model of fat. The choice of a bi-
exponential model for the fat signal was due to better fitting results than with a mono-exponential 
model, thus had no physiological reasons. The fat parameters were fixed to T2fl = 544 ms and T2fs = 
81 ms, cl = 0.33 and cs = 0.67, according to previous measures on the subcutaneous fat of healthy 
volunteers. The parameters T2m, Af and Am are computed excluding the first two echoes to minimize 
the impact from stimulated echoes. Additionally, fat fraction maps can be calculated as the ratio 
between the fat proton density and the sum of the water and fat proton densities: 
¼¼ =  c7, +  ,Î8c7, + ,Î8 +  1.8 ^ 
The water signal was corrected with a factor of 1.8 for multi-slice acquisitions to take into 
account the magnetization transfer process [16].  
4.4.2 Multi-component water T2 relaxation evaluation using ISIS-CPMG  
Changes in the water T2 value as obtained from the above-described water T2 maps are non-
specific and reflect overall (patho-) physiological alterations in any anatomical compartment. A 
combination of the basic spectroscopic CPMG sequence with volume selection techniques permits an 
evaluation of multi-T2 relaxation behaviour of tissue water. Studies based on such techniques have 
already demonstrated a multi-exponential behaviour of T2 relaxation in skeletal muscle [153]–[155]. 
In tissue, we would expect water molecules in at least two different environments. On one hand, 
“bound” water, which is in strong electrostatic dipole-dipole interactions with macromolecules, 
shows increased correlations times due to the restricted movement. On the other hand, “free” 
water, which can be found in the so-called bulk aqueous phase, is far enough from the these 
macromolecules leading to hydrogen bonding characteristics closer to pure water. Proton exchanges 
between bound and bulk water pools could then affect the entire tissue relaxation characteristic. 
Indeed, several studies observed three different fractions in the spin-echo decay of tissue water 
protons [153], [156]–[158]; one “short” component (T2 < 10 ms with a fraction of less than 15 %), an 
“intermediate” component (T2 between 20 and 50 ms with a fraction around than 80 to 90 %), and a 
“long” component (T2 > 100 ms with a fraction of less than 15 %). While the short component is 
commonly attributed to “bound” water, the intermediate and long components correspond to the 
bulk water pool. During the course of this work, the multi-T2 relaxation of skeletal muscle tissue was 
characterized using the ISIS-CPMG method that was implemented by Araujo et al. at the Institute of 
Methods for quantitative NMR acquisitions in the skeletal muscle
 
62 
Myology [17]. With this method, we can gain insight in the water distribution within muscle tissue 
(intracellular, interstitial, and vascular compartment).  
Figure 34 shows the RF pulse diagram of the CPMG sequence with a preceding ISIS 
localization module. In order to assure a complete selection of a volume of interest, the sequence 
has to be repeated eight times while three orthogonal slices of the ISIS module are selectively 
inverted. In the first loop, no inversion occurs, then from loop two to four, the three orthogonal 
slices are inverted, one by one (Acqu 2, Acqu 3 and Acqu 4). In loop five to seven, two of the three 
orthogonal slices are inverted per acquisition loop, varying the selected duo of slices (Acqu 6 and 
Acqu 7) and finally, all three orthogonal slices are inverted in loop 8 (Acqu 8). In each loop, a CPMG 
pulse train is launched just after the ISIS localization and fat-suppression module.  
 
Figure 34: General diagram of the ISIS-CPMG method showing the RF-pulse sequence and 
slice-selecting gradient. Signal localization is achieved by the ISIS method using inversion pulses that 
are selectively turned on following an eight-step combination (Acqu 1 to 8). A fat-suppression module 
is launched just after the ISIS module to supress the unwanted signal from intramuscular lipids. Then, 
the signal of the CPMG echo train is acquired.   
1H T2 spectra were obtained from the signal decay curves by the deconvolution method 
presented in the study of Araujo et al. [17] (Figure 35). The transverse relaxation decay can be 
described by the following matrix equation: 
ç =  ( Ù +  
Where Y is the vector containing the signal amplitudes at each echo time, P is the unknown 
vector containing the relative fraction of protons with a decay constant T2. A is a matrix containing 
the echo times and a number of possibly observable T2 values. E is the vector containing the 
corresponding measurement error. A solution for the ill-posed Laplace transform inversion problem 
can be solved using a regularized minimization approach: 
Ù =  minÝ ê ë ‖ç +  (  Ù‖ +  º ‖Ù‖ í 
4.5 Water T2 measurement 
 
63 
Where α is the L2- norm regularization parameter controlling the smoothness of the solution. 
Using a non-negative least-mean squares algorithm, spectra of the different T2 contributions were 
extracted. In skeletal muscle tissue, the proton T2 spectrum contained typically two separated T2 
pools with relative fractions and T2 values representing fast and slow relaxing components. Since two 
peaks were systematically observed in healthy subjects, we also compared the results to a non-linear 
bi-exponential fit in the following studies. This approach allows estimating confidence intervals for 
the calculated T2 values and fractions, which are difficult to assess using the T2 spectrum approach. 
Araujo et al. [17] attributed the short T2 component (T2 around 30 ms) to the relaxation behaviour of 
water in exchange between the intracellular and interstitial spaces and the long T2 component (T2 > 
100 ms) to the relaxation of water within the vascular space.  
 
Figure 35: Plot of 1H T2-decay curve obtained from the gastrocnemius medialis muscle of a 
healthy, male subject. The green line fitting the blue points corresponds to the fitted curve resulting 
from the regularized inversion solution using a nonnegative least-square method. The corresponding 
T2 spectrum shows two distinct T2 components characterized by their relative fraction and T2 value. 
Typical values in accordance with literature were observed: T2,s = 31.5 ms with relative fraction of 0.93 
and T2,l = 100.7 ms with relative fraction of 0.07. 
4.5    pH measurement 
Two different techniques were used to measure the pH of the dystrophic skeletal muscle 
tissue. The classic approach based on 31P spectroscopy was used on the preclinical 7T scanner. Since 
no 31P NMR coil was available in Erlangen, we had to measure the pH based on 1H spectra in the 
course of the DMD study. 
4.5.1 31P spectroscopy 
Several resonances such as Pi and γ-ATP are sensitive to physiological parameters including 
the pH. Assuming a pH-independence of PCr, measurement of the chemical shift difference between 
Pi and PCr represents one of the most used pH determination method in skeletal muscle (Figure 36).  




Figure 36: Typical in vivo 31P NMR spectrum from a murine skeletal leg (non-localized 
acquisition at 7T) showing relevant 31P containing metabolites such as adenosine triphosphate (ATP), 
phosphocreatine (PCr), and inorganic phosphate (Pi). By measuring the chemical shift difference 
between the Pi and PCr resonances, the pH can be determined. 
The pH can be measured using the PCr resonance as reference peak using the modified 
Henderson-Hasselbach equation [64]: 
áï = áðI + log  ] + ]Ø^_<`a]^_<`a +  ]  
Where pKa is the logarithm of the equilibrium constant for the exchange between the 
protonated and unprotonated form of the metabolite and δHmetab and δmetab the chemical shift of the 
protonated and unprotonated form of the metabolite, respectively. Based on pH calibration curves, 
values for pKa, δHmetab, and δmetab have been calculated for different metabolites that show a 
dependence on the pH. In our case, the chemical shift difference ]Ý  between the Pi and PCr 
resonances was used for pH measurement, resulting in the equation [159]: 
áï = 6.75 + log  3.27 + ]Ý]Ý +  5.69 
The cytosolic pH is commonly measured from the chemical shift difference between the Pi 
and PCr. However, in dystrophic muscles a second more alkaline resonance (Pib) at 0.3 ppm 
downfield from the cytosolic Pi (Pia) was observed [160]. Whereas the Pia peak has an intracellular 
origin, the origin of observed Pib remains uncertain. It could be either resulting from leaky dystrophic 
myocytes or from an increased interstitial space, thus being from extracellular origin [137].
4.5.2 1H spectroscopy 
The pH can also be measured using 1H NMRS exploiting the carnosine metabolite that 
resonates on the left side of the water signal (Figure 37). In resting muscle, carnosine can be found 
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only in the sarcoplasm, since extracellular carnosine is quickly degraded [137]. In the 1H spectrum, 
the resonances of carnosine are visible at around 7 and 8 ppm (-C4-H and -C2-H, respectively). Both 
resonances are sensitive to pH changes and based on their chemical shifts the intracellular pH can be 
measure using the water resonance as reference. We used the chemical shift difference ]VQØ 
between the -C2-H and residual water resonances to determine the pH [161]: 
áï = 6.81 + log  8.57 + ]VQØ]VQØ +  7.65 
 
Figure 37: Typical localized in vivo 1H NMR spectra from a voxel within the gastrocnemius 
muscle of a healthy human subject (acquired at 3T) A) with imperfect water suppression. B) In 1H 
NMR, intracellular pH measurement is based on the shift between the carnosine peaks at around 8 
and 7 ppm and the water peak (zoom of A). 
4.6    23Na NMR methods for sodium quantification 
4.6.1 Development of a non-localized 23Na NMR protocol 
 In general, 23Na NMR imaging sequences have long acquisition times that prevents their 
frequent application in clinical settings. Therefore, we implemented a non-localized 23Na 
spectroscopy protocol for skeletal muscle characterization that can be added to clinical studies since 
the acquisition time was limited to about 15 minutes.  
Three different sequences for seven sodium indices 
This multi-parametric protocol aims to derive quantitative indices reflecting the sodium 
distribution and interactions with macromolecules in the skeletal muscle, in particular the 
intracellular sodium content and the extracellular volume fraction.  
Before 23Na NMR acquisition, a B1+ calibration sequence using rectangular pulses determined 
the reference voltage for a 90° excitation pulse (Figure 38). A set of forty FIDs was acquired (TR/TE = 
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300/0.2 ms, number of experiments (NEX) = 5, FA = 90°, bandwidth (BW) = 2.5 kHz, vector size = 128 
points) with step-wise increased transmitter voltage (from 0.6 ⨯ V0 to 1.4⨯ V0, V0 = 100 V). The 
voltage corresponding to the highest signal intensity was then applied as the reference voltage for 
the entire 23Na NMR protocol. 
 
 
Figure 38: Voltage calibration for the 23Na NMR protocol: the RF voltage to produce a 90° FA 
was determined by increasing stepwise the emitter voltage. The voltage resulting in the highest signal 
intensity was used for the 23Na protocol acquisition. 
Figure 39 depicts the RF pulse sequences of the non- localized 23Na protocol that includes 
FID, TQF, and IR-LL sequence. The FID was acquired with a relatively long TR of 300 ms to allow full 
signal recovery after excitation. After a 90° excitation pulse, the signal decay was acquired with a 
short delay time of 200 µs to collect the signal from the fast T2 component. For phantom studies, the 
receiver BW was set to 2 kHz with a vector size of 256 points. 400 averages lead to a total acquisition 
time of two minutes. After data reconstruction, the area under the curve was calculated from the FID 
spectra in order to derive the total sodium signal. In addition, T2* spectra were first obtained from 
the temporal decay of the FID by the T2* deconvolution method presented in the study of Araujo et 
al. [17] (Figure 40, see paragraph 4.4.2). The 23Na T2*-decay curve was fitted using a nonnegative 
least-square method to extract T2* spectra. In biological tissue, the T2* spectrum contained 
systematically two separated T2 pools with relative fractions and T2* values representing the fast and 
slow relaxing components. Since two peaks were thoroughly observed, a bi-exponential model was 
used in our studies to fit the 23Na transverse relaxation decay, which allowed estimating confidence 
intervals. Thus, the FID sequence gives rise to the FID signal in arbitrary units (a.u.), a short T2* and 
long T2* in the order of few ms, as well as their relative fractions.  




Figure 39: RF sequence diagram for 23Na spectroscopy protocol that includes non- localized A) 
FID, B) TQF and C) IR-LL sequences. Next to the sequence diagram, corresponding human in vivo 
spectra are plotted for the FID and TQF sequence (acquired at 3T). Note the difference in the signal 
intensities between the FID and TQF signal. The IR-LL data was fit with a mono-exponential model to 
obtain a global T1 of the leg. TE echo time, TR repetition time, ɸ1, ɸ2, ɸ3 phase of pulses, TI inversion 
time, ES echo spacing.  
The selection of TQC (Figure 39B) was realized by a six-step phase cycling scheme [104] with 
three 90° excitation pulses of different phases (ɸ1 = 30°, 90°,150°,210°,270°, and 330°; ɸ2 = ɸ1 + 90°; 
ɸ3 = 0°). To increase the SNR, the number of repetitions was set to 3000 using a receiver BW of 2 kHz 
and a vector size of 256 points. To limit the acquisition time to five minutes, a TR of 100 ms was 
chosen. After reconstruction, the area under the curve was calculated from the TQF spectra in order 
to derive the signal of motionally restricted sodium ions. Additionally, the TQF/FID signal ratio was 
calculated indicating the distribution of ions between motionally restricted compartment and the 
total sodium pool. 




Figure 40: Plot of 23Na T2*-decay curve obtained for a healthy subject. The violet line fitting 
the blue points corresponds to the fitted curve resulting from the regularized inversion solution using 
a nonnegative least-square method. The corresponding T2* spectra shows two distinct T2* 
components characterized by their relative fraction and T2* value. Typical values in accordance with 
literature were observed: T2,s* = 0.9 ms with relative fraction of 0.38 and T2,l* = 13.4 ms with relative 
fraction of 0.62. 
To measure the global 23Na T1, the inversion-recovery Look-Locker sequence was acquired 
(Figure 39C). After the inversion pulse, a series of α° excitation RF pulses is applied to probe the 
apparent longitudinal relaxation. The echo train was performed with 75 equally distributed TI ranging 
from 5 ms to 375 ms, a FA of 3° and a short acquisition time of 1 ms with an acquisition BW of 10 kHz 
and a vector size of 32 points. In total, 950 echo train experiments were acquired with a TR of 450 ms 
resulting in a total acquisition time of seven minutes. T1 relaxation time was estimated from the IR-LL 
sequence by a mono-exponential model of the signal recovery at different time-points after 
magnetization inversion. 
Validation of the sequences in phantoms 
A validation on phantoms of the 23Na protocol was performed on the 3T scanner in Paris. TQF 
experiments were performed with τ1 = 11 ms, τ2 = 200 µs, and τ3 = 350 µs. The test included 
phantoms with same size, but different agarose (0.2, 0.5, 1, and 2 %) or NaCl (80, 120, 140, 160, and 
200 mM) concentrations (Figure 41). As expected, the FID signal increases with higher NaCl 
concentrations (R = 0.984), which represents the increasing number of sodium ions within the 
phantom. The FID signal decreases with higher agarose concentrations, in other words in higher 
motionally restricted media. This observation is due to the bi-exponential relaxation behaviour under 
conditions of restricted mobility (R = -0.911). In contrast, the TQF signal increases with higher 
agarose concentration since it originates from motionally restricted sodium ions (R = 0.998). The 
global T1 value shortens, due to the bi-exponential relaxation behaviour if the agarose concentration 
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is increased (R = -0.985). These in vitro observations were in line with previous studies performed on 
agarose or gelatine gels [162]. 
 
Figure 41: Correlation of FID signal with different concentrations of NaCl and correlations of 
FID signal, TQF signal, and T1 value with different concentrations of agarose. 
To calibrate and quantify the non-localized 23Na signals, a calibration phantom containing a 
shift reagent (TmDOTP5-) was placed next to the leg during 23Na acquisition. This SR phantom was 
filled with 140 mM NaCl and 24 mM TmDOTP5-. The signal calibration steps and its evaluation are 
explained in more detail in 5.2. The 23Na non-localized NMR protocol was also transferred from the 
human clinical scanner to the preclinical scanner for animal investigations. 
4.6.2 Double quantum filter with magic angle sequence 
To investigate quadrupolar interactions between the 23Na nuclei and their environment, a 
DQF-MA sequence (3.3.3) was implemented at the clinical scanner in Erlangen.  
The slowly tumbling 23Na nuclei in an anisotropic environment were measured with at the 
magic angle 54.7° (Figure 42). The DQF-MA was realized by a 4-steps-phase cycling scheme with the 
magic angle for the second and third RF pulse to suppress unwanted signal of third-rank DQC (Θ1 = 
90°, Θ2 = Θ3 = 54.7°, ɸ1= 0°, 90°,180°, and 270° ; ɸ2= ɸ1 ; ɸ3=0). To increase the SNR, the number of 
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repetitions was set to 2000 using a receiver BW of 5 kHz and a vector size of 256 points. To allow full 
relaxation a TR of 200 ms was chosen. After reconstruction, the area under the curve was calculated 
from the DQF-MA spectra in order to derive the signal of sodium ions in anisotropic motion. 
Additionally, the DQF-MA/TQF signal ratio was calculated indicating the fraction of motionally 
restricted ions in an anisotropic environment. 
 
Figure 42: RF sequence diagram for 23Na DQF-MA spectroscopic sequence. Next to the 
sequence diagram, corresponding human in vivo spectrum is plotted (acquired at 3T). TR repetition 
time, ɸ1, ɸ2, ɸ3 phase of pulses. 
4.6.3 Fast 23Na NMR imaging sequences 
 With the above-introduced non-localized protocol, the spatial information of the 23Na signal 
is lost. During this PhD, we set up a collaboration with a German team in Erlangen to assess ionic 
disturbances in the dystrophic muscle of DMD patients. They have developed a fast NMR 23Na 
imaging sequence for skeletal muscle tissue characterization. Here, the theory of this sequence will 
be briefly introduced followed by a presentation about 23Na NMRI signal calibration. 
Density-adapted 3D radial projection pulse sequence  
Because the sodium nucleus exhibits a bi-exponential relaxation with a fast component of 
around 1 ms in biological tissues [143], dedicated NMR pulse sequences with very short TEs are 
needed to record the complete relaxation behaviour. This reduction of the TE is achieved by different 
k-space sampling schemes such as sampling on centre-out radial lines (Figure 43B). The excitation 
pulse is followed immediately after a required hardware-dependent delay (e.g. 50 µs) by the signal 
acquisition. In a conventional radial gradient readout, the centre of k-space is more densely sampled 
as less points are acquired in the outer part due to the homogenous sampling speed of each radial 
spoke. This decreases the already poor SNR of the 23Na signal [13]. An inhomogeneous sampling 
scheme can result in an increase of image noise, since the SNR efficiency η is defined as [163]: 
Y =  \,õ³^\,´õ³^ 
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Where σ÷,øùú and σ÷,÷ûøùú are the standard deviations in image space for homogenous and 
inhomogeneous sampling densities, respectively. Thus, by manipulating the readout gradient during 
signal acquisition, the sampling scheme is changed from an inhomogeneous to a more homogenous 
distribution of the sampling density of the k-space.  
 
Figure 43: A) RF pulse and gradient diagram of the 3D radial sequence with i) a conventional 
gradient readout and ii) a density-adapted gradient readout. The conventional gradient readout uses 
a constant gradient strength after the gradient ramp, while the density-adapted readout gradient 
consists of three parts: (1) the gradient ramp, (2) a trapezoidal part with gradient strength G0, and (3) 
a density-adapted part that starts after t0 allowing in the following constant sampling density in the 
outer part of the k-space. B) Radial sampling scheme of the k-space: without density-adapted 
sampling, the centre of k-space is more densely sampled than the outer part. By manipulating the 
readout gradient, the sampling velocity is slowed down in the outer part of k-space leading to a more 
homogenous sampling scheme. 
Therefore, Nagel et al. [18] introduced a density-adapted 3D radial projection pulse sequence 
(DA-3DPR). Changes in the sampling density are achieved by manipulating the readout gradient 
during data acquisition (Figure 43A). As aforementioned, it is desirable to achieve a uniform sampling 
density throughout the k-space. However, due to hardware limitations (maximal possible gradient 
amplitude and slew rate), gradients cannot be designed in such a way that the averaged sampling 
density of k-space is constant. Thus, the density-adapted approach starts with an inhomogeneous 
sampling density during the ramp and the trapezoidal part with gradient strength G0. The period t0, 
corresponding to the time needed for the ramp and trapezoidal part, is kept as short as possible. 
Then, uniform sampling can be achieved for k-space by slowing down the sampling velocity in the 
outer part of k-space by reducing the amplitude of the readout gradient. The gradient strength after 
t0 is described by:  
ü7'8 =  ü 73  ü7' + '8 +  X8Q/X 
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Where k0 is the radius of the k-space at t0 and γ the gyromagnetic ratio. The homogenous 
distribution of the sampling points after t0 leads to a reduced image noise and consequently to an 
increased SNR. Additionally, k-space positions are sampled ahead of time compared to conventional 
radial sampling techniques. Therefore, less signal has decayed due to T2 relaxation for each k-space 
position. This causes less image blurring since high-spatial frequencies (i.e. edges, details) stored at 
the periphery of k-space are sampled faster [18]. Please refer to the publication for further 
explications about the optimization of the parameters such as the readout time, G0, and t0. 
In vivo application of the density-adapted 3D radial projection pulse sequence  
Two DA-3DPR sequences were parameterized at the 3T scanner in Erlangen; one DA-3DPR 
sequence to quantify TSC and another DA-3DPR sequence including an IR preparation pulse to obtain 
an intracellular weighted sodium signal (ICW). For the TSC acquisition, the acquisition time was 
reduced using a short TR of 50 ms leading to a T1 weighting. An ultra-short TE of 0.3 ms was achieved. 
The FA was set to 80° to match the Ernst angle of skeletal muscle tissue. Radial sampling was 
performed with 8264 projections and 384 averages per projection. The readout used a gradient 
amplitude G0 of 7.89 mT/m (t0 0.5 ms), a gradient slew rate of 170 T/m/s, and a readout window 
length of Treadout = 10 ms to achieve a nominal spatial resolution of 3 x 3 x 15 mm3. The gradient 
parameters were previously optimized for in vivo imaging [18]. A gradient spoiler after each readout 
with duration of 5.1 ms was used to spoil residual transverse magnetization. The acquisition time to 
obtain a single 3D TSC data set was 6 min 53 s. To obtain ICW images, an inversion pulse (pulse 
length of 1 ms) with a TI of 34 ms was applied to suppress the signal from “free” sodium nuclei 
originating from a liquid environment. Other parameters were TR = 124 ms, TE = 0.3 ms, and FA = 
90°. Radial sampling was performed with 4760 projections and 384 averages per projection. The 
signal was read out with a gradient amplitude G0 of 4.61 mT/m (t0 0.5 ms), a gradient slew rate of 
170 T/m/s, and a readout window length of Treadout = 20 ms to achieve a nominal spatial resolution of 
4 x 4 x 20 mm3 followed by a gradient spoiler of 5.1 ms. The acquisition time to obtain a single 3D 
ICW data set was 9 min 50 s. 
For anatomical reference imaging, a 1H FLASH (Fast low angle shot magnetic resonance 
imaging) sequence was acquired using the body coil for magnetization excitation and signal 
reception. These images were used to visualize blood vessels, which exhibit high sodium 
concentrations and should be avoided during the sodium quantification of the skeletal muscle tissue. 
Furthermore, anatomical reference images helped to delineate different muscle groups during 
regions-of-interest (ROI) determination. FLASH sequences were obtained with the following 
parameters: 24 slices with TE = 4.77 ms, TR = 308 ms, and a resolution of 1 x 1 x 5 mm3. Two averages 
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and a FA of 90° were applied to increase the SNR, which was intrinsically low due to the shielding of 
the 23Na volume coil (acquisition time (Tacq) = 2 min).  
For 23Na signal quantification, external calibration phantoms were placed next to the leg 
(Figure 44). After reconstruction of the 23Na images, the sodium signals were calibrated using the 
signal intensities of the reference phantoms. Exploiting the known NaCl concentration of the 
calibration standards (20 mM and 40 mM NaCl) and the background noise (0 mM NaCl) allowed the 
calibration and quantification of the TSC and ICW signals originating from the skeletal muscle tissue. 
The DA-3DPR sequences were acquired in vivo on healthy subjects (n = 6, five females, age 26.6 ± 3.4 
years) with four calibration standards of different NaCl and agarose concentrations (Table 7). 
Table 7: Composition of calibration phantoms used for 23Na imaging. 
Calibration phantom NaCl [mM] Agarose [%] 
1 40 0 
2 40 4 
3 20 0 
4 20 4 
Figure 44 depicts the higher spatial resolution of the 1H images (A) compared to the DA-3DPR 
23Na images of the leg without (B) and with (C) the IR pulse. The DA-3DPR 23Na images (B) show 
increased total sodium signal in the blood vessels (Table 8). Furthermore, a non-negligible sodium 
signal arises from the subcutaneous fat. The calibration standards with sodium concentration of 40 
mM (1 without agarose and 2 with agarose) appear with an about twice higher signal intensity than 
those with 20 mM (3 without agarose and 4 with agarose). The agarose standards appear lighter than 
the saline solution due to the decreased T1. 
Table 8: Signal intensities of calibration phantoms (1, 2, 3, and 4), muscle, blood, and 
subcutaneous fat in DA-3DPR 23Na images and DA-3DPR 23Na images with IR preparation pulse (n = 
6). 
ROI DA-3DPR [a.u.] DA-3DPR with IR [a.u.] 
1 0.018 ± 0.002 0.002 ± 0.001 
2 0.024 ± 0.002 0.012 ± 0.001 
3 0.009 ± 0.001 0.001 ± 0.000 
4 0.014 ± 0.001 0.008 ± 0.001 
Muscle 0.011 ± 0.002 0.006 ± 0.001 
Blood 0.022 ± 0.004 0.008 ± 0.001 
Sub. fat 0.007 ± 0.001 0.003 ± 0.002 




Figure 44: Images of two healthy female volunteers. A) T1 weighted 1H image of right leg with 
corresponding B) DA-3DPR 23Na image and C) DA-3DPR 23Na image with IR pulse (TI 34 ms). Four 
calibration standards are shown at the bottom of the leg with sodium concentration of 20 mM (3) 
and 40 mM (1) and with 4 % agarose and 20 mM (4) and 40 mM (2) mimicking Na+ with restricted 
mobility. 
The DA-3DPR 23Na images with IR pulse (C) demonstrate the suppression of sodium signal 
originating from a non-restricted environment since the signal from the calibration standards without 
agarose (1 and 3) vanishes. A small signal contribution still arises from the lateral part of phantom 1 
due to B1 inhomogeneities. In volunteer 1, the signal originating from the blood vessel in the medial 
part was also not completely supressed. Furthermore, only a very small sodium signal arises from the 
subcutaneous fat. These observations were partly in line with previous studies performed in vivo 
[83], where no signal intensity in the saline solution tube and a suppression of the intravascular 
sodium ions in 23Na-IR image were reported.  
For quantification purpose, TSC and ICW maps were calculated based on the signal intensities 
and known concentration of the reference tubes. The TSC maps were calculated with the agarose 
phantoms (2 and 4), since they reflect better the muscle tissue properties (restricted environment). 
The signal of the calibration references and the noise were fitted by a linear model, which was used 
to calculate the concentration maps (Figure 45). A linear polynomial model was fit was used to obtain 
the calibration curve: 
¶7E8 =  I4 E + I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Where I4and I are the fitting constants that are used to calculate the TSC and ICW maps 
pixel wise by calibrating the signal intensity of the DA-3DPR 23Na images: 
 ý =  á^ +  II4    
Where á^ is a pixel of the DA-3DPR 23Na image. The ROIs were traced on the 1H images on 
the lower leg and the reference tubes (Figure 46) and automatically registered to the 23Na TSC and 
ICW maps. For ICW signal calibration, we assigned 0.5 to phantom #2 and 1 to phantom #4 to obtain 
relative ICW values in a.u.. 
 
Figure 45: 23Na signal calibration using two reference phantoms with 20 mM and 40 mM NaCl 




Figure 46: 23Na signal calibration of the leg. A) ROIs are drawn manually on the 1H image in 
TA (green), SO (yellow), GM (orange), subcutaneous fat (blue), in the calibration standards, and in the 
background (red). B) TSC map and C) ICW map were calculated based on the calibration curve using 
the agarose phantoms (2 and 4) and the background noise. 
The average TSC and ICW values of healthy subjects were calculated for the tibialis anterior 
(TA), soleus (SO) and gastrocnemius medialis (GM) muscles as well as the subcutaneous fat (Table 9). 
The TSCs and ICW values were lower in the TA than the posterior muscle of the leg. The 
subcutaneous fat exhibits a non-zero sodium signal in the TSC and ICW maps confirming the 
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previously made visual observation. This fact should be taken into account for the TSC quantification 
of muscle in patients where an increased fat fraction is known to be present in skeletal muscle tissue 
such as in DMD patients. In other studies, a mean TSC of 24 ± 2 mM (healthy subjects) was calculated 
by linear extrapolation using only one reference tube with 51.3 mM NaCl and 5 % agarose gel [83]. 
Nevertheless, we suggest using at least two reference phantoms of different NaCl concentration with 
agarose that mimics the relaxation behaviour of muscle tissue as well as the background noise to 
obtain a more precise calibration curve for proper 23Na quantification. An additional saline phantom 
should be used to verify the efficiency of the liquid suppression in the DA-3DPR 23Na images with IR 
pulse.  
Table 9: Measured TSC and ICW of healthy volunteers (n = 6) of the TA, SO, and GM muscle as 
well as the subcutaneous fat. Values presented as mean and SD (standard deviation).  
ROI TSC [mM] ICW [a.u.] 
TA 15.3 ± 2.7 0.39 ± 0.03 
SO 17.6 ± 1.4 0.50 ± 0.02 
GM 17.5 ± 1.4 0.43 ± 0.03 
Sub. fat 7.7 ± 0.7 0.15 ± 0.04 
4.7   Post-processing tools and statistical analysis 
All 1H and 31P NMR spectra were processed using jMRUI [164]. The FF, water T2, and T1 maps 
were processed using Python reconstruction codes. ROIs were drawn on specific muscles using the 
free-ware segmentation software ITK-SNAP [165]. ISIS-CPMG and 23Na NMR data processing was 
carried out using Matlab (MathWorks, Inc., Natick, MA). 
Data were analysed and expressed as mean and standard deviation (SD). Statistical analysis 
was performed in SPSS (SPSS 22, SPSS Inc. Chicago, IL). 
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Characterization of healthy skeletal 
muscle tissue by 23Na NMR 
This chapter summarizes several experiments investigating the healthy skeletal muscle by 
23Na NMR. In a proof of concept study, we induced acute changes in extracellular volume fraction in 
skeletal muscle tissue of helahty volunteers. We then compared the sensitivity to track these 
changes of a standard 1H T2 imaging method to the fast 23Na NMR spectroscopy protocol (4.6.1). 
Using an external reference phantom, we validated an approach to quantify in vivo the 23Na signal of 
the 23Na NMR spectroscopy protocol (5.2). Furthermore, the impact of prolonged ischemia on the 1H 
T2 and 23Na signals of skeletal muscle was studied in mice where the physiological paradigm could be 
extended up to 40 minutes (5.3). The last part of this chapter is dedicated to investigate the 
environment of sodium ions in skeletal muscle tissue using MQF sequences (5.4).  
5.1    Monitoring the variations of 23Na NMR signals during different vascular filling 
conditions in comparison to 1H T2 alterations 
After the in vitro evaluation of the fast 23Na spectroscopic protocol (4.6.1), a proof of concept 
study investigated its sensitivity to monitor changes in extracellular volume fraction in skeletal 
muscle tissues. In order to evaluate the ability of 23Na spectroscopy to detect changes in the Na+ 
distribution between intra- and extracellular compartments, different experiments were conducted 
in vivo. First, the effect of a short-term ischemia on the Na+ bio-distribution in the leg muscle was 
monitored. Then, measurements were performed on the same lower leg muscles under different 
vascular filling conditions to manipulate the ratio of intra-/extracellular contributions to the Na+ pool 
and to test the ability to detect it by multi-parametric 23Na NMR. The sensitivity of the three non-
localized 23Na sequences were compared to that of a standard 1H T2 mapping method to these 
different conditions.  
5.1.1 Materials and methods 
Subjects and study design 
Sodium NMRS and proton NMRI were performed on 28 healthy volunteers (aged 28.2 ± 8.4 
years, 13 women and 15 men) as part of a methodology protocol approved by the local ethics 
committee (Comité de Protection des Personnes Ile de France VI). Before data acquisition, written 
informed consent was obtained from all subjects. Subjects underwent one of the two protocols 
described below. The first group of seven volunteers participated in protocol 1 dedicated to 
investigate the effect of a short-term ischemia on the sodium distribution in skeletal muscle (group 
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1). The other 21 volunteers were assigned to group 2 (n = 14) and group 3 (n = 7), which underwent 
protocol 2 with either 23Na NMR (group 2) or 1H T2 (group 3) acquisitions to compare the sensitivities 
of the two methods to detect acute changes in intra-/extracellular volume fractions. 
Protocol 1 
23Na NMR spectra were acquired during a short ischaemia in the right calf of group 1 (Figure 
47). Prior to the NMR acquisition a medical cuff was placed above the knee and the subjects rested 
supine on the bed during 30 minutes. Then the cuff was connected to a circuitry pressurized at 250 
mmHg to block instantaneously and completely the arterial inflow and the venous outflow. The cuff 
pressure was manually controlled from the outside of the magnet room by the manipulator using a 
mercury manometer (MERCUREX+; Spengler, Antony, France) combined with a fast switch valve 
system. During the 15-minute ischaemia, sodium homeostasis was monitored with series of short 
23Na sequences. 
 
Figure 47: Timeline of the ischemia protocol (protocol 1): (i) After 30 min supine rest, (ii) the 
medical cuff placed above the knee was rapidly inflated and the acquisition of the sodium spectra 
started. 
Protocol 2 
23Na NMR spectra and 1H NMR images of group 2 and 3 were acquired under three different 
vascular filling conditions: (i) vascular draining, (ii) vascular filling, and (iii) normal condition. The 
protocol timeline for the data acquisition is presented in Figure 48. These vascular conditions were 
imposed while the subject remained still in supine position inside the scanner. Vascular draining was 
initiated by wrapping an elastic compression band from toes to the knee. Then a medical cuff, placed 
over the knee, was inflated at 250 mmHg to block completely the arterial inflow and the venous 
outflow. The elastic compression band was then removed from the leg while keeping the cuff 
pressure high and after centring the leg in the magnet, the first set of data was acquired. Next, the 
cuff pressure was decreased to 60 - 70 mmHg in order to fill the capacitance vessels. After a five-
minute interval to allow for a stabilized vascular filling condition, another NMR data acquisition was 
performed. Finally, the cuff was fully released and again five minutes were given, this time to resume 
normal perfusion regime and the last series of NMR sequences was acquired. 




Figure 48: Timeline of the vascular filling conditions (protocol 2): (i) vascular draining was first 
applied with the calf positioned in the coil followed by the NMR acquisition (non-localized 23Na 
spectroscopic and 1H imaging acquisition or by 1H MSME acquisition). (ii) After vascular filling during 
a 5-minute interval initiated by a reduced cuff pressure, another NMR acquisition was launched. (iii) 
Normal condition: the pressure of the cuff was completely released and after a 5-minute break, the 
final sodium NMR and proton imaging were performed. 
NMR sequences 
For group 1 and 2, 23Na NMRS sequences were acquired with the linear volume 23Na leg coil. 
To minimize the leg movement, foam pads were inserted between the leg and the coil. The 23Na 
spectroscopy part consisted in FID, TQF, and IR-LL sequences with a total acquisition time of 14 
minutes for the second protocol. The sequences were acquired with the parameters as described 
in 4.6.1, except of a reduced vector size of 128 points for the FID and TQF. For group 1 the number of 
averages for the FID and TQF were reduced to acquire the two sequences with a temporal resolution 
of 1 min. The FID had 40 averages (Tacq = 12 s) and the TQF 500 averages (Tacq = 50 s). 
Changes in the leg volume between the different vascular filling conditions were monitored 
with a 3D FLASH sequence covering the whole calf using the body coil for magnetization excitation as 
well as signal reception. This sequence was acquired with the following parameters: TE/TR = 2.78/65 
ms, matrix size = 250 × 250 × 50 mm3, spatial resolution = 2.6 × 2.6 × 5 mm3, and Tacq = 1 min.  
For group 3, proton images were acquired with the 15 channel 1H knee coil (Figure 49A). 
Foam pads were inserted between the leg and the coil to minimize leg movements. To measure 
proton T2 weighted signal intensities and proton T2 values, a MSME sequence was acquired with 17 
different TEs: 8.5 - 144.5 ms, TR = 3000 ms, 5 slices with matrix size = 192 × 192 × 10 mm3, spatial 
resolution = 1.5 × 1.5 × 10 mm3, and Tacq = 3 min.  
Analysis of 23Na and 1H NMR data 
Sodium data were processed as described in 4.6.1. We obtained the following 23Na indices: 
FID signal, TQF signal, TQF/FID ratio, short T2* fraction, short and long T2*, and global T1. Total 
muscle volume estimation was performed on ImageJ [166] from the 1H FLASH images. ROIs were 
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manually drawn around the leg on 23 slices. Leg volumes were then calculated based on the 
exported ROIs (leg area x slice thickness).  
 
Figure 49: Standard 1H T2 imaging: A) a cross-sectional T2w image (TE = 34 ms); B) The ROIs 
used for analysis were traced within the muscles (TA orange; ED brown; TP pink; PL green; SO yellow; 
GL red; GM beige; Background noise grey). 
Proton T2 weighted signal intensities and proton T2 values were measured from the MSME 
sequences. ROIs were manually traced inside specific muscles (see Figure 49B; ED extensor 
digitorum, GL gastrocnemius lateral, GM gastrocnemius medial, PL peroneus longus, SO soleus, TA 
tibialis anterior, TP tibialis posterior). Proton T2 weighted (T2w) signal intensities were calculated as a 
mean signal intensity of each ROI in the T2w image at TE of 34 ms and the T2 maps were produced via 
a standard mono-exponential fit [64] .  
Statistical analysis  
Percentages of change of each parameter as compared to the control condition were 
determined. Statistical analysis was performed using ANOVA with repeated measures and Bonferroni 
post-hoc tests for pairwise comparisons to evaluate significant differences between the different 
conditions. Pearson correlations analysed the relationship between the variables. In all statistical 
tests, p < 0.05 was considered statistically significant. 
5.1.2 Results 
Impact of ischemia on 23Na NMR signal 
Figure 50 shows the evolution of the FID and TQF signals as well as the TQF/FID ratio during 
the 15-minute ischemic period. The signals have been normalized using the first time point as a 
reference. The normalized FID signal changes with time by -2 ± 2.7 %, not significant with repeated 
measures ANOVA. The normalized TQF signal was found to progressively decrease over time (-6 ± 1.7 
% at the end of the experiment). Repeated measures ANOVA indicated a significant decrease of the 
TQF signal after 15 minutes of ischemia (p < 0.05). The TQF/FID thus decreased by 4.1 ± 2.6 % (not 
significant). 




Figure 50: The effect of short-term ischemia in vivo in skeletal muscle measured by 23Na NMR. 
Vascular filling changes monitored by 23Na NMR 
Figure 51A displays the different sodium indices obtained by 23Na NMR in one volunteer of 
the group 2 under each vascular filling condition. As depicted, the FID, TQF signal, and T1 relaxation 
curves were modified in response to extracellular volume changes. The FID signal decreased from 
8.2x10-3 a.u. for the control condition to 7.4x10-3 a.u. while draining and increased to 9.7x10-3 a.u. 
under vascular filling. The TQF signal showed a different behaviour with a decrease from 5.5x10-5 a.u. 
to 5.4x10-5 a.u. during vascular filling and increases to 5.8x10-5 a.u. during vascular draining. The T1 
relaxation time showed a parallel behaviour as the FID signal, by dropping from 34.3 ms to 33.7 ms 
during draining and rose to 37.0 ms during filling. After deconvolution, two well-resolved Na+ pools 
could be identified for each vascular filling condition on the T2* spectra. One slice of the 1H FLASH 
volume is presented in Figure 51B, with the manual delineation of the leg. For this subject, the leg 
muscle volume was 1175 cm3 during vascular draining, 1273 cm3 during vascular filling, and 1180 cm3 
under control conditions. 




Figure 51: The sodium FID, TQF, and T1 recovery signals measured in a healthy young 22-year-
old female volunteer under different vascular filling conditions. A) The FID signal in the time domain is 
Fourier transformed to obtain the FID spectrum, which gives then the T2* spectrum by a T2* 
deconvolution of the FID signal decay. The T2* spectrum is plotted with logarithmically scaled abscise. 
The plots show the characteristic course of the vascular draining (red), vascular filling (blue), and 
control (black) conditions. B) The drawn ROI on the FLASH image of the right calf of the volunteer 
were used for the volume calculations. 
Figure 52 summarizes the mean values of the different indices extracted from the 23Na 
spectroscopic sequences and the leg volume of all subjects under the three different vascular filling 
conditions. Repeated measures ANOVA tests revealed significant variations of all the parameters 
between the three conditions (p < 0.05). At rest, the mean sodium FID signal was 2.5 ± 0.3x10-3 a.u., 
the global sodium T1 was 33.8 ± 2.2 ms, the sodium TQF signal 1.6 ± 0.3x10-4 a.u., and the TQF/FID 
ration 6.3 ± 1.0x10-2. Mean 23Na short T2* and long T2* were Ts,2* = 0.8 ± 0.2 ms and Tl,2* = 12.4 ± 1.8 
ms with mean fraction of 32 % and 68 %, respectively. Over all subjects, the mean leg volume at rest 
was 995.7 ± 160.2 cm3. 




Figure 52: Evolution of different 23Na parameters (FID signal, TQF/FID ratio, TQF signal, T1 
value, long T2* signal, short T2* fraction, and short T2* signal) and leg volume under three different 
vascular filling conditions (vascular draining: drain, vascular filling: fill, and control condition: ctrl). 
The boxes have lines at the lower quartile, median (red), and upper quartile with the length of the 
whiskers specified as 1.5 times the interquartile range. The red crosses mark outliers of the datasets. 
All measured changes of the 23Na variables and leg volume were calculated as percentage of 
change between the vascular filling or draining condition and the control condition (Figure 53). The 
23Na FID signal was non-significantly decreased under the drainage condition (-3.8 ± 7.4 %) and 
significantly increased in the filling conditions (+22.7 ± 3.2 %; p < 0.05), compared with the control 
condition. The opposite trend was observed for the short T2* fraction and the TQF/FID ratio, which 
both raised significantly during vascular draining (+13.0 ± 15.3 % and +13.1 ± 6.1 % respectively; both 
p < 0.05) and significantly decreased with vascular filling as compared to normal conditions (-18.2 ± 
23.0 % and -23.4 ± 4.9 % respectively; both p < 0.05). In parallel, the long T2* value was significantly 
increased during draining and filling (+6.4 ± 5.6 %; p < 0.05, +7.9 ± 4 %; p < 0.05 respectively). The 
short T2* value increased significantly during vascular draining (+18.0 ± 14.7 %; p < 0.05) and tends to 
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decrease during the filling condition (-6.4 ± 9.8 %). TQF signal was significantly higher with vascular 
draining (+9.3 ± 9.9 %; p < 0.05) and did not vary during vascular filling (-0.7 ± 5.7 %). On the 
contrary, significant increase was observed for global T1 values and muscle volume during vascular 
filling (respectively +8.2 ± 3.1 % and +5.5 ± 2.0 %; p < 0.05) while no significant alterations were 
detected during vascular draining (respectively -0.2 ± 3.5 % and -1.7 ± 1.8 %). 
 
Figure 53: The percentages of change of the 23Na parameters under vascular filling and 
vascular draining conditions compared with the control condition (§: p < 0.05). 
The changes in the FID signal and in muscle volume were significantly correlated (R = 0.53, p 
< 0.001), whereas no significant correlation was observed between the TQF signal changes and the 
muscle volume (R = 0.17, p < 0.001). Significant linear dependences between the TQF/FID ratio and T1 
values (R = -0.53, p < 0.001) and all the T2* parameters (short T2* fractions: R = 0.78; short T2*: R = 
0.77; and long T2*: R = 0.52, p < 0.001). Figure 54 depicts a selection of correlations from different 
23Na parameters and the leg volume. 
 




Figure 54: Correlation between FID signal and volume and between TQF/FID ratio and T1 
value. Additionally, highly significant correlations between TQF/FID ration and short T2* fraction and 
short T2* values were detected. Data acquired under vascular draining and vascular filling are 
depicted as red and blue circles, respectively. Black circles represent the data points collected during 
the control condition. 
Vascular filling changes monitored by 1H NMR 
The same vascular filling paradigm was applied to investigate the sensitivity of 1H T2 imaging 
to detect the extracellular volume fraction changes. Proton T2 values and proton T2w signal 
intensities were measured for different muscles, from which a mean value over all muscles was 
determined. At rest, the mean T2 was 43.3 ± 1.7 ms and the mean T2w intensity was 547.3 ± 16.3 a.u. 
Besides all measured changes of the 1H T2 and 1H T2w intensities were calculated as percentage of 
change between the vascular filling or draining condition and the control condition. Only two 
muscles changed significantly their T2 during the three conditions as determined by one-way ANOVA 
(p < 0.05). Post-hoc Bonferroni test disclosed that the T2 augmented significantly in the ED and the TP 
muscles during vascular filling compared to the control condition (1.7 ± 1.2 % and 1.6 ± 0.9 % 
respectively). Furthermore, repeated measures ANOVA tests revealed significant variations of the 
T2w intensities between the three conditions for three muscles (ED, GL, and TA; p < 0.05). Post-hoc 
tests using the Bonferroni correction revealed that the T2w intensities of the ED and TA muscles 
increased significantly during vascular filling (3.8 ± 1.8 % and 4.8 ± 1.4 % respectively) compared to 
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the control condition, whereas the T2w intensity of the GL muscle increased significantly during 
vascular draining (4.2 ± 2.5 %; p < 0.05) and shows no significant variation during the filling condition 
(1.0 ± 1.7 %; p = 0.5). The mean T2 and the mean T2w intensity taken over all muscles did not 
significantly differ between vascular filling conditions (one-way ANOVA test, Figure 55).  
 
Figure 55: The percentages of change of the mean T2w signal intensities and the mean T2 for 
all muscles under the vascular filling and vascular draining conditions compared with the control 
condition 
5.1.3 Discussion 
The intent of this study was to assess whether 23Na NMR could monitor acute changes in the 
extracellular volume fraction and compare the sensitivity of this method to standard proton T2 
imaging.  
15-minute ischemia 
In the first part of our study, we investigated the effect of a short-term ischemia on the 
sodium distribution in human skeletal muscle. This was an important preliminary step to make sure 
that the interpretation of the 23Na signal changes during the vascular volume manipulations would 
not be complicated by concurrent alterations of the intracellular Na+ distribution. Contrary to earlier 
findings in the ischemic heart [167], the total sodium content did not significantly vary within this 
short period of blood flow interruption. This can easily be understood considering the huge energy 
demand difference between the two organs in baseline conditions. Still, the TQF signal within the 
skeletal muscle tissue was decreased by approximately 6 % after the 15-minute ischemia.  
The same ischemic protocol was already used in our laboratory to study its impact on muscle 
oxygenation and perfusion. The ADP concentration increased by 7 % compared to the resting state 
after 6 minutes of ischemia indicating already a slight impairment of the muscle ATP metabolism 
[168]. A reduced activity of the Na-K ATPase would result in an increased intracellular sodium 
content as well as cell swelling. Regarding the 23Na nucleus, this effect would translate in an increase 
of the TQF signal [71], [169]. In our situation, the small decrease in TQF signal that was observed 
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during the 15-minute ischemia is contra-intuitive and was further investigated on animal models, 
where this ischemic paradigm was prolonged to 40 minutes (5.3). 
Extracellular volume fraction changes 
We then investigated the sensitivity of non-localized 23Na spectroscopy to monitor acute 
changes in the extracellular volume fraction including vascular draining and vascular filling. We 
hypothesized that the rapid inflation of the air cuff above the knee to 250 mmHg does 
instantaneously stop the blood circulation, and has no further high impact on the intracellular 
sodium concentration during the protocol. We considered the alterations of the 23Na signals being 
mainly due to changes of the extracellular volume fractions, or modification of interactions with 
macromolecules within the skeletal muscle tissue. 
First, although the FID signal sums extra- and intracellular sodium content, changes in the 
extracellular volume could be clearly detected with this sequence. To our knowledge, only one group 
before us has performed a 23Na NMRS study of the human skeletal muscle during short ischemic 
periods. Binzoni et al. analysed the interstitial fluid displacement in the gastrocnemius during short 
ischemic cycles. In their study, FID signal decreased during ischemia, followed by a rapid sodium 
increase during the hyperaemic reperfusion phase, which they attributed to volume changes in 
extracellular fluids [170]. In our work, we confirmed this hypothesis by the significant correlation 
observed between the muscle volume estimated with 1H imaging and the 23Na FID signal.  
Besides, slowly tumbling Na+ content in the muscle tissue was measured by acquisition of 
TQF spectra. Theoretically, as the TQF preparation filters out first and second order coherences, only 
23Na experiencing quadrupolar interactions are highlighted. The TQF signal is often associated to the 
sodium pool bound to macromolecules in the intracellular matrix. Changes in TQF signal are thus 
interpreted as modifications of intracellular Na+ concentration or intracellular volume fraction. 
However, some studies have already demonstrated that the 23Na TQF signal has contributions from 
the intra- as well as the extracellular Na+ pool. In previous work, the proportion of the total TQF 
signal originating from the extracellular compartment was found to be between 30 % and 60 % of 
total TQF signal [109], [110], [171]. The TQF arising from the extracellular space is likely a result from 
23Na nuclei being in close interaction with the macromolecules, which could explain the large 
correlation between TQF signal variations and intracellular Na+ content generally reported. Our 
results identified a small but significant increase of TQF signal under vascular draining as compared 
to control condition (+9.3 ± 9.9 %), while no significant changes were noticed between vascular filling 
and control condition. This observation tends to confirm the hypothesis that part of TQF signal 
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reflects the 23Na nuclei within the interstitial space, which is a priori the only compartment 
experiencing large modifications during our physiological paradigm. The increase of TQF signal likely 
reflects a more important interaction between 23Na nucleus and interstitial macromolecules caused 
by the additional drainage with the elastic band.  
Longitudinal and transverse relaxation time variations were evaluated during this protocol. 
Mono-exponential T1 recovery and bi-exponential T2* decay behaviours were observed in the calf 
muscle tissues. This corresponds to what is generally observed in skeletal muscle [172], and is 
explained by a two-component model in fast-exchange regime with a pool of Na+ ions within bulk 
isotropic medium and a pool of Na+ ions bound to macromolecules experiencing quadrupolar 
interactions. Global 23Na T1 relaxation times were significantly increased during vascular filling but 
this parameter did not allow differentiating between vascular draining and control conditions. This 
parameter was not the most sensitive index to discriminate between the three vascular filling 
conditions of our physiological paradigm. 
Mean T2* skeletal muscle tissue sodium relaxation times at rest were Ts,2* = 0.8 ± 0.2 ms 
(mean fraction of about 32 %) and Tl,2* = 12.4 ± 1.8 ms. These results are in agreement with previous 
findings. For example, at 1.5T in the skeletal muscle, Constantinides et al. found short and long T2* 
equal to 0.5 ± 2.1 ms and 12.3 ± 1.9 ms, respectively [143]. The short T2* fraction was increased 
during draining, decreased during vascular filling, and correlated significantly with the TQF/FID ratio. 
This confirms that the variation of the Na+ content bound to macromolecules and experiencing 
quadrupolar interactions could be efficiently monitor with our spectroscopic protocol. Finally, the 
TQF/FID ratio was found to be the most robust and sensitive index to discriminate between the three 
conditions.  
Comparison of 23Na and 1H NMR  
Proton T2 values in the muscle are elevated in different physiological and pathological 
scenarios such as necrosis and intracellular or interstitial oedema [127]. Methodological efforts 
improve the precision of the T2 maps [15], [16], but yet reliable interpretation of the data remains 
limited by the lack of specificity of the measure to the different underlying mechanism [127], [155], 
[173]. In our study, we observed no significant changes of the mean T2 or the mean T2w signal 
intensity during vascular draining or vascular draining. Only three muscles showed significant 
alterations of the signal intensity or T2 in one of the two conditions as compared to the control 
condition. More sophisticated proton multi-compartment T2 methodologies have been applied and 
demonstrated a better sensitivity to extracellular volume variations. Using a localised proton ISIS-
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CPMG sequence and a three-sites two-exchange model, authors provided quantitative information 
about histological tissues compartmentation and water exchange rates [17]. However, signal 
originating from lipids can hamper such a proton approach. The bias due to fat signal contamination 
can be avoided by using 23Na NMR, which represents an advantage for the characterization of cell 
viability in chronically affected muscle tissues.   
Despite significant changes in 1H NMR parameters of some muscles during vascular volume 
changes; the 23Na NMR approach seems to be much more sensitive to monitor acute changes in 
extracellular volume fractions. This can have an impact for monitoring the pathological alterations of 
patient groups showing alterations in the tissue cellular volume fraction (2.3).  
Limitations 
Problems arising with the 23Na NMR method are low SNR and strong sensitivity of the TQF 
signal intensity on B0 and B1 inhomogeneities [105]. Depending on the organ, sensitivity of 23Na NMR 
is 3000 to 20000 times smaller than the one of 1H [174]. For a sufficient SNR, sodium imaging 
requires generally long acquisition times [83], [175]. TQF sequences suffer from even lower SNR (~1 
order of magnitude lower than TSC sequences) and hence impose acquisition times incompatible 
with clinical use on patients [176]. Although promising, these imaging sequences should be further 
optimized to be frequently applied in clinical trials or natural history studies, since reduced 
acquisition time and patient comfort represent important issues when designing NMR protocols.  
Furthermore, concerns about absolute concentrations constitute the major limitation of this 
NMRS method for a direct application to longitudinal monitoring of Na+ during disease natural 
history studies or long-term clinical trials. We report this approach as highly sensitive to detect subtle 
modifications of sodium content or biodistribution when assessment is performed within a single 
spectroscopic session. Since the NMR signal does not only depend on spin concentration, but also on 
coil quality factor, on B1+ and B0 field, all these parameters have to be taken into account for 
quantification. So far, phantoms with known Na+ concentrations have been used as external 
references to quantify the sodium content in vivo in several 23Na NMR imaging studies [14], [72], 
[143], [177]. This idea was extended to our protocol by using an external phantom containing a 
shifting reagent to resolve the peak of the phantom separately and is presented in the next section 
(5.2). Even then, the B0 and B1 field inhomogeneities issue has to be carefully addressed, which is not 
a trivial task.  
Moreover, due to the non-localized approach, sodium pools from other tissue such as skin, 
tendons, and ligaments contributed to a certain extent to our results. Although its contribution is 
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obviously smaller than the one of skeletal muscle given the size difference of the organs, its real 
impact on our findings is still to be studied. One possible solution would be to use localized 
spectroscopy methods. Nevertheless, classical schemes such as point resolved spatially localized 
spectroscopy (PRESS) [178] would lead to too long TEs by preventing the acquisition of fast decaying 
23Na signals. Another localised method, namely ISIS [67], would be an alternative to acquire the 
sodium spectra including the short 23Na T2* components in a defined region.  
5.2    Signal quantification for non-localized 23Na NMR spectroscopy 
For the next step towards a successful implementation in (pre-) clinical protocols, we 
evaluated an approach to calibrate and quantify the 23Na signal from the non-localized spectroscopy 
protocol. A standardized and reliable approach is a pre-requisite to quantify the signals either to 
compare two distinct groups or to monitor muscle response to interventions in the course of 
longitudinal studies.  
5.2.1 Materials and methods 
Study design and NMR protocol 
The right calf of 19 healthy volunteers (aged 29.5 ± 9.7 years, seven women and twelve men) 
was scanned at 3T (PRISMA; SIEMENS Healthineers, Erlangen, Germany) under different vascular 
filling conditions (see protocol 2 in 5.1.1). The leg was placed inside the coil on a holder with a SR 
phantom (24 mM TmDOTP5- in 140 mM NaCl) to calibrate the FID and TQF signal originating from the 
leg (Figure 56A). The FID and TQF signals were acquired with the same parameters as in 5.1.1 with 
NEX = 100 (Tacq = 1 min) and NEX = 1500 (Tacq = 2 min 30 s), respectively. Additionally, a 3D 3-point 
Dixon sequence was performed at the end of the control condition using the body coil for 
magnetization excitation and signal reception with the following parameters: TR = 10 ms, 2 x 2 TEs = 
2.75/3.95 ms and 2.75/5.15 ms, FA = 3° and 64 slices of 5 mm thickness and resolution = 1.3 x 1.3 
mm². The slices were centred in the iso-centre at the magnet (2 x Tacq = 1 min 36 s).  
 




Figure 56: Calibration of the in vivo 23Na signal: A) Costume-made linear volume 23Na leg coil 
with the leg holder and shift reagent phantom used as external reference. B) Dixon image (TE = 2.75 
ms) of the leg and SR phantom. The ROI used for volume analysis was traced over all muscles (in 
violet) excluding bone, skin, and subcutaneous fat. 
Quantification of 23Na NMR signals 
23Na NMR spectra were processed as described in 5.1.1. Total muscle volume estimation was 
performed on the water maps derived from the 3-point Dixon images. ROIs were manually drawn on 
the muscle excluding bones on the 31 central slices (Figure 56B) to cover the whole leg inside the 
coil. Muscle volumes were calculated based on the exported ROIs (muscle area x slice thickness) for 
each slice that was acquired inside the 23Na coil.  
The muscle volume (volumeFID,leg) per slice derived from the water map was then weighted 
with the spatial 23Na coil sensitivity in the z-direction that was obtained by in vitro 23Na imaging of a 
NaCl filled bottle (Figure 57). The six central 1H slices were weighted with a factor one. The more 
lateral the slices, the lower was the weighting factor, as the coil sensitivity decreases drastically at 
the periphery of the coil. The TSC of the corrected leg volume was calculated on the known volume 
and Na+ concentration of the SR phantom as following:  
 ý =  DâF ( þ-àT¼  (  
¼_þ-àTÌÇ,_ 
Where DSRF is the concentration of NaCl in the SR phantom (24 mM), volumeSR the volume 
of the SR phantom (56 ml), and FIDSR and FIDleg the 23Na signal originating from the SR phantom and 
leg, respectively. For ICW, leg volume was weighted with the coil sensitivity to the fourth power due 
to the FID signal dependency of sin4(θ) after triple quantum filtering (3.3.3) to obtain the sensitivity-
weighted volume volumeTQF,leg. The ICW of the volume corrected leg was calculated using the FID 
signal from the SR phantom as followed: 
ýÚ =  DâF ( þ-àT¼  ( 
 o¼_þ-àTNnÌ,_ 
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Where DSRF is the concentration of NaCl in the SR phantom (24 mM), volumeSR the volume of 
the SR phantom (56 ml), and FIDSR and TQFleg the FID and TQF 23Na signal originating from the SR 
phantom and leg, respectively. 
 
Figure 57: Sensitivity profile of the 23Na coil along the length measured on a 140 mM NaCl 
containing bottle with a diameter of 9 cm. 
Statistical analysis  
Statistical analysis was performed using ANOVA with repeated measures and Bonferroni 
post-hoc tests for pairwise comparisons to evaluate significant differences between the different 
conditions. Pearson correlations analysed the relationship between the variables. In all statistical 
tests, p < 0.05 was considered statistically significant. 
5.2.2 Results 
Figure 58 shows the FID and TQF spectre aquired on one subject at control condition. The SR 
peak is only visible in the FID spectrum since the TQF filters the signal from motionally non-restricted 
environment out.  
Figure 59 summarizes the mean values of 23Na FID and TQF signals and the calculated TSC 
and ICW of all subjects under the three different vascular filling conditions. Repeated measures 
ANOVA tests revealed significant variations of all the parameters between the three conditions (p < 
0.05). At rest, the mean sodium FID signal originating from the leg was 0.075 ± 0.013 a.u., the mean 
sodium FID signal originating from the SR was 0.007 ± 0.001 a.u. and the sodium TQF signal 0.0056 ± 
0.0005 a.u.. The mean TSC of the leg was 14.99 ± 1.99 mM and the mean ICW 1.54 ± 0.12 a.u.. 




Figure 58: The sodium FID and TQF signals measured in a healthy young 23-year-old female 
volunteer at control condition. Notice the presence at around 0.7 kHz of the SR in the FID spectrum 
and its absence in the TQF spectre. 
During vascular draining, the FID signal changed by 3.09 ± 4.93% and the TQF signal increased 
significantly by 2.6 ± 1.41 % (p < 0.05). TSC changed by 1.3 ± 6.15 % and ICW increased by 2.6 ± 1.41 
% (p < 0.05). During the vascular filling, FID increased significantly by 15.89 ± 4.39 % (p < 0.05), TQF 
changed by 0.27 ± 1.18 %., TSC by 20.76 ± 4.92 % (p < 0.05), and ICW by 0.27 ± 1.18 % (p < 0.05). 
 
Figure 59: Evolution of 23Na FID signal and TQF signal before volume correction under three 
different vascular filling conditions (vascular draining: drain, vascular filling: fill, and control 
condition: ctrl). Based on the 23Na signals, TSC and ICW values were calculated for the three different 
vascular filling conditions taking the muscle volume and coil sensitivity into account. The boxes have 
lines at the lower quartile, median (red), and upper quartile with the length of the whiskers specified 
as 1.5 times the interquartile range. The red crosses mark outliers of the datasets. 
The changes in the FID and TQF signals correlated significantly with the muscle volume (R = 
0.56 and R = 0.78, respectively; both p < 0.005). Figure 60 illustrates the independence of muscle 
volume after the volume and coil-sensitivity correction step of the sodium indices. TSC and ICW 
showed both no correlation with the muscle volume (R = 0.11 with p = 0.4 and R = -0.16 with p = 
0.22, respectively).  




Figure 60: Important correlations of 23Na FID and TQF signal with muscle volume were 
detected. After correction, TSC and ICW showed no correlation with the muscle volume. Data 
acquired under vascular draining and vascular filling are depicted as red and blue circles, respectively. 
Black circles represent the data points collected during the control condition. 
5.2.3 Discussion 
The intent of this study was to establish a method to calibrate the non-localized 23Na signals, 
which can then be applied to quantify changes in the sodium content or distribution. An external 
calibration phantom with known sodium concentration and doped with SR was used to calibrate the 
23Na signals originating from the leg. To evaluate the method, we choose the same physiological 
protocol as in 5.1 to change the sodium content and distribution in the leg.  
In 5.1, we reported a mean 23Na FID signal of 2.5 ± 0.3x10-3 a.u. and a mean 23Na TQF signal 
of 1.6 ± 0.3x10-4 a.u. at rest, which are more than an order smaller than the values measured during 
the quantification study. This is due the NMR system upgrade from TIM TRIO to PRISMA that took 
place between the two studies. Additionally, the Laboratory obtained a new 23Na knee coil with a 
higher B1 homogeneity. However, the percentage of change between the vascular filling or draining 
conditions and the control condition of the FID and TQF remained similar after the system change. 
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Under the TIM TRIO and the old 23Na coil, the 23Na FID signal was non-significantly decreased under 
the drainage condition (-3.8 ± 7.4 %) and significantly increased in the filling conditions (+22.7 ± 3.2 
%; p < 0.05), compared with the control condition. TQF signal was significantly higher with vascular 
draining (+9.3 ± 9.9 %; p < 0.05) and did not vary during vascular filling (-0.7 ± 5.7 %). After the 
upgrade and with the new 23Na coil, the FID signal changed by -3.09 ± 4.93% under the vascular 
draining condition and increased significantly by +15.89 ± 4.39 % (p < 0.05). In parallel, TQF signal 
increased significantly by +2.6 ± 1.41 % (p < 0.05) during draining and did not vary during vascular 
filling (0.27 ± 1.18 %). The smaller changes in the TQF signals in the current study go hand in hand 
with much smaller SD and thus leading to significant increase of the TQF signal during draining 
compared to the control condition as it was observed before. Thus, the current study underlines also 
the reproducibility of the proposed non-localized 23Na protocol. 
The non-localized NMR signal depends highly on the charge present in the coil. This can be 
seen for example in the high correlation between the SR signal having a constant NaCl concentration 
and the muscle volume (R² = 0.9). The recorded signals thus have to be corrected for the changing 
load that is the volume of the leg inside the coil. As explained in 5.1.3, we considered that the muscle 
tissue is the main source of the sodium signal and we thus decided to take the muscle tissue volume 
from the water map to correct for the coil load. The TQF sowed a higher correlation (R = 0.78) with 
the muscle tissue volume than the FID signal (R = 0.56). This might be partly because the 23Na FID 
signal arises also from the subcutaneous fat and blood vessels, the latter exhibiting much higher 
sodium concentrations than skeletal muscle tissue. During the coherence pathway filtering, these 
contributions from freely moving sodium ions are suppressed and the 23Na TQF signal might arises 
primarily from the skeletal muscle (3.3.3). TQF imaging of the leg has indeed shown an excellent 
suppression of intravascular 23Na signal (8.2, not yet published). 
After the signal calibration that takes the coil sensitivity and the muscle volume into account, 
the calculated TSC and ICW values showed no correlation anymore with the muscle volume. They 
nevertheless exhibited the same changes under the three different vascular filling conditions as the 
uncorrected 23Na signals. An average TSC of 15 mM is in close accordance with the TSC values 
measured by NMRI in 4.6.3 (15.3 to 17.6 mM depending on the muscle).  
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5.3    Impact of prolonged ischemia in murine skeletal muscle monitored by 23Na 
and 1H NMR 
In 5.1, we reported non-significant changes in the 23Na FID signal in the human leg during a 
15-minute ischemia, whereas the 23Na TQF signal decreased by more than 5 % at the end of the 
ischemic period. We further wanted to investigate the behaviour of the 23Na signals on an animal 
model, where we could prolong the ischemic paradigm to 40 minutes and compare it to 1H T2 
changes.  
5.3.1 Materials and methods 
Study design and NMR protocol 
The NMR study was performed on male C57BL6 mice, which were bought from the Jackson 
Laboratory. The study was approved by the French Ministry of Higher Education and Research 
according to the European directive 2010/63/EU. The rodents received food and drink ad libitum. 
The C57BL6 mice were investigated at an age of three months. Animals were initially 
anesthetized with 4 % isoflurane, before we placed subcutaneous surgical threads above the knee of 
their left leg. The mice were then positioned onto the custom-made bed and their legs were centred 
at the iso-centre of the magnet. Ischemia was then achieved by a compression with the threads that 
were connected to a 500 g weight outside the magnet to completely block blood flow. During the 
NMR protocol, animals continued to be under anaesthesia using a breathing mask (1.5 – 2 % 
isoflurane in O2 at 1.5 l/min) and held on a heating pad at 42 °C to keep their body temperature 
constant. Animal respiration was monitored externally during imaging with a breathing surface pad. 
The lower legs of four other mice were scanned using the 1H protocol, which consisted of 
imaging and localised spectroscopy sequences to measure global and water T2. MSME imaging was 
performed using the following parameters: 32 echoes with TE = 5.15 - 164.82 ms, TR = 3500 ms, 
resolution = 0.2 x 0.2 mm², slice thickness = 1 mm, and Tacq = 2 min 20 s. In addition, the ISIS-CPMG 
sequence, which has been implemented on the 3T clinical scanner [17], was also programmed on the 
7T preclinical scanner by combining the existing CPMG sequence of Bruker with the ISIS module. T2 
spectra of the TA muscle were obtained with the following parameters: 500 echoes with echo space 
(ES) = 1 ms, TR = 4 s, voxel size = 1.5 x 1.5 x 5 mm3, NEX = 2, acquisition BW = 50 kHz and data points 
= 32, and Tacq = 1 min 4 s.    
The lower legs of four other mice were scanned using the 23Na protocol, which comprised 
non-localized FID and TQF sequences. The FID was acquired with the following parameters: 
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acquisition delay = 50 µs, TR = 200 ms, NEX = 250, FA = 90°, BW = 10 kHz, vector size = 300, and Tacq = 
50 s. TQF experiments used following parameters: τ1 = 4 ms, TR = 200 ms, NEX = 600, FA = 90°, BW = 
10 kHz, vector size = 300, and Tacq = 2 min. At the beginning and after ischemia, a FLASH sequence 
was acquired to track a possible leg movement and visualize the blocking of the blood vessels (1 slice 
with FA = 10°, TE = 2.6 ms, TR = 7.3 ms, resolution = 0.1 x 0.1 mm², slice thickness = 1 mm, NEX = 200, 
BW = 50 kHz, and Tacq = 2 min 11 s). 
Analysis of 23Na and 1H NMR data 
The T2 values obtained from the MSME were quantified by manually tracing ROI within 
muscle groups (anterior, medial, and posterior region). Due to the absence of fat-infiltration, the T2 
decay of the MSME sequence was calculated with a mono-exponential fit (excluding first two echoes) 
to obtain the global T2. The ISIS-CPMG T2 decay was fitted with a bi-exponential model resulting in a 
short and long T2 value and their relative fractions. The 23Na FID and TQF signals were processed as 
described in 4.6.1. The signal intensities were normalized to their first time point. 
Statistical analysis  
Statistical analysis was performed using ANOVA with repeated measures and Bonferroni 
post-hoc tests for pairwise comparisons to evaluate significant differences during the course of the 
ischemia. A p < 0.05 was considered statistically significant. 
5.3.2 Results 
FID signal, TQF signal, and TQF/FID ratio were modified during the course of the ischemia 
(Figure 61), with the FID signal increasing by around 5 %, the TQF signal decreasing on average by 10 
%, and the resulting TQF/FID ratio decreasing by 15 % after 40 minutes of ischemia. The TQF/FID 
ratio changed significantly from start to end of ischemia (p < 0.05). The leg movement due to the 
heavy external weight during the course of the ischemia was negligible small.  




Figure 61: The effect of prolonged ischemia in vivo in skeletal muscle measured by 23Na NMR. 
Evolution of the A) 23Na FID signal, B) 23Na TQF signal, and C) TQF/FID ratio during a 40-minute 
ischemia in skeletal muscle tissue (normalized with first time point, presented as mean with SD bars, n 
= 4). 
In the same time course, the mean (weighted over all muscles) of the global 1H T2 increased 
significantly from 26.3 ± 1.6 ms to 29.3 ± 1.3 ms (Figure 62A, p < 0.05). Besides, the ISIS-CPMG T2 
decay exhibited an increase in water short T2 from 25.0 ± 0.5 ms to 27.9 ± 0.4 ms (p < 0.05) with 
constant water long T2 (beginning 92.8 ± 19.7 ms vs end 90.5 ± 6.3 ms) and stable relative fractions 
(beginning 94.9 ± 1.7 % vs end 93.7 ± 1.1 %) (see Figure 62B-D). 




Figure 62: The effect of prolonged ischemia in vivo in skeletal muscle measured by 1H NMR. 
Evolution of A) the mean T2 of the leg muscles measured by a MSME sequence during ischemia and of 
B) the short and C) long T2 with D) the relative short T2 amplitude obtained by a biexponential fit of 
the ISIS-CPMG signal decay during ischemia (presented as mean with SD bars, n = 4). 
5.3.3 Discussion 
The 23Na data are in line with our former ischemia experiments carried out in humans (5.1). 
While the FID seemed to be stable during the short ischemia in human, the total sodium signal yet 
increased after 40 minutes by around 5 % in mice. In the same time course, the TQF signal decreased 
by around 10 %. These observations in mice demonstrated that the sodium distribution was altered 
since the TQF/FID ratio declined while global and short T2 of 1H increased and the relative volume 
fraction of the short T2 stayed constant during the whole period of ischemia.  
Ten years ago, Babsky et al. [179] studied the effect of prolonged global ischemia on Na+ 
concentrations in rat skeletal muscle post mortem over four hours. In their work, the total Na+ 
measured by an FID was unchanged compared to the pre-ischemic level during the first two hours of 
ischemia followed by a significant increase afterwards by 8 to 16 %. Since the sodium concentration 
in extracellular space, which makes up about 23 % of the tissue [180], is more than 10 fold higher 
than the sodium concentration in the intracellular space, more than 75 % of the tissue 23Na signal 
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originates from the extracellular space. To monitor changes in the intracellular sodium 
concentration, they acquired the 23Na FID signal using a shift reagent in a second group of rats to 
separate the intra- from the extracellular 23Na signals. Ischemia caused a progressive increase in the 
[Na+]i but only after the first hour of ischemia, with a parallel decrease of the extracellular sodium 
concentration. They reasoned that the cessation of the Na-K ATPase function and influx of Na+ causes 
the three-fold increase of [Na+]i.  
In SR experiments with rats, another group reported also that the intracellular sodium 
concentration increased monotonically six-fold during eleven hours of ischemia [181]. During the first 
90 minutes of ischemia the total 23Na signal increased by 10 %. While the extracellular 23Na signal 
increased slightly during the first 30 minutes and remained then constant, the [Na+]i doubled to its 
original value decreasing the transmembrane sodium gradient. They explained the initial total 23Na 
signal increase by an augmentation of the extracellular fluid and correlated the peak area temporally 
and quantitatively with the decrease in the total peak area of the 31P NMR spectrum. During 
ischemia, energy stores are mainly used to maintain membrane potential and ion 
compartmentalization [182]. Creatine phosphate, which acts as buffer in skeletal muscle under 
absence of oxygen and free fatty acids, is depleted to maintain an adequate rate of ATP production 
necessary for the activity of the Na-K ATPase. In concurrent 31P and 23Na NMR experiments [78], the 
intracellular sodium and phosphorus signals in rat leg muscle were monitored during ischemia. The 
phosphorylation potential was falling slowly until a critical value that was linked to the energetic 
failure of the Na-K ATPase triggering an increase of the intracellular sodium signal. The 31P spectra 
showed the effects of ischemia with an increase of the Pi peak and decrease of the PCr peak while 
intracellular acidosis gradually increased. After more than one hour, high-energy phosphorus 
metabolites were depleted and ATP started to decrease while the intracellular sodium initially at a 
constant level started to increase. Although, this study used different SR and ischemic protocols with 
most of the time only one animal, it illustrated that the intracellular 23Na signal stays during ischemia 
initially constant until the cessation of the Na-K ATPase function. We cannot be sure if we already 
reached this critical point after 40 minutes of ischemia with the mice. Interleaved or at least 
consecutive 31P and 23Na NMR acquisition would have been necessary to exclude clearly the failure of 
the Na-K ATPase. Our laboratory previously communicated a PCr depletion of around 60 % in mice 
during a 30-minute ischemia [183]. This observation could indicate that ATP stores are still buffered 
during the present time course, which likely ensured the activity of the Na-K ATPase.    
In this study, we additionally monitored the effect of prolonged ischemia on skeletal muscle 
tissue by 1H NMR to get an idea about changes in the fluid distribution. Histology has related the 
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increased global 1H T2 values during ischemia to muscle fibres swelling and interstitial spaces 
widening [184]. Additionally, the increase in short water T2 with constant relative fractions points to 
a redistribution of water within the extravascular compartment [17]. The parallel changes in 1H and 
23Na indices suggest that they are coupled or at least related, and likely reflect cell swelling with a 
stable vascular volume. 
The observed decrease in the TQF/FID seems to be first contra intuitive as we expect raising 
or at least stable intracellular sodium concentrations (and TQF/FID ratio). Although, the TQF 
sequence is frequently termed as intracellular weighted, it also has significant contributions from the 
extracellular space (3.3.3). FID experiments with SR and TQF experiments therefore do not see 
exactly the same sodium species. In general, the 23Na TQF/FID ratio depends on the local Na+ 
concentration, the water compartment size, as well as on the number of accessible “binding” sites. 
Filtering by TQF leaves only the Na+ pool subjected to interactions with macromolecules, partly but 
yet not exclusively found in the intracellular matrix [110]. Thus, despite the possible increase in 
intracellular sodium concentration and decreasing transmembrane sodium gradient [181], which we 
cannot completely exclude, a redistribution of extravascular water between interstitial and 
intracellular spaces was likely to decrease sodium-protein interactions as a result of the higher 
mobility while the number of accessible “binding” sites probably stayed constant. Consequently, 
quadrupolar interactions decreased and so did the TQF 23Na signal, and the TQF/FID 23Na ratio. For 
further experiments, it would be interesting to combine the present protocol first with SR and 
second with 31P NMR acquisitions for a better understanding of the underlying mechanisms. 
5.4    Double- and triple-quantum filtered 23Na NMR in human resting skeletal 
muscle tissue 
23Na NMRI has been used as a tool to determine the TSC in healthy and diseased tissues 
(3.4.2). Efforts have been also made to distinguish the intracellular from extracellular 23Na signal. 
Nevertheless, the complete potential of 23Na NMR still needs to be exploited since by using dedicated 
sequences insights in the Na+ molecular environment can be assessed. The quadrupole interactions 
between the 23Na nuclei and their environment lead to different transitions between the four energy 
levels (3.3.3).  
DQF [91] and TQF [144] NMR methods have been proposed to exclusively detect Na+ ions 
within motional restricted areas. Moreover, DQF-MA only detects signal from Na+ interacting with 
anisotropic structures, e.g. fibres [95]. Changes in the order could present a useful marker in some 
pathologies. While TQF sequences have been already applied several times on human subjects to 
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study for example the brain [107], [176], [185] and muscle [144] tissue, the use of DQF-MA 23Na NMR 
is even less exploited.  
Here, we compared both methods, DQF-MA and TQF, to characterize the microstructure of 
human muscle tissue. As in the aforementioned section of the thesis, non-selective FID sampling was 
conducted to enable fast data acquisition. Moreover, we wanted to establish reference values of 
lower leg muscle tissue of a healthy population.  
5.4.1 Materials and methods 
Nine healthy volunteers (aged 24.7 ± 1.7 years, four women and five man) were scanned at 
the Institute of Radiology in Erlangen. Data were acquired on the right calf after a resting period of 
30 minutes in supine position to avoid important fluid distributions during NMR acquisition due to 
postural changes.  
The FID was acquired with the following parameters: TR = 300 ms, NEX = 200, time delay = 
200 µs, BW = 5 kHz, vector size = 256 pts, and Tacq = 1 min. The TQF experiments used following 
parameters: τ1 = 3 ms, τ2 = 50 µs, and τ3 = 300 µs, TR = 200 ms, NEX = 1500, BW = 5 kHz, vector size = 
256 pts, and Tacq = 5 min. The evolution time τ1 was optimized to 3 ms based on the T2 values 
measured in 5.1 as in [84]  The DQF-MA experiments used following parameters: τ1 = 5 ms, τ2 = 50 µs, 
and τ3 = 300 µs, TR = 200 ms, NEX = 2000, BW = 5 kHz, vector size = 256 pts, and Tacq = 6 min 40 s. The 
preparation time τ1 was chosen according to previous in vivo DQF-MA FID measurements, which 
pointed out a maximum at 5 ms [186].   
After reconstruction of 23Na spectra, the area under the curve was calculated from the FID, 
the TQF and the DQF-MA spectra to derive the FID signal, the TQF signal, the DQF signal, and thus 
their ratios. The temporal decay of the total 23Na signal acquired by a FID was fitted by a bi-
exponential model taking the noise B into account to obtain short T2*, long T2*, and short T2* 
fraction F: 
.ÌÇ7'8 =  Å¼T Q<NO} + 71 + ¼8T Q<NO|Æ +  
Also the temporal TQF signal decay was fitted by a characteristic signal equation assuming 
negligible quadrupolar coupling [187]:  
.NnÌ7'8 =  ÅT Q<NO} + T Q<NO|Æ +  
Where B is again the noise, T2s and T2l the short and long transverse relaxation times. The 
ratios and fitting values were expressed as mean and SD. 




The TQF and DQF-MA signals are one and two orders of magnitude smaller than the FID 
signal (Figure 1Figure 63), respectively. The mean TQF/FID ratio representing the fraction of slowly 
tumbling ions out of the total sodium pool was calculated to be 0.095 ± 0.009. Moreover, the DQF-
MA/TQF ratio describes the fraction of the slowly tumbling sodium ions that are actually bound to 
ordered structures. This mean ratio was estimated as 0.097 ± 0.035. Thus, only a very small fraction 
(DQF-MA/FID = 0.009 ± 0.004) of sodium ions can be found in ordered environments. 
 
Figure 63: Examples of A) FID signal, B) TQF signal, and C) DQF-MA signal acquired on one 
volunteer showing the important differences in signal intensity between the three techniques. 
Figure 64 shows examples of temporal decays of the FID and TQF signals acquired on one 
volunteer and their corresponding fit to derive the short and long T2 values. For the FID, a mean short 
T2 of 1.01 ± 0.2 ms with a relative fraction of 0.336 ± 0.003 and a mean long T2 of 11.98 ± 1.19 ms 
were obtained. The TQF fitting resulted in a mean short T2 of 1.74 ± 0.08 ms and a mean long T2 of 
12.99 ± 1.49 ms.  
 
Figure 64: Example of A) normalized FID and B) normalized TQF signal decays acquired on one 
volunteer. The resulting fit curves are shown in red.   
 




In this work, 23Na DQF and TQF NMR examined the tissue microstructure of human lower leg. 
As described in 3.3.3, MQF sequences have been used to select sodium signals from different 
molecular environments. Tsang et al. [188] nicely illustrated the signal evolution using the spherical 
tensor operator notation during the TQF and DQF-MA experiment. In biological tissues, the TQF 
signal results from bi-exponential relaxation and residual time-averaged quadrupole interactions. On 
the other hand, the DQF-MA sequence only produces signal in the presence of residual time-
averaged quadrupole interactions (originating from ordered structures). In 1995, residual time-
averaged quadrupole interactions were reported in DQF spectra of human skeletal muscle tissue and 
brain [91]. This was the first in vivo observation indicating the existence of sodium ions in anisotropic 
motion because of their binding to ordered structures. 
The low DQF-MA/TQF ratio in the present study underlined that only a very small fraction of 
slowly tumbling Na+ are bound to ordered structures in calf muscle tissue. Similar observations have 
been made in the heart muscle, where SR-aided and SR-free TQF and DQF spectra were acquired 
during ischemia [71]. They reported a TQF/DQF ratio of 3.55 to 4.56 for the SR-free MQF spectra 
(resulting in DQF/TQF around 0.21 to 0.28). Although not reported, we would expect a lower DQF-
MA/TQF ratio, as the third-rank tensor contributions are filtered out at the magic angle. In the SR-
aided experiments, TQF spectra showed contributions from the intra- and extracellular space, while 
DQF-MA signal was recorded only from the extracellular space since the intracellular DQF spectrum 
contains solely contributions of third-rank tensor that are filtered out by the magic angle excitation 
[189]. Moreover, our reported DQF-MA/TQF fraction of about 0.1 in muscle might be even smaller 
than calculated due to field inhomogeneities and the non-localized approach. Phantom experiments 
demonstrated that in presence of B0 inhomogeneities, unwanted signal from Na+ nuclei exhibiting bi-
exponential decay cannot be completely suppressed in DQF imaging [188]. On the other hand, B0 
inhomogeneities can lead to loss of SNR for TQF sequences, which should be nevertheless not crucial 
for field strengths below 4.7T [103]. Additional inaccuracy to the measured signals can also occur 
because of B1 inhomogeneities especially for the DQF-MA. 
The short and long T2 values from the FID and TQF fits showed a good agreement with 
literature values [143], [144]. Thus, the values could be used as references for clinical studies as they 
could change during (patho-) physiological events. Alterations in the transversal relaxation times or 
their relative fraction in skeletal muscle have been already reported after exercise [72] and during 
vascular filling/draining (5.1 and 5.2).  
 23Na NMR sequences present research tools to enhance the sodium contrast that are so far 




generate contrast by filtering signal of different molecular environments without using invasive and 
toxic SR agents. Still, the validity and clinical utility are in question and more studies have to be 
performed to justify the effort of relaxation-based 23Na NMR for tissue characterization. Both, ratios 
and T2 values might be useful to study structural changes in muscle pathologies. By using TQF and 
DQF-MA sequences, the order of the skeletal muscle tissue and dynamics of motionally restricted 
sodium ions can be non-invasively probed. Exploring possible variations with disease may be 
particularly interesting in MD, where changes in the membrane structure take place.   
5.5    Conclusion 
Na+ holds a central position in the fluid homeostasis and thus the cell volume regulation as its 
accounts for 90 to 95 % of all solutes in the extracellular fluid while being the only cation exerting 
significant osmotic pressure [190]. The idea of performing 23Na spectroscopy to assess homeostasis 
and cell viability in vivo is not novel and dates back to the 1980s [78], [191]. However the 
spectroscopic approach seems to be nowadays left aside by most research groups currently focusing 
their efforts on improving spatial resolution of 23Na images by taking advantage of high field NMRI 
[177], [192], [193]. At the beginning of this chapter, we showed that biophysically relevant 
information related to the physiological status of skeletal muscle tissue could be acquired in less than 
15 minutes, at the expense of losing the spatial information. Thanks to the high SNR of this 
spectroscopic approach, we were able to monitor several 23Na NMR variables while filling or draining 
the vascular compartment. On the other hand, the standard 1H signal intensities and the 1H T2, which 
are usually used to characterize disease activity, have been found less sensitive to the extracellular 
volume fraction alterations when compared to the 23Na parameters.  
As demonstrated in our study changes in extracellular volume fraction are traceable by using 
non-localized 23Na NMR spectroscopy. This approach allows the monitoring of total and intracellular 
weighted 23Na signal, in addition to the distribution of Na+ in a time compatible with clinical 
investigation. This biophysical information can be used to assess ion homeostasis and cell integrity in 
skeletal muscle. In the context of neuromuscular disorders, these variables offer new options to 
investigate ion channel leakage, membrane integrity, or even fibrosis formation.  
For such longitudinal or comparative studies, signal calibration is indispensable. That is why 
we showed that despite the loss of spatial resolution the 23Na signal of the proposed spectroscopic 
protocol can be quantified using an external calibration phantom doped with SR. This method allows 
the calibration and quantification of TSC and ICW. A successful signal calibration then permits the 
extension of current clinical protocols with a short 23Na protocol to unlock questions regarding the 
Na+ homeostasis and volume fraction changes. Consequently, the proposed non-localized multi-
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parametric 23Na approach could represent a powerful tool to describe the onset phase of diseases, 
revisit several aspects of their pathogenesis, and ultimately monitor treatment in a novel non-
invasive fashion. 
As shown in human and mice, 23Na NMR indices can give insights into the volume fraction 
changes and the tissue microstructure of skeletal muscle tissue. Thus as next step, I studied the 
impact of increased membrane permeability of the dystrophic muscle on different 23Na spectroscopic 
indices and compared these measurements with more established biomarkers as the proton T2 and 
fat fraction.  
    107 
Preclinical studies of the murine 
dystrophic muscle  
6.1    Murine models for muscular dystrophies 
The heterogeneous group of MD is associated to different genetic mutations (2.5). Numerous 
animal models demonstrating similar phenotypes as observed in men have been identified or 
generated. Among the different species, murine models are the most widespread due to the short 
gestational and maturation time, the availability, and relatively low cost. Murine models represent a 
valuable tool to study the role of membrane proteins and the pathological progress of myopathies. 
Additionally, animal models are used nowadays in many preclinical trials to test possible therapeutic 
interventions. Therapeutic interventions for human muscle disorders are predominantly validated on 
murine models of homologous or analogous human disease. In several murine models the feasibility 
to restore a functional protein by gene transfer, genome editing, or exon skipping approaches has 
been demonstrated [194], [195]. Still, the success rate of translating preclinical trials in human 
clinical trials remains low [196]. Several limitations to translate data obtained from mouse to man 
exist, such as the difference in scale, growth, and response to pathological processes [197]. 
Nevertheless, NMR techniques can be used as a tool to characterize non-invasively animal models 
and to evaluate the impact of an intervention. On the other hand, new NMR methods can be 
validated on well-described murine models. The specificity of the NMR techniques to monitor certain 
pathologies can be endorsed with murine models as they represent a very homogenous group 
exhibiting a usually stable phenotype across strains. They also provide an easy access to histology to 
compare the sensitivity of the NMR approach with the underlying pathological changes.  
The mdx mouse is the most popular animal model for DMD. It was first described in 1984 as 
having a muscular dystrophy with a spontaneous mutation in the X chromosome (stop codon in exon 
23). The mdx model is similar to DMD patients as they lack dystrophin and share biochemical and 
histopathological features such as increased plasma levels of creatine kinase [198]. However, the 
phenotype is less severe than in human patients. The regenerative cycles exhaust in DMD at an early 
age leading to increased fibrosis, fatty infiltration, and premature death due to respiratory and heart 
failure [36]. On the opposite, the murine muscle shows cycles of degeneration and regeneration even 
during adult life. The high degree of fibrosis in DMD is only reproduced in the diaphragm muscle of 
mdx mice but not in their limb muscles [199]. The lifespan of mdx mice is hence only very fairly 
shortened. Despite intensive research on the mdx model, it is still unclear why the disease 
progression is much milder in comparison to DMD patients [200].  
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For LGMD2B, two murine models have been so far described with spontaneous mutations: 
the A/J strain with a retrotransposon insertion in dysferlin intron 4 and the SJL/J strain with a 
deletion of dysferlin exon 45 [201]. Several backcrossed strains carrying one of these mutations have 
been developed to improve the dysferlin-deficient murine model. One inbred strain is the BLAJ 
mouse, where the A/J mutation was introduced into the C57Bl/6J background strain in the laboratory 
of Isabelle Richard at Généthon [194]. The phenotype is generally mild with an onset at two months 
characterized by centronucleated fibres and areas of inflammation. Similar as in LGMD2B patients, 
proximal muscles are more severely affected than distal muscles. As described in 2.4, repeated 
muscle contractions lead to small membrane damages that are usually quickly resealed by the Ca+-
dependent repair mechanism involving also the dysferlin protein. Biondi et al. [202] studied the 
effect of exercise in the BLAJ model, which demonstrated a delayed membrane repair, typically seen 
in dysferlinopathies. They also exhibited dual effects of exercise: while eccentric exercise provokes 
extensive myoinjuries, non-eccentric exercise improved muscle strength and limited the disease 
progression in BLAJ mice. A virus-mediated gene transfer therapy in BLAJ mice led to a widespread 
but weak expression of the dysferlin protein [194]. The treated mice showed a restored membrane 
repair capacity, however the systematic injections improved only partly histological and functional 
features of the dysferlinopathy. This underlines that the dysferlin function is not only involved in the 
membrane repair, but has also other not-yet elucidated roles in cell function.     
 
Figure 65: Histology of the quadriceps muscle of MMex38 mice at A) 12 weeks, B) 20 weeks, 
and C) 60 weeks of age. The dystrophic phenotype worsens with age. Stained with Gomori’s 
trichrome. Provided by V. Schöwel. 
Another dysferlin-deficient murine model, called MMex38, has been recently generated by 
Verena Schöwel and co-workers [203]. The MMex38 mouse model (B6; 129P2-Dysftm1.1Mdcb) has a 
missense mutation in exon 38 of the DYSF gene. It has been shown that a missense mutation DYSF 
p.L1341P in the human dysferlin gene causes dysferlin protein misfolding leading to characteristics of 
a protein misfolding disease in a well-studied, large family cohort [204]. Thus, they developed the 
first knock-in dysferlin-deficient model analogues to the human mutation (target T>C mutation in 
murine DYSF exon 38 leading to DYSF p.L1360P (dysferlin isoform 2, NP_001071162.1)). The missense 
mutation in MMex38 leads to a dystrophic phenotype in three-month-old mice with a continuous 
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disease progression in later life (Figure 65). In young mice, a number of necrotic and regenerating 
fibres are visible (centronucleated fibres). The number of necrotic fibres is increasing significantly 
with age accompanied with fat infiltration and increased connective tissue. On protein level, the 
missense-mutated dysferlin is prematurely degraded. This protein misfolding leads to amyloid 
formation in aged muscle as seen in patients. Like the BLAJ model, the MMex38 displays significant 
endurance impairments on the treadmill and a delayed myofibre membrane resealing [Jakub 
Malcher et al. 2018 under revision].  
The objective of the current preclinical study was to characterize the skeletal muscle tissue of 
the MMex38 mice by standard NMR methods. This dysferlin-deficient model was already described 
by histology, but not by NMR yet. Thus, a NMR protocol for thighs and legs was implemented that 
consisted of T1 weighted anatomical imaging, 1H T2 and T1 measurements, fat fraction quantification 
and 31P NMRS. These 1H NMR data were compared to the more described BLAJ model and wild-type 
mice. 
In a protocol extension, different murine models of MD were used to validate novel NMR 
approaches. ISIS-CPMG and 23Na NMR spectra were acquired in skeletal muscle tissue of MMex38, 
mdx and wild-type mice. We compared their sensitivity and specificity to detect pathological 
alterations in dystrophic muscle to standard NMR methods. Furthermore, histology was performed 
to confirm the extent of pathological features. 
6.2    Materials and methods 
Murine models and study design 
The NMR protocols included four different murine strains. The dysferlin-deficient BLAJ and 
MMex38 mice were bred in the Max-Delbrück-Centrum für Molekulare Medizin, Berlin and the 
dystrophin-deficient mdx mice were obtained from UMS 28-Nouvelle Animalerie commune, Paris. 
C57BL10 mice served as wild-type (WT) for the dysferlin-deficient and mdx mice and were bought 
from the Janvier Laboratory. The study was approved by the French Ministry of Higher Education and 
Research according to the European directive 2010/63/EU. Mice received food and drink ad libitum. 
NMR acquisitions were performed on 1-year-old female mice (MMex38 n = 10, BLAJ n = 4, mdx n= 10, 
and WT n = 10). 
NMR protocol 
Animals were initially anesthetized with 4 % isoflurane before placed onto a custom-made 
bed. The biggest circumference of the legs was centred in the body coil at the iso-centre of the 
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magnet. During the NMR scanning, animals continued to be under anaesthesia using a breathing 
mask (1.5 – 2 % isoflurane in O2 at 1.5 l/min) and held on a heating pad at 42°C to keep their body 
temperature constant. Animal respiration was monitored externally during NMR acquisition with a 
breathing surface pad. 
All animals experienced to the first part of the study. The 1H NMR protocol for leg and thigh 
included T1-weighted high-resolution for anatomical images, multi-spin echo for T2 measurement, 
fast spin echo for T1 measurement, and localized 1H NMRS for fat quantification. The anatomical 
images were acquired with a RARE sequence (TR/TE = 3500/5.5 ms, FA = 90°, RARE factor = 8, 23 axial 
slices with resolution = 0.1 mm × 0.1 mm² and slice thickness = 0.5 mm, slice gap = 1mm, and Tacq = 2 
min 30 s). For the evaluation of disease activity, muscle water T2 values were measured by a non-fat 
supressed MSME imaging sequence with: 37 different TEs = 4.0 - 149.3 ms, TR = 750 ms, FA = 90°, 
acquisition BW = 200 kHz, 3 axial slices, resolution = 0.125 × 1.25 mm² and slice thickness = 1 mm, 
and Tacq = 13 min for legs/Tacq = 17 min for thighs). T1 values were measured by a RARE sequence with 
19 different TRs = 54.6 - 6500 ms, TE = 5.5 ms, excitation/refocusing FA = 90°/180°, RARE factor = 8, 
acquisition BW = 200 kHz, 1 axial slice, resolution = 0.125 × 1.25 mm² and slice thickness = 1 mm, and 
Tacq = 8 min for legs/Tacq = 10 min for thighs). Finally, PRESS sequences were acquired at two voxel 
locations to quantify the fat content in muscle (TE/TR = 15/1505 ms, voxel size = 2 × 2 × 3 mm3 with 
0.61 Hz/point spectral resolution, spectral BW = 5 kHz and 4096 data points, 200 averages, and Tacq = 
5 min). The voxels were positioned in the anterior and in the posterior part of both the right leg and 
the right thigh. For a good spectral quality, manual shimming was performed to obtain a linewidth of 
water that was below 30 Hz. The duration of the 1H NMR protocol was about three hours per animal 
including repositioning and shimming. 
For six MMex38, six mdx, and six WT, additional 31P spectra were acquired on the right leg. 
Non-localized 31P spectrum of the murine leg was acquired with TE/TR = 0.05/2500 ms, 200 µs hard 
pulse excitation with FA = 60°, spectral BW = 6009 Hz and 1026 data points, 720 averages, and Tacq = 
30 min. The power setting was used from preceding calibration experiments. For a good spectral 
quality, B0 mapping and additionally shimming was performed to obtain a linewidth of water that 
was below or equal to 70 Hz.  
The same mice also underwent a 23Na NMR protocol. A small cylindrical vial (2 mm diameter 
and 10 mm length) containing a solution of 140 mM NaCl doped with 24 mM TmPOPT5- was fixed to 
in the 23Na coil next to the leg. Bulk susceptibility of the TmDOTP5- solution shifted the resonance 
frequency by 37 ppm allowing discrimination from the signals of the hindlimb and the calibration 
phantom. The RF power to produce a 90° FA angle was determined by increasing the transmit power 
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stepwise (between 0.6 and 2.5 W). The 23Na protocol comprised non-localized FID, TQF, and IR-LL 
sequences as presented in 4.6.1. The FID was acquired with the following parameters: acquisition 
delay = 50 µs, TR = 200 ms, NEX = 250, BW = 10 kHz, vector size = 256 points, and Tacq = 50 s. TQF 
experiments were performed with following parameters: τ1/τ2/τ3 = 4/0.05/0.05 ms, TR = 200 ms, NEX 
= 600, BW = 10 kHz, vector size = 256 points, and Tacq = 2 min. The 23Na T1 values were obtained from 
the IR-LL with the following parameters: acquisition delay = 200 µs, TR = 200 ms, 55 echoes with ES = 
5 ms, NEX = 400, BW = 10 kHz, vector size = 30 points, and Tacq = 50 s.  
Finally, for the six mdx and six WT mice, the protocol was expanded by acquiring ISIS-CPMG 
sequences. 1H T2 spectra were obtained with the following parameters: 500 with ES = 1 ms, TR = 4 s, 
voxel size = 1.5 x 1.5 x 5 mm3, NEX = 2, BW = 50 kHz and data points = 32, and Tacq = 1 min 4 s. The 
voxel positions in the thigh and leg were the same as for the PRESS acquisitions. 
Analysis of NMR data 
To assess the muscle trophicity in dysferlin-deficient mice, cross sectional areas (CSA) of the 
quadriceps were drawn on the contractile tissue on the T1-weighted images avoiding the complete 
fat-replaced parts of the muscle (Figure 66A). For T1 and T2 measurements, ROIs were manually 
traced on the right and left leg and thigh within muscle compartment on MSME images (Figure 66B).  
 
Figure 66: A) Representative T1-weighted image of the thigh of a MMex38 mouse. CSA of the 
quadriceps were drawn on the contractile tissue avoiding the complete fat-replaced parts of the 
muscle (ROI_2). B) Representative axial MSME image (at TE 4 ms) of the left leg and thigh of a WT 
mouse. The overlay represents the manually traced ROIs in the different muscle compartments. Leg: 
Ant. (red) = TA/EDL, med. (green) = TP, and pos. (yellow, blue and turquois) = gastrocnemius, 
plantaris muscles; Thigh: ant. (red) = quadriceps, med. and pos. (yellow and blue) = biceps femoris 
and gluteus maximus. 
T1 values were fitted to a mono-exponential model. FF and water T2 values were measured 
using a tri-exponential analysis [16] with noise compensation due to the low SNR at higher TE. The 
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noise correction took into account the Rician noise of the background to calculate the true image 
intensities for the fit [205]: 
	 =  
| +  \²| 
Where A is the corrected image pixel intensity, M the measured pixel intensity and σ the 
background noise. Global T1, FF, and water T2 were determined as mean value of pixels within the 
drawn ROI with a confidence interval less than 10 [206]. The heterogeneity of muscle T2 was assessed 
by the coefficient of variation (CV) across ROIs. In addition, the percentage of pixels with a water T2 
higher than 36.7 ms were computed and reported as elevated T2. This threshold was determined 
from the mean value plus two SD of water T2 values of the WT mice.  
The 1H NMR spectra were processed with a 5 Hz Lorentzian apodization and manual zero and 
first order phasing correction. The water peak was set to 4.7 ppm. The amplitudes of three peak 
clusters in the proton spectra used for the fat ratio calculation as described in 4.2.1 (Figure 67). 
 
Figure 67: 1H NMR spectra with water suppression in the calf of a MMex38 and a WT mouse. 
Lipid 1 was assigned to methylene protons at Δppm = 0.8 - 1.8, Lipid 2 to α- or β-methylene protons at 
Δppm = 2 - 2.8, and Lipid 3 to olefinic protons at Δppm = 5.3 - 5.7. Note the residual peak of water at 
4.7 ppm. 
The 31P NMR spectres were smoothened with a 10 Hz Lorenzian filter followed by manual 
zero and first order phase correction. The resonances of PDE, Pi, PCr, and the three phosphate groups 
of ATP (γATP, αATP and βATP) were fitted with the AMARES algorithm from jMRUI. The pH was 
determined from the chemical shift between PCr and Pi according to the modified Henderson-
Hasselbalch equation (4.5.1). All 31P resonance integrals were corrected for saturation effects using a 
fully relaxed spectra with TR = 18 s. The broad, small peak at the phosphomonoesters (PME) 
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resonance was recorded, but not quantified since it was not detected in all mice. Only 31P spectra 
with a linewidth of PCr below or equal to 30 Hz were accepted for the analysis.  
The ISIS-CPMG T2 decay was fitted with a bi-exponential model resulting in a short and long 
T2 value and their relative fractions. The 23Na signals were calibrated with the leg volume and SR peak 
as described in 5.2. We obtained four different 23Na indices: FID, TQF, TQF/FID ratio, and global T1 
value. No T2* values were fitted due to the signal contamination of the SR phantom leading to signal 
superimposition of the relaxation decay. 
Histology  
After NMR acquisition, animals assigned to the extended protocol were euthanized by 
cervical dislocation under full anaesthesia. The anterior and posterior muscles of the right leg and 
thigh were harvested and preserved in formaldehyde solution (4 % in phosphate buffer saline). The 
samples were stained with hematoxylin and eosin (H&E) for a qualitative evaluation of the muscle 
tissue. Three transversal sections were cut in the proximal, medial, and distal part of the muscles, 
which were viewed at 10x magnification.  
Statistical analysis  
A non-parametric Kruskal-Wallis test with Dunn post-hoc multiple comparisons was used to 
evaluate the different NMR variables. 31P and 23Na NMR data were analysed using a single-factor 
ANOVA with a Bonferroni post hoc analysis. ISIS-CPMG data were analysed using Student’s t-test as 
this measure was only performed in two groups. Spearman-rank correlations analysed the 
correlation between the parameters. Statistical significance was considered at p < 0.05. 
6.3    Characterisation of a novel dysferlin-deficient murine model by NMR 
Anatomical imaging  
At 1 year of age, intramuscular fat infiltration could be clearly visualized on T1-weighted 
images of the thigh of both dysferlin-deficient murine models (Figure 68). Thighs of MMex38 showed 
heavily fat infiltrated muscle in the posterior medial muscle group as well as completely fat replaced 
muscles in the quadriceps. The T1-weighted images of BLAJ mice showed also hyperintensities in the 
thigh muscles; however, the quadriceps was less severely affected than in MMex38. The CSA of the 
quadriceps was significantly decreased in MMex38 (18.4 ± 2.8 mm², p < 0.05) and BLAJ (16.1 ± 2.3 
mm², p < 0.05) compared to WT (22.2 ± 0.5 mm²). On the contrary, leg muscles looked very 
homogenous in both models of dysferlin-deficiency. Thus, there was no visual difference between 
the leg of dysferlin-deficient mice and WT.  




Figure 68: T1-weighted images of the thigh and leg of WT, MMex38, and BLAJ mice. The 
images showed highly fat infiltrated muscles in the thighs of both dysferlin-deficient mouse models. 
Parts of the quadriceps of MMex38 were systematically replaced by fatty tissue. 
1H T2 and T1 mapping  
Figure 69 plots the T1 values of the different muscle compartments. The mean T1 in thighs 
and legs of MMex38 was 1.70 ± 0.07 s, for the BLAJ 1.73 ± 0.06 s, and for the WT 1.76 ± 0.07 s. The 
difference in T1 of the hindlimb muscles was only significant between the MMex38 and WT. This 
results from the significantly decreased T1 values in the posterior medial compartment of the thigh. 
Water T2 values and FF of the leg and thigh muscles are plotted in Figure 70 and Figure 71, 
respectively. The mean FF in thigh and leg of MMex38 was 0.13 ± 0.07, for the BLAJ 0.11 ± 0.05, and 
for the WT 0.08 ± 0.01 with a significant difference between the dysferlin-deficient models and WT (p 
< 0.05). While the leg muscles were not affected, the thigh muscles exhibited increased FF. NMR 
detected also increased water T2 in the calf and thigh muscles of MMex38 and BLAJ mice reflecting 
an ongoing disease activity. The mean water T2 of MMex38 and BLAJ was 27 ± 3 ms and for the WT 
24 ± 1 ms with a significant difference between the dysferlin-deficient models and WT. 
Elevated water T2 and CV of water T2 of the leg and thigh muscles are plotted in Figure 72 
and Figure 73, respectively. Dysferlin-deficient mice showed a much higher ratio of pixels with 
elevated water T2 (MMex38 global mean of 50 ± 28 % and BLAJ global mean of 50 ± 32 %) than WT 
(Global mean of 15 ± 8 %). The mean water T2 CV of MMex38 and BLAJ was 0.13 ± 0.02 and 0.12 ± 
0.02, respectively. This ratio was significantly higher than the one of WT with 0.01 ± 0.01. The high T2 
heterogeneity in dysferlin-deficient mice indicates tissue disorganization in the muscle tissue. 




Figure 69: T1 values of WT and dysferlin-deficient MMex38 and BLAJ mice: No significant 
differences were seen in the leg between the strains. In the thigh, the dysferlin-deficient mice showed 
decreased T1 values in the medial posterior compartment compared to WT (MMex38 n = 10, BLAJ n = 
4, and WT n = 10; $: p < 0.05). 
 
Figure 70: Fat fraction and water T2 values measured in the leg of WT and dysferlin-deficient 
MMex38 and BLAJ mice: No significant differences were seen in the FF between the strains. Dysferlin-
deficient mice showed increased water T2 values in the anterior and posterior compartment 
compared to the (MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p < 0.05). 
 




Figure 71: Fat fraction and water T2 values measured in the thigh of WT and dysferlin-
deficient MMex38 and BLAJ mice: Dysferlin-deficient mice showed systematically increased FF and 
water T2 values compared to WT (MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p < 0.05). 
 
Figure 72: Elevated water T2 and water T2 CV measured in the leg of WT and dysferlin-
deficient MMex38 and BLAJ mice: Dysferlin-deficient mice showed a higher percentage of elevated 
water T2 values as well as higher CV in the anterior and posterior compartment compared to WT 
(MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p < 0.05). 




Figure 73: Elevated water T2 and water T2 CV measured in the thigh of WT and dysferlin-
deficient MMex38 and BLAJ mice: Dysferlin-deficient mice showed higher percentage of elevated 
water T2 values as well as higher CV compared to WT (MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p 
< 0.05). 
1H NMR spectroscopy  
The localized 1H spectroscopy showed a significant accumulation of lipids in thigh and calf of 
MMex38 and BLAJ compared with WT (Figure 74). The fat ratio in the thigh muscles was higher in 
MMex38 than in BLAJ mice. 
 
Figure 74: Fat ratios measured by 1H spectroscopy in the leg of WT and dysferlin-deficient 
MMex38 and BLAJ mice: Dysferlin-deficient mice showed higher fat ratios especially in the thigh 
muscles compared to WT (MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p < 0.05). 
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31P NMR spectroscopy  
 Figure 75 presents the non-localized spectra of MMex38 and WT mice with the assigned 
phosphate resonances. Metabolic ratios were calculated with the Pi, PCr, and ATP peaks (Table 10). 
In MMex38, the PCr/ATP ratio tended to be lower and the Pi/ATP ratio higher than in WT (both not 
significant). The pH was significantly higher in MMex38 than in WT (7.16 ± 0.09 vs 7.06 ± 0.06). In 
contrast to WT, four out of six spectra of MMex38 mice showed a clear peak at the PME resonance. 
None of the phosphor metabolite ratios correlated with the fat fraction (all R² < 0.05). 
 
Figure 75: Resting 31P spectra (TR 2.5 s) acquired of the right leg are shown for MMex38 and 
WT. Peaks were assigned to PME (around 6 ppm), Pi (4.95 ppm), PCr (0 ppm), and the γ- (-2.4 ppm), 
α- (-7.5 ppm), and β-phosphate (-16 ppm) of ATP. Each spectra represents an average of 720 FIDs 
over 30 minutes.  
Table 10: Mean values ± SD for the different phosphate metabolites in WT and MMex38 
(MMex38 n = 6 and WT n = 5). Only the pH was significantly increased ($: p < 0.05).  
 
Pi/PCr Pi/ATP PCr/ATP pH 
MMex38 0.11 ± 0.03 0.29 ± 0.06 2.70 ± 0.45 7.16 ± 0.09$ 
WT 0.09 ± 0.02 0.27 ± 0.09 3.08 ± 0.30 7.06 ± 0.06 
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6.4   Results of standard NMR protocol for mdx model 
Anatomical imaging  
At 1 year of age, the T1-weighted images of the thigh of mdx mice showed few 
hyperintensities in the muscle tissue (Figure 76). No hyperintensities in the muscle tissue were visible 
in the leg muscles. 
 
Figure 76: T1-weighted imaging showed slightly fat infiltrated muscles in the thigh of mdx 
compared to WT. 
1H T2 and T1 mapping  
The mean T1 value of mdx was 1.77 ± 0.03 s and for the WT 1.76 ± 0.06 s. Significantly 
increased T1 values were found only in the anterior and medial compartment of the leg of mdx when 
compared to WT (Figure 77).  
 
Figure 77: T1 values of the WT and mdx mice: Significant differences were seen in the leg 
between the strains ($: p < 0.05). 
The mean FF of mdx was 0.09 ± 0.01 and for the WT 0.08 ± 0.01. No muscle compartment in 
mdx showed a significant increase in FF. NMR detected increased water T2 in the calf and thigh 
muscles of mdx reflecting an ongoing disease activity (Figure 78). The mean water T2 of mdx was 26.2 
± 1.7 ms and for the WT 24 ± 0.8 ms with a significant overall difference between the two strains (p < 
0.05). 





Figure 78: Water T2 values measured in the leg and thigh of the WT and mdx mice: Mdx mice 
showed increased water T2 values in several muscle compartments compared to WT ($: p < 0.05). 
Elevated water T2 and water T2 coefficient of variations of the leg and thigh muscles are 
plotted in Figure 79 and Figure 80, respectively. Mdx mice showed a higher ratio of pixels with 
elevated water T2 (Global mean of 42 ± 20 %) than WT (Global mean of 15 ± 8 %). The mean water T2 
CV of mdx and WT was 0.12 ± 0.01 and 0.10 ± 0.01, respectively (p < 0.05).  
 




Figure 79: Elevated water T2 and water T2 CV measured in the leg of WT and mdx mice: mdx 
showed a higher percentage of elevated water T2 values as well as higher CV in the anterior and 
posterior compartment compared to WT ($: p < 0.05). 
 
Figure 80: Elevated water T2 and water T2 CV measured in the leg of WT and mdx mice: mdx 
showed a higher percentage of elevated water T2 values as well as higher CV in the anterior and 
posterior compartment compared to WT ($: p < 0.05). 
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1H NMR spectroscopy  
The localized 1H spectroscopy showed a trend of elevated lipid ratios in mdx, that remained 
not significant compared with WT (Anterior leg: mdx 0.007 ± 0.005 and WT 0.007 ± 0.004; posterior 
leg: mdx 0.010 ± 0.003 and WT 0.005 ± 0.002; anterior thigh: mdx 0.014 ± 0.008 and WT 0.011 ± 
0.009; posterior thigh: mdx 0.018 ± 0.008 and WT 0.005 ± 0.004). 
31P NMR spectroscopy  
Figure 81 presents the non-localized spectra of mdx and WT. The mean of PCr/ATP and 
Pi/ATP were elevated compared to the WT (Table 11; both not significant). The pH was higher in mdx 
than in WT (7.14 ± 0.09 vs 7.06 ± 0.06). In contrast to WT, three out of five spectra of mdx mice 
showed a clear peak at the PME resonance. 
Table 11: Mean values ± SD for the different phosphate metabolites in WT and mdx (n = 5 
mice per group). No significant alterations were observed.  
 
Pi/PCr Pi/ATP PCr/ATP pH 
mdx 0.11 ± 0.04 0.36 ± 0.11 3.29 ± 0.28 7.14 ± 0.09 
WT 0.09 ± 0.02 0.27 ± 0.09 3.08 ± 0.30 7.06 ± 0.06 
 
Figure 81: Resting 31P spectra (TR 2.5 s) acquired on the right leg are shown for mdx and WT 
mice. Peaks were assigned to PME (around 6 ppm), Pi (4.95 ppm), PCr (at 0 ppm), and γ- (-2.4 ppm), 
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6.5    Validation of new NMR outcome measures on dystrophic murine models 
 In this subchapter, I present the results of the ISIS-CPMG and 23Na NMR acquisitions as well 
as the histological features. The new NMR indices are compared to the outcome measures of the 
standard protocol. 
ISIS-CPMG 
Figure 82 presents the results of this bi-exponential fit as mean of average and SD of the 
relative short T2 amplitude and short and long T2 values. A significant increase in the short T2 was 
observed in mdx compared to WT.    
 
Figure 82: Results obtained from the bi-exponential fit for the relative short fraction and short 
and long T2 values in WT and mdx (n = 6 mice per group). Short T2s were increased in the thigh and 
anterior compartment of the leg compared to the WT ($: p < 0.05). 
23Na NMR spectroscopy  
 During the course of the 23Na acquisitions of MMex38, the SR evaporated out of the small vial 
making a signal calibration impossible. Thus, only the TQF/FID ratio and T1 values were calculated for 
MMex38 and are presented in Table 12. The TQF/FID ratio was independent of the volume and 
considered to give a correct indication of sodium distribution in the leg between the two groups. The 
mean TQF/FID ratio was decreased in MMex38 mice while the mean T1 value was increased when 
compared to WT (both p < 0.05). An increased T1 was accompanied with a decrease in the TQF/FID 
ratio (Figure 83). 
Table 12: Mean values ± SD of the 23Na TQF/FID ratio and the 23Na T1 in WT and MMex38 
(MMex38 n = 6, WT n = 5). Significant alterations were observed in the TQF signal and the T1 values 
($: p < 0.05). 
 TQF/FID T1 [ms] 
MMex38 0.157 ± 0.043$ 36.6 ± 2.2$ 
WT 0.212 ± 0.034 32.7 ± 2.6 
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For the 23Na experiments in WT and mdx, a new vial for the SR reagent was used that was 
impermeable during the course of 23Na acquisitions. Table 13 presents the calibrated FID and TQF 
signal as well as the TQF/FID ratio and T1 values. The TQF/FID ratio were significantly increased in 
mdx mice when compared to WT. No significant changes were observed in the FID signal, the TQF 
signal and T1 values between mdx and WT. 
Table 13: Mean values ± SD of the sodium indices measured in WT and mdx: FID signal, TQF 
signal, TQF/FID ratio, and the T1 (mdx n = 6, WT n = 5). Significant alterations were observed in the 
TQF/FID ratio ($: p < 0.05). 
 
FID [a.u.] TQF [a.u.] TQF/FID T1 [ms] 
mdx 0.201 ± 0.014 0.05 ± 0.003 0.253 ± 0.026$ 32.9 ± 2.6 
WT 0.208 ± 0.031 0.044 ± 0.008 0.212 ± 0.034 32.7 ± 2.6 
As previously seen in MMex38 mice, an increased T1 was accompanied with a decrease in the 
TQF/FID ratio. Figure 83 illustrates the correlations of the TQF/FID ratio with the global sodium T1 
and the PCr/ATP ratio obtained by 31P NMR. No further correlations between 1H T2, 31P, and 23Na 
NMR parameters have been observed. 
 
Figure 83: Correlation between the TQF/FID ratio and 23Na T1 values and PCr/ATP ratio 
(including MMex38, mdx, and WT mice). 
Histology  
 To have a microscopic insight of the pathology present in the dystrophic muscles, H&E 
staining was performed. Consistent with the elevated fat ratios and increased disease activity (high T2 
values, high ratio of pixels with elevated T2, and high CV of T2), the histological slices of MMex38 
contain a mix of inflammation, degenerating and regenerating fibres, and an accumulation of lipid 
droplets. These features are especially pronounced in the proximal muscles compared to distal 
muscles that are more spared (compare Figure 84 and Figure 85). Inflammation, necrosis or fatty 
infiltration were not observed in either of the WT muscles (Figure 86). The muscles of mdx mice also 
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showed typical histological features of a dystrophic muscle including centronucleated fibres. In the 
proximal muscles of mdx mice several accumulations of mononuclear cells and few lipid droplets 
were observed (Figure 87). 
 
Figure 84: Visualisation of myofibre damage and mononuclear cell infiltration in the 
quadriceps of MMex38. H&E staining of the quadriceps muscle cross sections reveals the dysferlin-
deficient pathological process. The images show centrally nucleated fibres indicating ongoing necrosis 
and recuperation and fatty tissue replacement. Several accumulations of mononuclear cells were 
observed in dysferlin-deficient muscle tissue (right).  
 
Figure 85: Visualisation of myofibre degenerating and regenerating fibres in the leg of 
MMex38. H&E staining of the tibialis anterior muscle cross sections reveals centrally nucleated fibres, 
some atrophic fibres and lipid droplets. Few areas are infiltrated by mononuclear cells. 
 




Figure 86: Visualisation of healthy myofibres in the quadriceps of WT. The images show 
neither centrally nucleated fibres nor lipid droplets in the muscle tissue.  
 
Figure 87: Visualisation of myofibre damage and mononuclear cell infiltration in the tibialis 
anterior (left) and quadriceps muscles (right) of mdx. The images show centrally nucleated fibres 
indicating ongoing necrosis and recuperation. In the quadriceps of mdx mice, several accumulations 
of mononuclear cells and few lipid droplets were observed. 
6.6    Discussion 
6.6.1 NMR characterization of the dysferlin-deficient murine models 
Muscle dystrophies commonly exhibit a variety of pathological features that include muscle 
weakness, inflammation, loss of membrane integrity, necrosis, regeneration, and ultimately fat 
replacement. Here, we used a multi-parametric NMR approach to study the different underlying 




dysferlin-deficient murine model. The set of different NMR methods produced a variety of non-
invasive measures that allow monitoring the disease progression and activity. 
Quantitative NMRI and NMRS provided a variety of abnormal indices in thigh and leg muscles 
of both dysferlin-deficient animal models. The anatomical images indicated a very advanced disease 
progression in the proximal hindlimb muscles. The disease progression and activity was symmetrical 
between the left and right limbs. The visible fat infiltration in the thigh was confirmed by increased 
fat fraction measured by localized 1H spectroscopy as well as by 1H imaging. The reduced 1H T1 values 
in the medial posterior compartment of the thigh, which showed the highest FF of all muscle 
compartments based on MSME images, reflect also the presence of fat in the skeletal muscle tissue. 
Although T1 mapping is spatially localized, it was less sensitive than the spectroscopic approach to 
detect fat accumulation. Localized 1H NMR spectroscopy also detected a small but significant 
accumulation of lipids in the calf that was not detected by the fat fraction maps obtained by the tri-
exponential fit of the MSME signal decay. The fat ratios tended to be higher in the MMex38 murine 
model than the BLAJ model; however, a higher number of animals would be needed to confirm this 
observation. The reported increase of fatty tissue in the dysferlin-deficient mice is in accordance with 
previous study on BLAJ. Oil red O staining and electron microscopy revealed a significant lipid 
accumulation with areas of increased numbers of interstitial adipocytes within the myofibres of 
dysferlin-deficient mice [50]. Nagy et al. reported a progressive volume loss and fatty acid 
accumulation in the hip region observed by 1H NMR in six to twelve-month-old BLAJ mice [207]. 
Alterations in water T2 were monitored as they convey also information about the structural 
changes within the muscle. Both dysferlin-deficient murine models showed increased water T2 values 
as well as high percentage of pixels with elevated water T2 in leg and thigh muscles. No correlation 
existed between the water T2 and fat fraction. Thus, the elevated water T2 values reflect disease 
activity including inflammation, necrosis, and oedema. The coefficient of variation of water T2 
reflects the tissue heterogeneity and points to a tissue disorganization in dysferlin-deficient muscles 
[208]. Absence of correlation between T2 heterogeneity and the amount of fatty infiltration reflects 
mechanism of tissue disorganization other than fat infiltration. The high heterogeneity in the 
dysferlin-deficient mice could be attributed for example to development of interstitial fibrosis or 
centronucleated fibres.  
1H NMR data demonstrated that leg muscles are less affected by fat infiltration, but exhibit 
already high disease activity. 31P NMR was used to detect changes in dysferlin-deficient muscles 
before irreversible changes such as fatty infiltration occur. Thus, disturbances in energy metabolism 
were analysed in the dysferlin-deficient muscle of MMex38.  
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Energy metabolites quantified from 31P NMRS also revealed a significantly higher pH in the 
leg of MMex38. Some, but not all MMex38 mice also showed deficits in phosphocreatine. The 
decrease in the mean PCr/ATP ratio reflecting the energy state of muscle nevertheless was not 
significant due to the high SD. Human 31P NMR data revealed significantly higher Pi/PCr and pH and 
significantly lower PCr/ATP in the tibialis anterior muscle of dysferlinopathy patients compared to 
control [209]. To the best of my knowledge, no 31P NMR data was reported on dysferlin-deficient 
mice. A 1H NMR study reported decreased creatine levels in the gluteus maximus of 6 month old BLAJ 
mice, but no data was reported for one year old mice [207]. Thus, our results are in agreement with 
these studies, although we did not find significant alterations for all the reported indices. 
The NMR measures showed similar contrast between the two different dysferlin-deficient 
models, BLAJ and MMex38. However, the number of animals was very low and an increase in sample 
size would make the comparison more robust. Nevertheless, it seems that different mutations in the 
dysferlin gene lead to similar phenotype. So far, only very few NMR studies with dysferlin-deficient 
mouse models were presented providing insight into the pathophysiology. One reported as 
aforementioned a fatty acid accumulation and decreased creatine levels in the hip region of BLAJ 
mice [207]. Another study imaged the TA muscle of the A/J murine model after lengthening 
contractions [210]. In this longitudinal study, T2w imaging after contractions was performed up to 14 
days. They reported, much higher increase in T2 signal intensity in dysferlin-deficient muscles 
compared to control after injury relating their observation to the membrane repair impairments of 
the mouse model.  
Finally, the reported disease progression and disease activity are consistent with the 
pathological changes observed in human dysferlin-deficient patients [209]. This study investigated 
several NMR outcome measures that could be used to study the efficacy of therapeutically 
interventions for human dysferlin deficiency. Furthermore, it would be interesting to study the effect 
of exercise in the dysferlin-deficient model by different NMR techniques. An eccentric exercise study 
in combination with 1H T2, 31P NMR, and 23Na NMR could investigate the impairments of membrane 
repair in dysferlin-deficient muscles. However, due to time constraints this could not be performed 
yet. 
6.6.2 NMR characterization of the dystrophin-deficient murine models 
 The anatomical images revealed the mild phenotype of the dystrophin-deficient murine 
model. DMD patients can compensate more or less for the disease process until an age of about five 




Chronic muscle damage with inflammation, necrosis and oedema lead to the progressive muscle loss 
and replacement of muscle tissue by fibro-fatty tissue. In contrast, an active regeneration in mdx 
throughout their lifetime seems to counterweigh for the ongoing muscle damage. Thus, mdx skeletal 
muscle tissue does not resemble the one of DMD patients at an advanced stage of disease.  
 In the present study, no significant fat infiltration was detected by 1H NMR in thigh or leg 
muscles. An increase in T1 values in the anterior and medial muscles of the leg was paralleled with an 
increase in T2. As there was no correlation between the fat fraction and T1 values, concurrent 
changes in T1 and T2 can point to oedema in the muscle tissue. Increases in T1 were previously 
reported in GRMD dogs, a canine model for DMD [211]. The alterations in T1 were related to changes 
in the water molecular dynamics that also increased the muscle T2, however on a smaller scale. Mdx 
mice showed increased water T2 values as well as high ratio of pixels with elevated water T2 in leg 
and thigh muscles. No correlation existed between the water T2 and fat fraction. Thus, the elevated 
water T2 values reflect disease activity including inflammation, necrosis, and oedema. The increased 
water T2 heterogeneity in dystrophin-deficient muscles points to a tissue disorganisation. These 
changes in water T2 have also been observed in DMD patients [121], [125]. So far, some studies 
reported T2 changes in the mdx muscle. In 2013, a case study monitored temporal changes of the T2w 
intensities in the leg of one mdx mouse [212]. A peak in muscle weakness and 
degeneration/regeneration was reported between the 2nd and 5th weeks of life. The heterogeneity of 
hyperintensities increased up to 13 weeks of age and then decreased. Vohra et al. further 
investigated age-related T2 changes in hindlimb muscles of mdx mice [213]. They reported elevated 
global T2 values and increased percentage of pixels with elevated T2 (two times the SD) at all ages. 
Asynchronous and cyclical alterations in the global T2 were observed in 20 to 60 week-old mice with a 
mean muscle T2 peak at 7 - 8 weeks. Other studies used T2 measurements to study the impact of 
downhill running and gene therapy in mdx mice [214], [215]. Although, these studies used a mono-
exponential fit to determine the T2, their results reflect the inflammation and muscle damage 
present in mdx as the murine model shows no significant fatty infiltration.  
We further analysed impairments in energy metabolism in murine dystrophic muscle by 31P 
NMR. Several studies on DMD patients showed promising results to detect changes in dystrophin-
deficient muscles before onset of irreversible changes such as fatty infiltration [53], [60], [121], [216]. 
In our study, the PCr/ATP and Pi/ATP ratio as well as the pH tended to be increased compared to the 
WT. However, no significant alterations were measured. In contrast to WT, three out of five spectra 
of mdx mice showed a clear peak at the PME resonance. No PDE peak was visible in the murine 31P 
spectra as reported in dystrophic patients [53]. Increases in pH and Pi/ATP ratios are expected in 
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dystrophic muscles as they can serve as a marker of the membrane leakiness and the impairment of 
ionic intracellular homeostasis. The higher, but non-significant PCr/ATP ratio is first contra-intuitive, 
because dystrophic muscles have an increase in PCr/ATP reflecting a loss of metabolic efficiency 
[121]. Our observation that this ratio was not decreased was caused by two mdx mice, which seem to 
show no energy metabolism impairment. Thus, the presented results are pointing to the same 
direction as other 31P NMR studies on dystrophic muscles [217]. Heier et al. studied the potential of 
31P spectroscopy on mdx as an outcome measure translatable to human clinical trials [218]. Mdx 
mice showed a lower PCr/ATP ratio and an increase in Pi/ATP compared to WT at six weeks of age. 
This difference between WT and mdx disappeared after about 10 weeks of age. Thus, the peak stage 
of muscle weakness and necrosis was paralleled with energy metabolism deficiency that later 
improved during recovery phase. However, this longitudinal study included only mice from six to 
twelve weeks of age. Nevertheless, the age of our mdx mice might be also an important reason why 
we did not observe any significant alterations in the energy metabolism. 
6.6.3 Sensitivity of 23Na NMR and ISIS-CPMG sequences to the dystrophic muscle 
Our 1H NMR data demonstrated that hindlimb muscles of mdx and MMex38 exhibited active 
disease activity. In an extended NMR protocol, the murine models were used to test the sensitivity of 
the ISIS-CPMG method and our non-localized 23Na protocol (4.6.1).  
Regarding the T2 1H relaxometry study using ISIS-CPMG, only the short T2 was significantly 
increased in mdx compared to WT, whereas the long T2 and the relative fraction seemed not to be 
impacted by the dystrophic disease process. The increase in short water T2 with constant relative 
fractions points to an increase of water within the extravascular compartment [17]. Similar changes 
were observed in DMD patients (7.3). 
We further analysed impairments in sodium homeostasis in murine dystrophic muscle by 
23Na NMR. 23Na longitudinal relaxation times and 23Na TQF/FID ratio was determined from a non-
localized 23Na NMR spectroscopy protocol. Due to the short T1 relaxation time, we used a repetition 
time of 200 ms to determine the 23Na signals at fully relaxed longitudinal relaxation conditions. 
Another study reported an increase of intracellular sodium levels in the myocardium during hypoxia, 
while the T1 stayed constant [219]. This observation may indicate that 23Na T1 stays constant even 
when physiologically occurring alterations in the intracellular sodium concentrations occur. We 
reported here a significant decrease of the mean TQF/FID ratio and a significant increase of the T1 in 
MMex38 mice when compared to WT. In in vitro experiments (4.6.1), T1 values decrease with 




human, we reported a decrease in the TQF/FID ratio paralleled with an increase in T1 during the 
vascular filling condition. Thus, the present decrease in the ratio and increase in T1 point towards 
oedema in MMex38 mice. A similar observation has been described in brain tumours, where the 
percent of bound Na+ ions was dramatically decreased and the 23Na T1 relaxation time were 
increased [220]. 
 On the contrary, the 23Na TQF/FID ratio was increased in mdx mice compared to WT. No 
alterations were observed in the 23Na T1. This increase in the TQF/FID ratio can reflect the increased 
intracellular sodium concentration in mdx muscles. Elevated total sodium levels were measured in 
four-month old mdx mice using microelectrodes [221]. Based on intra- and extracellular volumes and 
sodium concentrations, the intracellular sodium concentration was calculated, which was 
approximately doubled in the mdx compared to WT. They suggested that the intracellular sodium 
concentration could be increased if Na-K ATPase is partially inhibited such as by a decrease in cellular 
ATP concentration in dystrophin-deficient cells [217]. The absence of dystrophin also changes the 
expression level and gating properties of the sodium channel Nav1.4 in mdx leading to increased 
sodium concentrations and enhanced cell death [61].  
 Important correlations have been found between 23Na and 31P NMR parameters. The sodium 
T1 correlated with the sodium distribution merging data from mdx, MMex38, and WT mice. If the 
percent of bound Na+ ions increases, then 23Na T1 relaxation time decreases due to the bi-
exponential nature of the sodium nuclei. It is interesting to see, that the dystrophin- and dysferlin-
deficient muscles do not seem to have the same 23Na NMR features. While the MMex38 mice 
showed an increase in T1 and a decrease in TQF/FID, the mdx mice exhibited an increase in TQF/FID 
ratio with an unchanged T1. This might reflect different pathophysiological processes as increase in 
intracellular sodium concentration and water redistribution in the different tissue compartments. 
The second important correlation was observed between PCr/ATP and the TQF/FID. In 
dystrophic muscle, reduced PCr/ATP levels could indicate a loss of metabolic activity/contractile 
tissue. Changes in both ratios could point to membrane leakiness/breakdown of membrane.  
The histological samples confirmed the dystrophic pattern in the dysferlin-deficient disease 
process. H&E staining demonstrated the presence of central nuclei with a mix of inflammation, 
hypertrophic fibres, and myofibre degeneration and regeneration in mdx as well as in MMex38. The 
visual inspection of all slices indicates that MMex38 show more intramuscular lipid droplets and a 
higher infiltration of mononuclear cells than mdx. These features are all sights of a dystrophic 
muscle, which were not observed in WT. 




The extended protocol only included six mice per group. I had also to discard some of the 
23Na and 31P spectra as they were of insufficient quality to be used for the analysis. Thus, this further 
reduced the sample size and might be one reason while no significant alterations have been found in 
Pi/ATP and PCr/ATP ratios as well as 23Na TQF signal. Furthermore, the 23Na signals were not 
calibrated for MMex38 mice due to the evaporation of the SR in course of experiment. For 31P and 
23Na a non-localized approach was chosen to increase the spectral quality and reduce acquisition 
times. Thus, spatial information was lost. The leg was carefully placed inside the coils during different 
set-ups to assure a consistency between the acquisitions. Due to the non-localized approach, sodium 
pools from other tissue such as skin, tendons, and ligaments contributed to a certain extent to our 
results. Although its contribution is obviously smaller than the one of skeletal muscle given the size 
difference of the organs, its real impact on our findings remains unclear. 
6.7    Conclusion 
Several NMR based biomarkers were tested to monitor the disease process in dystrophin- 
and dysferlin-deficient murine muscle. Tissue properties changed according to the underlying 
pathological process, which was successfully monitored by NMR. 
 
Figure 88: Similarities and discrepancies of different NMR parameters between murine 
models and corresponding human myopathy. 
 Figure 88 summarizes water T2 and fat fraction alterations in murine models and 
corresponding human dystrophies. The mdx model possesses sights of dystrophic muscle including 
increased water T2 values and associated parameters, which reflect the ongoing disease activity. 
However, the hindlimb muscles of mdx show no important fat infiltration and muscle wasting 




disease activity as well as disease progression reflected by the important fatty replacement were 
observed in the dysferlin-deficient murine models.  
In summary, murine models provide researchers with an important tool to study the 
pathological process in dystrophic muscles and to test novel therapies. Moreover, NMR can be used 
as a non-invasive method providing outcome measures for muscle damage. In this context, few gene 
correction studies in mdx and LGMD mouse models have already implemented NMR techniques. 
After gene transfer, 1H T2 changes were observed to monitor the correction of sarcolemma integrity 
[215], [222]. These studies show the potential trend to use NMR outcome measure for muscle 
damage use in preclinical trials. Moreover, well-described animal models can be used to test the 
sensitivity of new NMR approaches before translation to human studies. 
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Characterization of the dystrophic muscle 
by quantitative 23Na NMR and 1H NMR in 
a clinical setting 
7.1    Characterization of skeletal muscle of Duchenne muscular dystrophy patients 
by 23Na NMR and 1H NMR  
 DMD is a severe muscular dystrophy with chronic inflammation, ionic dysregulation, and 
exhaustion of regenerative capacities leading ultimately to progressive muscle wasting (2.5.2). Figure 
89 summarises the main underlying pathological processes in dystrophin-deficient muscles that are 
relevant to this study. Several NMR methods have been proposed to monitor non-invasively the 
disease activity and progression; please refer to 3.4 for a discussion about the current state and 
problems of diverse NMR techniques commonly used to examine MDs. Here, we performed a 
longitudinal NMR study of skeletal muscle tissue of DMD patients at the University Hospital in 
Erlangen.  
 
Figure 89: Schema of supposed underlying pathological processes in dystrophin-deficient 
muscle. While sodium and pH impairments occur at an early stage, the fibro-fatty infiltration presents 
the end stage of the disease leading to immobility at the beginning of the second decade of life. 
Different NMR methods are used to track the disease-related alterations including 23Na NMR, 1H T2 
mapping, 1H spectroscopy, and Dixon techniques. Figure based on [59], [61], [63], [145], [223].  
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The objective of this study was to combine different NMR methods and to evaluate their 
sensitivity to monitor the pathological processes of the dystrophic muscle at an early stage of the 
disease. Thus, ambulant DMD boys were examined at baseline and after six months to monitor the 
disease progression of the leg muscles. The NMR protocol included fat quantification, which is the 
most commonly employed NMR outcome measure for monitoring the disease progression in DMD 
patients [9]. Furthermore, water T2 measures were performed to monitor the disease evolution that 
precedes the fibro-fatty infiltration of the muscle tissue. ISIS-CPMG sequences were acquired for a 
more in-depth analysis of the T2 relaxation behaviour. We further tested 1H NMR-based pH and 
different 23Na NMR indices (4.6) as potential sensitive and early indicators of dystrophic muscle.   
7.2    Materials and methods 
Subjects and study design 
The ethic review board at the Friedrich-Alexander University approved the DMD NMR study 
(number: 250_16 Bc). A medical doctor provided participants and their legal guardian with clear 
information about the study and informed written consent was obtained before each exam. The 
medical history of each DMD patient was recorded; eleven boys with genetically confirmed diagnosis 
of DMD (age 8.3 ± 2.3 years) and one without genetically confirmed diagnosis of muscle dystrophy 
(age 16.5 years) were enrolled in the study (Table 14). Ten boys were under glucocorticoid treatment 
at the time of the NMR experiments. All boys showed clinical symptoms of muscle dystrophy; 
however, patient seven was still ambulant at 16 years of age, which indicates a milder form of muscle 
dystrophy. The inclusion criterion was the ability to stay still in the NMR scanner for the whole 
duration of the protocol. DMD patients were invited for a follow up visit at 6 months. To date, eight 
patients had their second visit. Twelve healthy boys (age 9.6 ± 2.3 years) were also recruited for one 
NMR examination as age-matched controls.  
NMR protocol 
A standardized protocol was implemented for the right lower leg. Subjects were lying feet 
first in supine position with the biggest circumference of the lower leg in the centre of the coil. The 
coil position was marked on the leg to ensure the same positioning of the leg between the different 
parts of the protocol. No anaesthesia was used and the children listened to audio files throughout 
the data acquisition while one relative was sitting next to them in the room. Nevertheless, we had to 
stop the NMR acquisition for patient 6 and 8 after the 1H part since they were too restless. The total 
scan time was between 60 and 75 minutes including shim and time for positioning between the 
different parts of the protocol.    
7.2 Materials and methods 
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#1 6.1 Yes Point mutation in Exon 39 (c.5530C>d) Yes Ataluren 
#2 9.8 Yes Deletion Exons 48-50 Yes Metformin, Citrulline 
#3 11.4 Yes Mutation Exon 51 (c.7541dupA) Yes  
#4 11.5 Yes Deletion Exons 18-19 Yes Idebenone 
#5 11.3 Yes Deletion Exons 48-50 Yes  
#6 5.6 No Point mutation in Exon 12 (c.1375G>T) Yes Ataluren 
#7 16.5 No No mutation found (histology) Yes  
#8 7.2 Yes Deletion Exons 28-43 No  
#9 7.2 Yes Deletion Exons 28-43 No  
#10 8.6 Yes Point mutation in Exon 41 Yes  
#11 7.0 No Deletion Exons 45 - 50 Yes  
#12 5.9 No Point mutation in Exon 46 (c. 6762+1G>T) Yes  
The 1H NMR protocol consisted of a 3-point gradient echo Dixon sequence [151] for fat 
quantification, a MSME sequence for T2 mapping and two localized spectroscopy sequences, PRESS 
[178] and ISIS-CPMG [17], to measure the intracellular pH and derive T2 spectra, respectively. The 3D 
3-point Dixon sequences were performed with the following parameters: TR = 10 ms, two times two 
TEs = 2.75/3.95 ms and 2.75/5.15 ms, FA of 3°, and 64 slices of 5 mm thickness and a resolution of 
1.3 x 1.3 mm2, whereas the middle slice was positioned at the iso-centre of the magnet (Tacq = 2 ⨯ 1 
min 36 s). The MSME images were acquired with a TR of 3 s and 32 equally distributed TEs from 9.5 
to 304 ms. Parallel imaging using GRAPPA [224] was performed with an acceleration factor of two 
(Tacq = 3 min 41 s). The central slice of the five slices with a slice thickness of 10 mm and a resolution 
of 1.4 x 1.4 mm2 was positioned in the iso-centre. For the 1H spectroscopy part, a localizer with 4 x 5 
x 4 slices localised in the gastrocnemius muscles was performed to ensure a proper voxel positioning 
on the gastrocnemius medialis muscle. The voxel dimension of 30 x 9 x 30 mm3 was reduced to the 
muscle size if too big. PRESS sequences with and without water suppression peak were performed 
using a TR = 3 s and a TE = 30 ms and 64 and 16 averages, respectively (total Tacq = 4 min 24 s). The 
ISIS-CPMG sequence used the same voxel size and position than the PRESS sequences with TR = 10 s 
and 400 echoes with ES = 2 (Tacq = 2 min 40 s) [17].  
For the 23Na NMR part, two DA-3DPR [18] were acquired, one without an IR pulse to quantify 
TSC and the second one with an IR pulse to obtain the ICW signal (4.6.3). Prior to the image 
acquisition, a non-selective B1+ calibration sequence using rectangular pulses determined the 
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reference voltage for a 90° excitation pulse of 500 µs length. This voltage was then applied as the 
reference voltage for the entire 23Na NMR protocol. For the TSC acquisitions following parameters 
were used: TE = 0.3 ms, TR = 50 ms, FA = 80° (Ernst angle), Treadout of 10 ms, and nominal spatial 
resolution = 3 x 3 x 15 mm³ (Tacq = 6 min 53 s). To obtain ICW images, an inversion pulse with a TI of 
34 ms was applied to suppress the signal from sodium ions with relaxation times similar to sodium 
ions in pure saline solution. Parameters were: TR = 124 ms, TE = 0.3 ms, FA = 90°, Treadout = 20 ms, and 
nominal spatial resolution = 4 x 4 x 20 mm³ (Tacq = 9 min 50 s). 
The sodium protocol was extended with three non-localized spectroscopy sequences: FID, 
TQF, and IR-LL that were introduced in 4.6.1. The FID sequence was acquired with the following 
parameters: TR = 300 ms, NEX = 200, time delay = 200 µs, BW = 5 kHz, vector size = 256 pts, and Tacq 
1 min. The TQF acquisition was realized with τ1 = 3 ms, τ2 = 200 µs, and τ3 = 300 µs, TR = 100 ms, NEX 
= 1500, BW = 5 kHz, vector size = 256 pts, and Tacq 2 min 30 s. During the FID and TQF acquisition, a 
SR as described in 5.2 was placed next to the leg. The IR-LL sequence was acquired without SR 
phantom and with 80 different inversion times (from 5 ms to 400 ms), FA = 3°, TR = 450 ms, NEX = 
500, BW = 10 kHz, vector size = 32 pts, and Tacq 3 min 45 s.  
Analysis of 23Na and 1H NMR data 
The T2 decay of the MSME images was fitted by a three-exponential fit (4.4.1). ROIs were 
manually traced within leg muscles on MSME images (see Figure 90: tibialis anterior (TA), extensor 
digitorum (ED), peroneus longus (PL), tibialis posterior (TP), soleus (SO), gastrocnemius medialis 
(GM), and gastrocnemius lateralis (GL)). The ROIs were interpolated on the FF maps derived from the 
Dixon method. 
FF and water T2 were determined as mean value of pixels within the drawn ROI. Only pixels 
with a confidence interval less than 10 were used for the analysis. The heterogeneity of muscle T2 
was assessed by the CV of water T2 across ROIs. In addition, the percentage of pixels with water T2 
higher than 40.3 ms were computed and reported as elevated T2. This threshold was determined 
from the mean value (35.73 ms) plus three SD (1.52 ms) of water T2 values of controls. 




Figure 90: ROIs were traced manually on the leg muscles: Orange tibialis anterior (TA), 
bordeaux extensor digitorum (ED), green peroneus longus (PL), pink tibialis posterior (TP), yellow 
soleus (SO), red gastrocnemius medialis (GM), and salmon pink gastrocnemius lateralis (GL). 
The water-suppressed and unsuppressed 1H NMR spectra were aligned with the water 
frequency at 4.7 ppm. Then, resonances between 0 and 4 ppm were removed using the HLSVD 
(Hankel Lanczos Squares Singular Values Decomposition) algorithm followed by manual zero and first 
order phase corrections. The peak of the two carnosine resonances (-C2-H and -C4-H) and the residual 
water peak were fitted with the AMARES algorithm (constraints for frequencies and linewidths, fixed 
phases, and Lorentzian line shapes). The pH was determined from the chemical shift between -C2-H 
and residual water resonance according to the modified Henderson-Hasselbalch equation (4.5.2). 
Only 1H spectra with a sufficient high SNR and sufficient low peak linewidth (< 12 Hz) to enable 
proper -C2-H carnosine resonance fitting were accepted for the analysis.  
The ISIS-CPMG T2 curves were fitted with a biexponential model resulting in a short and long 
T2 value and their relative fractions. After the 23Na imaging reconstruction, the sodium signals were 
calibrated using the signal intensities of the background noise and two reference phantoms (20mM 
and 40mM NaCl in 4% agarose). TSC and ICW maps were computed as described in 4.6.3 and then 
corrected for the fatty infiltration. The mean TSC and ICW values per muscle were corrected with the 
corresponding FF derived from the Dixon method. Due to the non-negligible sodium signal of fat, the 
median values of the subcutaneous fat were computed on seven DMD patients and six age-matched 
controls (TSC of subcutaneous fat = 7.9 mM and ICW of subcutaneous fat = 0.17 a.u.) to correct 
together with the FF the TSC and ICW of the muscle tissue: 
 ý^ÎÕ_ =  NV Q 7NV Ã( ÌÌ874 Q ÌÌ8      and     ýÚ^ÎÕ_ =  Vß Q 7VßÃ  ( ÌÌ874 Q ÌÌ8  
In the following, the fat-corrected TSCmuscle and ICWmuscle will be presented as TSC and ICW for 
the reader’s comfort. The 23Na NMRS signals were calibrated with the leg volume and SR peak as 
described in 5.2.1. We obtained different 23Na indices: FID signal, TQF signal, TQF/FID ratio, and 
global T1 value. No FID T2* values were fitted, because muscle 23Na signal decay is superimposed by 
the SR phantom signal resulting in a noisy signal decay. 
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Statistical analysis  
DMD and control groups were compared using Wilcoxon rank-sum tests, and the change 
between the two visits of the DMD patients were tested using Wilcoxon signed-rank tests. Repeated 
ANOVA taking the different muscles as intra-subject variable were performed for the overall changes 
in FF, T2, and 23Na imaging data sets. Spearman-rank correlations analysed the correlation between 
the parameters. Statistical significance was set to p < 0.05. 
7.3    Results 
 In the following, the results of the first visit of DMD patients will be presented in comparison 
with the control group. The second part is devoted to the longitudinal aspect of the study evaluating 
the NMR outcome measures obtained during the first and second visit of eight DMD boys. 
7.3.1 Visit 1: DMD in comparison with control group 
Fat fraction and 1H T2 mapping 
Figure 91 shows typical water and fat images with the corresponding fat fraction maps 
acquired in the leg of DMD patients derived from the Dixon method. While the six-year-old DMD 
patient exhibited very low fat fraction in all muscles, the fat fraction was elevated in the muscles of 
the eleven-year-old DMD patient, who was not able to walk more than ten meters without human 
assistance.  
 
Figure 91: Examples of A) fat image B) water image, and C) fat fraction map in the leg of six-




Table 15: 1H imaging results. FF, water T2, percentage of voxels with elevated T2, and 
coefficient of variation of T2 for DMD (n = 12) and control (n = 12) group per muscle and as mean over 
all muscles. $: significant difference between DMD and control group (p < 0.05). 
 
The mean fat fraction for all analysed muscles was 0.103 ± 0.087 for DMD patients and 0.03 ± 
0.012 for age-matched controls (Table 15). Five out of seven examined muscles exhibited a 
significant increase in the FF. The GL muscle had the highest mean fat fraction in DMD patients and 
the tibialis posterior muscle had the lowest.  
Figure 92 presents water T2 maps with the corresponding anatomical images acquired in the 
leg of DMD patients and control estimated via the tri-exponential model. While the water T2 was 
elevated in muscles of DMD patients even if they are still spared from fatty infiltration, the muscles 
of healthy control exhibit no elevated water T2. The mean water T2 for all analysed muscles was 37.9 
± 3.1 ms for DMD patients and 36.1 ± 1.4 ms for age-matched controls (Table 15). The water T2 
values were significantly higher in DMD patients compared to controls for most leg muscles, except 
the ED and PL muscles. Furthermore, DMD showed significantly higher ratio of pixels with elevated T2 
values and an increased water T2 coefficient of variation. 




Figure 92: Examples of A) MSME images (at TE 9.5ms) and corresponding B) water T2 maps in 
the leg of six- (Patient #1) and eleven-year-old (Patient #3) DMD patient as well as seven-year-old 
control. 
The measured alterations in FF and water T2 as a function of age are plotted in Figure 93. 
Both outcome measures demonstrate a highly intra- and inter-subject variability. While the FF of the 
youngest participating DMD patients lied in the normal range for most patient, their water T2 values 
were already elevated. Older patients showed elevated FF. Increased water T2 values can be 
observed in old and young DMD boys. The relatively low FF and water T2 values of the sixteen-year 
old patient were in line with his preserved motoric ability to walk, which together points to a milder 
form of dystrophy.  
 
Figure 93: FF and water T2 alterations for selected muscles of DMD patients plotted against 




ISIS-CPMG: T2 spectra 
Results of the T2 signal decay analysis showed a significant increase of the short T2 values in 
DMD patients, when compared to control group (Table 16). The mean long T2 value and the mean 
relative fraction of short T2 were not-significantly decreased in DMD patients.  
Table 16: ISIS-CPMG results. Relative fraction of short T2, short T2 and long T2 values for the 
GM muscle of DMD (n = 10) and control group (n = 11). $: significant difference between DMD and 
control group (p < 0.05). 
 
1H NMRS based pH 
The GM muscle showed a significantly increased pH (n = 9, mean 7.06 ± 0.03) compared to 
the control group (n = 12; 7.03 ± 0.02) (p = 0.02). The alterations in pH are plotted in Figure 94 
against the age of the patients. Non-published data acquired at the NMR Laboratory at the Institute 
of Myology in Paris on a bigger DMD cohort point to a similar observation that the pH at the onset of 
the disease is close to normal values. As in the present study the pH then reaches a peak at an age of 
around eight to nine years to then usually decrease.  
 
Figure 94: pH alterations for the GM muscle of DMD patients plotted against the age. Grey 
lines represent the mean ± SD (dashed line) of control cohort. 
Sodium imaging 
 Before the fat correction, fat correlated negatively with TSC (R = -0.32) and ICW (R = -0.46) 
for DMD patients. This correlation vanished after considering the fat correction (TSC: R = 0.08 and 
ICW: R = 0.08). As demonstrated in Figure 95, TSC and ICW were elevated in DMD patients compared 
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to healthy boys. The mean TSC for all analysed muscles was 24.7 ± 4.5 mM for DMD patients and 
16.7 ± 2.5 mM for age-matched controls (Table 17). The mean ICW for all analysed muscles was 0.69 
± 0.05 a.u. for DMD patients and 0.47 ± 0.04 a.u. for age-matched controls. The increase in TSC and 
ICW was significant in all examined leg muscles when compared to the healthy cohort. However, the 
ICW/TSC ratio did not differ between the DMD and healthy cohort.  
 
Figure 95: Examples of A) anatomical 1H images and corresponding B) TSC and C) ICW maps 
in the leg of five- (Patient #12) and eleven-year-old (Patient #3) DMD patient as well as eight-year-old 
control. 
Figure 96 depicts the alterations in TSC and ICW against the age of the patients. Moreover, 
the 23Na indices were frequently abnormal in DMD even when water T2, FF, and pH remained in the 
normal range (compare Figure 93 and Figure 94 with Figure 96). DMD patients at all ages exhibited 
abnormally elevated sodium indices, whereas FF increased with age and the water T2 and pH 
fluctuated during the course of disease. Figure 97 presents the 1H T2, 23Na TSC, and 23Na ICW maps of 
patient 2 and 10. In their cases, the muscles exhibited normal 1H T2 and 23Na TSC values, but elevated 




Table 17: 23Na imaging results. TSC, ICW, and their ratio for DMD (n = 10) and control group 
(n = 12) per muscle and as mean over all muscles. $: significant difference between DMD and control 




Figure 96: TSC and ICW alterations for different muscles of DMD patients plotted against the 
age. Grey lines represent the mean ± SD (dashed line) of control cohort. 
 




Figure 97: Examples of A) anatomical 1H images and corresponding B) TSC and C) ICW maps 
of two DMD patients (#2 and #10). While the proton T2 and 23Na TSC maps present muscles with 
values in a normal range, the ICW signals are elevated.  
Sodium spectroscopy 
 After calibrating the 23Na signals according to 5.2.1, the FID and TQF were still dependent on 
the leg volume. Thus, only their ratio and the global T1 value are presented in Table 18. While the 
TQF/FID ratio was found to be significantly increased in DMD patients (p = 0.01), no alterations were 
observed for the T1, when compared to the healthy cohort. The alterations in TQF/FID are plotted in 




Table 18: 23Na spectroscopy results. Non-localized TQF/FID ratio and global T1 value of DMD 
(n = 9) and control group (n = 10). $: significant difference between DMD and control group (p < 0.05). 
 
 
Figure 98: TQF/FID alterations in the leg of DMD patients plotted against the age. Grey lines 
represent the mean ± SD (dashed line) of control cohort. 
Correlation of different outcome measures 
Figure 99 presents the correlations between the 23Na imaging parameters and water T2. 
While TSC augmented with increased water T2 values (R = 0.64, p < 0.001), ICW values were also 
elevated in DMD patients with normal water T2 values (R = 0.34, p = 0.0014).  
 
Figure 99: Correlations of the TSC and ICW sodium signal with water T2: significant 
correlations between water T2 and TSC as well as ICW. Ctr control. 




Figure 100: Correlations of water T2, TSC, and ICW with pH. Ctr control. 
Figure 100 presents the correlations between the pH and the water T2 as well as the 23Na 
imaging indices. The highest correlation was found between the ICW and pH (R = 0.4, p = 0.08). 
7.3.2 Baseline and six-month follow up of DMD patients 
 Eight DMD patients were scanned a second time after an average of 6 months (25.0 ± 2.4 
weeks passed after the first visit). While the FF stayed constant or increased, water T2 values 
fluctuated between the two visits. Figure 101 presents the evolution of FF and water T2 for the SO 
and TA muscles. Table 19 presents the values for FF, water T2, TSC, and ICW at baseline and six-
month follow up as well as the percentage difference (delta). These outcome measures remained 
increased. The mean value of all muscles of FF increased from 0.07 ± 0.07 to 0.09 ± 0.09. The mean 
water T2 was 38.9 ± 3.8 ms at baseline and 39.2 ± 3.9 ms after six months. TSC and ICW (n = 7) were 
24.3 ± 3.1 mM and 0.69 ± 0.09 a.u. at baseline, and 27.7 ± 7.4 mM and 0.71 ± 0.15 a.u. during the 




Table 19: FF, water T2, TSC, and ICW across time in DMD patients for GM, SL, TA, and TP 




Figure 101: FF and water T2 at baseline and 6 months follow up of the SO and TA muscles for 
the eight DMD patients (Patient #1, #2, #3, #4, #5, #8, #9, and #10). Black lines represent the mean ± 
SD (dashed line) of control cohort. 
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 Figure 102 presents the evolution of TSC and ICW for the SO and TA muscles. Four out of the 
seven patients showed an increase in TSC and ICW in SO and TA muscles. For the other three, these 
values either stayed stable or decreased between the two visits. TSC and ICW values are increased 
during both visits when compared to the healthy cohort. For Patient #8, no 23Na values are plotted 
since the NMR acquisition was stopped after the 1H part during his first visit. 
 TQF/FID ratio obtained from the 23Na spectroscopy part did not vary between the two visits 
(0.11 ± 0.01 for both visits, n = 6). The mean pH was 7.06 ± 0.04 at baseline and 7.07 ± 0.04 after six 
months (n = 7). At baseline, the relative short T2 fraction derived from the ISIS-CPMG data sets was 
84 ± 9, the short T2 33 ± 3 ms, and the long T2 188 ± 47 ms. After six months, the relative short T2 
fraction was 87 ± 7, the short T2 34 ± 4 ms, and the long T2 171 ± 42 ms (the latter with p < 0.05, 
probably due to the high SD). 
 
Figure 102: TSC and ICW at baseline and 6 months follow up of the SO and TA muscles for the 
eight DMD patients (Patient #1, #2, #3, #4, #5, #9, and #10). Black lines represent the mean ± SD 




7.4    Discussion 
Here, we applied a multi-parametric NMR protocol comprising standard and emerging 
techniques to characterize the different pathological processes observed in a small cohort of DMD 
patients. In line with what has been previously described in a pilot 23Na NMRI study, we reported 
increased sodium concentrations in the muscle of dystrophic patients [14]. In our work, we 
demonstrated that DMD patients exhibited elevated TSC and ICW as well as water T2 in the early 
disease stage preceding the fatty infiltrations quantified with the Dixon-based fat fraction. The multi-
parametric approach allowed comparing the sensitivity of different NMR outcome measures to 
monitor the pathological processes in the dystrophic muscle tissue.  
The FF increases with age, and is currently the most used NMR outcome measure for the 
assessment of the disease progression in DMD. Natural history studies try to establish cut-off values 
to predict loss of ambulation [123], but the non-linear progression on an individual basis remains a 
big hurdle. The disease evolution depends on multiple factors, which are responsible for a high intra- 
and inter-subject variability. Here, we examined for example three boys of the same age (patient #3, 
#4, and #5) displaying a range of fatty infiltration as well as the ability to walk. While one was still 
able to walk without aid, the two others used a wheelchair to cover longer distances. Furthermore, 
we report a muscle- and subject-depending increase in the FF between the first and the second visit, 
which was only significant for the TA muscle. 
Water T2 and tissue heterogeneity were elevated in the muscle tissue of DMD patients 
reflecting the ongoing disease activity in the muscle tissue. However, water T2 fluctuated with age; 
while the youngest DMD patients showed increased water T2 values, some older patients had 
relatively mildly elevated water T2 values. Furthermore, no trend was observed between the first and 
second visit. It has been previously shown that the water T2 values are reduced by the corticoid 
treatment [12]. A significant drop in water T2 can be already observed after three months of 
corticosteroid therapy. In our study, all but two patients received a corticoid therapy, which could 
partly explain the drop in water T2 for some treated patients. An in-depth analysis of the water T2 
relaxation using ISIS-CPMG could provide additional information about changes of the myowater 
distribution in the different anatomical compartments. While the short T2 component reflects the 
relaxation behaviour of the water within the intracellular and interstitial spaces, the long T2 
component is attributed to the water within the vascular space [17]. In the present study, we 
observed an increase in the short T2 indicating pathological changes in the extravascular 
compartment. The elevated short T2 could for example point to present interstitial oedema a 
common feature of the dystrophic muscle.  
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The cell volume is indeed tightly linked to the tissue sodium concentration and the 
intracellular pH. For DMD patients, we derived from the 1H NMR spectra increased pH values that are 
thought to be predominantly if not exclusively of intracellular origin [137]. In line with this study, we 
also found normal carnosine-based pH values in presence of elevated water T2. No significant 
changes in the pH were observed between the two visits. Furthermore, TSC and ICW values were 
elevated in DMD patients. The sodium anomalies seemed to be systematically present in patients 
with DMD compared to controls and precede fatty degenerative changes. In addition, muscles that 
were relatively spared, such as the TA, showed increased TSC and ICW in all participating DMD 
patients. TSC and ICW were at baseline and after 6 months increased. The strong correlation 
between water T2 and TSC could reflect oedematous changes. On the other hand, the ICW was found 
to be also elevated in the presence of normal water T2. The ICW signal correlated with the 
intracellular pH, which underlines their thigh connection in the cell’s homeostasis. Similar to the mdx 
mice (6.5), the TQF/FID was also significantly elevated in DMD patients. Since the TQF increases with 
increasing correlation times, an elevation can indicate an increased intracellular sodium 
concentration. Thus, our observations of intracellular sodium accumulation and elevated intracellular 
pH strengthen the hypothesis of osmotic and intracellular oedema in the muscle of DMD patients 
[14].  
The question remains how the ICW can be elevated at normal water T2 values since the water 
distribution is tightly linked to the sodium homeostasis. One hypothesis could include an increased 
cellular fraction of normal myocytes, which is in contradiction with the known pathological processes 
in the dystrophic muscle. The second hypothesis includes an increase in ICW, which is associated 
with cell oedema resulting in a water T2 increase. However, this increase is counterbalanced by a 
decrease in extracellular fraction. 
Limitations 
This study, which is still in progress, has currently its limitation in the small number of 
subjects. For two out of the twelve participating patients, we had to stop the acquisition after the 1H 
part, because the children were not able to remain calm in the scanner. The parent of one of this 
child declined to come for a second visit. However, the second boy managed to pass the entire 
protocol during his follow-up examination after six months. Nevertheless, an appropriate choice of 





A special case represents the 16-year-old patient, who showed a preserved mobility and 
relatively mildly altered NMR variables when compared to the younger DMD patients. There was no 
confirmation of a genetic mutation in the dystrophin gene; however, the patient did exhibited high 
creatine kinase values. These observations could point towards a mild form of dystrophy, excluding 
DMD. Yet, we decided to keep the patient in the study cohort, because the main objective of the 
present study was to test the sensitivity of different NMR outcome measures.  
Compared to a previous study that investigated the pH and water T2 alterations in DMD 
patients [137], the water T2 values of our control group were higher. The increased mean water T2 
can be attributed to one healthy volunteer that presented increased water T2 values in all muscles 
(defined as mean plus two SD). Furthermore, the water T2 in the DMD cohort could be influenced by 
the different pharmaceutical treatments, which was not taken into account due to the limited 
number of participants. Secondly, to confirm the 1H-based pH observations in young DMD patients, 
more data are needed. We thus might pool the data from the Institute of Myology with the current 
study to confirm the pH alterations depending on age. 
Partial volume effects may lower the measured TSC and ICW, in particular in patients with 
high fat fraction, since fat tissue has lower sodium concentrations than muscle tissue [225]. Thus, the 
FF was taken into account for the sodium quantification in DMD patients. To prevent T1 weighting, 
sodium quantification should have been performed with a longer TR. Here, a T1 weighting was 
accepted to reduce the acquisition time of the protocol. The present T1 weighting of the 23Na images 
might affect the sodium quantification, in particular if T1 of muscle tissue deviates from the T1 values 
of the reference tubes and subcutaneous fat. Although, the T1 values of skeletal muscle tissue, 
subcutaneous fat, and agarose phantoms, which were measured in one healthy adult volunteer (T1 
between 22 and 25 ms), are in the same range, the impact of the dystrophic processes on the T1 of 
fat and muscle remains unclear. We assumed no T1 variances with pathology in the muscle tissue. It 
is possible that the global 23Na T1 is decreased in DMD patients, that would be compatible with an 
increase in the intracellular sodium content. Animal experiments showed that the intracellular T1 is 
smaller than the extracellular T1 [80], however exact values in human muscles are not known. Nagel 
et al. demonstrated on patients with muscular channelopathies, where increased intracellular 
sodium can be easily provoked, that the IR method could offer a weighting toward intracellular 
sodium [83]. However, the sufficiency to suppress the extracellular sodium is still not fully elucidated 
as it depends on the underlying T1 values. Thus, we cannot exclude possible contributions from 
extracellular sodium and further investigations are needed. Another limitation is that 23Na NMR 
signal of subcutaneous fat tissue might deviate from the signal of fat tissue in muscle. The IR 
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sequence was performed to supress the 23Na signal from extracellular oedema and vessels. However, 
using the IR method, the signal of the free sodium (NaCl solution containing phantoms) was not 
completely suppressed mainly due to B1 inhomogeneities.  
Thus, further steps would include increasing the number of subjects for the DMD and the 
control cohort. This could allow tackling the question of the benefit of 23Na NMR to the standard 1H 
protocol. Although, sodium anomalies were systematically present in the present DMD cohort, it is 
difficult to conclude that sodium alterations occur before water T2 increases. Nevertheless, sodium 
changes can occur while the water T2 remains normal. Additionally, further protocols could combine 
23Na NMR with 31P NMR to study in parallel alterations in the sodium concentration and the PDE 
levels, which has been proposed as early indicator of membrane functional disturbances in the 
dystrophic muscle [121], [135].  
7.5    Conclusion 
Our study shows that 23Na NMR might offer a sensitive outcome measure to monitor 
alteration of the dystrophic muscle at a very early stage. The observed sodium anomalies in DMD 
patients preceded clearly the fibro-fatty infiltration of the muscle tissue. Furthermore, we have seen 
elevated sodium indices even at normal water T2 and pH values. Based on our results, we are 
convinced that the role of 23Na NMR in myopathies is worth to be investigated further. Intracellular 
sodium accumulations are not always paralleled with proton T2 increases. Continuing the work - even 
in a combination with other NMR methods - might contribute to the understanding of various 
(patho-) physiological processes. In summary, the present data supports that 23Na NMR could serve 
as an early and sensitive biomarker in order to investigate ion channel leakage and membrane 
integrity.  
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General discussion, 
conclusion & perspectives 
In this chapter, the contributions of my work are discussed and some directions for future 
research are outlined. The objective of this thesis was to investigate the sensitivity of new NMR 
outcome measures to monitor the dystrophic processes in skeletal muscle tissue. NMR allows a non-
invasive evaluation of skeletal muscles over time, making it very well suited for longitudinal 
evaluation of patients during clinical trials. In MD patients, different NMR methods are currently 
being used to reveal the progressive destruction of muscle tissue that is gradually replaced by 
adipose tissues. Standard NMR techniques quantitatively estimate the degree of fat infiltration or 
measure the water T2. However, the fat fraction does not seem to be a predicative index of disease 
evolution due to the diverse phenotypic expression and non-linear progression as previously 
discussed (3.4.1). On the other hand, water T2 is a sensitive biomarker of the inflammatory/necrotic/ 
oedematous processes that precede the muscle replacement by fat, but might not detect the 
beneficial effect of any intervention in steroid-treated patients (3.4.1). Thus, sensitive and early NMR 
biomarkers that are more predictive of disease evolution are still needed to allow a short-term 
assessment of the response to treatment, such as perceptible changes in dystrophin expression. 
8.1    Methodological contributions of the thesis 
I therefore investigated the sensitivity of 23Na NMR to monitor changes in the ionic 
homeostasis and fluid distribution in healthy and dystrophic muscle. To do so, a non-localized 23Na 
NMR protocol was proposed to overcome the time constraints imposed in a clinical setting (4.6.1). 
My first contribution was to evaluate the sensitivity of the proposed protocol to monitor alterations 
in the vascular compartment fraction of healthy muscles (5.1). Different 23Na indices were tested 
including FID signal, TQF signal, TQF/FID ratio, the transversal relaxation times and their fractions, 
and the global longitudinal relaxation time. Among these indices, the TQF/FID ratio was the most 
sensitive parameter, which increased during vascular draining and decreased during vascular filling. 
While the decrease in the TQF/FID seemed mainly driven by the expansion of the vascular volume, 
the observed increase during draining was explained by a more important interaction between the 
23Na nuclei and interstitial macromolecules. It has been previously reported that only the vascular 
and interstitial water fractions changed between the three different vascular filling conditions in this 
time frame [17]. Therefore, the observed alterations in the TQF signal are not of intracellular but 
rather of interstitial origin. Thus, this work touched also upon the important question of the origin of 
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MQF signals, which will be further discussed below. Furthermore, with this human study, we 
demonstrated the higher sensitivity of 23Na NMR compared to standard 1H T2 methods to track 
changes in the extracellular volume fraction. This comparison was crucial to underline the utility and 
additional value of 23Na NMR and consequently to support its application in clinical studies. Another 
interesting contribution of my thesis consisted on studying the subtle effect of ischemia on the 23Na 
signals in human skeletal muscle. The intracellular sodium concentration in the ischemic heart 
increased three to four fold within a few minutes [167], [226]. Moreover, the interpretation of the 
23Na results of our vascular filling study was challenged by one reviewer when submitting the 
manuscript of our study for publication and during conference presentations. They expected a more 
substantial increase in intracellular sodium concentration during an ischemic paradigm that would 
affect 23Na signals during the 15 minutes of vascular draining. Consequently, the ischemic paradigm 
was extended to a murine experiment where the impact of a prolonged ischemia was examined 
(5.3). This murine study confirmed that - in stark contrast to the myocardium - the skeletal muscles 
seem to possess mechanisms that prevent an intracellular sodium overload over a longer time.  
As a next step, the 23Na NMR signal needed to be calibrated to obtain a reliable and 
reproducible outcome measure for longitudinal and interventional studies. I demonstrated the 
feasibility of signal calibration using an external reference phantom taking into account the leg 
volume and coil sensitivity (5.2). Since the FID and TQF signals were not dependent on the volume 
after the correction, we considered our non-localized 23Na protocol with this calibration approach to 
be suitable to examine the pathological changes associated to dystrophic muscles.  
Another contribution was the investigation of the higher-order energy-transitions by 23Na 
NMR (5.4). The majority of 23Na studies rely on the quantification of total sodium signal and - but to a 
lesser extent - on intracellular weighted signal based on IR methods. However, the analysis of the 
molecular environment of sodium ions is also of interest, as we would expect distinctive relaxation 
characteristics in muscular pathologies. MQFs provide direct information about the molecular 
environment based on quadrupolar interactions. Here, we reported a low DQF-MA/TQF ratio 
indicating that only a very small fraction of slowly tumbling sodium ions are bound to ordered 
structures in skeletal muscle tissue. We further reported for the first time in vivo short and long T2 
values of the TQF in skeletal muscle. Thus, this preliminary study on a healthy cohort provides a basis 
for further relaxation-based 23Na NMR studies on muscular dystrophies.  
In chapter 6, I first used standard NMR methods to characterize a new dysferlin-deficient 
murine model. My work delivered a detailed NMR characterization of the MMex38 model and 
compared it to BLAJ model, whose histological and functional features are well-described. To the 
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best of my knowledge, this study was the first comprehensive description of a murine dysferlin-
deficient model by different NMR modalities to concurrently measure FF, water T2 characteristics, 31P 
metabolites, and 23Na signals. Oil Red O staining and electron microscopy have already revealed 
before significant lipid accumulations within the myofibres of dysferlin-deficient mice [50]. This 
important fat infiltration, which is more pronounced in the proximal muscles than in the distal, was 
confirmed by increased NMR-based fat ratios. Our model description thus confirms the suitability of 
the MMex38 model to mimic the disease activity and progression of human LGMD 2B. This is in 
contrast to other murine dystrophic models like the mdx that fail to replicate the important 
progressive muscle-wasting present in human patients. An appealing next step in dysferlin-deficient 
muscle research would be thus to set up an exercise study to study the impairments in the 
membrane repair mechanisms. A multi-modality NMR protocol including 1H T2 relaxometry, 31P, and 
23Na NMR could investigate the impact of eccentric and concentric movement on dysferlin-deficient 
muscle tissue. 
In the second preclinical study, I tested the sensitivity of the proposed NMR parameters on 
different murine models of MD (mdx and MMex38 versus WT). This was the first 23Na NMR study on 
murine dystrophic muscle. The 23Na NMR indices were sensitive to distinguish the dystrophic from 
healthy skeletal muscle tissue. During the course of the experiment, I encountered the problem that 
the SR evaporated progressively from the calibration phantom, which complicated the quantification 
step. Changing the plastic vial to one made of glass solved this issue. The second parameter for 
validation was the T2 spectrum obtain from the ISIS-CPMG sequence. mdx mice exhibited higher 
short T2 compared to WT, which points together with constant relative fractions to a redistribution of 
water within the extravascular compartment. The same trend was observed in dystrophic patients 
(7.3.1), which encourages an extensive correlation with histology on mice to understand the 
pathophysiology behind these variations (alterations in the membrane permeability, necrosis, 
inflammation…). Thus, 1H T2 spectra and 23Na NMR indices were shown to be sensitive to detect 
changes in the dystrophic muscle in a small cohort. After further validation on more animals, these 
methods could be added to preclinical NMR studies as outcome measures for short-term assessment 
of the response to treatment. 
The final chapter on DMD patients constitutes the most important contribution of this thesis. 
Here, I demonstrated the utility of 23Na NMR in a clinical setting. Weber et al. reported that the 
muscular Na+ concentration in boys with DMD - as detected by 23Na NMRI - was increased and 
remained elevated in a re-examination compared to healthy controls [14], [60]. Based on these initial 
experiments, we further wanted to investigate the potential of 23Na NMR to serve as an early and 
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sensitive biomarker in MDs. Thanks to the collaboration with the University Hospital Erlangen, a 
comprehensive 1H and 23Na NMR study was organized to monitor pathological changes in the 
dystrophic muscle of DMD boys. In this ongoing work, we have evidence that an overload of Na+ is 
already present in muscle tissue of DMD patients before alterations of investigated 1H NMR-based 
parameters such as water T2, FF, and pH occur. This Na+ overload might be caused by an increased 
intracellular Na+ concentration as indicated by measurements with the inversion recovery 23Na NMRI 
technique. Our study indicates that 23Na NMR-based outcome measures offer new physiological 
information about the state of the tissue since we reported cases with normal water T2 and/or pH 
but increased TSC or ICW. Muscles that were relatively spared, such as the TA, also showed increased 
TSC and ICW in DMD patients. While we found a good correlation between water T2 and TSC, which 
could reflect oedematous changes, the ICW was found to be also elevated in the presence of normal 
water T2. Thus, ICW is most likely a more sensitive biomarker than TSC to reflect the Na+ imbalances. 
8.2    23Na NMR in the future: is it worth it? 
 Today, clinical 23Na NMR remains limited due to the high costs, long acquisition times as well 
as the complexity. Thus, the question is whether it is worth to lift 23Na NMR beyond the research 
field to address the need of an early and sensitive biomarker. This would be the case, if 23Na NMR 
proves to be more sensitive to certain pathological changes than 1H NMR and 31P NMRS providing 
additional information, which cannot be retrieved by other methods.   
A selection of sensitive 23Na NMR-based biomarkers related to disease activity has been 
proposed and provide additional information to 1H NMR-based indices. Several studies quantified the 
extent of disturbances in metabolism by 23Na NMRI in different tissues including brain, breast, and 
heart. After myocardial infarct, 23Na signal intensity stayed elevated in non-viable infarction at all 
time points up to one year. On the contrary, not all signal intensities in T2w 1H images were still 
elevated at day 90 [227]. During breast tumour screening, TSC were elevated in breast lesions as 
compared to normal glandular tissue and most likely benign lesions as well [228]. TSC as indicator 
associated with malignancy might hence improve specificity of lesion detection that commonly relies 
on gadolinium contrast-enhanced NMRI. In multiple sclerosis patients, increases of TSC were 
observed in lesions and more importantly in regions of normal-appearing white matter of 1H T2w 
images [229]. The authors suggested that TSC might represent an earlier marker of tissue injury. In 
addition to the commonly used TSC quantification, exploring relaxation based 23Na NMRI contrast 
could have interesting applications since relaxation is influenced by structure and content of 
molecular environment that change during pathologies. At 7T, 23Na NMRI depicted already variation 
in T2* times and concentrations between white and grey matter as well as between sub-cortical 
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regions in healthy subjects [230]. These few examples underline the potential role of 23Na NMR to 
either provide additional information or at least compensate controversial contrast-enhanced 
techniques. 
In this thesis, I showed that TSC and ICW are elevated in DMD, while the latter seems to be 
even more sensitive for the underlying pathological changes since it was elevated even when water 
T2 and pH was normal. Although, the number of participants is still limited, these observations can 
give already a strong indication in favour of the additional benefit of 23Na NMR in the MD field. It 
would be further interesting to study also the less severe BMD by 23Na NMR since these patients 
exhibit almost normal 1H T2 values, while metabolic changes occur early prior to fat infiltration [53], 
[133]. In FSHD, which is characterized by asymmetric dysfunction of muscular tissue, metabolic 
changes were observed only in fat infiltrated muscles [141]. Conversely, increased 1H T2 signal 
consistent with oedema were present in fat infiltrated and spared muscles [231]. Thus, we plan to 
explore further the pathological process of these MDs by 23Na NMR.   
All the aforementioned considerations make 23Na NMR an appealing method for non-
invasive, early, and longitudinal monitoring of dystrophic diseases. However, the signal origin should 
be investigated before the technique can be used at larger scale. Since the 23Na NMR signal 
originates from both intra- and extracellular compartments, the exact pathophysiological 
mechanisms behind the variations of 23Na signals in dystrophies is not perfectly understood. In the 
following, several experiments are proposed to expand current limited knowledge about the origin of 
signal in order to optimize and validate the most sensitive/specific 23Na indices for MD trials. 
The microscopic environment of Na+ ions in muscle tissue can by analysed with MQF 
sequences including TQF and DQF-MA since they are sensitive to the mobility of Na+ ions. The 
molecular correlation times can be additionally determined by measuring the 23Na longitudinal and 
transverse relaxation times at two different magnetic field strengths (e.g. 3T and 7T). A combination 
of the different parameters might then help to understand the origin of NMR signal alterations that 
are present in dystrophic muscle tissues, and to evaluate the specificity of 23Na NMR biomarkers. 
Moreover, application of SR in mice clearly separates the intra- from extracellular 23Na signal. First, 
relaxation times and derived correlation times for intra- and extracellular space can be determined 
based on SR experiments. Second, administering SR in mdx mice enables to study the potential 
leakage of the cell membrane by separating between intra- and extracellular sodium. Third, it 
permits to measure the fraction of signal arising from the different compartments for both MQF and 
IR methods. This would finally evaluate the most efficient sequence to separate the two 
compartments and propose a method based on 23Na NMR that could be applicable in MD patients. 




Figure 103: Conventional 1H and 23Na lower leg images of two healthy volunteers are 
compared to 23Na IR and TQF images (Reference tubes from left to right: 40 mM NaCl, 40 mM NaCl + 
4 % agarose, 20 mM NaCl, 20 mM NaCl + 4 % agarose ). Although the TQF images suffer from a lower 
SNR, the IR images showed remaining signal in agarose-free reference phantom. Furthermore, some 
23Na IR images showed remaining signal originating from blood vessels (volunteer 2), which was not 
seen in TQF images.  
Figure 103 depicts IR and TQF 23Na images of the leg of two healthy women in comparison to 
1H and conventional 23Na images. Both sequences had an acquisition time of 10 minutes. The IR 
method is prone to B1 inhomogeneities, which can be appreciated by the remaining signal in the 
periphery of agarose-free reference phantoms. Moreover, the 23Na IR image from volunteer 2 
showed remaining signal originating from blood vessels. Relaxation times need to be known exactly 
and residual signal contribution from extracellular compartment remains unclear. On the other hand, 
the TQF images suffer from a lower SNR compared to IR images. However, we achieved a good 
suppression of the mono-exponential relaxing sodium signal. Even if the MQF 23Na signal is only 
weighted towards intracellular compartment, it is a tool to obtain ratios of restricted 23Na vs 
hydrated 23Na. Nevertheless, off-resonances can result in signal loss due to destructive interference 
during phase cycling. 
One direction of new research is to optimize 23Na techniques for better suppression 
characteristics. This could be achieved for example by B0 and B1 correction or improving the phase 
cycling [105]. Phase sensitive B1 mapping has been shown to correct the transmit/receive profile of 
the RF coil and hence improve the accuracy of 23Na measurements [232]. However, this will add 
additional scan time to the protocol as two acquisitions with opposite phase offsets are required. 
Compressed sensing could be therefore a solution to accelerate image acquisition.  
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One important obstacle and limitation in this work was the absolute calibration of the 23Na 
NMRS signals. I validated the non-localized protocol in Paris on a healthy population at different 
vascular filling conditions. However, I was not able to calibrate the 23Na NMR signals in the same way 
in Erlangen and to render the 23Na signal independent of the leg volume. One cause could be the 
coils used. Although, the same manufacturer has built both 23Na coils, they have different SNR and B1 
homogeneity properties. We could therefore speculate that while the coil in Paris is independent of 
the charge it is not the case for Erlangen. Further experiments need to confirm this assumption. 
Thus, our idea to set up a non-localized protocol to reduce the acquisition time was not successful in 
Erlangen. Nevertheless, since a 23Na signal calibration was possible in Paris, we extended a current 
natural history protocol on DMD patients with the proposed protocol. This study is still ongoing and 
we will know more about the sensitivity of the 23Na spectroscopic indices in the near future. 
In a final step, the sensitivity of 23Na parameters to intervention has to be investigated so 
that 23Na NMR-based biomarkers are established for larger scale clinical trials. Different therapeutic 
approaches for the disease treatment have been tested giving hope for finding an effective drug in 
the future [1]. These therapeutic strategies include pharmacological, gene-based, and cell-based 
approaches. Pharmacological strategies promote the regeneration of the affected muscle and do not 
deliver the missing or repaired gene or protein. Thus, they treat the pathological consequences of 
the related mutation and not the cause per se. The used drugs try to improve the phenotype by 
counteracting the inflammation (e.g. corticosteroids), improving the calcium/sodium homeostasis 
(calcium/sodium channel blockers), increasing muscle strength (e.g. anabolic steroids, growth 
hormones), or increase the expression level of compensatory proteins (e.g. utrophin for dystrophin) 
[233], [234]. On the contrary, gene- and cell-based therapies target directly the mutation causing the 
disease and are especially promising when initiated at the early phase of the disease course. New 
genome editing tools such as TALEN and CRISP Cas9 enable a precise editing of the DNA correcting 
for the genetic mutations targeting the stem cell population in the muscle tissue. For example, 
mutations in exons can be restored by changing the reading frame of transcripts via exon skipping, 
exon deletion, frame shifting, or exon knock-in [235], [236]. One prominent example of an exon-
skipping based medication is eteplirsen, which was conditionally approved recently by the U.S. Food 
and Drug Administration for the treatment of DMD patients with a premature stop codon in exon 51 
(https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm521263.htm). 
 Whichever is the chosen treatment, NMR protocol should monitor the short-term treatment 
response in future clinical studies related to muscular dystrophies. So far, only a small number of 
clinical studies included NMR as outcome measure to test the sensitivity of the therapeutic 
strategies. DMD patients on corticosteroid treatment demonstrated a decrease in muscle water T2 
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and a slower fatty infiltration progression than steroid-naïve DMD boys [12]. In one pilot study, DMD 
boys were treated over a period of 16 weeks with L-arginine and metformin to increase nitric oxide 
levels to stimulate mitochondrial function and reduce oxidative stress in skeletal muscle tissue [237]. 
They stated a disease-slowing effect of the treatment since they have seen no significant increase in 
the Dixon-based fat fraction in line with improved muscle function. They expanded this study with a 
randomised placebo-controlled trial with functional test as primary endpoint and quantitative muscle 
NMR including Dixon and water T2 as secondary endpoint. NMR has also been suggested to be a 
useful outcome measure in DMD trials that aim to restore truncated dystrophin protein. Internal 
data has shown that exon-skipping based treatment improves to a small but significant extent 1H 
NMR-based outcome measures (delta FF). However, exploitation of 23Na NMR-based outcome 
measures in preclinical or clinical trials has not been yet described. Only one case report 
demonstrated that the diuretic agent eplerenone reduced the Na+ overload in one DMD patient 
[145]. Thus, the performance of 23Na NMR-based outcome measures in monitoring treatment 
response detection must be still precisely determined and compared to other advanced NMR 
biomarkers. Preclinical studies in dystrophic animal models can evaluate the short-term sensitivity of 
23Na NMR methods to a pharmaceutical intervention. Finally, the resulting selection of outcome 
measures could be transferred to clinical setting with a larger cohort using the current standard of 
care including corticosteroids or citrulline-metformin as well as new therapeutic strategies such as 
ion channel blockers, eplerenone, and eteplirsen.  
To sum up, 23Na NMR suffers from a low SNR and longer acquisition times when compared to 
1H NMR. It nevertheless provides additional physiological information about the state of tissue. 
Although only a small cohort of DMD patients have been so far scanned within the framework of this 
thesis, the application of 23Na NMR methods in dystrophic patients and animal models deserves 
further investigation, particularly in relation with their capacity to evaluate the disease evolution and 
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List of abbreviations and symbols 
Symbols  
1H  proton 
23Na  sodium 
31P  phosphorus 
 
B0  external static magnetic field 7e.g. 3 Tesla8 B1   radio frequency field 
dM,   Wigner rotation matrix element 7used to describe MQF8 
E  magnetic energy 
eQ   electric quadrupole moment of the nucleus 
fM, 7t8   time-dependent relaxation function 7used to describe MQF8 ħ   Dirac’s constant equals to h/2π 71.055 ⨯ 10-34 J s8 
h   Planck’s constant 76.626 ⨯ 10-34 J s8  
I  spin quantum number 7e.g. for 1H I = 1/2 and 23Na I = 3/28 
k   Boltzmann constant 71.381 ⨯ 10-23 J K-18 
l   rank of tensor Tl p  m  spin state 7azimuthal quantum number, direction of rotation8 
M0  longitudinal magnetization  Mx and My  transverse magnetizations  Mz   longitudinal magnetization  n  total number of nuclear spins in the macroscopic sample 
p   order 7or coherence8 of the tensor Tl p with abs7p8 ≤ l r   radius 
T   absolute temperature in units of Kelvin 
t  acquisition time 7in MQF sequence8 
T1  longitudinal relaxation time constant T2  transverse relaxation time constant T2*  fictitious transverse magnetization time constant due to the presence of inhomogeneity 7shorter than T28 T2l and T2l short and long transverse relaxation time constant T2w   T2 weighted 7NMR contrast8 Tl p  irreducible spherical tensor operator 7describes process during MQF sequences8  
γ   gyromagnetic ratio 7e.g. 1H 267.5 ⨯ 106 rad s-1 T-1 and 23Na 70.8 ⨯ 106 rad s-1 T-18 
δ   chemical shift 
η   viscosity coefficient 
θ4, θ, θX flip angle of the three RF pulses 7in MQF experiment8 
µ   nuclear magnetic moment 
σ   shielding constant 
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II 
τ1  preparation time 7in MQF sequence8 τ2  evolution time 7in MQF sequence8 τc   rotational correlation time  ϕ4, ϕ, ϕX RF pulse phases 7in MQF experiment8 Ψ   receiver phase 
ωL  Larmor frequency ωQ  quadrupolar interaction frequency ωlmmmm  averaged quadrupolar interaction frequency 
Abbreviations 
ADP   adenosine diphosphate 
AMP  adenosine monophosphate 
ATP  adenosine triphosphate  
BMD   Becker muscular dystrophy 
BW  bandwidth 
CPMG  Carr-Purcell-Meiboom-Gill (method to measure T2) 
CSA  cross sectional area 
CT  computed tomography 
CV  coefficient of variation 
DA-3DPR density-adapted 3D radial projection pulse sequence 
DGC  dystrophin-glycoprotein complex 
DMD  Duchenne muscular dystrophy 
DQC  double quantum coherences 
DQF  double quantum filter 
DQF-MA DQF with magic angle excitation (flip angle of 54.7°) 
DYSF  dysferlin gene (mutations associated to LGMDs) 
ECM  extracellular matrix 
ED   extensor digitorum muscle  
EFG  electric field gradients 
EMF  electromotive force 
EPG  extended phase graph (fitting approach) 
ES  echo spacing 
FA  flip angle 
FF  fat fraction 
FID  free induction decay 
FLASH  fast low angle shot magnetic resonance imaging 
FSHD  Facioscapulohumeral muscular dystrophy 
GL   gastrocnemius lateral muscle  
GM   gastrocnemius medial muscle  
GRE  gradient-echo imaging 
ICW  intracellular weighted 23Na signal  
IR  inversion recovery method (technique for T1 measurements) 
ISIS  image selected in vivo spectroscopy (localization method for spectroscopy) 
LGMD  limb-girdle muscular dystrophy 
  
III 
LL-IR  Look-Locker inversion recovery 
MD  muscular dystrophy 
MQC  multiple quantum coherences 
MQF  multiple quantum filters  
MSME  multi-slice multi-echo sequence 
MyHC  myosin heavy chain 
Na-K ATPase sodium-potassium pump 
Nav 1.4/1.5 sodium channels (two isoforms found in skeletal muscle) 
NCX  sodium-calcium exchanger (membrane transporter) 
NEX  number of experiments 
NHE  sodium-proton exchanger (membrane transporter) 
NMR   nuclear magnetic resonance 
NMRI  nuclear magnetic resonance imaging 
NMRS  nuclear magnetic resonance spectroscopy 
PCr  phosphocreatine 
PDE  phosphodiester 
Pi  inorganic phosphorus 
PL   peroneus longus muscle  
PME  phosphomonoesters 
PRESS  point resolved spectroscopy (localization method for spectroscopy) 
RARE  Rapid Acquisition with Relaxation Enhancement 
RF  radio frequency pulse 
ROI  region of interest 
RQI  residual quadrupolar interaction 
SC  satellite cells 
SD  standard deviation 
SNR  signal to noise ratio 
SO   soleus muscle  
SQC  single quantum coherences 
SR  shift reagent 
TA   tibialis anterior muscle  
Tacq  acquisition time 
TE  echo time 
TI   inversion time 
TP   tibialis posterior muscle 
TQC  triple quantum coherences 
TQF  triple quantum filter 
TR  repetition time 
TSC  total sodium content 
UTE  ultra-short echo time technique  
VAPOR   variable power and optimized relaxation delays (water suppression technique in NMR) 
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 IV 
List of figures 
Figure 1: Scheme of skeletal muscle and associated structures [21]. ..................................................... 9 
Figure 2: Distinctive banding pattern of muscle myofibrils originating from the arrangement of actin 
and myosin filaments. Zoom-in from [20]. ............................................................................................ 10 
Figure 3: Muscle metabolism systems supplying energy for muscle contraction. Adapted from [20]. 12 
Figure 4: Schematic diagram of main Na+ fluxes across the membrane. The following transmembrane 
proteins are involved: Na channel, Na-H exchanger, Na-Ca exchanger, and the Na-K ATPase. ........... 14 
Figure 5: Scheme of skeletal muscle regeneration represented by the four interrelated and time-
dependent phases: necrosis, inflammation, regeneration, and remodelling and maturation of the 
injured myofibre. Time line based on murine experiments. Adapted from [34]. h hours, d days, SC 
satellite cells. ......................................................................................................................................... 16 
Figure 6: Inflammatory infiltration in acute and chronic muscle repair. Acute injury of skeletal muscle 
leads to a rapid and controlled inflammation. Transient inflammatory infiltration occurs to remove 
damaged myofibres and promote regeneration and remodelling of the muscle. During chronic injury 
on the contrary, a persistent inflammatory infiltration leads to an excessive accumulation of 
extracellular matrix components. This deposition inhibits the myofibres repair and muscle 
replacement by fibrotic tissue occurs [37]. Bars = 50 µm. .................................................................... 17 
Figure 7: Dysferlin plays a key role in the Ca2+-dependent membrane repair. The dysferlin protein is 
located in the cell membrane and cytoplasmic vesicles. After a local injury, the Ca+ influx activates 
local calpains that cleave dysferlin protein. Dysferlin-containing cytoplasmic vesicles are recruited to 
the site of membrane injury. These vesicles fuse with one another and with the sarcolemma thus 
resealing the disrupted area. Adapted from [35]. ................................................................................ 19 
Figure 8: The dystrophin-glycoprotein complex (DGC) connects actin filaments through the cell 
membrane to the surrounding ECM [54]. ............................................................................................. 20 
Figure 9: Zeeman splitting of energy levels of a nucleus with spin I = 1/2. The degeneracy of the m 
sublevels is broken in the presence of an external magnetic field causing an energy separation 
between the m sublevels. ..................................................................................................................... 24 
Figure 10: Zeeman diagrams from spin I= 1/2 (1H and 31P) and spin I= 3/2 (23Na) in an external 
magnetic field 0 = 3T. .......................................................................................................................... 24 
  
V 
Figure 11: Population of spins in the presence of an external magnetic field 0. While the lower 
energy level corresponds to the magnetic moments parallel with 0, the spins in the higher energy 
level are aligned anti-parallel with 0. .................................................................................................. 25 
Figure 12: Magnetic moment & precessing in an external magnetic field 0. ...................................... 26 
Figure 13: Excitation of magnetization in the rotating frequency frame. A) At thermal equilibrium, a 
net magnetization vector along +z without a net magnetization in the transverse plane. B) The net 
magnetization rotates towards the +y-axis during the application of 1. C) If the RF pulse is calibrated 
for a complete excitation, a net magnetization vector along +y-axis is created and no magnetization 
remains along z-axis. ............................................................................................................................. 27 
Figure 14: Spin-lattice (T1) relaxation. A) The longitudinal magnetization relaxes back to thermal 
equilibrium value with a T1 relaxation time constant. B) After a 90° RF pulse no net macroscopic 
magnetization Mz’ remains. Given time, the longitudinal magnetization returns in an exponential 
manner. ................................................................................................................................................. 29 
Figure 15: Spin-spin (T2) relaxation. A) The transverse magnetization decays with a T2 relaxation time 
constant in a perfect homogeneous magnetic field and with a T2* relaxation time constant at 
presence of magnetic field inhomogeneity. B) After a 90° RF pulse excitation, the net magnetization is 
rotated towards +y’-axis and phase coherence is generated (transverse magnetization along the +y’-
axis). During the relaxation, the phase coherence decreases in the transverse plane and the resulting 
transverse magnetization disappears with time. .................................................................................. 30 
Figure 16: T1 and T2 relaxation times as a function of the correlation rate. The minimum of T1 and the 
“dip” of the T2 are at Larmor frequency f0. ........................................................................................... 31 
Figure 17: The free induction decay following an excitation pulse in the time-domain. The 
corresponding frequency-domain spectrum is obtained by computing the Fourier transform of the 
FID. ......................................................................................................................................................... 33 
Figure 18: Electric charge distribution of 1/2 and 3/2 nuclei. A spin 1/2 is spherical exhibiting no 
electric interaction between the nucleus and the electric field. On the other hand, a spin of 3/2 has a 
quadrupolar electric charge distribution that interacts with the electric field gradient. ..................... 35 
Figure 19: Time dependence of quadrupolar interactions in the laboratory frame. The quadrupolar 
interaction frequency ωQ is modulated in time due to thermal motion within the lattice. In liquid, the 
quadrupolar interactions are averaged to zero in a relatively short time. In biological tissue, the 
quadrupolar interaction frequency is slower resulting in non-zero averaged ωQ. Adapted from [69]. 35 
List of figures  
 
VI 
Figure 20: A) In vivo 23Na spectrum from human calf: the three single quantum coherences give rise 
to one broad peak. B) Energy levels of sodium nucleus in an external magnetic field. The spin 3/2 
nuclei can undergo single (-3/2 ↔ -1/2, -1/2 ↔ +1/2, +1/2 ↔ +3/2), double (-3/2 ↔ +1/2, -1/2 ↔ 
+3/2), and triple (-3/2 ↔ +3/2) quantum coherences/transitions. ..................................................... 36 
Figure 21: Schema of multiple quantum filter RF diagram with corresponding coherence order 
transfers and tensors Tl,p. A typical MQF sequence consists of three RF pulse of angle Θ and phase Φ. 
By proper phase cycling, DQC and TQC are selected and detected at the end of the third RF pulse. . 39 
Figure 22: Dependency of the transfer functions of second rank tensor T2-1 for DQF and of third rank 
tensor T3-1 for DQF and TQF on the flip angle in MQF experiments. At the magic angle (54.7°) only the 
contribution of T2-1 is detected by the DQF. .......................................................................................... 43 
Figure 23: Dixon-based fat fraction plotted against the age at baseline and one-year follow up. The FF 
in the upper limb correlated with age. Ambulatory patients are represented in blue, non-ambulant in 
red. Adapted from [125]. ...................................................................................................................... 46 
Figure 24: 1H NMRS based water T2 values for the soleus and vastus lateralis muscles were lower in 
CS boys compared to CS-naïve boys. CS corticosteroid treatment. Adapted from [12]. ...................... 47 
Figure 25: PDE/ATP ratios are increased in leg muscles in BMD patients with non-increased fat levels 
(NIFL) and increased fat levels (IFL) compared to healthy controls. * significantly higher PDE/ATP in 
BMD NIFL compared to controls. ▪ significantly higher PDE/ATP in BMD IFL compared to controls. GCL 
gastrocnemius lateralis, GCM, gastrocnemius medialis, PER, peroneus, SOL soleus, and TA tibialis 
anterior [53]. ......................................................................................................................................... 48 
Figure 26: Correlations between the water T2 and 1H-based pH (A) or the 31P-based pH (B). A group of 
DMD patients had normal 1H-measured pH values but elevated 31P-based pH and increased water T2. 
.... cut-off value: mean value plus two standard deviation in young healthy group [137]. ................... 49 
Figure 27: 1H (left) and 23Na NMR (right) image of a patient with myotonic dystrophy. Significant 
elevations in normalized 23Na signal intensities were measured in the patient (up to 70 % compared 
to not affected side). Adapted from [143]. ........................................................................................... 50 
Figure 28: Temporal changes of TSC in DMD patients before and after start of treatment. While the 
first patient (on the left) underwent eplerenone treatment, the second patient (on the right) was 
under glucocorticoid treatment. Both DMD patients were seven years old. 23Na signals were 
normalized using one phantom filled with 51.3 mM NaCl in 5 % agarose [145]. ................................. 51 
Figure 29: Typical localized in vivo 1H NMR spectra from a murine skeletal muscle (acquired at 7T) 
with water suppression showing the different resonances originating from lipids. ............................ 56 
  
VII 
Figure 30: The fat fraction map (FFmap) are generated by computing pixel wise the ratio between the 
fat map (Fmap) and the sum of water map (Wmap) and fat map (Fmap) based on the 3-point Dixon 
approach. ............................................................................................................................................... 58 
Figure 31: General diagram of the RARE sequence showing the RF-pulse sequence and sampling 
scheme of the k-space. The individual echoes are used to fill the lines of the k-space of a single 
image. .................................................................................................................................................... 59 
Figure 32: The spin echo pulse sequence consists of an initial 90° RF pulse followed by train of 180° 
RF pulses and results in multiple spin echo formations. ....................................................................... 60 
Figure 33: Plot of 1H T2-decay curve of muscle tissue obtained for a healthy subject. Examples of 
images acquired at different echo times are assigned to the relaxation curve. The green line fitting 
the blue points corresponds to the tri-component exponential fit without the two first points. T2 
values are calculated pixel wise to compute the corresponding T2 map. ............................................. 60 
Figure 34: General diagram of the ISIS-CPMG method showing the RF-pulse sequence and slice-
selecting gradient. Signal localization is achieved by the ISIS method using inversion pulses that are 
selectively turned on following an eight-step combination (Acqu 1 to 8). A fat-suppression module is 
launched just after the ISIS module to supress the unwanted signal from intramuscular lipids. Then, 
the signal of the CPMG echo train is acquired. ..................................................................................... 62 
Figure 35: Plot of 1H T2-decay curve obtained from the gastrocnemius medialis muscle of a healthy, 
male subject. The green line fitting the blue points corresponds to the fitted curve resulting from the 
regularized inversion solution using a nonnegative least-square method. The corresponding T2 
spectrum shows two distinct T2 components characterized by their relative fraction and T2 value. 
Typical values in accordance with literature were observed: T2,s = 31.5 ms with relative fraction of 
0.93 and T2,l = 100.7 ms with relative fraction of 0.07. ......................................................................... 63 
Figure 36: Typical in vivo 31P NMR spectrum from a murine skeletal leg (non-localized acquisition at 
7T) showing relevant 31P containing metabolites such as adenosine triphosphate (ATP), 
phosphocreatine (PCr), and inorganic phosphate (Pi). By measuring the chemical shift difference 
between the Pi and PCr resonances, the pH can be determined. ........................................................ 64 
Figure 37: Typical localized in vivo 1H NMR spectra from a voxel within the gastrocnemius muscle of a 
healthy human subject (acquired at 3T) A) with imperfect water suppression. B) In 1H NMR, 
intracellular pH measurement is based on the shift between the carnosine peaks at around 8 and 7 
ppm and the water peak (zoom of A). .................................................................................................. 65 
List of figures  
 
VIII 
Figure 38: Voltage calibration for the 23Na NMR protocol: the RF voltage to produce a 90° FA was 
determined by increasing stepwise the emitter voltage. The voltage resulting in the highest signal 
intensity was used for the 23Na protocol acquisition. ........................................................................... 66 
Figure 39: RF sequence diagram for 23Na spectroscopy protocol that includes non- localized A) FID, B) 
TQF and C) IR-LL sequences. Next to the sequence diagram, corresponding human in vivo spectra are 
plotted for the FID and TQF sequence (acquired at 3T). Note the difference in the signal intensities 
between the FID and TQF signal. The IR-LL data was fit with a mono-exponential model to obtain a 
global T1 of the leg. TE echo time, TR repetition time, ɸ1, ɸ2, ɸ3 phase of pulses, TI inversion time, ES 
echo spacing. ......................................................................................................................................... 67 
Figure 40: Plot of 23Na T2*-decay curve obtained for a healthy subject. The violet line fitting the blue 
points corresponds to the fitted curve resulting from the regularized inversion solution using a 
nonnegative least-square method. The corresponding T2* spectra shows two distinct T2* components 
characterized by their relative fraction and T2* value. Typical values in accordance with literature 
were observed: T2,s* = 0.9 ms with relative fraction of 0.38 and T2,l* = 13.4 ms with relative fraction of 
0.62. ....................................................................................................................................................... 68 
Figure 41: Correlation of FID signal with different concentrations of NaCl and correlations of FID 
signal, TQF signal, and T1 value with different concentrations of agarose. .......................................... 69 
Figure 42: RF sequence diagram for 23Na DQF-MA spectroscopic sequence. Next to the sequence 
diagram, corresponding human in vivo spectrum is plotted (acquired at 3T). TR repetition time, ɸ1, ɸ2, 
ɸ3 phase of pulses. ................................................................................................................................ 70 
Figure 43: A) RF pulse and gradient diagram of the 3D radial sequence with i) a conventional gradient 
readout and ii) a density-adapted gradient readout. The conventional gradient readout uses a 
constant gradient strength after the gradient ramp, while the density-adapted readout gradient 
consists of three parts: (1) the gradient ramp, (2) a trapezoidal part with gradient strength G0, and (3) 
a density-adapted part that starts after t0 allowing in the following constant sampling density in the 
outer part of the k-space. B) Radial sampling scheme of the k-space: without density-adapted 
sampling, the centre of k-space is more densely sampled than the outer part. By manipulating the 
readout gradient, the sampling velocity is slowed down in the outer part of k-space leading to a more 
homogenous sampling scheme. ............................................................................................................ 71 
Figure 44: Images of two healthy female volunteers. A) T1 weighted 1H image of right leg with 
corresponding B) DA-3DPR 23Na image and C) DA-3DPR 23Na image with IR pulse (TI 34 ms). Four 
calibration standards are shown at the bottom of the leg with sodium concentration of 20 mM (3) 
  
IX 
and 40 mM (1) and with 4 % agarose and 20 mM (4) and 40 mM (2) mimicking Na+ with restricted 
mobility. ................................................................................................................................................. 74 
Figure 45: 23Na signal calibration using two reference phantoms with 20 mM and 40 mM NaCl in 4 % 
agarose and the background noise. Based on the calibration curve, TSC and ICW maps are calculated 
pixel-wise. .............................................................................................................................................. 75 
Figure 46: 23Na signal calibration of the leg. A) ROIs are drawn manually on the 1H image in TA 
(green), SO (yellow), GM (orange), subcutaneous fat (blue), in the calibration standards, and in the 
background (red). B) TSC map and C) ICW map were calculated based on the calibration curve using 
the agarose phantoms (2 and 4) and the background noise. ............................................................... 75 
Figure 47: Timeline of the ischemia protocol (protocol 1): (i) After 30 min supine rest, (ii) the medical 
cuff placed above the knee was rapidly inflated and the acquisition of the sodium spectra started. . 78 
Figure 48: Timeline of the vascular filling conditions (protocol 2): (i) vascular draining was first applied 
with the calf positioned in the coil followed by the NMR acquisition (non-localized 23Na spectroscopic 
and 1H imaging acquisition or by 1H MSME acquisition). (ii) After vascular filling during a 5-minute 
interval initiated by a reduced cuff pressure, another NMR acquisition was launched. (iii) Normal 
condition: the pressure of the cuff was completely released and after a 5-minute break, the final 
sodium NMR and proton imaging were performed. ............................................................................. 79 
Figure 49: Standard 1H T2 imaging: A) a cross-sectional T2w image (TE = 34 ms); B) The ROIs used for 
analysis were traced within the muscles (TA orange; ED brown; TP pink; PL green; SO yellow; GL red; 
GM beige; Background noise grey). ...................................................................................................... 80 
Figure 50: The effect of short-term ischemia in vivo in skeletal muscle measured by 23Na NMR. ....... 81 
Figure 51: The sodium FID, TQF, and T1 recovery signals measured in a healthy young 22-year-old 
female volunteer under different vascular filling conditions. A) The FID signal in the time domain is 
Fourier transformed to obtain the FID spectrum, which gives then the T2* spectrum by a T2* 
deconvolution of the FID signal decay. The T2* spectrum is plotted with logarithmically scaled 
abscise. The plots show the characteristic course of the vascular draining (red), vascular filling (blue), 
and control (black) conditions. B) The drawn ROI on the FLASH image of the right calf of the 
volunteer were used for the volume calculations. ............................................................................... 82 
Figure 52: Evolution of different 23Na parameters (FID signal, TQF/FID ratio, TQF signal, T1 value, long 
T2* signal, short T2* fraction, and short T2* signal) and leg volume under three different vascular 
filling conditions (vascular draining: drain, vascular filling: fill, and control condition: ctrl). The boxes 
List of figures  
 
X 
have lines at the lower quartile, median (red), and upper quartile with the length of the whiskers 
specified as 1.5 times the interquartile range. The red crosses mark outliers of the datasets. ........... 83 
Figure 53: The percentages of change of the 23Na parameters under vascular filling and vascular 
draining conditions compared with the control condition (§: p < 0.05). .............................................. 84 
Figure 54: Correlation between FID signal and volume and between TQF/FID ratio and T1 value. 
Additionally, highly significant correlations between TQF/FID ration and short T2* fraction and short 
T2* values were detected. Data acquired under vascular draining and vascular filling are depicted as 
red and blue circles, respectively. Black circles represent the data points collected during the control 
condition................................................................................................................................................ 85 
Figure 55: The percentages of change of the mean T2w signal intensities and the mean T2 for all 
muscles under the vascular filling and vascular draining conditions compared with the control 
condition................................................................................................................................................ 86 
Figure 56: Calibration of the in vivo 23Na signal: A) Costume-made linear volume 23Na leg coil with the 
leg holder and shift reagent phantom used as external reference. B) Dixon image (TE = 2.75 ms) of 
the leg and SR phantom. The ROI used for volume analysis was traced over all muscles (in violet) 
excluding bone, skin, and subcutaneous fat. ........................................................................................ 91 
Figure 57: Sensitivity profile of the 23Na coil along the length measured on a 140 mM NaCl containing 
bottle with a diameter of 9 cm. ............................................................................................................. 92 
Figure 58: The sodium FID and TQF signals measured in a healthy young 23-year-old female volunteer 
at control condition. Notice the presence at around 0.7 kHz of the SR in the FID spectrum and its 
absence in the TQF spectre. .................................................................................................................. 93 
Figure 59: Evolution of 23Na FID signal and TQF signal before volume correction under three different 
vascular filling conditions (vascular draining: drain, vascular filling: fill, and control condition: ctrl). 
Based on the 23Na signals, TSC and ICW values were calculated for the three different vascular filling 
conditions taking the muscle volume and coil sensitivity into account. The boxes have lines at the 
lower quartile, median (red), and upper quartile with the length of the whiskers specified as 1.5 
times the interquartile range. The red crosses mark outliers of the datasets. ..................................... 93 
Figure 60: Important correlations of 23Na FID and TQF signal with muscle volume were detected. 
After correction, TSC and ICW showed no correlation with the muscle volume. Data acquired under 
vascular draining and vascular filling are depicted as red and blue circles, respectively. Black circles 
represent the data points collected during the control condition........................................................ 94 
  
XI 
Figure 61: The effect of prolonged ischemia in vivo in skeletal muscle measured by 23Na NMR. 
Evolution of the A) 23Na FID signal, B) 23Na TQF signal, and C) TQF/FID ratio during a 40-minute 
ischemia in skeletal muscle tissue (normalized with first time point, presented as mean with SD bars, 
n = 4). ..................................................................................................................................................... 98 
Figure 62: The effect of prolonged ischemia in vivo in skeletal muscle measured by 1H NMR. Evolution 
of A) the mean T2 of the leg muscles measured by a MSME sequence during ischemia and of B) the 
short and C) long T2 with D) the relative short T2 amplitude obtained by a biexponential fit of the ISIS-
CPMG signal decay during ischemia (presented as mean with SD bars, n = 4)..................................... 99 
Figure 63: Examples of A) FID signal, B) TQF signal, and C) DQF-MA signal acquired on one volunteer 
showing the important differences in signal intensity between the three techniques. ..................... 103 
Figure 64: Example of A) normalized FID and B) normalized TQF signal decays acquired on one 
volunteer. The resulting fit curves are shown in red. ......................................................................... 103 
Figure 65: Histology of the quadriceps muscle of MMex38 mice at A) 12 weeks, B) 20 weeks, and C) 
60 weeks of age. The dystrophic phenotype worsens with age. Stained with Gomori’s trichrome. 
Provided by V. Schöwel. ...................................................................................................................... 108 
Figure 66: A) Representative T1-weighted image of the thigh of a MMex38 mouse. CSA of the 
quadriceps were drawn on the contractile tissue avoiding the complete fat-replaced parts of the 
muscle (ROI_2). B) Representative axial MSME image (at TE 4 ms) of the left leg and thigh of a WT 
mouse. The overlay represents the manually traced ROIs in the different muscle compartments. Leg: 
Ant. (red) = TA/EDL, med. (green) = TP, and pos. (yellow, blue and turquois) = gastrocnemius, 
plantaris muscles; Thigh: ant. (red) = quadriceps, med. and pos. (yellow and blue) = biceps femoris 
and gluteus maximus........................................................................................................................... 111 
Figure 67: 1H NMR spectra with water suppression in the calf of a MMex38 and a WT mouse. Lipid 1 
was assigned to methylene protons at Δppm = 0.8 - 1.8, Lipid 2 to α- or β-methylene protons at 
Δppm = 2 - 2.8, and Lipid 3 to olefinic protons at Δppm = 5.3 - 5.7. Note the residual peak of water at 
4.7 ppm. ............................................................................................................................................... 112 
Figure 68: T1-weighted images of the thigh and leg of WT, MMex38, and BLAJ mice. The images 
showed highly fat infiltrated muscles in the thighs of both dysferlin-deficient mouse models. Parts of 
the quadriceps of MMex38 were systematically replaced by fatty tissue. ......................................... 114 
Figure 69: T1 values of WT and dysferlin-deficient MMex38 and BLAJ mice: No significant differences 
were seen in the leg between the strains. In the thigh, the dysferlin-deficient mice showed decreased 
List of figures  
 
XII 
T1 values in the medial posterior compartment compared to WT (MMex38 n = 10, BLAJ n = 4, and WT 
n = 10; $: p < 0.05). .............................................................................................................................. 115 
Figure 70: Fat fraction and water T2 values measured in the leg of WT and dysferlin-deficient 
MMex38 and BLAJ mice: No significant differences were seen in the FF between the strains. 
Dysferlin-deficient mice showed increased water T2 values in the anterior and posterior 
compartment compared to the (MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p < 0.05). ............... 115 
Figure 71: Fat fraction and water T2 values measured in the thigh of WT and dysferlin-deficient 
MMex38 and BLAJ mice: Dysferlin-deficient mice showed systematically increased FF and water T2 
values compared to WT (MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p < 0.05). ........................... 116 
Figure 72: Elevated water T2 and water T2 CV measured in the leg of WT and dysferlin-deficient 
MMex38 and BLAJ mice: Dysferlin-deficient mice showed a higher percentage of elevated water T2 
values as well as higher CV in the anterior and posterior compartment compared to WT (MMex38 n = 
10, BLAJ n = 4, and WT n = 10; $: p < 0.05). ........................................................................................ 116 
Figure 73: Elevated water T2 and water T2 CV measured in the thigh of WT and dysferlin-deficient 
MMex38 and BLAJ mice: Dysferlin-deficient mice showed higher percentage of elevated water T2 
values as well as higher CV compared to WT (MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p < 0.05).
 ............................................................................................................................................................. 117 
Figure 74: Fat ratios measured by 1H spectroscopy in the leg of WT and dysferlin-deficient MMex38 
and BLAJ mice: Dysferlin-deficient mice showed higher fat ratios especially in the thigh muscles 
compared to WT (MMex38 n = 10, BLAJ n = 4, and WT n = 10; $: p < 0.05). ...................................... 117 
Figure 75: Resting 31P spectra (TR 2.5 s) acquired of the right leg are shown for MMex38 and WT. 
Peaks were assigned to PME (around 6 ppm), Pi (4.95 ppm), PCr (0 ppm), and the γ- (-2.4 ppm), α- (-
7.5 ppm), and β-phosphate (-16 ppm) of ATP. Each spectra represents an average of 720 FIDs over 30 
minutes. ............................................................................................................................................... 118 
Figure 76: T1-weighted imaging showed slightly fat infiltrated muscles in the thigh of mdx compared 
to WT. .................................................................................................................................................. 119 
Figure 77: T1 values of the WT and mdx mice: Significant differences were seen in the leg between 
the strains ($: p < 0.05)........................................................................................................................ 119 
Figure 78: Water T2 values measured in the leg and thigh of the WT and mdx mice: Mdx mice showed 
increased water T2 values in several muscle compartments compared to WT ($: p < 0.05). ............. 120 
  
XIII 
Figure 79: Elevated water T2 and water T2 CV measured in the leg of WT and mdx mice: mdx showed 
a higher percentage of elevated water T2 values as well as higher CV in the anterior and posterior 
compartment compared to WT ($: p < 0.05). ..................................................................................... 121 
Figure 80: Elevated water T2 and water T2 CV measured in the leg of WT and mdx mice: mdx showed 
a higher percentage of elevated water T2 values as well as higher CV in the anterior and posterior 
compartment compared to WT ($: p < 0.05). ..................................................................................... 121 
Figure 81: Resting 31P spectra (TR 2.5 s) acquired on the right leg are shown for mdx and WT mice. 
Peaks were assigned to PME (around 6 ppm), Pi (4.95 ppm), PCr (at 0 ppm), and γ- (-2.4 ppm), α- (-
7.5 ppm), and β- (-16 ppm) ATP. Each spectrum represents an average of 720 FIDs over 30 minutes.
 ............................................................................................................................................................. 122 
Figure 82: Results obtained from the bi-exponential fit for the relative short fraction and short and 
long T2 values in WT and mdx (n = 6 mice per group). Short T2s were increased in the thigh and 
anterior compartment of the leg compared to the WT ($: p < 0.05). ................................................. 123 
Figure 83: Correlation between the TQF/FID ratio and 23Na T1 values and PCr/ATP ratio (including 
MMex38, mdx, and WT mice). ............................................................................................................ 124 
Figure 84: Visualisation of myofibre damage and mononuclear cell infiltration in the quadriceps of 
MMex38. H&E staining of the quadriceps muscle cross sections reveals the dysferlin-deficient 
pathological process. The images show centrally nucleated fibres indicating ongoing necrosis and 
recuperation and fatty tissue replacement. Several accumulations of mononuclear cells were 
observed in dysferlin-deficient muscle tissue (right). ......................................................................... 125 
Figure 85: Visualisation of myofibre degenerating and regenerating fibres in the leg of MMex38. H&E 
staining of the tibialis anterior muscle cross sections reveals centrally nucleated fibres, some atrophic 
fibres and lipid droplets. Few areas are infiltrated by mononuclear cells. ......................................... 125 
Figure 86: Visualisation of healthy myofibres in the quadriceps of WT. The images show neither 
centrally nucleated fibres nor lipid droplets in the muscle tissue. ..................................................... 126 
Figure 87: Visualisation of myofibre damage and mononuclear cell infiltration in the tibialis anterior 
(left) and quadriceps muscles (right) of mdx. The images show centrally nucleated fibres indicating 
ongoing necrosis and recuperation. In the quadriceps of mdx mice, several accumulations of 
mononuclear cells and few lipid droplets were observed. ................................................................. 126 
Figure 88: Similarities and discrepancies of different NMR parameters between murine models and 
corresponding human myopathy. ....................................................................................................... 132 
List of figures  
 
XIV 
Figure 89: Schema of supposed underlying pathological processes in dystrophin-deficient muscle. 
While sodium and pH impairments occur at an early stage, the fibro-fatty infiltration presents the 
end stage of the disease leading to immobility at the beginning of the second decade of life. Different 
NMR methods are used to track the disease-related alterations including 23Na NMR, 1H T2 mapping, 
1H spectroscopy, and Dixon techniques. Figure based on [59], [61], [63], [145], [223]. .................... 135 
Figure 90: ROIs were traced manually on the leg muscles: Orange tibialis anterior (TA), bordeaux 
extensor digitorum (ED), green peroneus longus (PL), pink tibialis posterior (TP), yellow soleus (SO), 
red gastrocnemius medialis (GM), and salmon pink gastrocnemius lateralis (GL). ............................ 139 
Figure 91: Examples of A) fat image B) water image, and C) fat fraction map in the leg of six-(Patient 
#1) and eleven-year-old (Patient #3) DMD patient derived from the Dixon method. ........................ 140 
Figure 92: Examples of A) MSME images (at TE 9.5ms) and corresponding B) water T2 maps in the leg 
of six- (Patient #1) and eleven-year-old (Patient #3) DMD patient as well as seven-year-old control.
 ............................................................................................................................................................. 142 
Figure 93: FF and water T2 alterations for selected muscles of DMD patients plotted against the age. 
Dashed grey lines represent the mean ± SD of control cohort. .......................................................... 142 
Figure 94: pH alterations for the GM muscle of DMD patients plotted against the age. Grey lines 
represent the mean ± SD (dashed line) of control cohort. ................................................................. 143 
Figure 95: Examples of A) anatomical 1H images and corresponding B) TSC and C) ICW maps in the leg 
of five- (Patient #12) and eleven-year-old (Patient #3) DMD patient as well as eight-year-old control.
 ............................................................................................................................................................. 144 
Figure 96: TSC and ICW alterations for different muscles of DMD patients plotted against the age. 
Grey lines represent the mean ± SD (dashed line) of control cohort. ................................................ 145 
Figure 97: Examples of A) anatomical 1H images and corresponding B) TSC and C) ICW maps of two 
DMD patients (#2 and #10). While the proton T2 and 23Na TSC maps present muscles with values in a 
normal range, the ICW signals are elevated. ...................................................................................... 146 
Figure 98: TQF/FID alterations in the leg of DMD patients plotted against the age. Grey lines 
represent the mean ± SD (dashed line) of control cohort. ................................................................. 147 
Figure 99: Correlations of the TSC and ICW sodium signal with water T2: significant correlations 
between water T2 and TSC as well as ICW. Ctr control. ...................................................................... 147 
Figure 100: Correlations of water T2, TSC, and ICW with pH. Ctr control. .......................................... 148 
  
XV 
Figure 101: FF and water T2 at baseline and 6 months follow up of the SO and TA muscles for the 
eight DMD patients (Patient #1, #2, #3, #4, #5, #8, #9, and #10). Black lines represent the mean ± SD 
(dashed line) of control cohort. ........................................................................................................... 149 
Figure 102: TSC and ICW at baseline and 6 months follow up of the SO and TA muscles for the eight 
DMD patients (Patient #1, #2, #3, #4, #5, #9, and #10). Black lines represent the mean ± SD (dashed 
line) of control cohort. ........................................................................................................................ 150 
Figure 103: Conventional 1H and 23Na lower leg images of two healthy volunteers are compared to 
23Na IR and TQF images (Reference tubes from left to right: 40 mM NaCl, 40 mM NaCl + 4 % agarose, 
20 mM NaCl, 20 mM NaCl + 4 % agarose ). Although the TQF images suffer from a lower SNR, the IR 
images showed remaining signal in agarose-free reference phantom. Furthermore, some 23Na IR 
images showed remaining signal originating from blood vessels (volunteer 2), which was not seen in 
TQF images. ......................................................................................................................................... 160 
 
 XVI 
List of tables 
Table 1: The four major classes of fibre and their phenotypes identified in mammalian muscle based 
on the MyHC composition. Note that IIb fibres are usually not found in human. MyHC, myosin heavy 
chain. Data extracted from [23]. ........................................................................................................... 11 
Table 2: Ion concentrations of intracellular and extracellular compartment of a mammalian cell. 
Values taken from [26]. ......................................................................................................................... 13 
Table 3: Selection of muscular dystrophies that are relevant to the current work. Note that all these 
diseases are inherited. .......................................................................................................................... 18 
Table 4: NMR properties of commonly used nuclei. Values extracted from [64]. ................................ 32 
Table 5: List of main biological and physical differences between 1H and 23Na NMR. ......................... 34 
Table 6: Irreducible spherical tensor operators for spin I= 3/2. Values taken from [70]. ..................... 39 
Table 7: Composition of calibration phantoms used for 23Na imaging. ................................................ 73 
Table 8: Signal intensities of calibration phantoms (1, 2, 3, and 4), muscle, blood, and subcutaneous 
fat in DA-3DPR 23Na images and DA-3DPR 23Na images with IR preparation pulse (n = 6). .................. 73 
Table 9: Measured TSC and ICW of healthy volunteers (n = 6) of the TA, SO, and GM muscle as well as 
the subcutaneous fat. Values presented as mean and SD (standard deviation). ................................. 76 
Table 10: Mean values ± SD for the different phosphate metabolites in WT and MMex38 (MMex38 n 
= 6 and WT n = 5). Only the pH was significantly increased ($: p < 0.05). .......................................... 118 
Table 11: Mean values ± SD for the different phosphate metabolites in WT and mdx (n = 5 mice per 
group). No significant alterations were observed. .............................................................................. 122 
Table 12: Mean values ± SD of the 23Na TQF/FID ratio and the 23Na T1 in WT and MMex38 (MMex38 n 
= 6, WT n = 5). Significant alterations were observed in the TQF signal and the T1 values ($: p < 0.05).
 ............................................................................................................................................................. 123 
Table 13: Mean values ± SD of the sodium indices measured in WT and mdx: FID signal, TQF signal, 
TQF/FID ratio, and the T1 (mdx n = 6, WT n = 5). Significant alterations were observed in the TQF/FID 
ratio ($: p < 0.05). ................................................................................................................................ 124 
Table 14: List of participating DMD patients with age, diagnosis and therapy................................... 137 
  
XVII 
Table 15: 1H imaging results. FF, water T2, percentage of voxels with elevated T2, and coefficient of 
variation of T2 for DMD (n = 12) and control (n = 12) group per muscle and as mean over all muscles. 
$: significant difference between DMD and control group (p < 0.05). ............................................... 141 
Table 16: ISIS-CPMG results. Relative fraction of short T2, short T2 and long T2 values for the GM 
muscle of DMD (n = 10) and control group (n = 11). $: significant difference between DMD and 
control group (p < 0.05)....................................................................................................................... 143 
Table 17: 23Na imaging results. TSC, ICW, and their ratio for DMD (n = 10) and control group (n = 12) 
per muscle and as mean over all muscles. $: significant difference between DMD and control group 
(p < 0.05). ............................................................................................................................................ 145 
Table 18: 23Na spectroscopy results. Non-localized TQF/FID ratio and global T1 value of DMD (n = 9) 
and control group (n = 10). $: significant difference between DMD and control group (p < 0.05). ... 147 
Table 19: FF, water T2, TSC, and ICW across time in DMD patients for GM, SL, TA, and TP muscle (n = 8 




[1] A. E. H. Emery, “The muscular dystrophies.,” Lancet, vol. 359, no. 9307, pp. 687–95, Feb. 
2002. 
[2] Y. Blat and S. Blat, “Drug Discovery of Therapies for Duchenne Muscular Dystrophy,” J. 
Biomol. Screen., vol. 20, no. 10, pp. 1189–1203, Dec. 2015. 
[3] T. Aslesh, R. Maruyama, and T. Yokota, “Skipping Multiple Exons to Treat DMD—Promises 
and Challenges,” Biomedicines, vol. 6, no. 1, p. 1, 2018. 
[4] J. Heckmatt, V. Dubowitz, and S. Leeman, “Detection of Pathological Change in Dystrophic 
Muscle with B-Scan Ultrasound Imaging,” Lancet, vol. 315, no. 8183, pp. 1389–1390, Jun. 
1980. 
[5] M. Swash, M. M. Brown, and C. Thakkar, “CT muscle imaging and the clinical assessment of 
neuromuscular disease,” Muscle Nerve, vol. 18, no. 7, pp. 708–714, Jul. 1995. 
[6] G.-H. Jahng, K.-L. Li, L. Ostergaard, and F. Calamante, “Perfusion magnetic resonance 
imaging: a comprehensive update on principles and techniques.,” Korean J. Radiol., vol. 15, 
no. 5, pp. 554–77, 2014. 
[7] T. Bezabeh, O. B. Ijare, A. E. Nikulin, R. L. Somorjai, and I. C. Smith, “MRS-based 
Metabolomics in Cancer Research.,” Magn. Reson. Insights, vol. 7, pp. 1–14, Jan. 2014. 
[8] E. Moser, F. Stahlberg, M. E. Ladd, and S. Trattnig, “7-T MR--from research to clinical 
applications?,” NMR Biomed., vol. 25, no. 5, pp. 695–716, May 2012. 
[9] P. G. Carlier, B. Marty, O. Scheidegger, P. Loureiro de Sousa, P.-Y. Baudin, E. Snezhko, and 
D. Vlodavets, “Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and 
Spectroscopy as an Outcome Measure for Clinical Trials,” J. Neuromuscul. Dis., vol. 3, no. 1, 
pp. 1–28, Mar. 2016. 
[10] C. Tonon, L. L. Gramegna, and R. Lodi, “Magnetic resonance imaging and spectroscopy in the 
evaluation of neuromuscular disorders and fatigue,” Neuromuscul. Disord., vol. 22, pp. S187–
S191, 2012. 
[11] U. Bonati, P. Hafner, S. Schädelin, M. Schmid, A. Naduvilekoot Devasia, J. Schroeder, S. 
Zuesli, U. Pohlman, C. Neuhaus, A. Klein, M. Sinnreich, T. Haas, M. Gloor, O. Bieri, A. 
Fischmann, and D. Fischer, “Quantitative muscle MRI: A powerful surrogate outcome measure 
in Duchenne muscular dystrophy,” Neuromuscul. Disord., vol. 25, no. 9, pp. 679–685, Sep. 
2015. 
[12] I. Arpan, R. J. Willcocks, S. C. Forbes, R. S. Finkel, D. J. Lott, W. D. Rooney, W. T. Triplett, C. 
R. Senesac, M. J. Daniels, B. J. Byrne, E. L. Finanger, B. S. Russman, D.-J. Wang, G. I. 
Tennekoon, G. A. Walter, H. L. Sweeney, and K. Vandenborne, “Examination of effects of 
corticosteroids on skeletal muscles of boys with DMD using MRI and MRS,” Neurology, vol. 83, 
no. 11, pp. 974–980, Sep. 2014. 
[13] A. M. Nagel, M.-A. Weber, A. Borthakur, and R. Reddy, “Skeletal Muscle MR Imaging Beyond 




Resonance Imaging of the Skeletal Musculature, M.-A. Weber, Ed. Springer Berlin Heidelberg, 
2013, pp. 115–133. 
[14] M.-A. Weber, A. M. Nagel, K. Jurkat-Rott, and F. Lehmann-Horn, “Sodium (23Na) MRI detects 
elevated muscular sodium concentration in Duchenne muscular dystrophy,” Neurology, vol. 77, 
no. 23, pp. 2017–2024, Dec. 2011. 
[15] B. Marty, P.-Y. Baudin, H. Reyngoudt, N. Azzabou, E. C. A. Araujo, P. G. Carlier, and P. L. de 
Sousa, “Simultaneous muscle water T2 and fat fraction mapping using transverse relaxometry 
with stimulated echo compensation,” NMR Biomed., vol. 29, no. 4, pp. 431–443, Apr. 2016. 
[16] N. Azzabou, P. Loureiro de Sousa, E. Caldas, and P. G. Carlier, “Validation of a generic 
approach to muscle water T2 determination at 3T in fat-infiltrated skeletal muscle,” J. Magn. 
Reson. Imaging, vol. 41, no. 3, pp. 645–653, Mar. 2015. 
[17] E. C. A. Araujo, Y. Fromes, and P. G. Carlier, “New Insights on Human Skeletal Muscle Tissue 
Compartments Revealed by In Vivo T2 NMR Relaxometry,” Biophys. J., vol. 106, no. 10, pp. 
2267–2274, May 2014. 
[18] A. M. Nagel, F. B. Laun, M. A. Weber, C. Matthies, W. Semmler, and L. R. Schad, “Sodium 
MRI using a density-adapted 3D radial acquisition technique,” Magn. Reson. Med., vol. 62, pp. 
1565–1573, 2009. 
[19] T. Gerhalter, P. G. Carlier, and B. Marty, “Acute changes in extracellular volume fraction in 
skeletal muscle monitored by 23 Na NMR spectroscopy,” Physiol. Rep., vol. 5, no. 16, p. 
e13380, Aug. 2017. 
[20] A. C. Guyton and J. E. Hall, Textbook of Medical Physiology, 11th ed. Philadelphia: Elsevier 
Inc., 2006. 
[21] S. Tajbakhsh, “Skeletal muscle stem cells in developmental versus regenerative myogenesis.,” 
J. Intern. Med., vol. 266, no. 4, pp. 372–89, Oct. 2009. 
[22] E. Negroni, T. Gidaro,  a Bigot, G. Butler-Browne, V. Mouly, and C. Trollet, “Stem cells and 
muscle diseases: advances in cell therapy strategies.,” Neuropathol. Appl. Neurobiol., vol. 33, 
no. 0, Nov. 2014. 
[23] K. Gundersen, “Excitation-transcription coupling in skeletal muscle: the molecular pathways of 
exercise.,” Biol. Rev. Camb. Philos. Soc., vol. 86, no. 3, pp. 564–600, Aug. 2011. 
[24] S. Schiaffino and C. Reggiani, “Fiber types in mammalian skeletal muscles.,” Physiol. Rev., vol. 
91, no. 4, pp. 1447–531, Oct. 2011. 
[25] M. Floeter, “Structure and Function of Muscle Fibers and Motor Units,” Disord. Volunt. Muscle, 
pp. 1–10, 2010. 
[26] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter, “Membrane Transport of 
small molecules and the electrical properties of membranes,” in Molecular Biology of the Cell, 
4th ed., New York: Garland Science, 2002, pp. 615–658. 
[27] Y. Vilin and P. Ruben, “Slow inactivation in voltage-gated sodium channels,” Cell Biochem. 
Biophys., vol. 35, pp. 171–190, Dec. 2001. 
[28] D. Baycin-Hizal, A. Gottschalk, E. Jacobson, S. Mai, D. Wolozny, H. Zhang, S. S. Krag, and M. 
J. Betenbaugh, “Physiologic and pathophysiologic consequences of altered sialylation and 
  
XXI 
glycosylation on ion channel function.,” Biochem. Biophys. Res. Commun., vol. 453, no. 2, pp. 
243–253, Oct. 2014. 
[29] F. Bezanilla, “How membrane proteins sense voltage.,” Nat. Rev. Mol. Cell Biol., vol. 9, no. 4, 
pp. 323–332, Apr. 2008. 
[30] E. Murphy and D. A. Eisner, “Regulation of Intracellular and Mitochondrial Sodium in Health 
and Disease,” Circ. Res., vol. 104, no. 3, pp. 292–303, Feb. 2009. 
[31] T. Clausen, “Quantification of Na+,K+ pumps and their transport rate in skeletal muscle: 
functional significance.,” J. Gen. Physiol., vol. 142, pp. 327–45, 2013. 
[32] G. Bhave and E. G. Neilson, “Body Fluid Dynamics: Back to the Future,” J. Am. Soc. Nephrol., 
vol. 22, pp. 2166–2181, Dec. 2011. 
[33] R. H. Sterns, “Disorders of Plasma Sodium — Causes, Consequences, and Correction,” N. 
Engl. J. Med., vol. 372, no. 1, pp. 55–65, 2015. 
[34] L. Barberi, B. M. Scicchitano, M. De Rossi, A. Bigot, S. Duguez, A. Wielgosik, C. Stewart, J. 
McPhee, M. Conte, M. Narici, C. Franceschi, V. Mouly, G. Butler-Browne, and A. Musarò, 
“Age-dependent alteration in muscle regeneration: The critical role of tissue niche,” 
Biogerontology, vol. 14, pp. 273–292, 2013. 
[35] S. T. Cooper and P. L. McNeil, “Membrane Repair: Mechanisms and Pathophysiology,” 
Physiol. Rev., vol. 95, no. 4, pp. 1205–1240, Oct. 2015. 
[36] I. Desguerre, M. Mayer, F. Leturcq, J.-P. Barbet, R. K. Gherardi, and C. Christov, “Endomysial 
fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with 
macrophage alternative activation.,” J. Neuropathol. Exp. Neurol., vol. 68, no. 7, pp. 762–773, 
2009. 
[37] C. J. Mann, E. Perdiguero, Y. Kharraz, S. Aguilar, P. Pessina, A. L. Serrano, and P. Muñoz-
Cánoves, “Aberrant repair and fibrosis development in skeletal muscle.,” Skelet. Muscle, vol. 1, 
no. 1, p. 21, Jan. 2011. 
[38] F. Lehmann-horn and K. Jurkat-rott, “Voltage-Gated Ion Channels and Hereditary Disease,” 
Physiol. Rev., vol. 79, no. 4, pp. 1317–1373, 1999. 
[39] R. Mantegazza and P. Bernasconi, “Inflammatory Myopathies: Dermatomyositis, Polymyositis 
and Inclusion Body Myositis,” in Madame Curie Bioscience Database, Austin: Landes 
Bioscience, 2000. 
[40] I. Dalkilic and L. M. Kunkel, “Muscular dystrophies: genes to pathogenesis,” Curr. Opin. Genet. 
Dev., vol. 13, no. 3, pp. 231–238, Jun. 2003. 
[41] W. Klingler, K. Jurkat-rott, F. Lehmann-horn, and R. Schleip, “The role of fibrosis in Duchenne 
muscular dystrophy,” Acta Myol., vol. 31, pp. 184–195, 2012. 
[42] J. Liu, M. Aoki, I. Illa, C. Wu, M. Fardeau, C. Angelini, C. Serrano, J. A. Urtizberea, F. Hentati, 
M. Ben Hamida, S. Bohlega, E. J. Culper, A. A. Amato, K. Bossie, J. Oeltjen, K. Bejaoui, D. 
McKenna-Yasek, B. A. Hosler, E. Schurr, K. Arahata, P. J. de Jong, and R. H. Brown, 
“Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle 
muscular dystrophy,” Nat. Genet., vol. 20, no. 1, pp. 31–36, Sep. 1998. 




Bourg, Z. Argov, M. Sadeh, I. Mahjneh, G. Marconi, M. R. Passos-Bueno, E. de S. Moreira, M. 
Zatz, J. S. Beckmann, and K. Bushby, “A gene related to Caenorhabditis 
elegansspermatogenesis factor fer-1is mutated in limb-girdle muscular dystrophy type 2B,” Nat. 
Genet., vol. 20, no. 1, pp. 37–42, Sep. 1998. 
[44] M. Fanin and C. Angelini, “Progress and challenges in diagnosis of dysferlinopathy,” Muscle 
Nerve, vol. 54, no. 5, pp. 821–835, Nov. 2016. 
[45] A. M. Cárdenas, A. M. González-Jamett, L. A. Cea, J. A. Bevilacqua, and P. Caviedes, 
“Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical 
targets in dysferlinopathies,” Exp. Neurol., vol. 283, pp. 246–254, Sep. 2016. 
[46] S. T. Cooper and S. I. Head, “Membrane Injury and Repair in the Muscular Dystrophies,” 
Neurosci., pp. 1–16, 2014. 
[47] D. Bansal, K. Miyake, S. S. Vogel, S. Groh, C.-C. Chen, R. Williamson, P. L. McNeil, and K. P. 
Campbell, “Defective membrane repair in dysferlin-deficient muscular dystrophy.,” Nature, vol. 
423, no. 6936, pp. 168–72, May 2003. 
[48] J. P. Kerr, A. P. Ziman, A. L. Mueller, J. M. Muriel, E. Kleinhans-Welte, J. D. Gumerson, S. S. 
Vogel, C. W. Ward, J. a Roche, and R. J. Bloch, “Dysferlin stabilizes stress-induced Ca2+ 
signaling in the transverse tubule membrane,” Proc. Natl. Acad. Sci. U. S. A., vol. 110, no. 51, 
pp. 20831–20836, 2013. 
[49] R. Han and K. P. Campbell, “Dysferlin and muscle membrane repair,” Curr. Opin. Cell Biol., 
vol. 19, no. 4, pp. 409–416, 2007. 
[50] M. D. Grounds, J. R. Terrill, H. G. Radley-Crabb, T. Robertson, J. Papadimitriou, S. Spuler, 
and T. Shavlakadze, “Lipid accumulation in dysferlin-deficient muscles,” Am. J. Pathol., vol. 
184, no. 6, pp. 1668–1676, 2014. 
[51] A. Kumar, N. Khandelwal, R. Malya, M. B. Reid, and A. M. Boriek, “Loss of dystrophin causes 
aberrant mechanotransduction in skeletal muscle fibers.,” FASEB J., vol. 18, pp. 102–113, 
2004. 
[52] M. M. Ghahramani Seno, C. Trollet, T. Athanasopoulos, I. R. Graham, P. Hu, and G. Dickson, 
“Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in 
muscle differentiation and contractile apparatus organization.,” BMC Genomics, vol. 11, p. 345, 
2010. 
[53] B. H. Wokke, M. T. Hooijmans, J. C. van den Bergen,  a G. Webb, J. J. Verschuuren, and H. E. 
Kan, “Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular 
dystrophy,” NMR Biomed., vol. 27, no. 11, pp. 1371–1377, Nov. 2014. 
[54] R. J. Fairclough, M. J. Wood, and K. E. Davies, “Therapy for Duchenne muscular dystrophy: 
renewed optimism from genetic approaches,” Nat. Rev. Genet., vol. 14, no. 6, pp. 373–378, 
Jun. 2013. 
[55] A. R. Burr, D. P. Millay, S. A. Goonasekera, K. H. Park, M. A. Sargent, J. Collins, F. 
Altamirano, K. D. Philipson, P. D. Allen, J. Ma, J. R. Lopez, and J. D. Molkentin, “Na+ 
Dysregulation Coupled with Ca2+ Entry through NCX1 Promotes Muscular Dystrophy in Mice,” 
Mol. Cell. Biol., vol. 34, no. 11, pp. 1991–2002, Jun. 2014. 
  
XXIII 
[56] D. G. Allen and N. P. Whitehead, “Duchenne muscular dystrophy – What causes the increased 
membrane permeability in skeletal muscle?,” Int. J. Biochem. Cell Biol., vol. 43, no. 3, pp. 290–
294, Mar. 2011. 
[57] A. Vontzalidis, G. Terzis, and P. Manta, “Increased dysferlin expression in Duchenne muscular 
dystrophy.,” Anal. Quant. Cytopathol. Histopathol., vol. 36, no. 1, pp. 15–22, Feb. 2014. 
[58] P. R. Turner, T. Westwood, C. M. Regen, and R. A. Steinhardt, “Increased protein degradation 
results from elevated free calcium levels found in muscle from mdx mice,” Nature, vol. 335, no. 
6192, pp. 735–8, 1988. 
[59] J. F. Dunn, K. a Burton, and M. J. Dauncey, “Ouabain sensitive Na+/K(+)-ATPase content is 
elevated in mdx mice: implications for the regulation of ions in dystrophic muscle.,” J. Neurol. 
Sci., vol. 133, pp. 11–15, 1995. 
[60] M.-A. Weber, A. M. Nagel, M. B. Wolf, K. Jurkat-Rott, H.-U. Kauczor, W. Semmler, and F. 
Lehmann-Horn, “Permanent muscular sodium overload and persistent muscle edema in 
Duchenne muscular dystrophy: a possible contributor of progressive muscle degeneration,” J. 
Neurol., vol. 259, no. 11, pp. 2385–2392, Nov. 2012. 
[61] C. Hirn, G. Shapovalov, O. Petermann, E. Roulet, and U. T. Ruegg, “Nav1.4 deregulation in 
dystrophic skeletal muscle leads to Na+ overload and enhanced cell death.,” J. Gen. Physiol., 
vol. 132, pp. 199–208, 2008. 
[62] E. Deval, D. O. Levitsky, E. Marchand, A. Cantereau, G. Raymond, and C. Cognard, 
“Na+/Ca2+ exchange in human myotubes: Intracellular calcium rises in response to external 
sodium depletion are enhanced in DMD,” Neuromuscul. Disord., vol. 12, pp. 665–673, 2002. 
[63] Y. Iwata, Y. Katanosaka, T. Hisamitsu, and S. Wakabayashi, “Enhanced Na+/H+ exchange 
activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 
receptors.,” Am. J. Pathol., vol. 171, no. 5, pp. 1576–1587, 2007. 
[64] R. A. De Graaf, In Vivo NMR Spectroscopy, 2nd ed. West Sussex: John Wiley& Sons, Ltd., 
2007. 
[65] M. H. Levitt, Spin Dynamics: Basics of Nuclear Magnetic Resonance, 2nd ed. West Sussex: 
John Wiley& Sons, Ltd., 2008. 
[66] P. A. Bottomley, “Selective volume method for performing localized NMR spectroscopy,” US 
Pat., vol. US 4480228, 1984. 
[67] R. . Ordidge, A. Connelly, and J. A. . Lohman, “Image-selected in Vivo spectroscopy (ISIS). A 
new technique for spatially selective nmr spectroscopy,” J. Magn. Reson., vol. 66, no. 2, pp. 
283–294, Feb. 1986. 
[68] W. D. Rooney and C. S. Springer, “The molecular environment of intracellular sodium: 23Na 
NMR relaxation.,” NMR Biomed., vol. 4, pp. 227–245, 1991. 
[69] W. D. Rooney and C. S. Springer Jr, “A Comprehensive Approach to the Analysis and 
Interpretation of the Resonances of Spins 3 / 2 from-Living Systems,” NMR Biomed., vol. 4, no. 
March, pp. 209–226, 1991. 
[70] G. Madelin, J.-S. Lee, R. R. Regatte, and A. Jerschow, “Sodium MRI: Methods and 




[71] J. S. Tauskela, J. M. Dizon, J. Whang, and J. Katz, “Evaluation of multiple-quantum-filtered 
23Na NMR in monitoring intracellular Na content in the isolated perfused rat heart in the 
absence of a chemical-shift reagent.,” J. Magn. Reson., vol. 127, pp. 115–127, 1997. 
[72] N. Bansal, L. Szczepaniak, D. Ternullo, J. L. Fleckenstein, and C. R. Malloy, “Effect of exercise 
on (23)Na MRI and relaxation characteristics of the human calf muscle.,” J. Magn. Reson. 
Imaging, vol. 11, no. 5, pp. 532–538, May 2000. 
[73] F. E. Boada, J. D. Christensen, F. R. Huang-Hellinger, T. G. Reese, and K. R. Thulborn, 
“Quantitative in vivo tissue sodium concentration maps: The effects of biexponential 
relaxation,” Magn. Reson. Med., vol. 32, pp. 219–223, 1994. 
[74] M. M. Pike, S. R. Simon, J. a Balschi, and C. S. Springer, “High-resolution NMR studies of 
transmembrane cation transport: use of an aqueous shift reagent for 23Na.,” Proc. Natl. Acad. 
Sci., vol. 79, no. 3, pp. 810–814, Feb. 1982. 
[75] R. K. Gupta, P. Gupte, and R. D. Moore, “NMR Studies of Intracellular Metal Ions in Intact Cells 
and Tissues,” Ann. Revi. Biophys. Bioeng., vol. 13, pp. 221–246, 1984. 
[76] M. M. Pike, J. C. Frazer, D. F. Dedrick, J. S. Ingwall, P. D. Allen, C. S. Springer, and T. W. 
Smith, “23Na and 39K nuclear magnetic resonance studies of perfused rat hearts. 
Discrimination of intra- and extracellular ions using a shift reagent,” Biophys. J., vol. 48, no. 1, 
pp. 159–173, Jul. 1985. 
[77] H. Naritomi, M. Kanashiro, M. Sasaki, Y. Kuribayashi, and T. Sawada, “In vivo measurements 
of intra- and extracellular Na+ and water in the brain and muscle by nuclear magnetic 
resonance spectroscopy with shift reagent.,” Biophys. J., vol. 52, no. 4, pp. 611–616, 1987. 
[78] H. Blum, M. D. Schnall, B. Chance, and G. P. Buzby, “Intracellular sodium flux and high-energy 
phosphorus metabolites in ischemic skeletal muscle.,” Am. J. Physiol., vol. 255, no. 3 Pt 1, pp. 
C377-84, Sep. 1988. 
[79] J. D. Makos, C. R. Malloy, and A. D. Sherry, “Distribution of TmDOTP5- in rat tissues: 
TmDOTP5- vs. CoEDTA- as markers of extracellular tissue space.,” J. Appl. Physiol., vol. 85, 
no. 5, pp. 1800–1805, Nov. 1998. 
[80] P. M. Winter, V. Seshan, J. D. Makos,  a D. Sherry, C. R. Malloy, and N. Bansal, “Quantitation 
of intracellular [Na+] in vivo by using TmDOTP5- as an NMR shift reagent and extracellular 
marker.,” J. Appl. Physiol., vol. 85, no. 5, pp. 1806–1812, 1998. 
[81] P. M. Winter and N. Bansal, “TmDOTP(5-) as a (23)Na shift reagent for the subcutaneously 
implanted 9L gliosarcoma in rats.,” Magn. Reson. Med., vol. 45, no. 3, pp. 436–442, 2001. 
[82] N. Bansal, M. J. Germann, I. Lazar, C. R. Malloy, and  a D. Sherry, “In vivo Na-23 MR imaging 
and spectroscopy of rat brain during TmDOTP5- infusion.,” J. Magn. Reson. Imaging, vol. 2, 
pp. 385–391, 1992. 
[83] A. M. Nagel, E. Amarteifio, F. Lehmann-horn, and K. Jurkat-rott, “3 Tesla Sodium Inversion 
Recovery Magnetic Resonance Imaging Allows for Improved Visualization of Intracellular 
Sodium Content Changes in Muscular Channelopathies,” Invest. Radiol., vol. 46, no. 12, pp. 
759–766, 2011. 
[84] G. Jaccard, S. Wimperis, and G. Bodenhausen, “Multiple-quantum NMR spectroscopy of S=3/2 
  
XXV 
spins in isotropic phase: A new probe for multiexponential relaxation,” J. Chem. Phys., vol. 85, 
no. 11, p. 6282, 1986. 
[85] J. Pekar and J. S. Leigh, “Detection of biexponential relaxation in sodium-23 facilitated by 
double-quantum filtering,” J. Magn. Reson., vol. 69, no. 3, pp. 582–584, Oct. 1986. 
[86] G. Navon, “Complete elimination of the extracellular 23Na NMR signal in triple quantum filtered 
spectra of rat hearts in the presence of shift reagents,” Magn. Reson. Med., vol. 30, pp. 503–
506, 1993. 
[87] C. Tanase and F. E. Boada, “Triple-quantum-filtered imaging of sodium in presence of B(0) 
inhomogeneities.,” J. Magn. Reson., vol. 174, no. 2, pp. 270–8, Jun. 2005. 
[88] G. Navon, H. Shinar, U. Eliav, and Y. Seo, “Multiquantum filters and order in tissues,” NMR 
Biomed., vol. 14, no. 2, pp. 112–132, Apr. 2001. 
[89] R. Reddy, M. Shinnar, Z. Wang, and J. S. Leigh, “Multiple-quantum filters of spin-3/2 with 
pulses of arbitrary flip angle.,” J. Magn. Reson. B, vol. 104, no. 2, pp. 148–52, Jun. 1994. 
[90] N. Müller, G. Bodenhausen, and R. R. Ernst, “Relaxation-induced violations of coherence 
transfer selection rules in nuclear magnetic resonance,” J. Magn. Reson., vol. 75, no. 2, pp. 
297–334, 1987. 
[91] R. Reddy, L. Bolinger, M. Shinnar, E. Noyszewski, and J. S. Leigh, “Detection of Residual 
Quadrupolar Interaction in Human Skeletal Muscle and Brain in vivo via Multiple Quantum 
Filtered Sodium NMR Spectra,” Magn. Reson. Med., vol. 33, no. 1, pp. 134–139, Jan. 1995. 
[92] J. R. C. van der Maarel, “Thermal relaxation and coherence dynamics of spin 3/2. I. Static and 
fluctuating quadrupolar interactions in the multipole basis,” Concepts Magn. Reson., vol. 19A, 
no. 2, pp. 97–116, 2003. 
[93] S. Wimperis, P. Cole, and P. Styles, “Triple-quantum-filtration NMR imaging of 200 mM sodium 
at 1.9 Tesla,” J. Magn. Reson., vol. 98, no. 3, pp. 628–636, Jul. 1992. 
[94] G. Bodenhausen, H. Kogler, and R. R. Ernst, “Selection of coherence transfer pathways in 
NMR experiments,” J. Magn. Reson., vol. 58, pp. 370–388, 1984. 
[95] U. Eliav, H. Shinar, and G. Navon, “The formation of a second-rank tensor in 23Na double-
quantum-filtered NMR as an indicator for order in a biological tissue,” J. Magn. Reson., vol. 98, 
no. 1, pp. 223–229, Jun. 1992. 
[96] R. Stobbe and C. Beaulieu, “In vivo sodium magnetic resonance imaging of the human brain 
using soft inversion recovery fluid attenuation,” Magn. Reson. Med., vol. 54, pp. 1305–1310, 
2005. 
[97] R. Griffey, B. Griffey, and N. Matwiyoff, “Triple-Quantum-Coherence-Filtered Imaging of 
Sodium Ions in Vivo at 4.7 Tesla,” Magn. Reson. Med., vol. 13, pp. 305–313, 1990. 
[98] Y. Gao, J. James, and N. Bansal, “Noninvasive Monitoring of CCl4 Induced Acute and Chronic 
Liver Damage in Rat by SQ and TQF 23Na MRI,” in ISMRM, 2009, vol. 17, p. 614. 
[99] K. J. Ooms, M. Cannella, A. J. Vega, M. Marcolongo, and T. Polenova, “23Na TQF NMR 
imaging for the study of spinal disc tissue.,” J. Magn. Reson., vol. 195, no. 1, pp. 112–5, Nov. 
2008. 




implantation site and growth of hepatocellular carcinoma on apparent diffusion coefficient of 
water and sodium MRI.,” NMR Biomed., vol. 25, no. 2, pp. 312–21, Feb. 2012. 
[101] A. Borthakur, E. Mellon, S. Niyogi, W. Witschey, J. B. Kneeland, and R. Reddy, “Sodium and 
T1rho MRI for molecular and diagnostic imaging of articular cartilage.,” NMR Biomed., vol. 19, 
no. 7, pp. 781–821, Nov. 2006. 
[102] C. Tanase and F. E. Boada, “Algebraic description of spin 3/2 dynamics in NMR experiments.,” 
J. Magn. Reson., vol. 173, no. 2, pp. 236–53, Apr. 2005. 
[103] A. Tsang, R. W. Stobbe, and C. Beaulieu, “Evaluation of B0-inhomogeneity correction for triple-
quantum-filtered sodium MRI of the human brain at 4.7 T.,” J. Magn. Reson., vol. 230, pp. 134–
44, May 2013. 
[104] N. Benkhedah, P. Bachert, W. Semmler, and A. M. Nagel, “Three-dimensional biexponential 
weighted 23 Na imaging of the human brain with higher SNR and shorter acquisition time,” 
Magn. Reson. Med., vol. 70, no. 3, pp. 754–765, Sep. 2013. 
[105] L. Fleysher, N. Oesingmann, and M. Inglese, “B0 inhomogeneity-insensitive triple-quantum-
filtered sodium imaging using a 12-step phase-cycling scheme.,” NMR Biomed., vol. 23, no. 10, 
pp. 1191–1198, Dec. 2010. 
[106] N. Benkhedah, P. Bachert, and A. M. Nagel, “Two-pulse biexponential-weighted 23Na 
imaging.,” J. Magn. Reson., vol. 240, pp. 67–76, Mar. 2014. 
[107] D. P. Fiege, S. Romanzetti, C. C. Mirkes, D. Brenner, and N. J. Shah, “Simultaneous single-
quantum and triple-quantum-filtered MRI of 23Na (SISTINA).,” Magn. Reson. Med., vol. 69, no. 
6, pp. 1691–6, Jun. 2013. 
[108] V. Seshan, A. D. Sherry, and N. Bansal, “Evaluation of triple quantum-filtered 23Na NMR 
spectroscopy in the in situ rat liver,” Magn. Reson. Med., vol. 38, no. 5, pp. 821–827, Nov. 
1997. 
[109] V. D. Schepkin, I. O. Choy, T. F. Budinger, D. Y. Obayashi, S. E. Taylor, W. M. DeCampli, S. 
C. Amartur, and J. N. Young, “Sodium TQF NMR and intracellular sodium in isolated crystalloid 
perfused rat heart.,” Magn. Reson. Med., vol. 39, no. 4, pp. 557–563, Apr. 1998. 
[110] T. R. Eykyn, D. Aksentijević, K. L. Aughton, R. Southworth, W. Fuller, and M. J. Shattock, 
“Multiple quantum filtered 23Na NMR in the Langendorff perfused mouse heart: Ratio of 
triple/double quantum filtered signals correlates with [Na]i,” J. Mol. Cell. Cardiol., vol. 86, pp. 
95–101, Sep. 2015. 
[111] L. A. Jelicks and R. K. Gupta, “On the extracellular contribution to multiple quantum filtered 
23Na NMR of perfused rat heart.,” Magn. Reson. Med., vol. 29, no. 1, pp. 130–3, Jan. 1993. 
[112] L. A. Jelicks and R. K. Gupta, “Double-quantum NMR of sodium ions in cells and tissues. 
Paramagnetic quenching of extracellular coherence,” J. Magn. Reson., vol. 81, no. 3, pp. 586–
592, Feb. 1989. 
[113] W. a Murphy, W. G. Totty, and J. E. Carroll, “MRI of normal and pathological skeletal muscle,” 
Am. J. Radiol., vol. 146, pp. 565–574, 1986. 
[114] V. Ricotti, M. R. B. Evans, C. D. J. Sinclair, J. W. Butler, D. A. Ridout, J.-Y. Hogrel, A. Emira, J. 
M. Morrow, M. M. Reilly, M. G. Hanna, R. L. Janiczek, P. M. Matthews, T. A. Yousry, F. 
  
XXVII 
Muntoni, and J. S. Thornton, “Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-
Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials,” 
PLoS One, vol. 11, no. 9, p. e0162542, Sep. 2016. 
[115] S. C. Forbes, R. J. Willcocks, W. T. Triplett, W. D. Rooney, D. J. Lott, D.-J. Wang, J. Pollaro, C. 
R. Senesac, M. J. Daniels, R. S. Finkel, B. S. Russman, B. J. Byrne, E. L. Finanger, G. I. 
Tennekoon, G. a. Walter, H. L. Sweeney, and K. Vandenborne, “Magnetic Resonance Imaging 
and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne 
Muscular Dystrophy: A Multicenter Cross Sectional Study,” PLoS One, vol. 9, no. 9, p. 
e106435, 2014. 
[116] D. J. Lott, S. C. Forbes, S. Mathur, S. A. Germain, C. R. Senesac, H. Lee Sweeney, G. A. 
Walter, and K. Vandenborne, “Assessment of intramuscular lipid and metabolites of the lower 
leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy,” 
Neuromuscul. Disord., vol. 24, pp. 574–582, 2014. 
[117] W. T. Triplett, C. Baligand, S. C. Forbes, R. J. Willcocks, D. J. Lott, S. DeVos, J. Pollaro, W. D. 
Rooney, H. L. Sweeney, C. G. Bönnemann, D.-J. Wang, K. Vandenborne, and G. A. Walter, 
“Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle,” Magn. 
Reson. Med., vol. 72, no. 1, pp. 8–19, Jul. 2014. 
[118] A. Mankodi, C. A. Bishop, S. Auh, R. D. Newbould, K. H. Fischbeck, and R. L. Janiczek, 
“Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne 
muscular dystrophy,” Neuromuscul. Disord., vol. 26, no. 10, pp. 650–658, Oct. 2016. 
[119] J. Burakiewicz, C. D. J. Sinclair, D. Fischer, G. A. Walter, H. E. Kan, and K. G. Hollingsworth, 
“Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy,” J. Neurol., 
vol. 264, no. 10, pp. 2053–2067, Oct. 2017. 
[120] B. H. Wokke, C. Bos, M. Reijnierse, C. S. van Rijswijk, H. Eggers, A. Webb, J. J. Verschuuren, 
and H. E. Kan, “Comparison of dixon and T1-weighted MR methods to assess the degree of fat 
infiltration in duchenne muscular dystrophy patients,” J. Magn. Reson. Imaging, vol. 38, no. 3, 
pp. 619–624, Sep. 2013. 
[121] C. Wary, N. Azzabou, C. Giraudeau, J. Le Louër, M. Montus, T. Voit, L. Servais, and P. Carlier, 
“Quantitative NMRI and NMRS identify augmented disease progression after loss of 
ambulation in forearms of boys with Duchenne muscular dystrophy,” NMR Biomed., vol. 28, no. 
9, 2015. 
[122] J.-Y. Hogrel, Y. Barnouin, N. Azzabou, G. Butler-Browne, T. Voit, A. Moraux, G. Leroux, A. 
Behin, J. S. McPhee, and P. G. Carlier, “NMR imaging estimates of muscle volume and 
intramuscular fat infiltration in the thigh: variations with muscle, gender, and age,” Age 
(Omaha)., vol. 37, no. 60, pp. 1–11, Jun. 2015. 
[123] A. Fischmann, P. Hafner, M. Gloor, M. Schmid, A. Klein, U. Pohlman, T. Waltz, R. Gonzalez, T. 
Haas, O. Bieri, and D. Fischer, “Quantitative MRI and loss of free ambulation in Duchenne 
muscular dystrophy.,” J. Neurol., vol. 260, no. 4, pp. 969–74, Apr. 2013. 
[124] M. Torriani, E. Townsend, B. J. Thomas, M. A. Bredella, R. H. Ghomi, and B. S. Tseng, “Lower 




study,” Skeletal Radiol., vol. 41, no. 4, pp. 437–445, Apr. 2012. 
[125] J.-Y. Hogrel, C. Wary, A. Moraux, N. Azzabou, V. Decostre, G. Ollivier, A. Canal, C. Lilien, I. 
Ledoux, M. Annoussamy, N. Reguiba, T. Gidaro, A. G. Le Moing, R. Cardas, T. Voit, P. G. 
Carlier, and L. Servais, “Longitudinal functional and NMR assessment of upper limbs in 
Duchenne muscular dystrophy,” Neurology, vol. 86, pp. 1022–1030, Mar. 2016. 
[126] R. J. Willcocks, W. D. Rooney, W. T. Triplett, S. C. Forbes, D. J. Lott, C. R. Senesac, M. J. 
Daniels, D.-J. Wang, A. T. Harrington, G. I. Tennekoon, B. S. Russman, E. L. Finanger, B. J. 
Byrne, R. S. Finkel, G. A. Walter, H. L. Sweeney, and K. Vandenborne, “Multicenter 
prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular 
dystrophy cohort,” Ann. Neurol., vol. 79, no. 4, pp. 535–547, Apr. 2016. 
[127] I. Arpan, S. C. Forbes, D. J. Lott, C. R. Senesac, M. J. Daniels, W. T. Triplett, J. K. Deol, H. L. 
Sweeney, G. A. Walter, and K. Vandenborne, “T2 mapping provides multiple approaches for 
the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study 
of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy,” NMR Biomed., 
vol. 26, no. 3, pp. 320–328, Mar. 2013. 
[128] Y. Huang, S. Majumdar, H. K. Genant, W. P. Chan, K. R. Sharma, P. Yu, M. Mynhier, and R. 
G. Miller, “Quantitative MR relaxometry study of muscle composition and function in duchenne 
muscular dystrophy,” J. Magn. Reson. Imaging, vol. 4, no. 1, pp. 59–64, Jan. 1994. 
[129] H. K. Kim, T. Laor, P. S. Horn, J. M. Racadio, B. Wong, and B. J. Dardzinski, “T2 Mapping in 
Duchenne Muscular Dystrophy: Distribution of Disease Activity and Correlation with Clinical 
Assessments,” Radiology, vol. 255, no. 3, pp. 899–908, Jun. 2010. 
[130] R. J. Willcocks, W. T. Triplett, S. C. Forbes, H. Arora, C. R. Senesac, D. J. Lott, T. R. 
Nicholson, W. D. Rooney, G. A. Walter, and K. Vandenborne, “Magnetic resonance imaging of 
the proximal upper extremity musculature in boys with Duchenne muscular dystrophy,” J. 
Neurol., vol. 264, no. 1, pp. 64–71, Jan. 2017. 
[131] P. G. Carlier, “Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: Different 
methodology, different information and different implications,” Neuromuscul. Disord., vol. 24, 
no. 5, pp. 390–392, May 2014. 
[132] R. M. Lebel and A. H. Wilman, “Transverse relaxometry with stimulated echo compensation.,” 
Magn. Reson. Med., vol. 64, no. 4, pp. 1005–14, Oct. 2010. 
[133] B. H. Wokke, J. C. Van Den Bergen, M. T. Hooijmans, J. J. Verschuuren, E. H. Niks, and H. E. 
Kan, “T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients,” 
Muscle Nerve, vol. 53, no. 1, pp. 38–43, Jan. 2016. 
[134] T.-J. Hsieh, T.-S. Jaw, H.-Y. Chuang, Y.-J. Jong, G.-C. Liu, and C.-W. Li, “Muscle Metabolism 
in Duchenne Muscular Dystrophy Assessed by In Vivo Proton Magnetic Resonance 
Spectroscopy,” J. Comput. Assist. Tomogr., vol. 33, no. 1, pp. 150–154, Jan. 2009. 
[135] M. T. Hooijmans, E. H. Niks, J. Burakiewicz, J. J. G. M. Verschuuren, A. G. Webb, and H. E. 
Kan, “Elevated phosphodiester and T2 levels can be measured in the absence of fat infiltration 
in Duchenne muscular dystrophy patients,” NMR Biomed., vol. 30, no. 1, p. e3667, Jan. 2017. 
[136] B. Barbiroli, R. Funicello, A. Ferlini, P. Montagna, and P. Zaniol, “Muscle energy metabolism in 
  
XXIX 
female DMD/BMD carriers: A31P-MR spectroscopy study,” Muscle Nerve, vol. 15, no. 3, pp. 
344–348, Mar. 1992. 
[137] H. Reyngoudt, S. Turk, and P. G. Carlier, “1 H NMRS of carnosine combined with 31 P NMRS 
to better characterize skeletal muscle pH dysregulation in Duchenne muscular dystrophy,” 
NMR Biomed., vol. 31, no. 1, p. e3839, Jan. 2018. 
[138] T. a. Willis, K. G. Hollingsworth, A. Coombs, M.-L. Sveen, S. Andersen, T. Stojkovic, M. Eagle, 
A. Mayhew, P. L. de Sousa, L. Dewar, J. M. Morrow, C. D. J. Sinclair, J. S. Thornton, K. 
Bushby, H. Lochmüller, M. G. Hanna, J.-Y. Hogrel, P. G. Carlier, J. Vissing, and V. Straub, 
“Quantitative muscle MRI as an assessment tool for monitoring disease progression in 
LGMD2I: a multicentre longitudinal study.,” PLoS One, vol. 8, no. 8, p. e70993, 2013. 
[139] T. a Willis, K. G. Hollingsworth, A. Coombs, M.-L. Sveen, S. Andersen, T. Stojkovic, M. Eagle, 
A. Mayhew, P. L. de Sousa, L. Dewar, J. M. Morrow, C. D. J. Sinclair, J. S. Thornton, K. 
Bushby, H. Lochmuller, M. G. Hanna, J.-Y. Hogrel, P. G. Carlier, J. Vissing, and V. Straub, 
“Quantitative Magnetic Resonance Imaging in Limb-Girdle Muscular Dystrophy 2I: A 
Multinational Cross-Sectional Study,” PLoS One, vol. 9, no. 2, p. e90377, Feb. 2014. 
[140] B. Janssen, N. Voet, A. Geurts, B. van Engelen, and A. Heerschap, “Quantitative MRI reveals 
decelerated fatty infiltration in muscles of active FSHD patients,” Neurology, vol. 86, no. 18, pp. 
1700–1707, May 2016. 
[141] H. E. Kan, D. W. J. Klomp, M. Wohlgemuth, I. van Loosbroek-Wagemans, B. G. M. van 
Engelen, G. W. Padberg, and A. Heerschap, “Only fat infiltrated muscles in resting lower leg of 
FSHD patients show disturbed energy metabolism.,” NMR Biomed., vol. 23, no. 6, pp. 563–8, 
Jul. 2010. 
[142] S. Gerevini, M. Scarlato, L. Maggi, M. Cava, G. Caliendo, B. Pasanisi, A. Falini, S. C. Previtali, 
and L. Morandi, “Muscle MRI findings in facioscapulohumeral muscular dystrophy,” Eur. 
Radiol., vol. 26, no. 3, pp. 693–705, Mar. 2016. 
[143] C. D. Constantinides, J. S. Gillen, F. E. Boada, M. G. Pomper, and P. A. Bottomley, “Human 
skeletal muscle: sodium MR imaging and quantification-potential applications in exercise and 
disease.,” Radiology, vol. 216, no. 2, pp. 559–68, Aug. 2000. 
[144] T. Kushnir, T. Knubovets, Y. Itzchak, U. Eliav, M. Sadeh, L. Rapoport, E. Kott, and G. Navon, 
“In Vivo 23Na NMR Studies of Myotonic Dystrophy,” Magn. Reson. Med., vol. 37, pp. 192–196, 
1997. 
[145] P. A. Glemser, H. Jaeger, A. M. Nagel, A. E. Ziegler, D. Simons, H. Schlemmer, F. Lehmann-
Horn, K. Jurkat-Rott, and M. Weber, “23Na MRI and myometry to compare eplerenone vs. 
glucocorticoid treatment in Duchenne dystrophy.,” Acta Myol., vol. 36, no. 1, pp. 2–13, 2017. 
[146] F. Lehmann-Horn, M.-A. Weber, A. M. Nagel, H.-M. Meinck, S. Breitenbach, J. Scharrer, and 
K. Jurkat-Rott, “Rationale for treating oedema in Duchenne muscular dystrophy with 
eplerenone.,” Acta Myol., vol. 31, no. 1, pp. 31–9, May 2012. 
[147] G. Chang, L. Wang, M. E. Schweitzer, and R. R. Regatte, “3D 23Na MRI of human skeletal 
muscle at 7 Tesla: initial experience.,” Eur. Radiol., vol. 20, no. 8, pp. 2039–46, Aug. 2010. 




G. Webb, “Time-efficient interleaved human 23 Na and 1 H data acquisition at 7 T,” NMR 
Biomed., vol. 28, no. 10, pp. 1228–1235, Oct. 2015. 
[149] W. T. Dixon, “Simple proton spectroscopic imaging.,” Radiology, vol. 153, no. 1, pp. 189–194, 
Oct. 1984. 
[150] F. Schick, B. Eismann, W.-I. Jung, H. Bongers, M. Bunse, and O. Lutz, “Comparison of 
localized proton NMR signals of skeletal muscle and fat tissuein vivo: Two lipid compartments 
in muscle tissue,” Magn. Reson. Med., vol. 29, no. 2, pp. 158–167, Feb. 1993. 
[151] G. H. Glover and E. Schneider, “Three-point Dixon technique for true water/fat decomposition 
with B0 inhomogeneity correction.,” Magn. Reson. Med., vol. 18, no. 2, pp. 371–83, 1991. 
[152] D. C. Look and D. R. Locker, “Time saving in measurement of NMR and EPR relaxation times,” 
Rev. Sci. Instrum., vol. 41, no. 1970, pp. 250–251, 1970. 
[153] G. Saab, R. T. Thompson, and G. D. Marsh, “Multicomponent T 2 Relaxation of In Vivo 
Skeletal Muscle,” Magn. Reson. Med., vol. 157, no. 1999, pp. 150–157, 2000. 
[154] G. Saab, R. T. Thompson, and G. D. Marsh, “Effects of exercise on muscle transverse 
relaxation determined by MR imaging and in vivo relaxometry,” J Appl Physiol, vol. 88, no. 1, 
pp. 226–233, 2000. 
[155] E. A. Louie, D. F. Gochberg, M. D. Does, and B. M. Damon, “Transverse relaxation and 
magnetization transfer in skeletal muscle: Effect of pH,” Magn. Reson. Med., vol. 61, no. 3, pp. 
560–569, Mar. 2009. 
[156] C. F. Hazlewood, D. C. Chang, B. L. Nichols, and D. E. Woessner, “Nuclear Magnetic 
Resonance Transverse Relaxation Times of Water Protons in Skeletal Muscle,” Biophys. J., 
vol. 14, no. 3, pp. 583–606, 1974. 
[157] P. S. Belton, R. R. Jackson, and K. J. Packer, “Pulsed NMR Studies in striated muscle. 
Transverse nuclear spin relaxation times and freezing effects,” Biochim. Biophys. Acta (BBA)-
General Subj., vol. 286, pp. 16–25, 1972. 
[158] B. M. Fung and P. S. Puon, “Nuclear magnetic resonance transverse relaxation in muscle 
water.,” Biophys. J., vol. 33, no. January, pp. 27–37, 1981. 
[159] R. B. Moon and J. H. Richards, “Determination of intracellular pH by 31P magnetic 
resonance.,” J. Biol. Chem., vol. 248, no. 20, pp. 7276–8, Oct. 1973. 
[160] C. Wary, T. Naulet, J.-L. Thibaud, A. Monnet, S. Blot, and P. G. Carlier, “Splitting of Pi and 
other 31P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy,” NMR 
Biomed., vol. 25, no. 10, pp. 1160–1169, Oct. 2012. 
[161] J. Pan, J. Hamm, D. Rothman, and R. Shulman, “Intracellular pH in human skeletal muscle by 
1H NMR.,” Proc. Natl. Acad. Sci. USA, vol. 85, no. 21, pp. 7836–7839, 1988. 
[162] G. S. Payne and P. Styles, “Multiple-quantum-filtered 23Na NMR spectroscopy in model 
systems,” J. Magn. Reson., vol. 95, pp. 253–266, 1991. 
[163] J.-R. Liao, J. M. Pauly, T. J. Brosnan, and N. J. Pelc, “Reduction of motion artifacts in cine MRI 
using variable-density spiral trajectories,” Magn. Reson. Med., vol. 37, no. 4, pp. 569–575, Apr. 
1997. 
[164] D. Stefan, F. Di Cesare, A. Andrasescu, E. Popa, A. Lazariev, E. Vescovo, O. Strbak, S. 
  
XXXI 
Williams, Z. Starcuk, M. Cabanas, D. van Ormondt, and D. Graveron-Demilly, “Quantitation of 
magnetic resonance spectroscopy signals: the jMRUI software package,” Meas. Sci. Technol., 
vol. 20, no. 10, p. 104035, Oct. 2009. 
[165] P. a. Yushkevich, J. Piven, H. C. Hazlett, R. G. Smith, S. Ho, J. C. Gee, and G. Gerig, “User-
guided 3D active contour segmentation of anatomical structures: Significantly improved 
efficiency and reliability,” Neuroimage, vol. 31, no. 3, pp. 1116–1128, 2006. 
[166] W. S. Rasband, “ImageJ,” U. S. National Institutes of Health, Bethesda, Maryland, USA. U.S. 
National Institutes of Health, Bethesda, Maryland, p. http://imagej.nih.gov/ij/, 2017. 
[167] M. M. Pike, M. Kitakaze, and E. Marban, “23Na-NMR measurements of intracellular sodium in 
intact perfused ferret hearts during ischemia and reperfusion,” Am. J. Physiol. Heart Circ. 
Physiol., vol. 259, no. 6, pp. H1767-1773, 1990. 
[168] C. Brillault-Salvat, E. Giacomini, L. Jouvensal, C. Wary, G. Bloch, and P. G. Carlier, 
“Simultaneous determination of muscle perfusion and oxygenation by interleaved NMR 
plethysmography and deoxymyoglobin spectroscopy,” NMR Biomed., vol. 10, no. 7, pp. 315–
323, 1997. 
[169] J. M. Dizon, J. S. Tauskela, D. Wise, D. Burkhoff, P. J. Cannon, and J. Katz, “Evaluation of 
triple-quantum-filtered 23Na NMR in monitoring of Intracellular Na content in the perfused rat 
heart: comparison of intra- and extracellular transverse relaxation and spectral amplitudes.,” 
Magn. Reson. Med., vol. 35, no. 3, pp. 336–45, Mar. 1996. 
[170] T. Binzoni, V. Quaresima, G. Barattelli, E. Hiltbrand, L. Gürke, F. Terrier, P. Cerretelli, and M. 
Ferrari, “Energy metabolism and interstitial fluid displacement in human gastrocnemius during 
short ischemic cycles.,” J. Appl. Physiol., vol. 85, no. 4, pp. 1244–1251, 1998. 
[171] G. Navon, H. Shinar, U. Eliav, and Y. Seo, “Multiquantum filters and order in tissues.,” NMR 
Biomed., vol. 14, no. 2, pp. 112–132, Apr. 2001. 
[172] P. M. Winter and N. Bansal, “Triple-Quantum-Filtered 23Na NMR Spectroscopy of 
Subcutaneously Implanted 9L Gliosarcoma in the Rat in the Presence of TmDOTP5−,” J. 
Magn. Reson., vol. 152, no. 1, pp. 70–78, Sep. 2001. 
[173] L. L. Ploutz-Snyder, S. Nyren, T. G. Cooper, E. J. Potchen, and R. a Meyer, “Different effects 
of exercise and edema on T2 relaxation in skeletal muscle.,” Magn. Reson. Med., vol. 37, no. 
5, pp. 676–82, May 1997. 
[174] G. Madelin and R. R. Regatte, “Biomedical applications of sodium MRI in vivo.,” J. Magn. 
Reson. Imaging, vol. 38, no. 3, pp. 511–529, Sep. 2013. 
[175] R. W. Stobbe and C. Beaulieu, “Residual quadrupole interaction in brain and its effect on 
quantitative sodium imaging,” NMR Biomed., vol. 29, no. 2, pp. 119–128, Feb. 2016. 
[176] L. Fleysher, N. Oesingmann, R. Brown, D. K. Sodickson, G. C. Wiggins, and M. Inglese, 
“Noninvasive quantification of intracellular sodium in human brain using ultrahigh-field MRI,” 
NMR Biomed., vol. 26, no. January, pp. 9–19, 2013. 
[177] S. Nielles-Vallespin, M.-A. Weber, M. Bock, A. Bongers, P. Speier, S. E. Combs, J. Wöhrle, F. 
Lehmann-Horn, M. Essig, and L. R. Schad, “3D radial projection technique with ultrashort echo 




Med., vol. 57, no. 1, pp. 74–81, Jan. 2007. 
[178] P. A. Bottomley, “Spatial localization in NMR spectroscopy in vivo.,” Ann. N. Y. Acad. Sci., vol. 
508, pp. 333–548, Jan. 1987. 
[179] A. M. Babsky, S. Topper, H. Zhang, Y. Gao, J. R. James, S. K. Hekmatyar, and N. Bansal, 
“Evaluation of extra- and intracellular apparent diffusion coefficient of sodium in rat skeletal 
muscle: Effects of prolonged ischemia,” Magn. Reson. Med., vol. 59, no. 3, pp. 485–491, Mar. 
2008. 
[180] M. I. Lindinger and G. J. Heigenhauser, “Intracellular ion content of skeletal muscle measured 
by instrumental neutron activation analysis.,” J. Appl. Physiol., vol. 63, no. 1, pp. 426–33, Jul. 
1987. 
[181] J. A. Balschi, J. A. Bittl, C. S. Springer, and J. S. Ingwall, “31P and23Na NMR spectroscopy of 
normal and ischemic rat skeletal muscle. Use of a shift reagentin vivo,” NMR Biomed., vol. 3, 
no. 2, pp. 47–58, Apr. 1990. 
[182] P. M. Walker, “Ischemia/Reperfusion Injury in Skeletal Muscle,” Ann. Vasc. Surg., vol. 5, no. 4, 
pp. 399–402, Jul. 1991. 
[183] B. Matot, G. Jouvion, A. B. Martins-Bach, C. Wary, and P. G. Carlier, “Metabolic and 
hemodynamic alterations in the mdx skeletal muscle revisited using multi-parametric functional 
NMR,” in WMS, 2012. 
[184] S. Loerakker, C. W. J. Oomens, E. Manders, T. Schakel, D. L. Bader, F. P. T. Baaijens, K. 
Nicolay, and G. J. Strijkers, “Ischemia-reperfusion injury in rat skeletal muscle assessed with 
T2-weighted and dynamic contrast-enhanced MRI,” Magn. Reson. Med., vol. 66, no. 2, pp. 
528–537, Aug. 2011. 
[185] M. Petracca, R. O. Vancea, L. Fleysher, L. E. Jonkman, N. Oesingmann, and M. Inglese, 
“Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study,” 
Brain, vol. 139, no. 3, pp. 795–806, Mar. 2016. 
[186] L. V. Gast, M. Uder, and A. M. Nagel, “In Vivo Double Quantum Filtered 23Na Imaging of 
Human Skeletal Muscle,” in ISMRM, 2017, p. 2959. 
[187] I. Hancu, J. R. C. van der Maarel, and F. E. Boada, “A Model for the Dynamics of Spins 3/2 in 
Biological Media: Signal Loss during Radiofrequency Excitation in Triple-Quantum-Filtered 
Sodium MRI,” J. Magn. Reson., vol. 147, no. 2, pp. 179–191, Dec. 2000. 
[188] A. Tsang, R. W. Stobbe, and C. Beaulieu, “In vivo double quantum filtered sodium magnetic 
resonance imaging of human brain,” Magn. Reson. Med., vol. 73, no. 2, pp. 497–504, Feb. 
2015. 
[189] J. S. Tauskela, J. M. Dizon, P. J. Cannon, and J. Katz, “Detection of an Extracellular 
Contribution from a Second-Rank Tensor to the Double-Quantum-Filtered 23Na NMR 
Spectrum in the Isolated Perfused Rat Heart,” J. Magn. Reson., vol. 108, pp. 165–169, 1995. 
[190] E. N. Marieb and K. Hoehn, Human Anatomy & Physiology, 7th ed. San Francisco, CA: 
Pearson Benjamin Cummings, 2007. 
[191] S. M. Eleff, M. D. Schnall, L. Ligetti, M. Osbakken, V. H. Subramanian, B. Chance, and J. S. 
Leigh, “Concurrent measurements of cerebral blood flow, sodium, lactate, and high-energy 
  
XXXIII 
phosphate metabolism using 19F, 23Na, 1H, and 31P nuclear magnetic resonance 
spectroscopy.,” Magn. Reson. Med., vol. 7, no. 4, pp. 412–24, Aug. 1988. 
[192] P. Linz, D. Santoro, W. Renz, J. Rieger, A. Ruehle, J. Ruff, M. Deimling, N. Rakova, D. N. 
Muller, F. C. Luft, J. Titze, and T. Niendorf, “Skin sodium measured with 23Na MRI at 7.0 T.,” 
NMR Biomed., vol. 28, no. 1, pp. 54–62, Jan. 2015. 
[193] G. Madelin, R. Kline, R. Walvick, and R. R. Regatte, “A method for estimating intracellular 
sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic 
resonance imaging,” Sci. Rep., vol. 4, pp. 1–7, Apr. 2014. 
[194] W. Lostal, M. Bartoli, N. Bourg, C. Roudaut, A. Bentaib, K. Miyake, N. Guerchet, F. 
Fougerousse, P. McNeil, and I. Richard, “Efficient recovery of dysferlin deficiency by dual 
adeno-associated vector-mediated gene transfer,” Hum. Mol. Genet., vol. 19, no. 10, pp. 1897–
1907, May 2010. 
[195] J. N. Robinson-Hamm and C. A. Gersbach, “Gene therapies that restore dystrophin expression 
for the treatment of Duchenne muscular dystrophy,” Hum. Genet., vol. 135, no. 9, pp. 1029–
1040, Sep. 2016. 
[196] S. Perrin, “Preclinical research: Make mouse studies work,” Nature, vol. 507, no. 7493, pp. 
423–425, Mar. 2014. 
[197] T. A. Partridge, “The mdx mouse model as a surrogate for Duchenne muscular dystrophy,” 
FEBS J., vol. 280, no. 17, pp. 4177–4186, Sep. 2013. 
[198] G. Bulfield, W. G. Siller, P. A. Wight, and K. J. Moore, “X chromosome-linked muscular 
dystrophy (mdx) in the mouse.,” Proc. Natl. Acad. Sci. U. S. A., vol. 81, no. 4, pp. 1189–92, 
1984. 
[199] H. H. Stedman, H. L. Sweeney, J. B. Shrager, H. C. Maguire, R. a Panettieri, B. Petrof, M. 
Narusawa, J. M. Leferovich, J. T. Sladky, and  a M. Kelly, “The mdx mouse diaphragm 
reproduces the degenerative changes of Duchenne muscular dystrophy,” Nature, vol. 352, no. 
6335, pp. 536–539, Aug. 1991. 
[200] G. B. Banks and J. S. Chamberlain, “Chapter 9 The Value of Mammalian Models for Duchenne 
Muscular Dystrophy in Developing Therapeutic Strategies,” in Current Topics in Developmental 
Biology, 1st ed., vol. 84, no. 8, Elesvier Inc., 2008, pp. 431–453. 
[201] M. a. Hornsey, S. H. Laval, R. Barresi, H. Lochmüller, and K. Bushby, “Muscular dystrophy in 
dysferlin-deficient mouse models,” Neuromuscul. Disord., vol. 23, pp. 377–387, 2013. 
[202] O. Biondi, M. Villemeur, A. Marchand, F. Chretien, N. Bourg, R. K. Gherardi, I. Richard, and F.-
J. Authier, “Dual Effects of Exercise in Dysferlinopathy,” Am. J. Pathol., vol. 182, no. 6, pp. 
2298–2309, Jun. 2013. 
[203] L. Heidt, M. Bader, S. Spuler, and V. Schoewel, “A novel mutation in DNAJB6 causes a more 
severe phenotype and greater loss of anti-aggregation function,” Neuromuscul. Disord., vol. 24, 
no. 9–10, pp. 902–903, Oct. 2014. 
[204] K. Wenzel, M. Carl, A. Perrot, J. Zabojszcza, M. Assadi, M. Ebeling, C. Geier, P. N. Robinson, 
W. Kress, K.-J. Osterziel, and S. Spuler, “Novel sequence variants in dysferlin-deficient 




Mutat., vol. 27, no. 6, pp. 599–600, Jun. 2006. 
[205] H. Gudbjartsson and S. Patz, “The rician distribution of noisy mri data,” Magn. Reson. Med., 
vol. 34, no. 6, pp. 910–914, Dec. 1995. 
[206] D. M. Bates and D. G. Watts, Eds., Nonlinear Regression Analysis and Its Applications. 
Hoboken, NJ, USA: John Wiley & Sons, Inc., 1988. 
[207] N. Nagy, R. J. Nonneman, T. Llanga, C. F. Dial, N. V. Riddick, T. Hampton, S. S. Moy, K. K. 
Lehtimäki, T. Ahtoniemi, J. Puoliväli, H. Windish, D. Albrecht, I. Richard, and M. L. Hirsch, “Hip 
region muscular dystrophy and emergence of motor deficits in dysferlin-deficient Bla/J mice,” 
Physiol. Rep., vol. 5, no. 6, p. e13173, Mar. 2017. 
[208] J. L. Thibaud, A. Monnet, D. Bertoldi, I. Barthélémy, S. Blot, and P. G. Carlier, 
“Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear 
magnetic resonance imaging,” Neuromuscul. Disord., vol. 17, no. 7, pp. 575–584, 2007. 
[209] N. Azzabou, H. Reyngoudt, F. E. Smith, H. Hilsden, A. Blamire, P. G. Carlier, and J. F. 
Consortium, “NMR imaging and 31P-NMRS of the skeletal muscle in a multi-center 
dysferlinopathy study: One-year follow-up.,” in ESMRMB, 2016, p. 428. 
[210] J. A. Roche, M. E. Tulapurkar, A. L. Mueller, N. van Rooijen, J. D. Hasday, R. M. Lovering, and 
R. J. Bloch, “Myofiber Damage Precedes Macrophage Infiltration after in Vivo Injury in 
Dysferlin-Deficient A/J Mouse Skeletal Muscle,” Am. J. Pathol., vol. 185, no. 6, pp. 1686–1698, 
Jun. 2015. 
[211] J.-L. Thibaud, N. Azzabou, I. Barthelemy, S. Fleury, L. Cabrol, S. Blot, and P. G. Carlier, 
“Comprehensive longitudinal characterization of canine muscular dystrophy by serial NMR 
imaging of GRMD dogs,” Neuromuscul. Disord., vol. 22, pp. S85–S99, Oct. 2012. 
[212] S. J. Pratt, S. Xu, R. J. Mullins, and R. M. Lovering, “Temporal changes in magnetic resonance 
imaging in the mdx mouse.,” BMC Res. Notes, vol. 6, no. 1, p. 262, 2013. 
[213] R. S. Vohra, S. Mathur, N. D. Bryant, S. C. Forbes, K. Vandenborne, and G. A. Walter, “Age-
related T2 changes in hindlimb muscles of mdx mice,” Muscle Nerve, vol. 53, no. 1, pp. 84–90, 
Jan. 2016. 
[214] S. Mathur, R. S. Vohra, S. A. Germain, S. Forbes, N. D. Bryant, K. Vandenborne, and G. A. 
Walter, “Changes in muscle T2 and tissue damage after downhill running in mdx Mice,” Muscle 
Nerve, vol. 43, no. 6, pp. 878–886, Jun. 2011. 
[215] G. Walter, L. Cordier, D. Bloy, and H. L. Sweeney, “Noninvasive monitoring of gene correction 
in dystrophic muscle,” Magn. Reson. Med., vol. 54, no. 6, pp. 1369–1376, 2005. 
[216] G. J. Kemp, D. J. Taylor, J. F. Dunn, S. P. Frostick, and G. K. Radda, “Cellular energetics of 
dystrophic muscle,” J. Neurol. Sci., vol. 116, no. 2, pp. 201–206, Jun. 1993. 
[217] J. F. Dunn, S. Frostick, G. Brown, and G. K. Radda, “Energy status of cells lacking dystrophin: 
an in vivo/in vitro study of mdx mouse skeletal muscle,” Biochim. Biophys. Acta - Mol. Basis 
Dis., vol. 1096, no. 2, pp. 115–120, Feb. 1991. 
[218] C. R. Heier, A. D. Guerron, A. Korotcov, S. Lin, H. Gordish-Dressman, S. Fricke, R. W. Sze, E. 
P. Hoffman, P. Wang, and K. Nagaraju, “Non-Invasive MRI and Spectroscopy of mdx Mice 
Reveal Temporal Changes in Dystrophic Muscle Imaging and in Energy Deficits,” PLoS One, 
  
XXXV 
vol. 9, no. 11, p. e112477, Nov. 2014. 
[219] L. S. Prince, S. K. Miller, G. M. Pohost, and G. A. Elgavish, “The longitudinal relaxation time 
(T1) of the intracellular 23Na NMR signal in the isolated perfused rat heart during hypoxia and 
reoxygenation.,” Magn. Reson. Med., vol. 23, no. 2, pp. 376–82, Feb. 1992. 
[220] V. D. Schepkin, U. Gawlick, B. D. Ross, and T. L. Chenevert, “Detection of triple quantum Na 
NMR in normal and tumored mouse brain.,” in ISMRM, 2003, vol. 11, p. 39. 
[221] J. F. Dunn, N. Bannister, G. J. Kemp, and S. J. Publicover, “Sodium is elevated in mdx 
muscles: Ionic interactions in dystrophic cells,” J. Neurol. Sci., vol. 114, no. 1, pp. 76–80, Jan. 
1993. 
[222] C. A. Pacak, G. A. Walter, G. Gaidosh, N. Bryant, M. A. Lewis, S. Germain, C. S. Mah, K. P. 
Campbell, and B. J. Byrne, “Long-term skeletal muscle protection after gene transfer in a 
mouse model of LGMD-2D,” Mol. Ther., vol. 15, no. 10, pp. 1775–1781, 2007. 
[223] A. R. Burr and J. D. Molkentin, “Genetic evidence in the mouse solidifies the calcium 
hypothesis of myofiber death in muscular dystrophy,” Cell Death Differ., vol. 22, no. 9, pp. 
1402–1412, Sep. 2015. 
[224] M. A. Griswold, P. M. Jakob, R. M. Heidemann, M. Nittka, V. Jellus, J. Wang, B. Kiefer, and A. 
Haase, “Generalized autocalibrating partially parallel acquisitions (GRAPPA),” Magn. Reson. 
Med., vol. 47, no. 6, pp. 1202–1210, Jun. 2002. 
[225] R. Umathum, M. B. Rösler, and A. M. Nagel, “In Vivo 39K MR Imaging of Human Muscle and 
Brain.,” Radiology, vol. 269, no. 2, pp. 569–76, 2013. 
[226] S. E. Anderson, C. Z. Dickinson, H. Liu, and P. M. Cala, “Effects of Na-K-2Cl cotransport 
inhibition on myocardial Na and Ca during ischemia and reperfusion,” Am J Physiol Cell 
Physiol, vol. 270, no. 2, pp. C608-618, Feb. 1996. 
[227] J. J. W. Sandstede, H. Hillenbrand, M. Beer, T. Pabst, F. Butter, W. Machann, W. Bauer, D. 
Hahn, and S. Neubauer, “Time course of 23Na signal intensity after myocardial infarction in 
humans,” Magn. Reson. Med., vol. 52, no. 3, pp. 545–51, 2004. 
[228] R. Ouwerkerk, M. a. Jacobs, K. J. MacUra, A. C. Wolff, V. Stearns, S. D. Mezban, N. F. Khouri, 
D. a. Bluemke, and P. a. Bottomley, “Elevated tissue sodium concentration in malignant breast 
lesions detected with non-invasive 23Na MRI,” Breast Cancer Res. Treat., vol. 106, pp. 151–
160, 2007. 
[229] M. Inglese, G. Madelin, N. Oesingmann, J. S. Babb, W. Wu, B. Stoeckel, J. Herbert, and G. 
Johnson, “Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 
tesla.,” Brain, vol. 133, no. Pt 3, pp. 847–57, Mar. 2010. 
[230] B. Ridley, A. M. Nagel, M. Bydder, A. Maarouf, J.-P. Stellmann, S. Gherib, J. Verneuil, P. Viout, 
M. Guye, J.-P. Ranjeva, and W. Zaaraoui, “Distribution of brain sodium long and short 
relaxation times and concentrations: a multi-echo ultra-high field 23Na MRI study,” Sci. Rep., 
vol. 8, no. 1, p. 4357, Dec. 2018. 
[231] S. D. Friedman, S. L. Poliachik, G. T. Carter, C. B. Budech, T. D. Bird, and D. W. W. Shaw, 
“The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy,” 




[232] J. Lommen, S. Konstandin, P. Krämer, and L. R. Schad, “Enhancing the quantification of tissue 
sodium content by MRI: time-efficient sodium B 1 mapping at clinical field strengths,” NMR 
Biomed., vol. 29, no. 2, pp. 129–136, Feb. 2016. 
[233] C. Mozzetta, G. Minetti, and P. L. Puri, “Regenerative pharmacology in the treatment of genetic 
diseases: The paradigm of muscular dystrophy,” Int. J. Biochem. Cell Biol., vol. 41, no. 4, pp. 
701–710, Apr. 2009. 
[234] T. S. Khurana and K. E. Davies, “Pharmacological strategies for muscular dystrophy,” Nat. 
Rev. Drug Discov., vol. 2, no. 5, pp. 379–390, May 2003. 
[235] V. Pini, J. E. Morgan, F. Muntoni, and H. C. O’Neill, “Genome Editing and Muscle Stem Cells 
as a Therapeutic Tool for Muscular Dystrophies,” Curr. Stem Cell Reports, vol. 3, no. 2, pp. 
137–148, Jun. 2017. 
[236] P. Gee, H. Xu, and A. Hotta, “Cellular Reprogramming, Genome Editing, and Alternative 
CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy,” 
Stem Cells Int., vol. 2017, no. DMD, pp. 1–11, 2017. 
[237] P. Hafner, U. Bonati, B. Erne, M. Schmid, D. Rubino, U. Pohlman, T. Peters, E. Rutz, S. Frank, 
C. Neuhaus, S. Deuster, M. Gloor, O. Bieri, A. Fischmann, M. Sinnreich, N. Gueven, and D. 
Fischer, “Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and 
Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study,” 
PLoS One, vol. 11, no. 1, p. e0147634, Jan. 2016. 
  
 
  
  
